Protein-protein interaction mapping to study the role of RNF41 in intracellular trafficking by Masschaele, Delphine
Protein-protein interaction mapping to study


























































Thesis submitted to fulfill the requirements for the





Protein-protein interaction mapping to study the 




Promotor: Prof. Dr. Jan Tavernier 
 
Thesis submitted to fulfill the requirements for the degree of Doctor in Health Sciences. 
Faculty of Medicine and Health Sciences 



















Promotor: Prof. Dr. Jan Tavernier 
Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent University, Belgium 
Center for Medical Biotechnology, VIB 
 
Chair 
Prof. Dr. Frank Speleman 
Center for Medical Genetics, Ghent University and Hospital 
Cancer Research Institute Ghent 
 
Members of the examination committee 
Prof. Dr. Sarah Gerlo 
Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent University, Belgium 
Center for Medical Biotechnology, VIB 
 
Prof. Dr. Jan Gettemans 
Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent University, Belgium 
 
Prof. Dr. Roosmarijn Vandenbroucke 
Department of Biomedical molecular biology, Faculty of Science, Ghent University, Belgium 
Center for Inflammation Research, VIB 
 
Dr. Ragna Sannerud 
Department of Neuroscience, Faculty of Medecine, KU Leuven, Belgium 
Center for Brain & Disease Research, VIB , Laboratory of Membrane Trafficking 
 
Dr. Ignace Lasters 
CTO Complix, Belgium 
 
Prof. Dr. Erich Wanker 




Table of contents 
 
List of abbreviations                                                                                                                                                1 
 
Summary                                                                                                                                                                   5 
 
Samenvatting                  6 
 
Introduction                                                                                                                                                              9 
1. Intracellular trafficking                                                                                                                                   11 
1.1. Bidirectional vesicle transport             11 
1.1.1. Coats                12 
1.1.2. Rab GTPases                            16 
1.1.3. Tethering complexes                           18 
1.1.4. SNAREs                              23 
1.2. Ubiquitination                26 
1.3. The secretory pathway                            28     
1.4. The endocytic pathway                            29 
1.4.1. Clathrin-dependent endocytosis                                                30 
1.4.2. Clathrin-independent endocytosis                               30 
1.4.3. Endocytosis and signaling                                          33 
1.5. Post-endocytic trafficking                           34 
1.5.1. Lysosomal degradation                           34 
1.5.2. Recycling                             37 
1.5.3. Retrograde transport                           38 
1.5.4. Ectodomain shedding                           39 
1.6. Autophagy                             40 
 
2. RNF41                43 
2.1. RNF41, a RING finger ubiquitin ligase            43 
2.2. Role of RNF41 in signaling             44 
2.2.1. ErbB3 signaling              44 
2.2.2. Immune signaling              45 
2.3. Role of RNF41 in apoptosis             46 
2.4. Role of RNF41 in trafficking via USP8            47 
2.5. Role of RNF41 in diseases             48 
2.5.1. ErbB3 signaling in cancer             48 
2.5.2. Dysregulation of BRUCE in cancer            50 
2.5.3. Loss of cell polarity in cancer            50 
2.5.4. Aberrant LR signaling in Prader-Willi syndrome                        50  
2.5.5. Loss of parkin in Parkinson’s disease           51 
2.5.6. Drug-mediated regulation of RNF41           52 
 
3. Detection of protein-protein interactions            54 
3.1. Binary techniques              55 
3.1.1. Yeast two-hybrid              55 
3.1.2. Protein complementation assays            56 
3.1.3. MAPPIT               57 
3.2. Co-complex techniques             58 
3.2.1. AP-MS               58 
3.2.2. BioID               58 
3.2.3. Virotrap               59 
Scope of the thesis               77 
Results                 81 
1. RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes        83 
2. A high-confidence interactome for RNF41 built on multiple orthogonal assays                   119 
3. The role of RNF41 in selective autophagy          163 
 
Discussion and future prospects            181 
Addendum                                                                                                                                                             199 
1. KISS, a mammalian two-hybrid method for in situ analysis of protein-                                        201 
protein interactions          
2. Straightforward protein-protein interaction interface mapping via                                             213 
random mutagenesis and MAPPIT  
 
Curriculum Vitae             225 
Acknowledgements             227 
 





AD: activation domain 
ADAM: a disintegrin and metalloproteinase 
AgRP: agouti-related protein 
AMPK: AMP-activated protein kinase  
AMSH: associated molecule with the SH3 
domain of STAM 
AP: adaptor protein 
AP2S1: Adaptor related Protein complex 2 
Sigma 1 subunit 
AP-MS: affinity-purification-mass 
spectrometry 
APP: amyloid precursor protein 
AR: androgen receptor 
ARE: androgen response element 
ARF: ADP ribosylation factor 
ARL: ARF-like 
ATG: autophagy-related protein 
BAR: Bin-Amphiphysin-Rvs 
BiFC: Bimolecular fluorescence 
complementation 
BioID: proximity-dependent biotin 
identification 
BIR: baculoviral IAP repeat 
BRUCE: BIR repeat containing ubiquitin-
conjugating enzyme 
C/EBPβ: CCAAT/Enhancer-binding protein β 
 
 
CATCHR: complexes associated with tethering 
containing helical rods 
CBP: calmodulin binding peptide 
CC: coiled-coil 
CCP: clathrin-coated pit 
CCV: clathrin-coated vesicles 
CDC42: Cell division control protein 42 
CHMP: charged multivesicular body protein 
CI-M6PR: cation-independent M6PR 
CLEC16A: C-type lectin domain family 16, 
member A 
CLICs: clathrin-independent carriers 
CMA: chaperone-mediated autophagy 
CME: clathrin-mediated endocytosis 
COG: conserved oligomeric Golgi complex 
COP: coat protein complex  
CORVET: class C core vacuole/endosome 
tethering 
CTxB: Cholera toxin B subunit 
CXCR4: chemokine receptor 4 
DBD: DNA binding domain 
DFCP1: Double FYVE-containing protein 1 
DHFR: dihydrofolate reductase 
DIABLO: Direct IAP-Binding protein with Low 
pI 
DOR: - opioid receptor  
DUB: deubiquitinating enzyme 
1
DVL: Dishevelled  
EARP: endosome-associated recycling protein 
ECM: extracellular matrix 
EE: early endosome 
EGFR: Epidermal growth factor receptor 
EHD: Eps15 homology domain 
EPOR: Erythropoietin receptor 
EpsinR: Epsin related protein 
ER: endoplasmic reticulum 
ERAD: ER-associated degradation 
ERC: endocytic recycling compartment 
ERGIC: ER- to- Golgi intermediate 
compartment 
ESCRT: endosomal sorting complexes required 
for transport 
FEME: fast endophilin-mediated endocytosis 
FlnA: Filamin A 
FLRF: fetal liver RING finger 
FYVE: Fab1, YOTB, Vac1 and EEA1 
GAP: GTPase Activating Protein 
GARP: Golgi-associated retrograde protein 
GBM: glioblastoma multiforme 
GDF: GDP Dissociating Factor 
GDI: GDP Dissociating Inhibitor 
GDP: guanosine 5′-diphosphate 
GEEC: GPI-anchored protein enriched 
compartment 
GEF: Guanine Nucleotide Exchange Factor 
GGA: Golgi-localized, -ear containing, ADP-
ribosylation factor-binding protein 
GLUE: GRAM-like ubiquitin-binding in EAP45 
GLUT1: glucose transporter 1 
GM-CSF: granulocyte-macrophage colony-
stimulating factor 
GPCR: G-protein coupled receptor 
GPI: glycosylphosphatidylinositol 
GRAF: GTPase regulator associated with focal 
adhesion kinase 
GTP: gua osi e 5′-triphosphate 
GTPase: guanosine 5′-triphosphatases 
HBx: hepatitis B virus encoded X protein 
HDAC6: histone deacetylase 6 
HECT: homologous to the E6AP carboxyl 
terminus 
HOPS: homotypic fusion and vacuole protein 
sorting 
HPLC: high-performance liquid 
chromatography 
HPV16: human papillomavirus 16 
HRS: hepatocyte growth factor receptor 
tyrosine kinase substrate 
HSC: hematopoietic stem cells 
HSC70: heat shock protein 70 
huORF: human open reading frame 
IAP: inhibitor of apoptosis proteins 
IFN-β: i terfero -β 
IGF-1R: insulin-like growth factor-1 receptor 
IL-2Rβ: interleukin 2 receptor β 
ILVs: intraluminal vesicles 
2
IRF3: interferon regulatory factor-3 
JAK: Janus kinase 
JIP: c-Jun N-terminal interacting kinase 
KISS: KInase Substrate Sensor 
KITENIN: KAI1 C-terminal interacting 
tetraspanin  
LAMP1: lysosomal-associated membrane 
protein 1 
LBPA: phospholipid lysobisphosphatidic acid 
LDLR: low-density lipoprotein receptor 
LE: late endosome 
LIFR: Leukaemia inhibitory factor receptor 
LPS: lipopolysaccharide 
LR: leptin receptor 
M6PR: mannose-6-phosphate receptor 
MAGEL2: melanoma antigen L2 
MALS: Multi-angle light scattering 
MaMTH: mammalian membrane two-hybrid 
MAPPIT: MAmmalian Protein-Protein 
Interaction Trap 
MHC: major histocompatibility complex 
MTC: multisubunit tethering complex 
mTORC1: mammalian target of rapamycin 
complex 1 
MVBs: multivesicular bodies 
MYTH: membrane-based Y2H 
NDN: necdin 
NPY: neuropeptide Y 
NRDP1: neuregulin receptor degradation 
protein-1 
NRZ: NAG, RINT-1, ZW10 
NSF: N-ethylmaleimide-sensitive fusion 
protein 
N-WASP: neuronal Wiskott-Aldrich syndrome 
protein 
OPTN: optineurin 
PA: phosphatidic acid 
PAK1: p21-activated kinase 1 
PAR2: protease-activated receptor 2 
PAS: pre-autophagosomal structure 
PCa: Prostate cancer  
PCA: protein complementation assay 
PH: pleckstrin homology 






PIP: phosphatidylinositol phospholipid 
PIP5K: phosphatidylinositol-4-phosphate 5-
kinase 
PKC: protein kinase C 
PLD: phospholipase D 
PM: plasma membrane 
POMC: pro-opiomelanocortin 
PPI: protein-protein interaction 
PTM: post-translational modification 
PWS: Prader-Willi syndrome 
PX: phox homology 
3
RAC1: Ras-related C3 botulinum toxin 
substrate 1 
RARα: reti oic acid receptor 
RBR: RING-between-RING 
RE: recycling endosome 
RHOA: Ras homolog gene family member A 
RING: Really Interesting New Gene 
RTK: receptor tyrosine kinase 
RTN4A: Reticulon 4A 
SEC: Size exclusion chromatography 
SILAC: stable-isotope labelling with amino 
acids in cell culture 
SM: Sec1/Munc18-like 
SMAC: second mitochondria-derived activator 
of caspases 
SNAP: soluble NSF attachment protein 
SNARE: soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor 
SNX: sorting nexin 
STAM: Signal transducing adapter molecule 
STAT: signal transducers and activators of 
transcription 
STX: syntaxin 
STxB: Shiga toxin B subunit 
SV40: simian virus 40 
TACE: TNFα co erti g e zy e 
TAP: tandem affinity purification 
TBK1: TANK-binding kinase 1 
TCR: T cell antigen receptor 
TEV: tobacco etch virus 
TfR: transferrin receptor 
TGFβR: tra sfor i g gro th factor β receptor 
TGN: trans-Golgi network 
TIP47: tail-interacting protein of 47 kD 
TLR: Toll-like receptor 
TRAPP: transport protein particle  
TSG101: Tumor susceptibility gene 101 
TYK2: tyrosine kinase 2 
Ubl: ubiquitin-like protein  
UEV: ubiquitin E2 variant 
UIM: ubiquitin-interacting motif 
ULK: Unc-51 like autophagy activating kinase 
UPL: Ubl-specific proteases 
USP8: Ubiquitin-specific protease 8 
UVRAG: UV radiation resistance associated 
gene 
VAMP: Vesicle-associated membrane protein 
VANGL: Vang-like protein  
VLPs: virus-like particles 
VPS52: vacuolar protein sorting 52 
VSV-G: vesicular stomatitis virus G 
VTI1A: Vesicle transport through interaction 
with T-SNAREs 1A 
WIPI2: WD repeat domain phosphoinositide-
interacting protein 2 
Y2H: Yeast Two-Hybrid 
Y3H: Yeast three-hybrid 
4
Summary 
Intracellular trafficking of proteins and lipids is essential for maintaining cellular homeostasis. The 
biosynthetic pathway delivers newly synthesized proteins to their final destination either inside or 
outside the cell, while the endocytic pathway controls the transport of molecules that enter the cell. 
These pathways are interconnected as they share intracellular compartments and protein machinery. 
Coat proteins, small G proteins from the RAB and ARF family, tethering complexes and SNARE 
proteins all work together to balance targeting, retention and retrieval mechanisms necessary to 
maintain a steady state within these intracellular compartments. Defects in these highly regulated 
processes often lie at the basis of pathologies such as neurodegenerative, inflammatory and 
cardiovascular diseases and several cancers. Furthermore, the trafficking machinery is often hijacked 
by viruses and bacteria to gain access into the living cells. Therefore, it is of great interest to acquire 
knowledge about intracellular transport and proteins that regulate these trafficking steps, especially 
since it also offers opportunities to be used as a delivery system for therapeutic molecules. Our lab 
previously identified RNF41 as a key regulator of basal cytokine receptor trafficking. This E3 ligase 
blocks lysosomal sorting and simultaneously enhances ectodomain shedding of JAK2-associated 
cytokine receptors such as the leptin, IL-6 and LIF receptor by ubiquitinating and destabilizing the 
deubiquitinase USP8. In this way, RNF41 indirectly destabilizes the ESCRT-0 complex which results in 
the rerouting of these cytokine receptors from the lysosomal degradation pathway towards 
compartments for ectodomain shedding. To further elucidate the role of RNF41 in intracellular 
trafficking we used a strategy where we expand the characterization of RNF41 based on the function 
of newly identified RNF41 interaction partners. An initial array MAPPIT screen led to the 
identification of VPS52 as a novel RNF41 interaction partner. VPS52 is a subunit of two distinct 
tethering complexes GARP and EARP, which are respectively involved in retrograde cargo transport 
from the endosomes to the Golgi network and cargo recycling to the plasma membrane. We show 
that RNF41 ubiquitinates and relocates VPS52 away from its subcellular location. It thereby affects 
EARP function resulting in defective transferrin recycling. We next performed additional RNF41 
screens using Virotrap, BioID and AP-MS and combined them with data from previously performed 
microarray MAPPIT and Y2H screens in order to build an RNF41 interactome network. This allowed us 
to identify highly confidential interaction partners of RNF41 and highlights its possible implication in 
certain functional clusters. As such, we reveal a role for AP2S1, the sigma subunit of the clathrin-
mediated endocytosis adaptor protein AP-2, in leptin and LIF receptor signaling and show that RNF41 
stabilizes and relocates AP2S1. Finally, further characterization of immunofluorescent detected 
RNF41-positive structures exposed a role for RNF41 in autophagy. We show that RNF41 is necessary 
to maintain the levels of the autophagy receptor p62 and phosphorylated TBK1. Additional detected 
interactions between RNF41 and autophagy related proteins Beclin1, ATG14, WIPI2 and ATG5 
indicated that RNF41 functions in autophagosome biogenesis of the selective autophagy pathway 
aggrephagy. Collectively, our findings of possible functions of RNF41 in recycling, endocytosis and 
autophagy further establish the importance of RNF41 intracellular trafficking. Moreover, RNF41 has 
been implicated in several disorders like Parki so ’s disease, cardio yopathies a d cancer, which 
resemble pathologies associated with dysfunctional intracellular trafficking. Our characterization of 
the interactions between RNF41 and proteins involved in intracellular trafficking, and the elucidation 
of how these interactions relate to these processes could therefore provide new insights for the 
development of novel therapeutics.  
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Samenvatting 
Intracellulair transport van eiwitten en vetten is essentieel voor het behoud van homeostase 
binnenin de cel. De secretorische route levert nieuw gevormde eiwitten naar hun uiteindelijke 
bestemming binnen of buiten de cel, terwijl de endocytische route het vervoer van moleculen regelt 
die binnen komen in de cel. Deze twee routes zijn gelinkt aan elkaar aangezien ze hiervoor dezelfde 
eiwitten en sommige dezelfde intracellulaire compartimenten kunnen gebruiken. Coat eiwitten, 
kleine G eiwitten van de RAB en ARF familie, tethering complexen en SNARE eiwitten werken samen 
om vesikels met een bepaalde cargo naar het juiste compartiment te sturen, terug te brengen of de 
cargo ter plaatse te houden en bewaren op deze manier het dynamisch evenwicht binnenin deze 
intracellulaire compartimenten. Afwijkingen in deze sterk gereguleerde processen liggen vaak aan de 
basis van verscheidene kankers, en van neurodegeneratieve, inflammatoire en cardiovasculaire 
ziektebeelden. Daarbovenop kunnen deze transportroutes gekaapt worden door verscheidene 
virussen en bacteriën die zo hun weg banen in de cel. Kennis over intracellulair transport en de 
eiwitten die deze stappen reguleren is daarvoor van groot belang, zeker aangezien deze ook gebruikt 
kunnen worden als toedieningsweg voor therapeutische moleculen. Onze onderzoeksgroep 
identificeerde RNF41, een E3 ligase, als een belangrijke regulator van het intracellulair transport van 
JAK2-geassocieerde type I cytokine receptoren zoals de leptine, LIF en IL-6 receptor. Via ubiquitinatie 
en redistributie van het de-ubiquitinerend enzyme USP8 zorgt RNF41 voor een indirecte 
destabilisatie van het ESCRT-0 complex. Dit leidt tot de her-oriëntatie van deze receptoren bestemd 
voor lysosomale degradatie naar cellulaire compartimenten waar ectodomain shedding plaatsvindt. 
Om de rol van RNF41 in intracellulair transport uitgebreider te bestuderen gebruikten we een 
methode waarbij we RNF41 verder karakteriseren op basis van de functie van nieuw geïdentificeerde 
RNF41 interactiepartners. Een initiële array MAPPIT screen leidde tot de identificatie van VPS52 als 
een nieuwe interactiepartner van RNF41. VPS52 is een subunit van het GARP en EARP complex, die 
respectievelijk betrokken zijn in retrograad cargo transport van endosomen naar het Golgi netwerk 
en in recyclering van cargo terug naar het plasma membraan. We tonen aan dat RNF41 ubiquitinatie 
en relocalizatie van VPS52 veroorzaakt, waarbij VPS52 op een andere locatie terecht komt in de cel 
en op deze manier leidt tot een verstoorde EARP-gemedieerde transferrine recyclering. Om het 
interactienetwerk van RNF41 verder uit te bouwen werd gebruik gemaakt van verschillende 
methodes zoals Bio-ID, Virotrap en AP-MS om bijkomstige RNF41 screens uit te voeren. Deze 
resultaten werd gecombineerd met data van reeds uitgevoerde microarray MAPPIT en Y2H screens 
om zo verder het RNF41 interactoom uit te bouwen. Dit liet ons toe om met sterke zekerheid RNF41 
interactiepartners te identificeren en een mogelijke rol van RNF41 in bepaalde functionele clusters 
op te lichten. Op deze manier ontdekten we een rol voor AP2S1, het sigma subunit van het clathrine-
gemedieerde endocytose adaptor eiwit AP-2, in leptine en LIF receptor signalering. Daarnaast 
toonden we aan dat RNF41 AP2S1 kan stabiliseren en relocalizeren. Tot slot onthulden we een rol 
voor RNF41 in autofagie via de karakterisering van de RNF41-positieve structuren gedetecteerd met 
immunofluorescentie. We toonden aan dat RNF41 belangrijk is om de niveaus van de autofagie 
receptor p62 en gefosforyleerd TBK1 te behouden. Dit, samen met gedetecteerde interacties tussen 
RNF41 en de autofagie-gerelateerde eiwitten Beclin1, ATG14, WIPI2 en ATG5, wijst erop dat RNF41 
een rol speelt in de vorming van autofagosomen betrokken in de selectieve autofagie route genaamd 
aggrefagie. Alles samen wijzen onze bevindingen op een mogelijke rol van RNF41 in recyclering, 
endocytose en autofagie, wat verder het belang van RNF41 in intracellulair transport bevestigt. 
Bovendien is RNF41 betrokken in verschillende stoornissen zoals de ziekte van Parkinson, 
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cardiomyopathie en kanker, ziektebeelden die tevens geassocieerd zijn met verstoord intracellulair 
transport. Onze karakterisering van de interacties tussen RNF41 en eiwitten betrokken in 
intracellulair transport, samen met de opheldering hoe deze interacties betrokken zijn tot de 
processen in intracellulair transport, kan mogelijks leiden tot bijkomende inzichten voor de 

























































































1. Intracellular trafficking 
 
1.1. Bidirectional vesicle transport 
What goes up, ust o e do …, si ila  to this uote ega di g the la  of g a ity, one could say 
hat goes out, ust o e a k i  to define the law of intracellular trafficking. It is essential for 
tissue and organ functioning that eukaryotic cells communicate with their environment by releasing 
lipids and proteins outside the cell and by compensatory uptake of material. This forward flow of 
cargo counterbalanced by the retrograde movement of material is executed by the secretory and 
endocytic pathways. The secretory pathway delivers newly synthesized lipids, secretory and 
membrane proteins via the ER (endoplasmic reticulum) and the Golgi complex to the cell surface, the 
extracellular space or the appropriate intracellular compartment, while the endocytic pathway 
internalizes material from the extracellular environment and cell surface and sorts cargo via the EEs 
(early endosomes) into the correct intracellular compartment. The cargo is either destined for 
degradation in the lysosomes or gets recycled back to the PM (plasma membrane) via the RE 
(recycling endosomes). Next to this, material also traffics between the different internal 
compartments that constitute the cell (Figure 1). These cellular compartments are characterized by 
distinct lipid and protein compositions, which maintain their integrity and functionality by 
bidirectional fluxes that retrieve transport machinery components and proteins back to their original 
compartment. Bidirectional traffic is defined by a tightly regulated process of vesicular transport, 
where membrane-enclosed vesicles bud from a donor compartment and fuse with an acceptor 
compartment, a process that takes only seconds. This is coordinated by a series of consecutive steps, 
where cargo selection and vesicle budding, mediated by protein coats, is followed by motor protein 
(kinesin, dynein and myosin)-driven transportation along microtubules or actin to reach their 
destination compartment. Here, vesicles interact with the target membrane with the help of 
tethering complexes and small GTPases (guanosine 5′-triphosphatases) that determine the specificity 
of vesicle targeting, resulting in membrane fusion with the aid of SNARE (soluble N-ethylmaleimide-
sensitive factor attachment protein receptor) proteins (Figure 2; [1–3]).  
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Figure 1: Overview of intracellular transport pathways. The arrows represent transport steps between the 
compartments of the secretory, endocytic and lysosomal pathways. EE (early endosome); LE (late endosome), 
RE (recycling endosome); ERC (endocytic recycling compartment); ER (endoplasmatic reticulum); ERGIC (ER-
Golgi intermediate compartment). Figure adapted from [4]. 
 
 
Figure 2: General mechanism of intracellular vesicular budding and fusion. Vesicles (transport carriers) bud from 
the donor membrane, a process mediated by small GTPases (guanosine 5′-triphosphatases) and coat proteins. 
These coat proteins are also involved in the sorting of cargo into vesicles. After scission, mediated by coats or 
accessory proteins, vesicles uncoat (note: uncoating may take place in cytosol, prior to tethering; or at the 
target membrane after tethering; or after fusion [5]) and are transported along the cytoskeleton components to 
reach the acceptor membrane. Small GTPases recruit tethering factors that assist the R (arginine)-SNAREs 
(soluble N-ethylmaleimide-sensitive factor attachment protein receptors) on vesicles to pair with specific Q 
(glutamine)-SNAREs on acceptor membrane (see 1.1.4), resulting in fusion of the vesicle with the proper 
acceptor membrane and cargo release in the acceptor compartment. Figure adapted from [2]. 
 
1.1.1 Coats 
Electron microscopy studies first identified transport vesicles surrounded by an electron-dense coat. 
These small vesicles, with a 60-100nm diameter, were located at the cell surface and in intracellular 
compartments [6]. Three types of coated vesicles have been identified so far, CCV (clathrin-coated 
vesicles), COPI (coat protein complex I) and COPII-coated vesicles (summarized in Table 1 and Figure 
3; note: all proteins described in this thesis are human, unless otherwise specified). These coat 
components are necessary for the induction of membrane curvature, the recruitment of cargo, 
vesicle budding and the final uncoating steps.  
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Figure 3: Coats involved in intracellular trafficking steps. Involvement of Clathrin (green), COPI (Coat protein 
complex I, purple) and COPII (Coat protein complex II, blue) is depicted on the figure. Clathrin coats contain 
different adaptor and accessory proteins at different locations. The roles of clathrin at plasma membrane in 
endocytosis and of COPII vesicles at ER export are well-known. Uncertainty remains about the exact function of 
clathrin at the TGN, recycling and late endosomes and secretory vesicles, and of COPI at the ERGIC (ER-to-Golgi 
intermediate compartment) and Golgi complex. EE (early endosome); LE (late endosome), RE (recycling 
endosome); ERC (endocytic recycling compartment); ER (endoplasmatic reticulum); ERGIC (ER-Golgi 
intermediate compartment). Figure adapted from [4]. 
 
CCVs bud from the PM, TGN (trans-Golgi network) and endosomes [7]. Clathrin exists as a three-
legged structure called a triskelion, composed of three heavy chains and three light chains (Figure 4). 
These clathrin triskelions polymerize into a polyhedral coat surrounding membrane vesicles [8]. The 
clathrin coat acts as a scaffold and is recruited to different membranes by specific AP (adaptor 
protein) complexes that are also responsible for cargo binding. Five different AP complexes (AP-1, -2, 
-3, -4 and -5) have been identified, of which AP-1 and AP-2 sort cargo proteins into CCVs [9]. Both AP-
1 and AP-  a e hete otet a e s, o sisti g of t o la ge su u its  a d β  i  AP- ; α a d β  i  AP-2), 
a ediu  su u it μ  i  AP- ; μ  i  AP-  a d a s all su u it σ  i  AP- ; σ  i  AP-2). AP-1 is 
located at the TGN and endosomes, and mediates bidirectional transport between these organelles, 
while AP-2, located at the PM, plays a role in clathrin-dependent endocytosis (Figure 4, [10,11]). GGA 
(Golgi-lo alized, -ear containing, ADP-ribosylation factor-binding proteins) and HRS (hepatocyte 
growth factor receptor tyrosine kinase substrate) are two alternative clathrin adaptors that also 
function in clathrin-mediated vesicle budding. The monomeric GGA adaptor regulates the sorting of 
cargo from the TGN to endosomes and lysosomes, sometimes simultaneously with AP-1 [12], 
whereas dimeric HRS sorts ubiquitinated cargo from the EEs to the LEs (late endosomes) [13]. Both 
AP-1 and GGAs are recruited to membranes via the RAS superfamily of ARF (ADP ribosylation factor) 
small GTPases (Figure 4). The ARFs regulate the assembly and disassembly of the coats by 
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respectively switching between an active (GTP gua osi e ′-triphosphate) bound) and inactive (GDP 
(gua osi e ′-diphosphate) bound) state. Conversely, AP-2 and HRS directly interact with 
phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) and phosphatidylinositol (3)-phosphate (PI(3)P) 
present in the cell membrane [14,15].  
COPI and COPII can be considered as multisubunit protein complexes, where the COPI coatomer is a 
complex of seven proteins divided into two subcomplexes, the F-su o ple : β, , , ζ a d the B-
su o ple : α, β′, . These COPI coat components have sequence homology to the clathrin AP-2 and 
AP-2 adaptor proteins [14]. COPI vesicles traffic from the Golgi to the ER and between Golgi cisternae 
and are, similar to the clathrin adaptors AP-1 and GGAs, recruited to membranes via ARF1. On the 
other hand, COPII coats are composed of four proteins that form the SEC13-SEC31 and SEC23-SEC24 
subcomplexes, of which the latter is responsible for cargo recruitment. COPII vesicular traffic from 
the ER to the Golgi and COPII membrane recruitment depend on the ARF-related protein SAR1 
(Figure 4).  
 
Figure 4: Schematic representation of the different coat proteins. A and B: Clathrin triskelion with CHC (clathrin 
heavy chain) and CLC (clathrin light chain) interacts with the appendage domain of the β1 or β2 subunit of 
adaptor protein AP-1 or AP-2. C: Clathri  i tera ts with the hi ge a d GAE -adaptin ear) domains of the GGA 
(for Golgi-lo alized, -ear-containing, ADP-ribosylation factor-binding protein) adaptor protein. D: Clathrin 
interacts with a clathrin-box motif in HRS (hepatocycte growth factor-regulated tyrosine kinase substrate). E: 
Structure of the COPI (coat protein complex I) coat protein, the structure of the F-su o ple  β, , , ζ  is ased 
on the model of AP-1 and -2 because of the homology of their subunits, while the arrangement of the B-
subcomplex (α, β′, ) has not been elucidated yet. F: Structure of the COPII (coat protein complex II) coat 
protein. The small G proteins ARF1 and SAR1 are shown next to the coat proteins that they regulate. GAT (GGAs 
and TOM1 (target of Myb 1)); VHS (VPS27, HRS and STAM); UIMs (ubiquitin- interacting motifs); FYVE (FAB1, 
YOTB, VAC1 and EEA1). Figure adapted from [14].  
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COPI, COPII and the clathrin adaptors recognize different motifs present in the cytosolic domain of 
transmembrane cargo proteins. AP-1 and AP-2 adaptors bind the acidic dileucine motif [D/E]XXXL[L/I] 
and the tyrosine- ased otif  Y φ (where φ indicates a hydrophobic residue) [16]. GGAs bind to 
cargo proteins with a DXXLL motif, while HRS directly interacts with ubiquitinated cargo via its UIM 
(ubiquitin-interacting motif) domain. COPI-coated vesicles capture proteins carrying the "KKXX", 
"KXKXX" or "FFXXRRXX" motif and COPII-coated vesicles recognize the di-acidic motif DXE [2,17,18].  
After coat formation, vesicles bud by scission of the neck, thereby detaching the forming vesicle from 
the donor membrane. For COPI and COPII coated vesicles this process is induced by coat 
polymerization, whereas CCVs depend on the action of amphiphysin that recruits the GTPase 
dynamin followed by endophilin to induce membrane deformation and scission. In the final 
uncoating step, the coat components are released prior to membrane fusion, although recent data 
suggest that coats appear to be involved in the tethering step, and thus may remain attached much 
longer than previously assumed [5]. These cytosolic coat proteins are then recycled for the next 
round of vesicle budding. Also here, the uncoating mechanisms for COPI and COPII coats differs from 
CCVs. For COPI and COPII this requires GTP hydrolysis of ARF1 and SAR1 respectively, while the 
ATPase HSC70 (heat shock protein 70) and auxilin work together to drive clathrin coat disassembly 
[10,14,17].  
Table 1: Overview of the different coat proteins and their properties.  
Coats Subunits Recruitment to 
membrane via 
GTPase 
Location Function Motif 
Clathrin-AP-1  , β1, μ1, σ1  ARF1  (via  and 
β1 subunit)  
TGN/endosomes bidirectional 
sorting of proteins 
between TGN and 
endosomes 
the σ1 subunit 
recognizes the 
"[DE]XXXL[LI]" 
motif and the µ1 
subunit 
recognizes the 
Yxxφ  motif 
present in cargo 
Clathrin-AP-2 α, β , μ , σ  PI(4,5)P2 (via α 
and μ2 subunit) 
plasma 
membrane 




the σ2 subunit 
recognizes the 
"[DE]XXXL[LI]" 




present in cargo 
Clathrin-GGA GGA ARF1 (via GAT 
domain) 
TGN/endosomes sorting of proteins 





"DXXLL" motif in 
present in cargo 
Clathrin-HRS HRS PI(3)P (via FYVE 
domain) 
endosomes sorting of proteins 







β, , , ζ; B-
subcomplex: 
α, β′,             
ARF  ia  
subunit) 
Golgi/ER sorting of proteins 
from the Golgi to 
the ER and 
between Golgi 
cisternae 













ER sorting of proteins 
from the ER to the 
Golgi  
SEC24 recognizes 
the "DXE" motif 
present in cargo 
AP-1/2 (adaptor protein-1/2); ARF1 (ADP ribosylation factor 1); PI(4,5)P2 (phosphatidylinositol (4,5)-
bisphosphate); PI(3)P (phosphatidylinositol (3)-phosphate); GGA (Golgi-localized, -ear-containing, ADP-
ribosylation factor-binding protein); HRS (hepatocycte growth factor-regulated tyrosine kinase substrate); ER 
(endoplasmic reticulum); TGN (trans-Golgi network); COPI/II (coat protein complex I/II); GAT (GGAs and TOM1 
(target of Myb 1)); VHS (VPS27, HRS and STAM); FYVE (FAB1, YOTB, VAC1 and EEA1);UIMs (ubiquitin- 
interacting motifs). Table adapted from [14,17].  
1.1.2 RAB GTPases 
RAB proteins are small (21–25 kDa) GTPases that belong to the RAS superfamily. Approximately 70 
RAB proteins have been identified in humans, of which nearly 50 are involved in intracellular 
trafficking [19]. These RAB GTPases have been implicated in the regulation of vesicle formation, 
transportation along the cytoskeleton, docking and fusion through the recruitment of effector 
proteins. The importance of RABs is reflected by various diseases such as to Charcot-Marie-Tooth 
Type 2B and Carpenter syndrome [20,21], due to mutations in RAB proteins, while altered expression 
of RAB genes is associated with diseases su h as a e  a d Alzhei e s disease [22,23]. RAB 
proteins function as molecular switches, and cycle between the cytosolic GDP-bound inactive and 
membrane-anchored GTP-bound active form. The cytosolic inactive RABs bind to GDI (GDP 
Dissociating Inhibitors) and membrane binding depends on the GDF (GDP Dissociating Factor) that 
catalyzes the dissociation of GDI from RAB proteins, allowing insertion into the membrane. Here, 
GEFs (Guanine Nucleotide Exchange Factors) catalyze GDP dissociation, allowing GTP binding and 
activation of RABs, resulting in their interaction with different effectors. RABs are converted back to 
their inactive GDP-bound state by GTP hydrolysis, mediated by GAPs (GTPase Activating Proteins). 
These inactive RABs are then removed from the membrane by GDI, reforming the cytosolic RAB-GDI 
complex [24,25]. Reversible membrane association of RABs is achieved by the attachment of a 
geranylgeranyl (20-C) group, rendering the protein hydrophobic ([26], Figure 5).  
 
Figure 5: RAB GTPase (gua osi e 5′-triphosphatase) cycle. Cytosolic inactive GDP (gua osi e 5′-diphosphate)-
bound RABs are associated with GDI (GDP Dissociating Inhibitor). GDF (GDP Dissociating Factor) mediates the 
displacement of GDI, allowing GDP-RABs to insert into the membrane via its geranylgeranyl group (pink). GEFs 
(Guanine Nucleotide Exchange Factors) catalyze the exchange of GDP for GTP (guanosine 5′-triphosphate), 
resulting in RAB activation and interaction with its effector. GAPs (GTPase Activating Proteins) convert the 
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active GTP-bound RABs back to the GDP-bound inactive form via GTP hydrolysis, thereby releasing Pi (inorganic 
phosphate). The inactive RABs are removed from the membrane by GDI that maintains GDP-RABs in the 
cytoplasm ready for the next cycle. Figure adapted from [25].  
RAB proteins localize to the membranes of transport vesicles and other membrane bound organelles 
from where they control a specific trafficking step. Since RAB proteins accumulate at these distinct 
compartments, they are often used as markers for different organelles [27] and discrimination 
between endosomes is based on the different RAB populations and lipid composition of the 
membrane. Each step in intracellular trafficking is mediated by a different RAB protein, although 
some RABs can act at multiple stages of the secretory and endocytic pathway. The most generic RABs 
relevant to this thesis are described below and their function and effectors are listed in Table 2 and 
depicted in Figure 6 [19,24,28,29]. RAB5, the EE marker regulates traffic from the PM to the EE [30] 
whereas the LE marker RAB7 is involved in early-to-late endosome and LE to Golgi transport [31]. 
RAB4 and RAB11 are typically involved in recycling, where RAB4 mediates fast recycling from EEs to 
the PM, while RAB11 regulates slow recycling through the REs [32–34]. RAB9, located on LE mediates 
traffic towards the TGN [35], while RAB14, found at both TGN and EE, controls EE to Golgi transport 
[36]. Conversely, Golgi-localized RAB6 regulates Golgi to endosome transport [37], and additionally, 
RAB6 also functions in the secretory pathway by mediating intra-Golgi transport [38]. Similarly, next 
to the RE, RAB11 also associates with the Golgi and regulates transport from EEs to the TGN [39] and 
from the TGN to the PM [40]. In this way, RAB11 connects the endocytic and secretory pathway. 
Moreover, RAB11, in addition to RAB35 and RAB27, has been shown to play a role in exosome 
biogenesis and secretion. Other important secretory RABs are the ER-localized RAB1 and RAB2 that 
regulate ER to Golgi transport [41].   
 
Figure 6: Location and function of RAB GTPases relevant for this thesis. For details regarding function, we refer 
to Table 2 and text. EE (early endosome); LE (late endosome), RE (recycling endosome); ERC (endocytic recycling 
compartment); ER (endoplasmatic reticulum); ERGIC (ER-Golgi intermediate compartment). Figure adapted 
from [25,28].  
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Table 2: Overview of the most typical RABs involved in intracellular trafficking. 
RABs Location Trafficking function Effectors 
RAB1 ER/Golgi ER–Golgi transport p115 (tethering factor) 
RAB2 ER/Golgi ER–Golgi transport p115 and Golgin45 (coiled-coil Golgi protein) 
RAB4 EE recycling EE to PM Rabaptin-4/Rabaptin-5 (required for protein 
sorting and recycling) 
RAB5 EE, CCV endocytosis and EE fusion EEA1 and CORVET (tethering factors)/ p150 
and VPS34 (PI3K class III subunits) 
RAB6 Golgi intra-Golgi transport; Golgi to 
PM, endosomes and ER 
transport 
VPS52 (subunit of tethering factor GARP) 
RAB7 LE EE-LE transport; LE-Golgi 
transport 
HOPS (tethering factor)/ VPS35 (retromer 
subunit) 
RAB8 TGN secretory vesicle transport to 
PM 
exocyst (tethering factor) 
RAB9 LE LE-Golgi transport TIP47 (Cargo adaptor, involved in sorting CI-
M6PR to TGN) 
RAB11 TGN/RE recycling RE to PM; EE-TGN and 
TGN-PM transport; exosome 
secretion 
Myosin 5B (motor protein); RAB11-FIPs 
(family interacting proteins; facilitate vesicle 
recycling) 
RAB14 EE/Golgi trafficking between Golgi and 
EE 
KIF16B (motor protein) 
RAB22 EE/TGN; RE EE-TGN transport; recycling RE 
to PM 
EEA1  
RAB27 LE, lysosome LE/lysosome to PM transport; 
exosome secretion 
granuphilin-a/b and exophilin-5 (involved in 
exosome secretion) 
RAB35 EE recycling EE to PM; exosome 
secretion 
FSCN1 (fascin homolog 1, actin-bundling 
protein) 
EE (early endosome); LE (late endosome), RE (recycling endosome); ERC (endocytic recycling compartment); ER 
(endoplasmatic reticulum); PM (plasma membrane); CCV (clathrin-coated vesicles); CORVET (class C core 
vacuole/endosome tethering); HOPS (homotypic fusion and vacuole protein sorting); TIP47 (tail-interacting 
protein of 47 kD). Table adapted from [19,24,29]. 
1.1.3 Tethering complexes 
Tethering factors are extended proteins or protein complexes that function in the initial docking or 
idgi g  of t a spo t esi les to the ta get e a e p io  to fusio . This is a o plished  
recognizing and binding specific determinants on these vesicles. Vesicle tethering is a highly 
regulated process involving interaction with RABs, SNAREs and coat proteins. These interactions also 
specify the location of tethering factors, where they can act alone or with other tethering factors in 
one trafficking event or participate in more events. Loss of tethering factors often results in a block 
of membrane transport and impaired organization and identity of compartments pointing to their 
role as essential mediators of intracellular transport [42]. Tethering factors can be divided in two, 
highly conserved classes: the long coiled-coil proteins and the MTCs (multisubunit tethering 
complexes). The coiled-coil tethers are large hydrophilic homodimeric proteins comprising two 
globular heads connected by a long coiled-coil domain. These large tethers can form a bridge over a 
distance of up to 200nm [43]. Coiled-coil tethers such as p115, p230, GM130, GCC88 and GCC185 are 
mostly present at the Golgi, although some, like EEA1, are present at endosomes (overview in Table 
3). The MTCs can be subdivided into CATCHR (complexes associated with tethering containing helical 
rods) and non-CATCHR complexes, based on their structural and sequence similarities. The COG 
(conserved oligomeric Golgi complex), NRZ (NAG, RINT-1, ZW10); DslI in yeast), GARP (Golgi-
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associated retrograde protein), EARP (endosome-associated recycling protein) and the exocyst 
complex belong to the CATCHR family, while TRAPPI (transport protein particle I), TRAPPII, TRAPIII, 
HOPS (homotypic fusion and vacuole protein sorting) and CORVET (class C core vacuole/endosome 
tethering) make up the non-CATCHR family [4] (overview in Table 3 and Figure 7 and 8). Each 
member of the MTC consists of 3 to 10 subunits, resulting in an overall molecular weight of 250 to 
800kDa. In contrast to the coiled-coil tethers, these MTCs can only bridge over a distance of up to 
30nm [43]. Accordingly, coiled-coil tethers are considered to play a role in the initial, highly dynamic 
stages of tethering due to their ability to form transient, reversible and low-affinity interactions [44]. 
Conversely, MTCs that capture targets at short distances, possibly interact simultaneously with 
different transport components through their multiple subunits, and could therefore couple vesicular 
tethering, docking and fusion events. The discovery that the coiled-coil p115 tether directly interacts 
with the COG complex suggested that coiled-coil tethers and MTCs likely cooperate during these 
steps [45].  
 
 
Figure 7: Schematic overview of the subcellular location of the different tethering complexes. Coiled-coil tethers 
are indicated in yellow, multisubunit tethering complexes of the CATCHR (complexes associated with tethering 
containing helical rods) family in green, and of the non-CATCHR family in blue. For details regarding function, 
we refer to Table 3 and text. EE (early endosome); LE (late endosome); RE (recycling endosome); ERC (endocytic 
recycling compartment); ER (endoplasmatic reticulum); ERGIC (ER-Golgi intermediate compartment); CORVET 
(class C core vacuole/endosome tethering); HOPS (homotypic fusion and vacuole protein sorting); COG 
(conserved oligomeric Golgi complex); NRZ (NAG, RINT-1, ZW10), GARP (Golgi-associated retrograde protein), 
EARP (endosome-associated recycling protein); TRAPP (transport protein particle). Figure adapted from [4,42].  
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Figure 8: Schematic representation of coiled-coil tethers and multisubunit tethering complexes of the CATCHR 
(complexes associated with tethering containing helical rods) and non-CATCHR family. The coiled-coil tethers 
consist of a long coiled-coil domain that associate with the Golgi membrane through interactions with other 
Golgi-localized proteins via two globular heads (e.g. p230, GCC185, GCC85, Golgin97), or through carboxy-
terminal transmembrane domains (e.g. Giantin and CASP). CATCHR family tethering factors: eight subunits of 
the COG (conserved oligomeric Golgi complex) complex are organized in two structurally and functionally 
distinct lobes (green and purple). The GARP (Golgi-associated retrograde protein) and EARP (endosome-
associated recycling protein) complexes share VPS51, VPS52 and VPS53 (green), while VPS54 and syndetin 
(purple) are specific for the GARP and EARP complex respectively. The Exocyst subunits SEC3 and EXO70 (purple) 
interact with the plasma membrane, while SEC15 (green) interacts with the vesicle through vesicle-localized 
RAB8. Non-CATCHR family tethering factors: VPS33, VPS16, VPS18 and VPS11 (blue) are the common subunits 
of the HOPS (homotypic fusion and vacuole protein sorting) and CORVET (class C core vacuole/endosome 
tethering) complex, while VPS41 and VPS39 (orange) represent HOPS specific subunits, and VPS8 and VPS3 
(orange) CORVET specific subunits. The core subunits of the TRAPP (transport protein particle) complexes 
(TRAPPC1-6) are indicated in blue, and the TRAPPII (C9, C10, C13) and TRAPPIII (C8, C12) specific subunits are 
indicated in orange. For more details about the function we refer to Table 4 and text. Figure adapted from 
[42,46,47].  
 
As previously mentioned, tethering factors are RAB effectors, and activated GTP-bound RABs 
facilitate the recruitment of tethers to specific locations. The exocyst complex consisting of SEC3, 
SEC5, SEC6, SEC8, SEC10, SEC15, EXO70 and EXO84 mediates the transport of secretory vesicles from 
the TGN and RE to the PM. It binds to the RAB GTPase RAB8 on secretory vesicles via its subunit 
SEC15, and to the Rho GTPases RHOA (Ras homolog gene family member A), RAC1 (Ras-related C3 
botulinum toxin substrate 1) and CDC42 (Cell division control protein 42) at the PM via SEC3 [48–50]. 
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The RAB1 effector COG consists of 8 subunits, COG1-8, and acts as a tether for intra-Golgi transport 
next to regulating retrograde transport from endosomes to Golgi [51]. VPS51, 52, 53 and VPS54 
compose the GARP complex, which is recruited by RAB6 through its VPS52 interaction and functions 
in retrograde traffic from the endosomes to the TGN [37,52]. The GARP subunit VPS54 is replaced by 
Syndetin to form another complex called EARP. Although VPS52 is a mutual subunit of both the GARP 
and EARP complex, there is no evidence that RAB6 recruits the EARP complex, moreover, the EARP 
complex was shown to colocalize with RAB4, RAB5 and RAB11, making these possible candidates for 
EARP recruitment [53]. HOPS and CORVET were respectively shown to be RAB7 and RAB5 effectors. 
HOPS regulates the endolysosomal pathway, while CORVET functions upstream of HOPS and 
mediates TGN to EE transport. HOPS and CORVET share four subunits, VPS11, VPS16, VPS18 and 
VPS33. The other subunits (VPS39 and 41 for HOPS and VPS3 and 8 for CORVET) are responsible for 
changing the RAB-interacting specificity from RAB7 (HOPS) to RAB5 (CORVET) [54]. In certain cases, 
tethering factors can function both as an effector and activator of RAB proteins. This is the case for 
the HOPS complex, where VPS39 functions as GEF and promotes RAB7-GDP to RAB7-GTP conversion 
[55]. TRAPPI and TRAPPII were also identified as GEFs, where the shared subunits TRAPPC1, 
TRAPPC3, TRAPPC4 and TRAPPC5 are necessary for RAB1 GEF activity [56–58]. Two additional 
subunits (TRAPPC2 and TRAPPC6) further compose TRAPPI, which functions as a tether in ER to Golgi 
transport, while five additional subunits (TRAPPC2, TRAPPC6, TRAPPC13, TRAPPC9 and TRAPPC10) 
are found in the TRAPPII complex that mediates intra-Golgi transport and endosome to Golgi 
transport [4,59,60].  
As stated before, vesicles can retain protein coats at least through the initiation of tethering since 
many tethers were found to interact with coat proteins. COG3 of the COG complex and the coiled 
oil tethe  p  sho ed spe ifi  i te a tio s ith the β COPI su u it [61,62], while the TRAPPC10 
su u it of TRAPPII i te a ted ith the  COPI su u it [58]. The ER-localized NRZ/DslI complex 
regulates the retrograde transport of COPI vesicles from the Golgi to the ER. In yeast, the Dsl1 
su u it i te a ts ith oth the α a d  COPI su u it [63], while the mammalian Dls1 homolog, 
ZW10, lacks this binding site and additionally requires UVRAG1 (UV radiation resistance associated 
gene 1) for this COPI interaction [64,65]. Furthermore, the TRAPPI tether directly binds to SEC23 of 
COPII vesicles via its TRAPPC3 subunit [56,66].  
Tethering factors further couple the process of vesicle recognition to the process of membrane 
fusion by physically interacting with SNAREs. Moreover, some tethers, like p115 are able to induce 
SNARE-mediated membrane fusion by promoting SNARE complex formation. p115 couples COPI 
vesicles to the Golgi membrane by sequentially linking GM130 to Giantin, followed the induction of 
GOSR1-STX5 (syntaxin 5) SNARE complex assembly [67]. The GARP complex also directly interacts 
with a SNARE protein. The VPS51 subunit binds to the N-terminal Habc domain of the STX6 (Tlg1p in 
yeast) SNARE present on the Golgi membrane. It has been suggested that this VPS51 interaction 
results in the release of the autoinhibition caused by closed conformation, where the N-terminal 
domain interacts with the C-terminal SNARE motif of STX6 (see 1.1.4; [52,68]). The HOPS complex has 
also been shown to interact with the SNARE STX8 (Vam7 in yeast) and as such plays a role in initiating 
SNARE complex assembly [69]. Furthermore, COG and NRZ complexes interact with intra-Golgi 
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GM130 / Golgi involved in p115-
dependent tethering 
RAB1 STX5 COPI 
Giantin / Golgi involved in p115-
dependent tethering 
RAB1 STX5 COPI 
CASP / Golgi retrograde transport in 
Golgi 
? ? ? 
GMAP210 / Golgi intra-Golgi trafficking ARF1 ? ? 
GCC185 / TGN Endosome-TGN 
transport 
RAB9 ? ? 





p230 / TGN anterograde transport 
from TGN 
ARL1/3 ? ? 
Golgin97 / TGN anterograde transport 
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fusion at EE 
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endosome functions upstream of 
HOPS, endosome fusion; 
TGN-EE transport 
RAB5 ? ? 
COPI/II (coat protein complex I/II); MTC (multisubunit tethering complex); CATCHR (complexes associated with 
tethering containing helical rods); EE (early endosome); RE (recycling endosome); ERC (endocytic recycling 
compartment); ER (endoplasmatic reticulum); CORVET (class C core vacuole/endosome tethering); HOPS 
(homotypic fusion and vacuole protein sorting); COG (conserved oligomeric Golgi complex); NRZ (NAG, RINT-1, 
ZW10), GARP (Golgi-associated retrograde protein), EARP (endosome-associated recycling protein); ARF (ADP 
ribosylation factor); ARL (ARF-like); RHOA (Ras homolog gene family member A); RAC1 (Ras-related C3 
botulinum toxin substrate 1); CDC42 (Cell division control protein 42); TRAPP (transport protein particle); VTI1B 
(Vesicle transport through interaction with T-SNAREs 1B); STX (syntaxin); VAMP (Vesicle-associated membrane 
protein); AP-3 (adaptor protein-3). Table Adapted from [5,42,43].  
1.1.4 SNAREs 
Membrane fusion requires the interaction between SNARE proteins associated with the two 
opposing membranes. Originally, SNAREs were classified as v-(vesicle) or t-(target membrane) 
SNAREs, based on their subcellular localization [72]. However, this classification is confusing when 
homotypic fusion between two organelle membranes or vesicles takes place and many SNAREs are 
found on both vesicles and target membranes. Therefore, a new nomenclature was introduced 
depending on a single key residue that is either arginine (R-SNAREs) or glutamine (Q-SNAREs) [73]. 
Membrane fusion usually requires four SNAREs and this complex generally consist of one R-SNARE 
and three Q-SNAREs. The R-SNARE often originates from the vesicle, while the Q-SNAREs are mostly 
present on the target organelle [74]. The SNAREs assemble into a trans-SNARE complex, also called 
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SNAREpin, which bridges the two opposing membranes resulting in membrane fusion. A single 
SNARE can be assembled into more than one trans-SNARE complex and can regulate multiple fusion 
events, also, several SNARE complexes can be formed but not all will functionally drive membrane 
fusion [75].  
SNAREs typically contain an evolutionary conserved 60 to 70 amino acid SNARE motif which consists 
of heptad repeats that have the ability to form coiled-coils (Figure 9). This motif allows assembly into 
a tight four-helix bundle in the trans-SNARE complex and is connected by a short linker to a 
hydrophobic transmembrane domain at its C-terminus. Of the 38 identified SNAREs in humans, seven 
(SNAP-23, SNAP-25, SNAP-29, SNAP47, STX9/19, STX11 and YKT6) do not contain this 
transmembrane domain and instead associate with membranes via different lipid modifications such 
as palmitoylation and prenylation [47]. In contrast to the conserved SNARE motifs, SNAREs contain 
different types of independently folded N-terminal domains [76]. Some SNAREs have an N-terminal 
Habc domain that reversibly associates with the SNARE motif on the same SNARE thereby forming a 
closed conformation and preventing the SNARE from assembling into the SNARE complex [77].  
These N-terminal regions can also interact with SM (SEC1/Munc18-like) proteins, a small family of 
soluble proteins essential for fusion [78]. SM proteins stimulate specific SNARE pairing and 
considerably accelerate the rate of SNARE-mediated fusion [79,80]. Next to SM proteins, tethering 
factors also influence trans-SNARE complex formation. Their ability to interact with both SNAREs and 
SM proteins through their different subunits, either simultaneously or sequentially contributes to the 
spatial and temporal regulation of trans-SNARE assembly and to its stability [47,67,81]. The tethering 
factors GARP and COG, both involved in endosome to TGN transport, were found to regulate the 
assembly of the same SNARE complex: STX6-STX16-VTI1A (Vesicle transport through interaction with 
T-SNAREs 1A)-VAMP4 (Vesicle-associated membrane protein 4) (see Figure 10; [52,82–84]). It is 
currently unclear why these and other tethers have overlapping functions. Binding affinity between 
tethers and SNAREs or PTMs (post-translational modifications) might additionally influence and 
regulate SNARE assembly [47].  
 
Figure 9: Schematic presentation of different SNAREs (soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor). Most SNAREs contain one SNARE motif, while SNAP-23, SNAP-25, SNAP-29 and SNAP-47 
contain two SNARE motifs. These latter SNAREs, together with STX (syntaxin) 9/19, STX11 and YKT6, also lack a 
C-terminal TM (transmembrane domain), but associate with membranes via palmitoylation and/or prenylation. 
Many SNAREs contain an N-terminal regulatory region comprising a Habc domain, with or without a short N-
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terminal peptide that can interact with SM (SEC1/Munc18-like) proteins. VAMP4 (Vesicle-associated membrane 
protein 4) contains an N-terminal motif that can interact with the TGN. VTI1A/B (Vesicle transport through 
interaction with T-SNAREs 1A/B). Figure adapted from [47].  
 
Figure 10: Overview of known mammalian SNARE complexes in intracellular trafficking. R (arginine)-SNAREs 
(soluble N-ethylmaleimide-sensitive factor attachment protein receptors) are indicated in red, Q (glutamine)-
SNAREs in purple. EE (early endosome); LE (late endosome); RE (recycling endosome); ERC (endocytic recycling 
compartment); ER (endoplasmatic reticulum); ERGIC (ER-Golgi intermediate compartment); STX (syntaxin); 
VAMP (Vesicle-associated membrane protein). Figure adapted from [47].  
 
SNARE assembly is an ordered process of continuous coiling that starts at the N-terminus of the 
SNARE otif a d p o eeds i  a zippe -like  fashio  to a ds their C-terminal membrane anchors. In 
this way the SNAREs form a tight, stable four-helix bundle which attaches the membranes together 
thereby generating energy to initiate fusion [85]. Tightening of the rigid linkers between the 
transmembrane domain and SNARE motifs transmits enough energy onto the membranes to 
overcome the repulsive electrostatic forces between them, which further bends the membranes and 
disrupts the lipid bilayer thereby forming a fusion stalk. This is followed by hemifusion, a state where 
the lipids of the proximal membrane leaflets interact, and eventually leads to the breakdown of the 
distal membrane leaflets, resulting the opening of the fusion pore (see Figure 11, [86,87]).  Although 
othe  fusio  odels e ist, this stalk h pothesis  as e pe i e tall  e ified and is the most 
generally assumed model [88]. Finally, after fusion, SNARE complexes convert from a trans- to a cis- 
configuration, where all the SNAREs in the complex reside together in the resulting fused membrane. 
This cis-SNARE complex is disassembled by the actions of the ATPase NSF (N-ethylmaleimide-
sensitive fusion protein) and its cofactor SNAP (soluble NSF attachment protein), resulting in the 
recycling of SNAREs for subsequent rounds of fusion [72]. 
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Figure 11: Schematic representation of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor) assembly and stalk hypothesis. The vesicular R (arginine)-SNARE interacts with three Q (glutamine)-
SNAREs on the acceptor membrane through the N-terminal end of the SNARE motifs, forming a four-helical 
trans-complex. This trans-complex progresses from a loose state, where only the N-terminal portions of the 
SNARE otifs are zipped up , i to a tight state, where the zipping process towards the C-terminal membrane 
anchors is almost completed. This tightening transmits energy onto the membranes resulting in disruption of 
the outer membrane lipid bilayer thereby forming a fusion stalk. This is known as hemifusion, a state in which 
the outer membrane leaflets are already continuous, but no connection has formed. Hemifusion proceeds with 
interaction of the lipids from the inner membrane leaflet thereby disrupting them, resulting in the opening of a 
fusion pore. During fusion the trans-complex relaxes into a cis-configuration. These cis-complexes are 
disassembled by NSF (N-ethylmaleimide-sensitive fusion protein) and SNAP (soluble NSF attachment protein) 
proteins. Figure adapted from [88].  
 
1.2 Ubiquitination 
Correct intracellular sorting of proteins also depends on ubiquitination, one of the most common 
PTMs. Direct ubiquitination, interaction with sorting factors that contain ubiquitin binding domains 
or deubiquitinating events regulate the itineraries of cargo and affect their localization, trafficking 
and abundance. Ubiquitin is a highly conserved 76 amino acid protein, ha a te ized  a o e β-
grasp fold consisting of two α-heli es a d fi e β-sheets i  a ββαββαβ a a ge e t. It is ubiquitously 
expressed in all eukaryotes and attaches covalently to a target protein during ubiquitination. 
Ubiquitination is a three-step process involving the actions of an activating (E1), conjugating (E2) and 
ligating (E3) enzyme (see Figure 12). During the initial step, ubiquitin is activated by the E1 enzyme in 
an ATP-dependent manner, resulting in a thioester bond between the C-terminal glycine of ubiquitin 
and the active site cysteine residue in the E1. Secondly, ubiquitin is transferred from the E1 to the 
cysteine residue of an E2 enzyme via a trans(thio)esterification reaction. Finally, an E3 ligase 
mediates the transfer of ubiquitin from the charged E2 to a lysine residue in the substrate resulting in 
an isopeptide bond between the carboxyl-terminal glycine in ubiquitin and the -amino group of 
lysine residues in the substrate [89]. To date, there are only few E1 enzymes identified in humans 
compared to the amount of E2 enzymes (~40) and E3 ligases (>600) of which the latter and largest 
group provides substrate specificity in the ubiquitination process [90]. E3 ligases can be classified in 
three types depending on the presence of characteristic domains and on the mechanism of ubiquitin 
transfer to the substrate proteins. The HECT (homologous to the E6AP carboxyl terminus) E3 ligases 
contain the HECT domain and catalyze ubiquitin transfer to the substrate protein in a two-step 
process. They first couple ubiquitin onto the catalytic cysteine in their HECT domain followed by 
26
transfer to the substrate [91]. The RBR (RING-between-RING) E3 ligases similarly mediate ubiquitin 
transfer through this two-step reaction [92]. A third group, the RING (Really Interesting New Gene) 
E3 ligases comprise the largest family of E3 enzymes and have a characteristic RING domain that 
mediates the direct transfer of ubiquitin to the substrate. These E3 ligases thus act as a scaffold, 
binding both the E2 enzyme and the substrate protein [93].  
 
Figure 12: The ubiquitination cascade. The glycine residue at the C-terminus of ubiquitin is adenylated by E1, 
followed by attack of a cysteine side chain in E1, resulting in an E1-ubiquitin thioester intermediate. The 
activated ubiquitin is subsequently transferred to a cysteine residue in the active site of an E2 via a 
trans(thio)esterification reaction. Finally, an E3 ubiquitin ligase catalyzes the transfer of ubiquitin to the target 
substrate. RING E3s simultaneously bind the Ubl-E2 thioester complex and the substrate, and mediate the 
transfer of ubiquitin directly from the E2 to the lysine on the substrate. HECT E3s first transfer ubiquitin to a 
catalytic cysteine in the HECT E3 via trans(thio)esterification, followed by the transfer of the ubiquitin to the 
lysine on the substrate. The RBR E3s function like the HECT E3s and bind the Ubl-E2 thioester complex via their 
RING domain, followed by transfer of ubiquitin to a catalytic cysteine in their RING2 domain before transfer to 
the substate. In a last step, DUBs can remove ubiquitin from the substrate, thereby enabling recycling of 
ubiquitin. Figure adapted from [94].  
Substrates can undergo monoubiquitination or polyubiquitination at one or more lysine residues. 
Ubiquitin itself has seven lysine residues (K6, K11, K27, K29, K33, K48 and K63), and all of these, also 
including the amino-terminal methionine of ubiquitin, can be used to assemble polyubiquitin chains 
of variable lengths [95]. Different chain linkages can lead to different functional outcomes. The most 
common are K48- and K63-polyubiquitin chains, with well characterized cellular functions. K48-
linkages typically lead to proteasomal degradation, while K63 chains play a role in cell signaling, 
endocytosis and DNA damage repair [96]. The third most abundant linkage type, K11 chains, 
regulates both degradative and non-degradative pathways and has been implicated in different 
signaling pathways [97]. Not much is known for the other linkage types.  
The formation of poly-ubiquitin chains can occur on the same lysine residue (homotypic chain 
linkages) or it can be a combination of different lysine linkages, resulting in mixed or branched 
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structures (heterotypic chain linkages). Next to this, ubiquitin itself can also undergo PTMs like 
phosphorylation, acetylation and SUMOylation, which further contributes to the complexity of the 
ubiquitin code and the fate of the different substrates [98–100]. Moreover, ubiquitin can be removed 
from substrates through the action of roughly 90 identified DUBs (deubiquitinating enzymes), which 
strictly control the ubiquitination process [101]. Altogether, ubiquitin constitutes a sorting tag which 
has extensive functions in the regulation of protein degradation, the ERAD (ER-associated 
degradation) pathway, DNA repair, endocytosis, apoptosis and autophagy (see 1.6; [90,100]).  
Additionally, the u i uiti  β-grasp fold was found to be conserved in other proteins called Ubls 
(ubiquitin-like proteins), although they share little sequence identity [102]. These Ubls, including 
SUMO, NEDD8, ISG15, ATG8 (autophagy-related protein 8), ATG12, FUB1, FAT10, URM1, and UFM1, 
modify proteins by using a cascade reaction similar to that of the ubiquitin conjugation system. E1, 
E2 and E3 enzymes specific to each Ubl are utilized to covalent link the Ubl to a lysine in its substrate. 
Next to this, the Ubls also require isopeptidases, or UPLs (Ubl-specific proteases), that have a dual 
function. One the one hand they process Ubl precursors by removing the C-terminal residues thereby 
exposing the Gly-Gly motif necessary for conjugation. On the other hand, analogous to DUBs for 
ubiquitin, they remove Ubls from their modified targets [94]. The Ubl-modified proteins are involved 
in cellular functions such as DNA replication and repair, intracellular trafficking, cell cycle 
progression, immune response, autophagy and apoptosis [103]. 
 
1.3 The secretory pathway  
As mentioned before, the biosynthetic secretory pathway transports soluble and transmembrane 
proteins and lipids through a series of organelles and delivers them to their proper destination, 
either in or outside the cell. Soluble proteins can be secreted in a constitutive manner or in a 
regulated way, upon different neural or hormonal stimuli. The secretory organelles, consisting of the 
rough ER, ER exit sites, ERGIC (ER- to Golgi intermediate compartment) and the Golgi complex each 
have a distinct organization and structure and provide a proper environment for protein folding and 
protein modification, which includes the addition of sugars and lipids [104–106]. Proteins require an 
ER signal sequence, generally at the N-terminus, to enter the ER during or after translation. Here, 
proteins are subjected to quality control by molecular chaperones that ensure proper folding and 
assembly [107]. Misfolded and excess proteins are ubiquitinated and targeted to the ERAD pathway 
that delivers the ubiquitinated proteins via retrotranslocation back to the cytosol resulting in 
proteasomal degradation [108]. Properly folded proteins are packaged in COPII-coated vesicles and 
leave the ER at the ER exit sites followed by transportation to the cis Golgi cisternae. The Golgi 
complex is defined by cis-, medial- and trans-cisternae, each containing different protein-modifying 
enzymes. To date, there are three different models explaining cargo movement between these Golgi 
cisternae and future experiments are needed to reach a consensus. The vesicular transport model 
stated that COPI-coated vesicles bud from a donor compartment and fuse with an acceptor 
compartment. In this way they are involved in the anterograde and retrograde transport of cargo and 
resident proteins (glycosylation enzymes), respectively, between the Golgi cisternae. In contrast, the 
cisternal maturation model suggests that the Golgi is a dynamic organelle in which Golgi cisternae 
mature with the cargo inside by fusing with retrograde vesicles coming from more mature cisternae 
and by producing retrograde vesicles that fuse with younger cisternae. The cargo progresses as a 
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result of maturation of an earlier compartment into a later one. Finally, the rapid partitioning model 
assumes that the Golgi cisternae are continuous, in which cargo as well as resident proteins and 
lipids travel bidirectionally between the different cisternae [109,110]. In the last step of the secretory 
pathway, the secretory vesicles, usually CCVs, detach from the trans-Golgi and fuse with the PM, EE 
or LE to deliver their proteins and lipid cargo.  
The cells can also secrete proteins via other, unconventional pathways involving vesicles such as 
apoptotic bodies (50-500nm), released by cells undergoing apoptosis; microvesicles (>100nm) 
budding directly from the plasma membrane and exosomes (~30-100nm), derived from the 
intraluminal vesicles in the LE. Although both contain miRNA and mRNA, microvesicles and exosomes 
vary in their protein composition, morphology and density ([111,112]; exosomes are further 
discussed in 1.5.1).  
 
1.4 The endocytic pathway 
Cells internalize macromolecules and membrane proteins such as receptors, channels and 
transporters from the PM during endocytosis. In this way, endocytosis regulates many processes 
ranging from nutrient uptake, antigen presentation, receptor signaling and downregulation, to 
fundamental cellular programs including polarization, migration, differentiation, adhesion and 
mitosis [113]. On the downside, many pathogens and toxins hijack the endocytic pathway to gain 
access into the cell [114,115]. Next to the well-known clathrin dependent endocytic pathway, many 
other clathrin-independent routes exist including the caveolae-dependent, ARF6-dependent, Flotillin-
dependent, CLIC/GEEC (clathrin-independent carriers/GPI-anchored protein enriched 
compartments), IL Rβ (interleuki   e epto  β) and FEME (fast endophilin-mediated endocytosis) 




Figure 13: Schematic representation of the different endocytotic pathways. Different coat proteins or actin 
filaments that mediate membrane deformation are indicated on the scheme. Clathrin, caveolae, IL2Rβ 
(i terleuki  2 re eptor β) endocytosis and FEME (fast endophilin mediated-endocytosis) depend on dynamin. 
Cargo delivered via the clathrin-dependent, caveolae-dependent, ARF6 (ADP ribosylation factor 6)-dependent, 
Flotillin-dependent, CLIC/GEEC (clathrin-independent carriers/GPI-anchored protein enriched compartment), 
IL2Rβ, FEME pathwa  a d a ropi o tosis are se d to the early endosomes. Phagocytosed cargo is delivered 
to the lysosomes. AP-2 (adaptor protein-2 ;   o o  hai . Figure adapted from [116–118].  
 
1.4.1 Clathrin-dependent endocytosis  
CME (clathrin-mediated endocytosis) is the best characterized endocytic pathway. In this pathway, 
adaptor protein AP-2 is recruited to the PI(4,5)P2 enriched regions of the PM with the help of other 
scaffolding proteins such as FCHO, EPS15 and intersectin, and selects cargo by recognizing distinct 
sorting signals present in their cytoplasmic tail [119]. AP-2 simultaneously binds cargo and clathrin, 
thereby coupling cargo capture with clathrin coat assembly [119–121]. The clathrin triskelions 
polymerize into hexagons and pentagons to form the clathrin coat around the growing pit. 
Maturation of the resulting CCP (clathrin coated pit) is driven by clathrin polymerization and other 
BAR (Bin-Amphiphysin-Rvs) domain-containing proteins such as amphiphysin, endophilin, and sorting 
nexin 9, which are known to generate membrane curvature [122]. These latter proteins subsequently 
recruit dynamin resulting in membrane scission and release of the CCV into the cell, followed by 
HSC70- and auxilin-mediated uncoating and fusion with the EE (see 1.1.1; [123,124]). Next to AP-2, 
other cargo-specific adaptors such as β-arrestin, AP180, epsin, HIP1 and NUMB are involved in CME. 
These adaptors recognize alternative motifs, including ubiquitinated and phosphorylated cargo, and 
are able to bind AP-2 and as such recruit different receptors to the AP-2 hub [124,125]. This diversity 
of adaptor proteins reflects the broad range of cargo such as RTKs (receptor tyrosine kinases), GPCR 
(G-protein coupled receptors), LDLR (low-density lipoprotein receptor) and the TfR (transferrin 
receptor) undergoing CME. There seems to be a redundancy in the sorting of cargo in CCP/CCV, as in 
the absence of one adaptor, other adaptors with lower-affinity interaction for the cargo are able to 
recruit the CME machinery. CCV have been shown to contain more than one type of cargo, however, 
it is not clear whether sorting of cargo already occurs in CCV or in sorting endosomes. Since multiple 
receptors are endocytosed in the same cell, it is possible that the specific adaptor proteins 
recognizing different motifs are responsible for clustering cargo into distinct CCP/CCV, ensuring 
cargo-dependent vesicle trafficking towards their appropriate intracellular destination [123].  
1.4.2 Clathrin-independent endocytosis 
Next to CME, several other clathrin-independent endocytic pathways exist, involving different 
protein machinery. Caveolae-mediated endocytosis is the second best studied endocytic pathway, in 
which caveolae represent specialized lipid rafts, enriched in cholesterol and sphingolipids that form 
flask- or omega-shaped invaginations of the PM [126]. Similarly to CME, dynamin is required to pinch 
off caveolae. The main structural component of caveolae is caveolin-1, a small integral membrane 
protein capable of binding cholesterol and fatty acids. Caveolin-1 assembles with cavins, which are 
cytosolic coat proteins, to form caveolae [127]. As caveolin-1 binds fatty acids, it is able to 
endocytose GPI (glycosylphosphatidylinositol)-linked proteins, glycosphingolipid GM1 together with 
its ligand CTxB (Cholera toxin B subunit) and ganglioside receptors for SV40 (simian virus 40) virions 
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[128–130]. Several kinases and phosphatases have been shown to regulate caveolae-dependent 
endocytosis, but the specific coordination is still unclear. In addition to its role in endocytosis, 
caveolae regulate lipid metabolism and play a role in sensing cell surface tension. Furthermore, 
caveolae may act as signaling platforms since many signaling proteins have been found to associate 
with and were regulated by caveolae [131].  
Another dynamin-dependent, cholesterol sensitive endocytic pathway is the IL- Rβ i te leuki   
e epto  β  route [132]. IL2 activates a PI(3,4,5)P3 signaling cascade that in turn sequentially 
activates the GTPases RHOA and RAC1 [133]. The downstream RAC1 target PAK1 (p21-activated 
kinase 1) subsequently phosphorylates cortactin and promotes its interaction with N-WASP 
(neuronal Wiskott-Aldrich syndrome protein) which assemble into a complex that mediates actin 
polymerization during endocytosis [134]. Next to the IL-2R, this pathway also internalizes several 
other receptor complexes that contain the common cytokine receptor gamma chain via these small 
non-coated invaginations [135]. 
Besides caveolin-dependent endocytosis, GPI-linked proteins are also endocytosed via a dynamin-
independent route which is mediated by non-coated tubulovesicular carriers called CLICs (clathrin-
independent carriers). These CLICs are directly derived from the PM and mature into tubular early 
endocytic compartments called GEECs (GPI-anchored protein enriched compartments). Apart from 
GPI-linked proteins, this CLIC/GEEC pathway also accommodates the endocytosis of CTxB as well as 
the constitutive uptake of bulk fluid and membrane [123,136]. The CLIC/GEEC pathway is controlled 
by the cholesterol-sensitive GTPase CDC42. Cycling between the GTP-bound active and GDP-bound 
inactive state of CDC42 is required for the recruitment of the actin polymerization machinery. The 
regulation of CDC42 itself is achieved by the concerted actions of the GTPases ARF1 and two GAPs, 
GRAF1 and GRAF2 [137–139].  
An alternate dynamin-independent pathway relying on the cycling state of a GTPase is the ARF6-
dependent endocytic pathway [140]. A wide variety of cargo have been identified for this pathway 
including GLUT1 (glucose transporter 1), MHC (major histocompatibility complex) I and II proteins, 
and GPI-anchored proteins CD55 and CD59 [141–144]. ARF6 activates PIP5K (phosphatidylinositol-4-
phosphate 5-kinase) to produce PI(4,5)P2, thereby stimulating actin polymerization. In most cases, 
activated ARF6 is not required for endocytosis but instead regulates the recycling from this pathway 
through the activation of PLD (phospholipase D) which generates PA (phosphatidic acid) [145–147]. 
Since CME also requires PI(4,5)P2, ARF6 can also affect CME [148]. The ARF6-dependent and 
CLIC/GEEC pathways seem to internalize similar cargo and although they are considered as separate 
pathways, it is possible that these entry routes share a similar mechanism, but this however, remains 
uncertain [117,123]. 
Flotillin proteins are found in distinct membrane microdomains and their homology to caveolin1 
implies an analogous manner of PM lipid ordering to that found in caveolae [149]. This flotillin-
dependent endocytic pathway represents another dynamin-independent route that internalizes 
CTxB, GPI-linked CD59 and cell surface proteoglycans [149–151]. Flotillin can act as a pathway 
upstream of CLIC/GEEC as it was also found to be concentrated in the membranes of early CLIC/GEEC 
intermediates [139].  
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In contrast to the small-scale endocytic processes, macropinocytosis and phagocytosis represent two 
large-scale clathrin-independent internalization routes, where the former is responsible for fluid 
uptake and the latter internalizes large particles. These pathways are triggered by and dependent on 
actin-mediated remodeling of the PM. Macrophages, monocytes and neutrophils are well-known 
phagocytic cells that depend on small GTPases for the uptake of particles. CDC42, RHOA and RAC1 
are necessary to form extensions around the particle and recruit N-WASP and actin to further induce 
phagocytosis [152]. Amphiphysin 1, a BAR domain containing protein usually associated with CME, 
also appears to be important for phagocytosis [153]. On the other hand, macropinocytosis requires 
the kinase PAK1 to bind and activate the GTPase RAC1. Next to this, macropinoctosis also depends on 
the actions of PI3K (Phosphatidylinositol-3-kinase), SRC and RAS [154–156]. Cortactin and dynamin 
together with several kinases and adhesion molecules are implied in the formation of membrane 
ruffles giving rise to macropinosomes and evidence shows that the EGF receptor can also be 
internalized via this pathway [157,158]. 
Since CME is relatively slow in internalizing proteins, the cell is in need of some fast endocytic 
pathways to respond to certain physiological stimuli. Next to macropinocytosis, FEME represents a 
process that rapidly removes receptors and proteins from the cell surface in a not-constitutively 
active way. In the FEME pathway, the BAR-containing protein endophilin mediates membrane 
deformation. The resulting tubulovesicular structures lack clathrin, but depend on dynamin and actin 
polymerization to induce membrane scission. FEME further relies on Rac and Rho GTPases, and the 
PI3K and PAK1 kinases [159]. Endophilin directly or indirectly associates with many activated GPCRs 
and RTKs leading to their rapid internalization, also Shiga and Cholera toxins were found to hijack this 
pathway [160].  
 
Table 4: Overview of the different endocytic pathways. 
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FEME tubulovesicular;  
< 1µm 
endophilin yes RHOA, RAC1 RTKs, GPCRs, 
toxins 
actin, PI3K 
IL2Rβ i terleuki  2 re eptor β ; CLIC/GEEC (clathrin-independent carriers/GPI-anchored protein enriched 
compartments); ARF6 (ADP ribosylation factor 6); FEME (fast endophilin-mediated endocytosis); RTKs (receptor 
tyrosine kinases); GPRC (G-protein coupled receptor); TfR (transferrin receptor); LDLR (low-density lipoprotein 
receptor); AP-2 (adaptor protein-2); CTxB (Cholera toxin B subunit); SV40 (simian virus 40); GPI 
(glycos lphosphatid li ositol ; TGFβR tra sfor i g growth fa tor β re eptor ; IGF-1R (insulin-like growth 
factor-1 receptor); N-WASP (neural Wiskott-Aldrich syndrome protein); RAC1 (Ras-related C3 botulinum toxin 
substrate 1); RHOA (Ras homolog gene family member A); GRAF1/2 (GTPase regulator associated with focal 
adhesion kinase-1/2); MHC I/II (major histocompatibility complex I/II); GLUT1 (glucose transporter 1); PI3K 
(phosphatidylinositol-3-kinase); PKC (protein kinase C); IL-2Rβ i terleuki  2 re eptor β ;   o o  hai ; 
HDAC6 (histone deacetylase 6). CDC42 (Cell division control protein 42). Table adapted from [113,123].  
 
1.4.3 Endocytosis and signaling 
 
Endocytosis regulates signaling by internalizing and trafficking receptors and their associated 
signaling molecules. Vice versa, the activation of receptors or downstream effectors can also 
stimulate receptor endocytosis. Endocytosis controls the number of receptors at the PM available for 
activation and limits the signaling intensities. Moreover, it also regulates the fate of signaling 
molecules by routing them towards degradation or recycling pathways. Signaling however is not 
confined to the PM, and endocytosis can contribute actively to signaling. During this endocytic 
transport, cargo can undergo several PTMs, including (de)-phosphorylation and ubiquitination, which 
can influence the signaling cascade [161]. Afte  i te alizatio , a go s each the EEs which serve as 
key sorting stations. These endosomes also function as signaling platforms that regulate signaling 
complexes containing receptors, signaling enzymes and effectors in a spatial and temporal manner 
[162,163]. CME and clathrin-independent endocytosis can directly control the biological outcome of 
signaling. This is exemplified by the EGFR where CME is associated with receptor recycling and 
sustains signaling while clathrin-independent endocytosis leads to receptor degradation and signal 
termination [164]. In addition, EGFR signaling is tightly regulated by the concentration of ligand to 
avoid overstimulation. The EGFR is primarily internalized via CME at low doses of EGF, which results 
in the recycling of internalized receptors back to the PM to maintain MAPK/ERK signaling necessary 
for cell proliferation. High doses of EGF trigger EGFR internalization by fast clathrin-independent 
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pathways which rapidly remove EGFR from the PM and routes them towards the lysosomes for 
degradation. This protects the cell from excessive EGFR signaling and anti-apoptotic responses which 
are generally observed during tumorigeneses [165].    
1.5 Post-endocytic trafficking 
As previously mentioned, after internalization cargo enters the EEs where they are sorted towards 
the lysosomes for degradation, sent to the TGN via retrograde transport or recycled back to the PM. 
Cargo traffic and sorting is achieved through a tight spatial and temporal control of early, late and 
recycling endosomes which all display a unique identity depending on their luminal pH, PIP 
(phosphatidylinositol phospholipid) composition and RAB GTPase content. However, these 
endosomes represent a dynamic network in which molecules and cargoes are actively exchanged 
[118]. Endosomes are enriched in specific PIPs, which originate from phosphatidylinositol, 
synthesized in the ER and subsequently delivered to the endosomal compartments. Different lipid 
kinases and phosphatases regulate the reversible (de-)phosphorylation at the 3, 4 and 5 position of 
the inositol ring [166]. During trafficking, proteins containing FVFE and PX (phox homology) domains 
primarily bind PI(3)P (phosphatidylinositol (3)-phosphate) present on EEs and ILVs (intraluminal 
vesicles), while proteins with a PH (pleckstrin homology) domain interacts with either PI(4)P, 
PI(4,5)P2, PI(3,4)P2 or PI(3,4,5)P3 [167]. PIPs can recruit activators and inactivators of RAB proteins 
and conversely, PIP kinases and phosphatases have been found to be RAB effectors. In this way, PIPs 
and RABs closely coordinate membrane identity [19,168].  
1.5.1 Lysosomal degradation 
As EEs mature into LEs, their lumens acidify through the actions of a v-type vacuolar H+ ATPase 
which functions as a proton pump [169]. The acidification of EEs, LEs and lysosomes is important for 
receptor-ligand uncoupling, lysosomal enzyme activity and transport [170]. The switch from EE to LE 
is also driven by the conversion from RAB5 and PI(3)P to RAB7 and PI(3,5)P2 [171]. This is 
accompanied by the replacement of the tethering complex CORVET by HOPS along with the 
concomitant SNARE proteins further determining membrane fusion specificity [172]. Activated 
signaling receptors and other proteins destined for degradation are sorted into ILVs (intraluminal 
vesicles), which protrude from the limiting (inner) membrane from endosomes towards the lumen. 
Vacuolar regions containing ILVs detach, or mature, from the EEs and form MVBs (multivesicular 
bodies) that eventually fuse with the LEs. The term MVBs is under debate, since some refer to this as 
transport intermediates between EEs and LEs, while others consider MVBs to be an alternative name 
for LEs [173]. These LEs function as a second sorting station in the endosomal system. When these 
LEs fuse with lysosomes they target their cargo for degradation, next to this, LE that fuse with the PM 
result in the release of ILVs as exosomes (see below, [174]). Moreover, certain cargo like the M6PR 
(mannose-6-phosphate receptor) undergoes retrograde traffic from the LE back to the TGN [175].  
The ESCRT (endosomal sorting complexes required for transport) machinery forms a key mediator for 
ILV biogenesis and cargo sorting into ILVs. This highly conserved ESCRT machinery comprises five 
protein complexes; ESCRT-0, -I, -II, -III and the VPS4 ATPase complex, that are sequentially recruited 
to the membrane (see Figure 14 and Table 5 for ESCRT complexes and their subunits). The sorting of 
K63-linked polyubiquitinated cargo into ILVs is initiated by PI(3)P, which is generated by the RAB5 
effector VPS34, a PI(3)K [176]. The FYVE domain containing HRS subunit of the ESCRT-0 complex is 
hereby recruited to the EE and binds ubiquitinated cargo. The other ESCRT-0 subunit STAM (Signal 
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transducing adapter molecule), as well as ESCRT-I subunits TSG101 (Tumor susceptibility gene 101) 
and ESCRT-II subunit EAP45 also interact with ubiquitinated cargo via their respective ubiquitin 
binding domains. Next, ESCRT-0 recruits ESCRT-I, which further aids the cargo sorting process and 
delivers them to the ESCRT-II complex. ESCRT-I together with ESCRT-II is capable of inducing 
membranes to bud into the lumen and stabilize the bud neck of the growing vesicle. The EAP20 
subunit of ESCRT-II interacts with the CHMP6 (charged multivesicular body protein 6) subunit of 
ESCRT-III and converts it into an active nucleator for ESCRT-III assembly on endosomes. The CHMP4 
subunit of ESCRT-III then forms multimeric filaments organized in spirals that bend the endosomal 
membrane away from the cytoplasm to form invaginated buds. The ESCRT-III complex further 
recruits the DUBs USP8 (Ubiquitin-specific protease 8) and AMSH (associated molecule with the SH3 
domain of STAM), which remove ubiquitin from the cargoes present in the ILVs. Finally, the VPS4 
ATPase complex binds and unfolds the ESCRT-III complex which eventually results in ILV budding 
[177–180]. Additionally, The ESCRT machinery is known to have other functions, ranging from HIV 
viral budding and autophagy to cytokinesis [181–183].  
 
Figure 14: Schematic representation of the ESCRT (endosomal sorting complexes required for transport) 
machinery involved in ILV (intraluminal vesicle) biogenesis and cargo sorting. The ESCRT-0 subunit HRS 
(hepatocyte growth factor receptor tyrosine kinase substrate) is recruited to the endosomal membrane via its 
PI(3)P-binding FYVE (FAB1, YOTB, VAC1 and EEA1) domain. Polyubiquitinated cargo is recognized by the UIM 
(ubiquitin-interacting motif) domains of HRS and STAM (signal transducing adapter molecule), the second 
ESCRT-0 subunit. ESCRT-0 recruits ESCRT-I, where TSG101 (Tumor susceptibility gene 101) is also capable of 
interacting with ubiquitinated cargo via its UEV (ubiquitin E2 variant) domain. Next, the cargo is delivered to the 
ESCRT-II complex, where the EAP45 subunit interacts with both PI(3)P and ubiquitin via its GLUE (GRAM-like 
ubiquitin-binding in EAP45) domain. The ESCRT-III complex orchestrates the last steps in the ILV biogenesis. 
ESCRT-III is recruited via its CHMP6 (charged multivesicular body protein 6) subunit by EAP20, which further 
activates and initiates ESCRT-III filament assembly by recruiting CHMP4. Together with CHMP1, 2, 3 and 5, 
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CHMP4 forms membrane-bound filament spirals around the invagination. The ESCRT-III complex also recruits 
DUBs, like USP8 and AMSH, which deubiquitinate cargo prior to fission and budding. Ultimately, the ESCRT-III 
complex is disassembled by the VPS4 ATPase complex which also drives membrane constriction and fission. Ub 
(ubiquitin). Figure adapted from [178].  
In contrast to their physical properties and ultrastructure, the molecular distinction between LEs and 
lysosomes is not clearly delineated. Almost all proteins, including the main membrane constituents 
LAMP1 (lysosomal-associated membrane protein 1) and LAMP2, are present in both LEs as in 
lysosomes [171]. LBPA (phospholipid lysobisphosphatidic acid) however, is a specific LE phospholipid 
and has the intrinsic capacity to deform membranes. Together with the ESCRT-associated protein 
ALIX, LBPA plays a role during ILV formation within LEs [184–186]. Furthermore, evidence shows that 
LEs and lysosomes also function as signaling organelles. For instance, membrane contacts between 
MVB and the ER allows the ER-resident phosphatase PTB1B to dephosphorylate activated EGFR 
(epidermal growth factor receptor) present in the MVB, and promotes sequestration of EGFR onto 
the ILVs [187]. Additionally, cholesterol, an essential lipid that plays important roles in membrane 
composition and other cellular processes such as steroidogenesis and signal transduction, reaches 
the LEs and lysosomes via the endocytosed LDL receptor.  Here, it is released after cholesterylester 
hydrolysis and is further transported to the PM, ER and mitochondria to fulfill its function [188]. 
Cholesterol also activates mTORC1 (mammalian target of rapamycin complex 1), present on LE and 
lysosomes [189]. mTORC1 is a key regulator of cell growth, metabolism and autophagy by functioning 
as a sensor for nutrients, energy and stress signals (see 1.6; [190]).  
As mentioned above, LEs can either fuse with the lysosome for degradation or with the plasma 
membrane to release exosomes into the extracellular space. Exosomes are secreted in a constitutive 
or stimulus-dependent way, by various cell types such as hematopoietic, epithelial, neural and tumor 
cells [111]. As such they mediate intercellular communication in several biological processes which is 
accomplished through different mechanisms of interaction with their target cells. Exosomes can 
directly interact with receptors on these target cells thereby activating intracellular signaling 
pathways. Next to this, exosomes can fuse with the plasma membrane and deliver their content into 
the cytosol, or they are fully internalized via endocytic pathways [191]. Exosomes generally contain 
proteins and lipids involved in ILV biogenesis (ALIX, LBPA, TSG101), membrane transport and fusion 
(RAB GTPase, SNAREs, annexins, and flotillins) and proteins associated with lipid microdomains 
(integrins and tetraspanins) [111]. Next to this, many exosomes contain MHC I and II molecules 
thereby modulating the immune response. Exosomes derived from pathogen-infected or tumor cells 
can act as antigen presenting vesicles and activate T-cells when the MHC peptide directly interacts 
with its cognate T-cell receptor. On the other hand, exosomes can be engulfed and processed by 
antigen presenting cells and as such result in T-cell activation [111]. Additionally, exosomes are 
involved in the pathology of neurodegenerative diseases as the  a  a go su h as Aβ, α-synuclein, 
tau and prions [192]. Most interesting, exosomes also contain mRNA and miRNA, which were found 
to have a tumor promoting effect [193,194]. These exosomal miRNAs can be used as non-invasive 
diagnostic biomarkers as they differ in amount and composition between healthy and sick 
individuals, and are stably present in body fluids such as blood, urine, saliva and cerebrospinal fluid. 
Moreover, exosomes have distinct surface proteins that reflect their tissue or cell origin. Next to this, 
exosomes can be exploited as drug delivery vectors to transfer exogenous miRNAs into cells for gene 
therapy since they are composed of cell membranes and hold great promise to cross the blood-brain 
barrier [195].  
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Table 5: Overview ESCRT complex. 
Complex Subunits Function 
ESCRT-0 HRS, STAM1/2 Cargo recognition 
ESCRT-I TSG101, VPS37A/B/C/D, MVB12A/B, VPS28 Upstream adaptor 
ESCRT-II EAP45, EAP30, EAP20  Bridging adaptor 
ESCRT-III CHMP1A/B , CHMP2A/B, CHMP3, CHMP4A/B/C, 
CHMP5, CHMP6 
Membrane remodelling/filament 
VPS4 ATPase VPS4A/B, VTA1 Membrane remodelling/ATPase 
ALIX / Interacts with ESCRT-I and ESCRT-III. 
Involved in ILV biogenesis.  
ESCRT (endosomal sorting complexes required for transport); HRS (hepatocyte growth factor receptor tyrosine 
kinase substrate); STAM (signal transducing adapter molecule); TSG101 (Tumor susceptibility gene 101); VPS 
(vacuolar protein sorting); CHMP (charged multivesicular body protein); ILV (intraluminal vesicle). 
1.5.2 Recycling  
The recycling pathway is crucial for maintaining cell homeostasis and returns unbound receptors, 
which underwent low pH-mediated ligand dissociation, back to the cell surface. Cargo can undergo 
recycling to the PM by a direct route from the EEs, also called fast recycling, or through a slow, 
indirect route via the REs. Recycling thereby plays a role in various processes such as cytokinesis, cell 
adhesion and morphogenesis, cell fusion and polarity [196]. The TfR and LDL receptor respectively 
carrying iron and cholesterol are often seen as classic recycling cargo internalized via CDE that 
undergo constitutive recycling back to the cell surface, while other cargo, such as signaling receptors, 
often require specific cytoplasmic sequences for recognition and sorting into REs. The recycling 
process is mediated by RAB and ARF GTPases and their effectors together with EHD (EPS15 homology 
domain) proteins which are involved in scaffolding, membrane tubulating and fission processes. The 
fast recycling route carries cargo such as the TfR and glycosphingolipids back to the PM. This pathway 
is mediated by RAB4 and RAB35 [32,34]. The slow recycling route traffics cargo from the EE via the 
ERC (endocytic recycling compartment), from which REs emerge, to the PM. The ERC is a collection of 
tubular organelles, emanating from the EEs that is often localized centrally, near the microtubule 
organizing center and Golgi complex and is molecularly characterized by the presence of RAB11 
and/or EHD1 [147,196,197]. There are several recycling pathways from the ERC back to the cell 
surface, all mediated by RAB11. This was seen via the TfR which, next to undergoing fast recycling, 
was found to be recycled back via RE that were different from tubular RE carrying clathrin-
independent endocytosed cargo back to the PM. This latter pathway was additionally found to 
depend on RAB22 as well as ARF6 and actin [198]. As mentioned above (see 1.4.2), ARF6 activates 
PLD present on the RE and PIP5K thereby respectively generating PA and PI(4,5)P2. Both products are 
important for recycling functions and recruit several proteins involved in vesicle formation, fusion 
and actin polymerization [145,146,199]. ARF6 also promotes recycling of cargo by interacting with 
and recruiting the exocyst complex [200], and regulates the direction of transport along microtubules 
by interacting with and controlling JIP (c-Jun N-terminal interacting kinase) 3 and JIP4 binding to 
motor proteins kinesin and dynein [201]. REs are also implicated in TLR4 and Delta-Notch signaling 
events. RAB11 was found to be involved in recruiting TLR4 from the ERC to phagosomes thereby 
controlling IRF3 (interferon regulatory factor-3) activation and IFN-β i te fe o -β  p odu tio  [202]. 
RAB11-positive REs also recycle activated Delta back to the PM, and in this way regulate the 
availability of ligand for the Notch receptor [203].  
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1.5.3 Retrograde transport 
Next to the recycling pathway, retrograde transport represents a second major pathway that diverts 
cargo away from lysosomal degradation. Retrograde trafficking is involved in the retrieval of sorting 
receptors, processing proteases, SNAREs, lipids and other molecules from the PM or endosomes back 
to the TGN. Accordingly, the TGN herein represents a major sorting hub that connects the secretory 
pathway to the endo-lysosomal system. This pathway has a crucial role in development and nutrient 
homeostasis and aberrant retrograde traffic results in various pathogenesis such as Alzheime s a d 
Parkinson s disease and lysosomal storage disorders. Similarly to other trafficking routes, the 
retrograde machinery relies on the cooperation of different GTPases, coat proteins, tethering factors 
and SNAREs [204]. Two retrograde trafficking pathways emerge from the tubular endosomal 
network, one that sorts cargo from the EE and/or RE to the TGN and another that transports cargo 
from the LE to the TGN. The TGN resident protein TGN46 (TGN38 in yeast) and the endopeptidase 
furin, both cycling between the Golgi, endosomes and PM, use these different pathways and traffic 
respectively via the EE/RE and the LE back to the Golgi network [205–207]. The former EE/RE 
pathway is also hijacked by several bacterial and plant toxins such as cholera toxin, Shiga toxin and 
ricin, to reach the Golgi and ER and eventually the cytosol, where they exert their cytotoxic effects 
[208,209]. Another well-known protein that utilizes retrograde traffic is the CI-M6PR (cation-
independent M6PR) which, at steady state, cycles between the Golgi, PM and LEs. The M6PR binds 
newly synthesized lysosomal hydrolases that are modified in the Golgi network with a M6P and 
transports them towards the endosomes where the acidic environment contributes to their release. 
The hydrolases traffic further to the lysosomes where they accumulate and become active, while the 
M6PR is retrieved back to the TGN. Abnormal M6PR trafficking results in the secretion of lysosomal 
hydrolases into the extracellular space and gives rise to dysfunctional lysosomes [210]. This CI-M6PR 
uses both retrograde traffic pathways to reach the Golgi network, where the EE/RE to Golgi traffic 
depends on the retromer complex, while the LE to Golgi transport follows a RAB9/TIP47 (tail-
interacting protein of 47 kD)-dependent pathway [211–213].  
The retromer is a multiprotein complex, whose subunits recognize retrograde cargo, promote sorting 
into the tubular endosomal network and stimulate microtubule-dependent transport of cargo 
carriers to the TGN [204,214]. The retromer constitutes two subcomplexes, a cargo selection trimer 
consisting of VPS26, VPS29 and VPS35, and a dimer of SNX (sorting nexin) proteins, usually a SNX1/2 
or SNX5/6 heterodimer or a SNX3 homodimer [215]. SNX proteins contain a PX domain responsible 
for membrane association via its interaction with PIPs, and a BAR domain that is able to drive, sense 
and stabilize membrane curvature (see Figure 15, [216]). SNX3 however, does not contain a BAR 
domain and so far it is unclear how the SNX3-retromer mediates cargo transport. These different 
SNX-retromers contribute to cargo selectivity as the SNX-BAR retromers sort cargo such as TGN46, 
M6PR, STxB and SorLA, whereas the SNX3-retromer specifically sorts Wntless [217,218]. Other cargo, 
like furin does not depend on the retromer for its sorting to the TGN [219]. Next to endosome-to-
TGN cargo sorting, the retromer also plays a role in trafficking of cargo from the EE to the PM or RE 
by associating with different SNX proteins [216]. AP1-clathrin coated vesicles together with adaptor 
protein EpsinR (Epsin related protein) are the main coat proteins involved in the endosome to TGN 
trafficking [220]. Upon TGN arrival, tethering factors such as the GARP and COG complex and several 




Figure 15: SNX (sorting nexin)- BAR (Bin-Amphiphysin-Rvs)- retromer mediated trafficking. While ubiquitinated 
cargo is selected for degradation by the ESCRT complex, cargo destined for the TGN (trans-Golgi network), REs 
(recycling endosomes) or PM (plasma membrane) is recognized by the retromer complex. The core VPS35-
VPS29-VPS26 heterotrimer is responsible for cargo selection, where the VPS35 subunit interacts with cargo. The 
SNX-BAR proteins are characterized by a PX (Phox homology) domain that binds PI(3)P, and a BAR domain. The 
BAR domain allows the SNX-BARs to form dimers, and the concave surface of the BAR domain bears basic 
residues that associate with the membrane via electrostatic interactions thereby sensing and driving membrane 
curvature. The exact composition of the mammalian SNX-BAR subcomplex is still uncertain, although the 
current view is that it comprises a dimer of SNX1/2 with SNX5/6. Membrane remodeling is further assisted by 
actin polymerization eventually resulting in the scission of a cargo-enriched tubular transport carrier. Ub 
(ubiquitin). Figure adapted from [222].  
 
The retromer complex has ee  i pli ated i  Alzhei e s disease, and mutations of several retromer 
subunits were found to be associated with the disease [223,224]. APP (amyloid precursor protein) 
binds the receptor SorLA, which traffics between the TGN, PM and EE via its interaction with the 
VPS26 subunit of the retromer [225]. Loss of the retromer leads to the accumulation of APP in the 
e doso es hi h is se ue tiall  lea ed  the β a d  secretases residing at the same subcellular 
location, esulti g i  i eased a loid β p odu tio . Furthermore, mutations in VPS35, another 
subunit of the retromer were found to be associated with Pa ki so s disease [226].  
 
1.5.4 Ectodomain shedding 
 
Several membrane-anchored proteins, such as cell adhesion molecules, growth factors, cytokines, 
and receptors, are known to be released from the cell surface via ectodomain shedding. Ectodomain 
shedding is a highly regulated and selective process, only occurring for about 2% of the membrane-
bound proteins. It rapidly converts membrane proteins into soluble effectors, and concomitantly, 
reduces the levels of cell surface expression thereby modulating various signaling processes involved 
in proliferation, differentiation, migration and inflammation with consequences for several diseases 
[227,228]. Various stimuli are known to induce ectodomain shedding, some of which, like phorbol 
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esters, globally activate shedding whereas others stimulate shedding of specific ectodomains [229]. 
Shedding is executed by sheddases, which are members of the ADAM (a disintegrin and 
metalloproteinase) family [230]. ADAM  o  TACE TNFα o e ti g e z e  as the fi st ide tified 
sheddase that, e t to TNFα, also mediates ectodomain shedding of several other membrane-bound 
proteins such as the LR (leptin receptor), IL6R, L-selectin, V-CAM1, ERBB , APP, TGFα, HB-EGF and 
many others [231–233]. ADAMs are produced as zymogens that are activated by the serine 
endopeptidase furin and other proprotein convertases present in the TGN, PM and endosomal 
compartments which remove their prodomains [234,235]. There is no consensus motif that defines 
the cleavage site in substrates for the different ADAM proteins, instead substrate recognition 
depends on the structure of the cleavage region and the distance from the PM [236].   
Next to ADAM17, ADAM10 also mediates the shedding of the IL-6R and LR [232,237]. This results in 
the release of soluble cytokine receptors in the extracellular environment, which can protect 
circulating cytokines from degradation or glomerular filtration, thereby prolonging their half-life and 
potentiating signaling. Furthermore, ectodomain shedding enables trans-signaling of cells expressing 
the signal transducing components of the corresponding soluble receptor. For example, soluble IL-
Rα a  ind the gp130 chain thereby allowing IL-6 signaling in IL- Rα-deficient cells [238]. On the 
other hand, soluble cytokine receptors can act as antagonists where they function as decoy receptors 
by capturing and sequestering ligand away from the membrane bound receptors resulting in 
inhibited signaling [239].  
 
1.6 Autophagy 
Autophagy is the process in which toxic aggregates, invading microorganisms and damaged 
organelles are cleared from the cytoplasm. This highly conserved catabolic process is essential for cell 
survival, stress responses and homeostatis and involves engulfment by a double-membrane 
organelle called the autophagosome, which transports the autophagic cargo to the lysosomes for 
degradation [240]. Autophagy was originally considered to be a non-selective, bulk degradation 
pathway, induced upon starvation, where the generated metabolites are reused either as sources of 
energy or building blocks for the synthesis of new molecules. However, it is now clear that autophagy 
can also be a highly selective process in terms of cargo that can be captured within the 
autophagosome. Several autophagic cargo receptors such as p62, OPTN (optineurin), NDP52 and 
NBR1 mediate the selective autophagy of aggregated proteins (aggrephagy), mitochondria 
(mitophagy), peroxisomes (pexophagy), ribosomes (ribophagy), pathogens (xenophagy) and 
endoplasmic reticulum (reticulophagy) [241–243]. Next to autophagy, also termed macroautophagy, 
two other autophagic processes exist, microautophagy and CMA (chaperone-mediated autophagy), 
which additionally contribute to the delivery of autophagic cargo into lysosomes. In contrast to 
(macro-) autophagy, CMA and microautophagy do not involve vesicular intermediates. CMA 
substrates contain a KFERQ-like motif that is recognized by HSC70. HSC70 subsequently delivers the 
substrate to the lysosomal receptor Lamp2A, which in turn oligomerizes and mediates the 
translocation of the unfolded substrate into the lysosomal lumen [244]. In microautophagy, cytosolic 
components are taken up via invaginations of the LEs in a selective or unselective manner, which 
traps the cytoplasmic material into ILVs. Selective microautophagy requires both the ESCRT system 
and HSC70 for the uptake of its substrates [245].  
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Autophagy initiates with the formation of an isolation membrane (or phagophore) followed by 
membrane nucleation and expansion which eventually leads to the formation of a double-
membraned autophagosome. The autophagic machinery mediating these different steps consists of 
at least 36 ATGs that were originally identified in yeast, but are evolutionary well conserved in 
mammalian cells. 17 ATGs comprise the core autophagic machinery and can be subdivided into four 
key functional complexes termed the ULK (Unc-51 like autophagy activating kinase) complex, the 
class III PI3K complex I and two ubiquitin-like conjugation complexes, ATG12-ATG5-ATG16 and LC3 
(or ATG8) (see Figure 16; [246,247]). These ATGs act together with general membrane trafficking 
components such as coat proteins, SNAREs and RABs to regulate autophagosome biogenesis, 
maturation and subsequent fusion with the lysosomes [248].  
The ULK kinase complex composed of ULK1/2, ATG13, ATG101 and FIP200 is crucial for the induction 
of autophagy and is in turn positively and negatively regulated by the glucose and amino acid sensing 
kinases AMPK (AMP-activated protein kinase) and mTORC1 respectively. Under nutrient-rich 
conditions, this complex is phosphorylated and inhibited by mTORC1, while starvation blocks 
mTORC1 activity, resulting in the release and recruitment of ULK1/2 to the isolation membrane 
where it can phosphorylate and activate ATG13 and FIP200 [249,250]. Simultaneously with ULK 
complex activation, the class III PI3K complex I is activated, which is required for isolation membrane 
nucleation. This complex consists of Beclin1, VPS34, VPS15 and ATG14. ULK1 phosphorylates Beclin1 
and activates the lipid kinase VPS34, which in turn generates PI(3)P on the surface of the isolation 
membrane resulting in the recruitment of WIPI2 (WD repeat domain phosphoinositide-interacting 
protein 2) and DFCP1 (Double FYVE-containing protein 1) [251,252]. WIPI2 targets the first ubiquitin-
like conjugating complex ATG12-ATG5-ATG16 to the PI(3)P enriched isolation membrane, which is 
necessary for isolation membrane elongation [253]. In this complex, ATG12 is covalently conjugated 
to ATG5 via the concerted actions of ATG7 (~E1) and ATG10 (~E2). ATG5 then associates with ATG16 
to form the ATG12-ATG5-ATG16 complex. The second ubiquitin-like conjugating system mediates the 
lipidation of LC3 (ATG8) which results in the conjugation of LC3 to phosphatidylethanolamine, or 
LC3II [254]. Here, the protease ATG4 cleaves the C-terminus of LC3 thereby exposing a glycine 
residue. This LC3I is then converted to LC3II with the assistance of ATG7 (~E1), ATG3 (~E2) and the 
ATG12-ATG5-ATG16 complex which acts as an E3-like enzyme [255]. In contrast to the ATG12-ATG5-
ATG16 complex, LC3II remains associated with the mature autophagosome until its degradation in 
lysosomes [256]. The transmembrane protein ATG9 is another important ATG involved in the 
elongation of the isolation membrane. ATG9 is located at the TGN, EEs, REs and LEs, and autophagy 
activation drives the ULK1-mediated trafficking of this membrane-delivering ATG9 to the 
autophagosomal formation site. This ATG9-dependent lipid delivery together with the LC3 lipidation 
process allows for further elongation and closure of the autophagosome membranes [257]. The 
complete autophagosome is transported via microtubules to the LE or lysosomes, where it eventually 
fuses, forming an amphisome or autolysosome. This fusion involves the class III PI3K complex II, 
consisting of Beclin1, VPS34, VPS15 and UVRAG (instead of ATG14 in complex I), the ESCRT 
machinery, RAB7, the HOPS tethering complex and SNARE protein Stx17 [258–260].    
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Figure 16: Schematic representation of the autophagy process. The isolation membrane is derived from several 
organelles including the ER (endoplasmic reticulum), mitochondria, endosomes and the Golgi. Autophagosome 
formation is initiated by the ULK1 (Unc-51 like autophagy activating kinase 1) kinase complex (ULK1, ATG13, 
FIP200, ATG101), which is activated upon starvation and inhibited by mTORC1 (mammalian target of rapamycin 
complex 1). ULK1 phosphorylates and activates the Class III PI3K (phosphatidylinositol-3 kinase) complex I 
(Beclin1, VPS34, VPS15, ATG14), which generates PI(3)P on the surface of the isolation membrane. This recruits 
DFCP1 (Double FYVE-containing protein 1) and WIPI2 (WD repeat domain phosphoinositide-interacting protein 
2), which in turn recruits the ATG12-ATG5-ATG16 complex. This complex is formed via an ubiquitin-like 
conjugation system where ATG7 and ATG10 function as E1 and E2 respectively. ATG12-5-16 itself acts as an E3 
ligase in the lipidation process of LC3 together with ATG7 (E1) and ATG3 (E2), resulting in anchoring of LC3II in 
the isolation membrane. ATG9 is also recruited to the isolation membrane and functions together with LC3II in 
the further elongation and closure of the autophagosome. Finally, the Class III PI3K complex II (Beclin1, VPS34, 
VPS15, UVRAG (UV radiation resistance associated gene)) is involved in fusion with the lysosome resulting in an 
autolysosome. Figure adapted from [261,262].  
 
In yeast, the isolation membrane originates from a single PAS (pre-autophagosomal structure), near 
the vacuole [263]. In multicellular eukaryotes however, the membrane sources for the 
autophagosome appear to derive from several organelles.  Next to the consensus that the ER-
mitochondrion interface is the main source for the isolation membrane, various reports indicate that 
it also receives input from the ER exit sites, ERGIC, Golgi, PM, EEs and REs, although the general 
assembly remains unclear [260,264]. The formation of the isolation membrane appears to rely on 
several proteins such as STX17 and RAB1, together with the TRAPPIII tethering complex which 
interacts with COPII coat proteins [265]. Other endosomal RAB proteins such as RAB4, RAB5, RAB7 
and RAB11 are also implicated in autophagy, especially since the endosomes provide membrane 




2.1. RNF41, a RING finger ubiquitin ligase 
 
RNF41 (RING (really interesting new gene) finger protein 41) was first discovered in 2001 as FLRF 
(fetal liver RING finger), a protein differentially expressed in mouse fetal liver and bone marrow 
hematopoietic stem cells and progenitors [266]. The human ortholog of this 317 amino acid 
containing protein was later identified as NRDP1 (neuregulin receptor degradation protein-1), due to 
its interaction with and degradation of ERBB3 and ERBB4 receptors. RNF41 was found to be 
ubiquitously expressed in human adult tissues, although expression was more pronounced in heart, 
brain and skeletal muscle. It consists of an N-terminal RING finger domain, followed by two other zinc 
finger domains, a CC (coiled-coil) domain and a C-terminal substrate binding domain (Figure 17). 
RING finger proteins represent a large class of E3 ubiquitin ligases involved in many cellular processes 
such as cell cycle regulation, transcriptional control and apoptosis. They recruit E2 conjugating 
enzymes via their RING domain and mediate the transfer of ubiquitin to substrates interacting with 
the substrate binding domain as well as the E3 ligase itself [267]. The Met-Gly sequence at the N-
terminus of RNF41 suggests a putative myristoylation site, which could imply membrane anchoring 
but still needs further experimental validation [268,269]. Over the years it has become clear that 
RNF41 is involved in a diverse set of cellular processes including signaling of various receptors, 
intracellular trafficking and apoptosis. Furthermore, its implication in several diseases has been the 
topic of many studies. This chapter will highlight the functions of RNF41 in these different processes 
(Figure 18).  
  
Figure 17: Schematic representation of the different domains present in RNF41 (RING finger protein 41). An N-
terminal myristoylation site (yellow) is followed by a RING (really interesting new gene) domain, a CC (coiled-
coil) domain and a C-terminal substrate binding domain.  
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Figure 18: RNF41 (RING finger protein 41) function in cellular processes and disease. This scheme depicts the 
processes and implicated proteins or diseases regulated by RNF41 that will be highlighted in this chapter. IL-3R 
(interleukin 3 receptor); EPOR er thropoieti  re eptor ; RARα reti oi  a id re eptor α ; C/EBPβ 
(CCAAT/Enhancer- i di g protei  β ; USP8 (Ubiquitin-specific protease 8); LR (leptin receptor); LIFR (leukaemia 
inhibitory factor receptor); IL-6R (interleukin 6 receptor); HPV (human papilloma virus); BRUCE (BIR repeat 
containing ubiquitin-conjugating enzyme).  
 
2.2. Role of RNF41 in signaling 
Our lab previously showed that RNF41 attenuates the signaling of several JAK2-associated type I 
cytokine receptors, including the LR (leptin receptor), LIFR (Leukaemia inhibitory factor receptor), IL-
6R (interleukin 6 receptor), IL-3R (interleukin 3 receptor) and EPOR (erythropoietin receptor) [232]. 
Likewise, RNF41 reduces the signaling of RTKs (receptor tyrosine kinases) ERBB3 and ERBB4, and 
differentially regulates TLR (Toll-like receptor) signaling. Although it is still unclear how RNF41 
downregulates type I cytokine receptor signaling, the mode of action and implications for the other 
receptors are more elaborated and described below.  
2.2.1. ERBB3 signaling 
ERBB3 is a member of the epidermal growth factor (EGF) receptor family of RTKs, consisting of four 
closely related type 1 transmembrane receptors (EGFR, ERBB2, ERBB3 and ERBB4). These receptors 
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play a role in highly regulated and complex signaling pathways involved in cell proliferation, 
differentiation and survival, where aberrant signaling generally results in the development of various 
tumors [270]. In contrast to the other ERBB receptors, ERBB3 lacks intrinsic tyrosine kinase activity 
and requires heterodimerization with other ERBBs in order to function. ERBB2, which has no direct 
ligand, is the most potent candidate for this heterodimerization [271].  
RNF41 interacts with the ERBB3 receptor via its substrate binding domain and thereby regulates 
ERBB3 steady state levels through ligand-independent ubiquitination and proteasomal degradation 
[268,269,272]. RNF41 localized at the ER elicits proteasomal degradation of properly folded ERBB3 
receptors via the ERAD pathway [273]. Recently, the factor that regulates this RNF41-mediated ERAD 
ERBB3 degradation was identified as RTN4A (Reticulon 4A), a structural protein of ER tubules. This 
protein, upregulated by acute cellular stress, sequesters RNF41 into ER tubules, thereby isolating it 
from ERBB3 receptors and ERAD ubiquitination machinery located in the rough ER sheets. This allows 
ERBB3 receptors to mature and traffic to the plasma membrane where they can respond to their 
ligand [274]. On the other hand, RNF41 present at endosomes is able to down-regulate mature 
internalized ERBB3 receptors upon ligand stimulation by diverting them away from recycling 
pathways to lysosomes for degradation [275]. This is accomplished by ligand-induced stabilization of 
USP8, a DUB known to stabilize RNF41 ([276], see 2.4). Collectively, these studies introduce RNF41 as 
a key component in the regulation of ERBB3 signaling, thereby preventing excessive signaling. As 
such, RNF41 was found to be a crucial component in the differentiation process of melanocytes 
during zebrafish embryogenesis by modulating ERBB3 signaling in neural crest cells [277]. 
2.2.2. Immune signaling 
Screening of cDNA libraries revealed a differential expression of Rnf41 in mouse fetal liver and bone 
marrow HSC (hematopoietic stem cells) and progenitors during blood cell development. Rnf41 is 
upregulated in mouse fetal liver HSC, but not in progenitors and mature blood cells; whereas in adult 
mice, Rnf41 is expressed in a heterogeneous population of bone marrow HSC, downregulated in the 
progenitor cell population and upregulated again as these progenitors differentiate into mature 
lymphoid and myeloid cell types [266]. More evidence for the involvement of RNF41 in 
hematopoiesis was presented by Jing et al, where RNF41 interacted with and downregulated IL-3R, 
EPOR a d RARα eti oi  a id e epto  le els i  a liga d i depe de t a . As su h, RNF  
attenuated erythroid and myeloid differentiation of mouse cells in response to IL-3, Epo and RA 
[278]. Additionally, in the presence of IL-4, RNF41 ubiquitinated and activated the transcription 
fa to  C/EBPβ CCAAT/E ha e - i di g p otei  β . This p o oted alte ati e a ti atio  of ouse 
macrophages (M2), which are known to be essential for anti-parasite immunity and constructive 
processes like wound healing and tissue repair [279]. 
RNF41 further influences the innate immune response by controlling TLR signaling in mouse 
macrophages. By acting both as an adaptor and E3 ligase, RNF41 mediates K48-linked 
polyubiquitination of MYD88 and K63-linked polyubiquitination of TBK1 (TANK binding kinase 1). This 
results on the one hand in the attenuation of MYD88-dependent activation of NF-κB a d AP-1 and 
inhibits the production of pro-inflammatory cytokines, suggesting that RNF41 inhibits LPS 
(lipopolysaccharide)-induced classical activation of macrophages (M1). On the other hand, RNF41 
potentiated TRIF-dependent activation of TBK1 and IRF3, thereby promoting the production of type I 
interferon. In this way, RNF41-transgenic mice are protected against infection with vesicular 
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stomatitis virus [280]. Similarly, the anti-inflammatory effects of the drug Luteolin in mouse 
microglial cells can be ascribed to stabilization of RNF41 by upregulation of USP8, thereby 
suppressing the production of pro-inflammatory cytokines [281]. Also, RNF41 was found to interact 
with TBK1 in the large yellow croaker, suggesting that RNF41 can regulate TBK1 and immune 
response in fish [282].  
RNF41 is also linked to the adaptive immune response by negatively regulating CD8+ T cell activation.  
RNF41 hereby mediates K33-linked polyubiquitination of ZAP70, a signaling kinase essential for TCR 
(T cell antigen receptor) signaling, which promotes dephosphorylation of ZAP70 by acidic 
phosphatase-like proteins STS1 and STS2, resulting in its inactivation and subsequent termination of 
early TCR signaling. This regulation of TCR signaling has implications in autoimmune diseases, like 
experimental autoimmune encephalitis, where RNF41 might have pathogenic effects at the initial 
stage of the disease and protective effects in a later stage of disease progression. Moreover, CD8+ 
cells from mice deficient in Rnf41 were able to elicit resistance to intracellular Listeria 
monocytogenes infection in liver and spleen and inhibit the growth of B16 melanoma tumors in mice, 
further confirming that RNF41 deficiency promotes the cytotoxicity of CD8+ T cells [283].  
 
2.3. Role of RNF41 in apoptosis 
Apoptosis is a highly regulated process in multicellular organisms resulting in total non-immunogenic 
cellular disintegration. During this process, apoptotic cells go through sequential steps that include 
cell shrinkage and blebbing, chromatin condensation, cytoskeletal collapse, nuclear and DNA 
fragmentation followed by the release of apoptotic bodies that are engulfed by neighboring cells. Cell 
death can be triggered by a wide variety of stimuli and conditions, both physiological and 
pathological, but once initiated, apoptosis proceeds through a common pathway [284]. The primary 
mediators of apoptosis are caspases, cytosolic cysteine proteases that cleave proteins C-terminal of 
aspartate residues. Through an irreversible cascade of auto- and trans-cleavage steps of different 
initiator caspases, activated executioner caspases cleave downstream targets resulting in rapid cell 
death [285]. Apoptosis can be blocked by multiple proteins of which many are known to interfere 
with caspase function in a direct or indirect way. BCL2, a membrane protein localized to the outer 
membrane of mitochondria inhibits apoptosis by blocking the efflux of cytochrome c from 
mitochrondria, which interferes with caspase-9 activation [286,287], while p53 is known to directly 
bind with and inhibit caspases [288]. Another group of anti-apoptotic proteins is the IAP (inhibitor of 
apoptosis proteins) family. Members of this family are characterized by the presence of one to three 
tandem BIR (baculoviral IAP repeat) domains that are able to bind and inhibit specific caspases. In 
addition to BIR domains, certain IAPs contain a RING-finger domain which allows these IAPs to 
catalyze ubiquitination and degradation of themselves and other proteins important for apoptosis 
[289]. BRUCE (BIR repeat containing ubiquitin-conjugating enzyme, also Apollon or BIRC6), is a giant 
(528 kDa) IAP containing a single N-terminal BIR domain and, unlike other IAPs, a C-terminal E2 motif, 
which can form thioester bonds with ubiquitin [290]. BRUCE functions as an inhibitor of apoptosis by 
interacting and inhibiting initiator caspases-8 and -9 and executioner caspases-3, -6 and -7 and by 
ubiquitinating and degrading the pro-apoptotic mitochondrial protein SMAC/DIABLO (second 
mitochondria-derived activator of caspases/Direct IAP-Binding protein with Low pI) [291]. Contrary to 
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other mammalian IAPs, BRUCE is essential for the viability of various cell lines, and Bruce deficient 
mice died at the embryonic or neonatal stage [291,292].    
RNF41 interacts with and ubiquitinates BRUCE, resulting in its proteasomal degradation. In response 
to pro-apoptotic stimuli, this RNF41-mediated degradation of BRUCE causes caspase-3 activation and 
promotes apoptosis [292]. As such, RNF41 plays an important role in apoptosis of human glioma 
cells. BRUCE is upregulated in gliomas that are resistant to certain DNA-damaging agents, and 
antisense oligonucleotides against BRUCE enhance apoptosis induced by these agents [293]. In 
contrast, RNF41 and (cleaved) caspase-3 expression was found to be relatively lower in human 
glioma tissues compared to non-tumorous brain tissues. RNF41 overexpression promoted apoptosis 
in glioma cells by degrading BRUCE and activating caspase-3. This apoptosis was aggravated upon 
Temozolomide treatment, a drug used for glioma chemotherapy. Contrary, RNF41 depletion 
inhibited this Temozolomide-induced apoptosis [294]. Similarly, upregulation of RNF41 by LPS in 
neurons of the cerebral cortex of adult rats enhanced the expression of cleaved caspase-3 and 
suppressed the levels of BRUCE, suggesting that RNF41 contributes to neuronal apoptosis in a 
neuroinflammation model [295].  
2.4. Role of RNF41 in trafficking via USP8 
Spatiotemporal control of protein ubiquitination is regulated by DUBs. The DUB USP8 (or UBPy) was 
first identified as a protein involved in the control of cell proliferation, where it accumulates in 
response to growth stimulation and is downregulated upon growth arrest conditions [296]. USP8 is 
known for its role in endocytic trafficking by deubiquitinating the ESCRT-0 proteins STAM and HRS, 
and by directly deubiquitinating cargo like RTKs and GPCRs. This differential deubiquitination of 
either endosomal transport machinery or cargo, together with the type of cargo, decides on the fate 
of e epto s. USP  deu i uiti ates the GPCRs DOR - opioid receptor) and PAR2 (protease-activated 
receptor 2) and the ion-channel KCa3.1, resulting in receptor degradation by trafficking towards 
lysosomes [297–299]. Contrary to this, deubiquitination of the RTKs EGFR, Met and ERBB3 by USP8 
protects these receptors from lysosomal degradation and assists in the sorting towards recycling 
endosomes [300–302]. On the other hand, USP8-mediated deubiquitination of the sorting proteins 
STAM and HRS stabilizes the ESCRT-0 complex and directs the GPCR CXCR4 (chemokine receptor 4) 
towards lysosomes for further degradation [303]. This deubiquitination of the ESCRT-0 proteins is 
necessary to maintain endosomal morphology as USP8 depletion results in endosomal swelling and 
accumulation of ubiquitinated species on these endosomes [304–306].  
Next to the N-terminal MIT domain and carboxyl-terminal catalytic domain, responsible for 
endosomal location and deubiquitinating enzyme activity respectively, USP8 contains a centrally 
located rhodanese domain [307]. USP8 deubiquitinates and stabilizes RNF41 through interaction via 
its rhodanese domain [276,308]. Furthermore, our group showed that USP8 itself is a target of RNF41 
and interacts with its substrate binding domain [309]. By ubiquitinating and suppressing USP8, RNF41 
indirectly destabilizes the ESCRT-0 complex and influences the intracellular trafficking of JAK2-
associated type I cytokine receptors. In this way, RNF41 inhibits the lysosomal degradation of the LR, 
LIFR and the IL-6R and subsequently reroutes them towards compartments for ectodomain shedding, 
resulting in increased soluble receptors by ADAM proteases [232,309]. Moreover, a recent 
collaboration with the group of prof. Wevrick (University of Alberta, Canada) revealed that MAGEL2 
(melanoma antigen L2), a candidate gene for the neurodevelopmental disease Prader-Willi, is 
47
responsible for the recruitment of the LR to the sorting endosomes via its interaction with NDN 
(necdin). MAGEL2 was found to interact with both RNF41 and USP8 where it deubiquitinates and 
stabilizes RNF41, and destabilizes USP8 and STAM. In this way, the NDN-MAGEL2-RNF41-USP8 
complex controls LR cell surface expression and degradation in a ligand-independent way [310]. 
These data suggest that USP8 targets these type I cytokine receptors for lysosomal degradation the 
same way as it targets CXCR4 [303].  
Direct deubiquitination of ERBB3 by USP8 resulting in blocked lysosomal degradation, as described in 
Niendorf et al., might also explain the results observed in Cao et al., where RNF41 enhances 
lysosomal degradation of ERBB3 [275,301]. Since RNF41 ubiquitinates and suppresses USP8 [309], 
RNF41 might in this way reverse the inhibition of lysosomal degradation, resembling the situation in 
USP8 depleted cells. This reciprocal RNF41-USP8 regulation also affects BRUCE, where USP8 and 
RNF41 play a role in cytokinesis by modulating the ubiquitination state of BRUCE. Here, USP8 
counteracts the RNF41-mediated BRUCE ubiquitination thereby blocking its proteasomal 
degradation. Maintaining BRUCE levels appear to be crucial since depletion of BRUCE causes 
defective abscission in the final stage of cytokinesis and cytokinesis-associated apoptosis [276,311]. 
 
2.5. Role of RNF41 in diseases 
 
2.5.1. ERBB3 signaling in cancer 
RNF41-mediated modulation of ERBB3 signaling was primarily established in breast cancer cell lines. 
Overexpression of RNF41 in human breast cancer cells suppresses ERBB3 levels thereby inhibiting 
cellular growth and motility, while loss of RNF41 promotes breast tumor progression by enhancing 
ERBB2/ERBB3 signaling. Moreover, RNF41 expression levels in breast cancer patient primary tumors 
and in mouse mammary tumors were found to inversely correlate with ERBB3 levels [312]. 
Importantly, these mouse mammary tumors employ post-transcriptional mechanisms to suppress 
RNF41, since transgenic expression of RNF41 cDNA could not restore RNF41 levels nor suppress 
elevated ERBB3 levels [313]. Another study suggested RNF41 as a novel prognostic biomarker for 
breast cancer, based on 113 primary breast cancer samples. Here, low RNF41 expression implied a 
decreased overall and disease-free survival of patients [314].  
Next to breast cancer, aberrant ERBB3 signaling has been implicated in many other types of cancers 
[315], and for most of these, RNF41 was found to play a role in the underlying mechanism. 
Prostate cancer cells (PCa) rely on signaling through the AR (androgen receptor) and ERBB3 receptor 
for maintenance and progression. In these androgen-dependent cancer cells, the transcription factor 
AR induces ERBB3 degradation by upregulating RNF41 transcription [316]. Upregulation of RNF41 by 
AR can only occur in the presence of nuclear FlnA (Filamin A), which stimulates AR binding to RNF41 
ARE (androgen response element) [317]. Drugs like Celexocib that, besides its well-established 
function as a COX2 inhibitor, upregulate RNF41 and subsequently suppress ERBB3 are of great 
interest, since ERBB3 signaling leads to constitutive, ligand-independent activation of the AR and 
renders PCa cells indifferent to androgen withdrawal therapies [318].  
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In comparison to normal brain tissue, ERBB3 levels are abundant in high-grade glioblastoma 
multiforme, a malignant tumor of the central nervous system. Also here, depletion of RNF41 was 
found to dysregulate ERBB3 signaling, contributing to glioma migration and invasion, whereas 
overexpression of RNF41 inhibited tumor progression [319]. Wu et al, reported an alternatively 
spliced short variant of RNF41 (NRDP1S), lacking the first 71 amino acids and thus the RING domain, 
which was expressed in normal human brain tissue and absent in glioma tissues. NRDP1S stabilizes 
RNF41 resulting in augmented ERBB3 degradation and inhibition of tumor growth. In this way, 
NRDP1S deficiency could also play an important role in the loss of RNF41 [320]. Another study 
reported that overexpression of the CC domain of RNF41, which also stabilizes RNF41, resulted in 
enhanced ERBB3 ubiquitination and degradation [321]. This indicates that both NRDP1S and the CC 
domain of RNF41 could function as tumor suppressors.   
HCC (hepatocellular carcinoma) development is closely linked to hepatitis B infection [322]. 
Overexpression of ERBB3 has been observed in hepatocellular carcinoma and HBx (hepatitis B virus 
encoded X protein) was recently found to post-translationally regulate ERBB3 levels [323]. Analogous 
to breast cancer, prostate cancer and glioma, an inverse correlation between RNF41 and ERBB3 
protein levels was found in HBx-induced hepatocellular carcinoma tissues. HBx increased ERBB3 
protein expression by destabilizing RNF41, which subsequently promoted the proliferation of HCC 
cells [324]. Also in pancreatic cancer cells, overexpression of ERBB3 is associated with a decreased 
cell survival. The retinoic acid derivative ABPN (A4-amino-2-(butyrylamino)phenyl (2E,4E,6E,8E)- 3,7-
dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)- 2,4,6,8-nonatetraenoate) was found to suppress 
pancreatic cancer growth by upregulating RNF41 via unknown mechanisms, which causes 
degradation of ERBB3 and downregulation of the ERBB3 and downstream AKT, MAPK and JNKs 
signaling pathway [325].  
RNF41 also downregulates ERBB3 levels in a HPV16 (human papillomavirus 16)-containing cell line 
[326]. During viral integration in the cellular genome, the E2 protein, involved in replication of HPV 
DNA, is lost, which lifts the inhibition of the viral oncogenes E6 and E7. RNF41 was found to interact 
with the E2 protein of HPV16. By competing for RNF41, E2 upregulated the amount of ERBB3 
receptors localizing on the cell membrane which might favor a more stable proliferative effect in 
epithelia where the viral replication takes part [326].  
 
In contrast to the previously described cancers where ERBB3 appears to be a big culprit, the heart 
relies on ERBB3 signaling and its downstream RAS/MEK/ERK, PI3K/AKT and STAT3 pathways for 
cardiac cell survival [327]. Ischemia/reperfusion- and doxorubicin-induced cardiac injury cause an 
upregulation of RNF41 in mouse heart cells, resulting in increased cardiac apoptosis, autophagy and 
oxidative stress thereby further promoting cardiac injury and dysfunction. These effects result from 
an RNF41-mediated inactivation of cardiac ERBB3 and subsequent dysregulation of its downstream 
signaling pathways. Therefore, targeted therapy to decrease RNF41 expression specifically in the 
heart may help ameliorate ischemic and doxorubicin-induced cardiac injury [328,329]. Moreover, an 
RNF41 polymorphism was recently found to be associated with the risk of congenital heart disease in 
Chinese Mongolian population, further suggesting that RNF41 plays an important role in heart 
diseases [330]. Finally, the human and mouse RNF41 sequences contain a potential binding site for 
Nkx-2.5, a transcription factor that regulates heart development and disease [266].  
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Next to ERBB3, RNF41 was also found to interact with and suppress ERBB4 [268]. KITENIN (KAI1 C-
terminal interacting tetraspanin or VANGL1 (Vang-like protein 1)) can interact with the C-terminal 
domain of RNF41 and this interaction renders ERBB4 resistant to RNF41-mediated degradation [331]. 
In CRC (colorectal cancer) tissues, the KITENIN/ERBB4-DVL2 (Dishevelled 2)-c-Jun axis was identified 
as a novel, EGFR-independent unconventional downstream signal of EGF [332]. EGF stimulated the 
formation of a KITENIN/ERBB4/RNF41 complex, leading to targeted degradation of DVL2 by RNF41 
and resulting into upregulation of c-Jun, thus enhancing CRC cell motility [331]. This implies that the 
function of RNF41 in colorectal cancer is in strong contrast to the other described cancers, where 
RNF41 acts as a suppressor via degradation of ERBB3. A clear understanding of the exact mechanism 
of RNF41 is essential for the development of possible RNF41-targeted anti-cancer strategies.  
 
2.5.2. Dysregulation of BRUCE in cancer    
RNF41 appears to be a pro-apoptotic protein by promoting degradation of both BRUCE and ERBB3 
[269,292]. In this way, RNF41 contributes to the suppression of several cancers. Loss of RNF41 in 
human glioma cells augments glioma progression through reduction of apoptosis via upregulated 
BRUCE levels [294] and via dysregulation of ERBB3 signaling [319]. Likewise, in pancreatic cancer 
cells, the retinoic acid derivative ABPN downregulated protein levels of both ERBB3 and BRUCE, by 
upregulating RNF41, thereby suppressing pancreatic cancer cell growth [325]. Additionally, reduced 
and enhanced protein levels of RNF41 and BRUCE respectively, were detected in renal cell carcinoma 
tissues compared to normal tissues. Also here, RNF41 affected cell viability and apoptosis via 
degradation of BRUCE [333], however, ERBB3 was not found to be upregulated in this type of cancer 
[334].  
2.5.3. Loss of cell polarity in cancer  
In addition to aberrant signaling of the EGFR family and inhibition of apoptosis, loss of polarity is also 
commonly observed in cancer cells and RNF41 has been implicated in the regulation of cell polarity in 
several ways. Phosphorylation of RNF41 by the Ser/Thr kinase Par-1b targets laminin-111 receptors 
to the basolateral membrane, which facilitate cell anchorage to laminin-111, a major component of 
the ECM (extracellular matrix). This establishes the cell-ECM contacts required for apical-basal cell 
polarity in epithelial cells [335]. On the other hand, RNF41 downregulates VANGL-dependent non-
canonical Wnt signaling, a pathway necessary for planar cell polarity in neuronal development. By 
interacting with KITENIN and VANGL2, RNF41 mediates the K63-linked polyubiquitination of DVL, 
thereby inhibiting its recruitment to activated Frizzled receptors, resulting in suppressed Wnt 
signaling. This non-canonical Wnt signaling contributes to GBM (glioblastoma multiforme) 
progression and highlights a role for RNF41 in regulating GBM cell motility and invasiveness [336].  
2.5.4. Aberrant LR signaling in Prader-Willi syndrome 
LR signaling in the brain is critical for the regulation of energy balance, body weight and glucose 
homeostasis by the actions of leptin in the arcuate nucleus of the hypothalamus where it inhibits 
orexigenic AgRP/NPY (agouti-related protein/ neuropeptide Y) neurons and stimulates anorexigenic 
POMC (pro-opiomelanocortin) neurons [337]. PWS (Prader-Willi syndrome) is a genetic disorder 
caused by a deletion or disruption of genes, including MAGEL2 and NDN, located on chromosome 
15q11-q13 and is characterized by hypotonia, mental retardation, endocrine dysfunction, energy 
imbalance and obesity [338]. Likewise, mice lacking Magel2 were found to be obese with endocrine 
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deficits and exhibit decreased muscle tone. Although these mice have increased levels of leptin they 
appeared to be insensitive to leptin, even when peripherally administered, suggesting that loss of 
Magel2 propagates in PWS through leptin sensing pathways [339]. Moreover, these Magel2-null 
mice were found to have diminished levels of LR and RNF41, and enhanced levels of USP8 and 
STAM1 [310]. RNF41, USP8 and STAM1 are proteins that regulate LR processing [309], and MAGEL2, 
which is highly expressed in the arcuate nucleus, stabilizes RNF41 and destabilizes USP8 and STAM1. 
In this way, MAGEL2 can contribute to the regulation of LR trafficking in POMC neurons [310,340]. 
The loss of MAGEL2 results in destabilized RNF41 and hampers LR cell surface expression, 
internalization and degradation, which can explain the leptin-regulated phenotypes like leptin 
resistance, obesity and glucose dysregulation observed in Magel2-null mouse models of PWS [310]. 
2.5.5. Loss of pa ki  i  Pa ki so s disease 
Pa ki so s disease is a o o  eu odege e ati e diso de  characterized by loss of dopaminergic 
neurons in the substantia nigra and the presence of abnormal protein aggregates called Lewy bodies 
[341]. Patients develop movement disorders like tremors, rigidity, slowness of movement and 
experience variable manifestations of dementia. Both genetic defects and environmental factors like 
o idati e st ess a e auses of Pa ki so s disease. Loss-of-function mutations in the parkin gene are 
the predominant cause of early onset familial Pa ki so s disease [342]. Parkin contains two RING 
domains and functions as an RBR E3 ligase [343]. It here  u i uiti ates su st ates i ludi g α-
synuclein, Pael receptor, CDCrel-1, tubulin, synphilin-1, synaptotagmin, cyclin E, and p38. Loss of 
function mutations in parkin cause accumulation and aggregation of these substrates, resulting in 
death of dopaminergic neurons [344].  
RNF41 ubiquitinates and degrades parkin, and as such stabilizes its substrate CDCrel-1 [345,346]. 
Furthermore, RNF41 overexpression enhanced the production of intracellular ROS (reactive oxygen 
species), while co-expression of parkin reversed this effect [346]. In this way, RNF41 might be 
i ol ed i  the pathoge esis of Pa ki so s disease  odulati g oth pa ki  sta ilit  a d the 
intracellular redox state. Knock out of parkin in mice models causes only mild phenotypes, whereas 
the manifestations in Drosophila are more dramatic and mimic the pathological phenotypes of 
patie ts ith Pa ki so s disease [347]. Overexpression of Drosophila RNF41 in Drosophila 
dopa i e gi  eu o s p o oked se e al Pa ki so s disease-like phenotypes including loss of these 
dopaminergic neurons and impaired flight ability. Here, RNF41 reduced Drosophila parkin and 
overexpression of human parkin reversed the observed phenotypes [348]. This suggests that the 
levels of parkin are important to protect against RNF41-induced toxicity and that RNF41 might be 
o side ed a the apeuti  ta get i  Pa ki so s disease. RNF  a  also o t i ute to Pa ki so s 
disease by influencing cell growth and apoptosis when cells are exposed to environmental factors, as 
RNF41 sensitized cells to external oxidative stress inducers like hydrogen peroxide and 
hydroxynonenal, resulting in apoptosis [349]. Notably, a clinical gene association study failed to show 
a positive association between the RNF41 gene a d Pa ki so s disease de elop e t i  the Chi ese 
population [350]. However, since the pathogenesis of the disease can be influenced by ethnic 
background and geographic origin of the patients, perhaps screening for RNF41 mutations should be 
performed in other populations.  
Parkin is also implicated in regulation of mitochondrial dynamics [347]. Moreover, selective 
recruitment of parkin to damaged mitochondria promotes mitophagy [351]. Soleimanpour et al. 
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discovered another protein, CLEC16A (C-type lectin domain family 16, member A), to be involved in 
the regulatio  of itophag  i  pa eati  β ells. CLEC16A was found to protect RNF41 from 
proteasomal degradation by a yet unknown mechanism. Loss of CLEC16A in pancreatic islets of mice 
significantly reduced RNF41 and increased parkin levels and upregulated early mitophagy. In 
addition, CLEC16A loss of function impaired autophagosomal-lysosomal trafficking in late mitophagy, 
causing defects in the clearance of unhealthy mitochondria [352]. As mitochondrial function is 
imperative for glucose-stimulated insulin release, this dysregulation of glucose homeostasis in 
pa eati  β ells a  lead to diabetes [353]. Thus CLEC16A regulation of the RNF41-parkin 
interaction a  egulate β ell fu tio  a d p e e t diabetes by controlling mitophagy. Furthermore, 
Pdx1, a transcription factor and master regulator of pa eati  β-cell development, was found to 
regulate the expression of CLEC16A and to control downstream effects on RNF41, and can in this way 
direct autophagosome-lysosome fusion during mitophagy [354].   
The reciprocal RNF41-USP8 regulation can, next to cytokinesis (see 2.4) also coordinate mitophagy as 
USP8 was found to remove K6-linked polyubiquitin chains from parkin [355]. This is a crucial step for 
efficient recruitment of parkin to depolarized mitochondria, suggesting a role for USP8 in promoting 
parkin-mediated mitophagy and perhaps a function for USP8-RNF41-Parkin as a tripartite protein 
complex in the regulation of mitophagy. 
 
2.5.6. Drug-mediated regulation of RNF41  
Collectively, the described literature suggests that RNF41 may act as a tumor suppressor by 
maintaining ERBB3 receptors at modest levels. It also functions as a pro-apoptotic protein by 
targeting BRUCE. Additionally, RNF41 might be considered as therapeuti  ta get fo  Pa ki so s 
disease since it suppresses the levels of parkin. Knowledge about the exact mode of action of RNF41 
is crucial to determine whether to use RNF41 inhibitors or activators as treatment in the different 
diseases (an overview of RNF41 in diseases is listed in Table 6).  
RNF41 is regulated at transcriptional and post-translational levels (see Table 7). RNF41 mRNA and 
protein levels are upregulated upon LPS stimulation, both in mouse macrophages and in the cerebral 
cortex of rats [280,295] and by the non-steroidal anti-inflammatory drug Celexocib and the androgen 
receptor in prostate cancer cells [316,318]. Contrary to this, the microRNA miR-497 binds to RNF41 
mRNA and impairs its translation in colorectal cancer cells [356]. Doxorubicin and ABPN, two 
chemotherapy agents, can respectively upregulate RNF41 protein expression in heart tissue of 
mouse and in pancreatic cancer cells by currently unknown mechanisms [325,329]. Moreover, the 
chemotherapeutic drug Lenalidomide inhibits the E3 ligase activity of RNF41 and thus its auto-
ubiquitination resulting in increased RNF41 levels in an erythroid progenitor cell line [357]. A 









Table 6:  Role of RNF41 in disease. 
Disease RNF41 function References 
Breast cancer RNF41 suppresses ERBB3.  Downregulated RNF41 and upregulated 
ERBB3 levels in breast cancer cells.  
[312–314] 
Prostate cancer RNF41 suppresses ERBB3. The AR upregulates RNF41 transcription 
and induces ERBB3 degradation.  
[316–318] 
Glioma RNF41 suppresses BRUCE. Downregulated RNF41 and upregulated 
BRUCE levels in human glioma tissues. 
[294] 
RNF41 suppresses ERBB3. Downregulated RNF41 and upregulated 
ERBB3 levels in human glioma tissues. 
[319,320] 
RNF41 downregulates non-canonical Wnt signaling, resulting in 
inhibited glioma progression. 
[336] 
Pancreatic cancer RNF41 suppresses ERBB3 and BRUCE. ABPN upregulates RNF41, 
thereby decreasing ERBB3 and BRUCE resulting in suppressed 
pancreatic cancer cell growth. 
[325] 
Cardiac disease RNF41 suppresses ERBB3. ERBB3 is necessary for cardiac cell 
survival. Ischemia/reperfusion and doxorubicin upregulate RNF41 
in mouse heart, resulting in increased cardiac injury 
[328,329] 
Identification of an RNF41 polymorphism associated with the risk 




RNF41 suppresses ERBB3. Downregulated RNF41 and upregulated 
ERBB3 levels in HBx-induced hepatocellular carcinoma tissues. 
[324] 
Colorectal cancer miR-497 inhibits RNF41 translation. Downregulated RNF41 and 
upregulated miR-497 in colorectal cancer tissues. 
[356] 
RNF41 suppresses DVL2. EGF stimulation leads to the formation of 
a KITENIN/ERBB4/RNF41 complex, which degrades DVL2, resulting 
in c-Jun upregulation and enhanced colorectal cancer cell motility.  
[331] 
Renal cell carcinoma RNF41 suppresses BRUCE. Downregulated RNF41 and upregulated 





RNF41 downregulates CD8 +T cell receptor signaling. Upregulation 
of RNF41 in CD8+ T cells infiltrated into the brain of mice during 
induction of EAE.  
[283] 
Pa ki so s disease RNF41 suppresses parkin. RNF41 degrades parkin and stabilizes its 
substrate CDCrel- . RNF  i  D osophila p o oked Pa ki so s 
disease-like phenotypes like loss of dopaminergic neurons.  
[346,348,349] 
Diabetes CLEC16A stabilizes RNF41. CLEC16A controls β-cell function and 
prevents diabetes by controlling mitophagy through its actions on 
RNF41 and parkin 
[352,354] 
Psychiatric illness Identification of RNF41 as candidate gene for anxiety-like 




MAGEL2 stabilizes RNF41. Loss of MAGEL2 destabilizes RNF41 and 
dysregulates LR trafficking resulting in leptin resistance and 
obesity in the MAGLE2-null mouse model of PWS 
[310] 
RNF41 (RING finger protein 41); AR (androgen receptor); BRUCE (BIR repeat containing ubiquitin-conjugating 
enzyme); APBN (A4-amino-2-(butyrylamino)phenyl (2E,4E,6E,8E)- 3,7-dimethyl-9-(2,6,6-trimethyl-1-
cyclohexenyl)- 2,4,6,8-nonatetraenoate); HBx (hepatitis B virus encoded X protein); DVL2 (Dishevelled 2); EGF 
(Epidermal growth factor); KITENIN (KAI1 C-terminal interacting tetraspanin); CLEC16A (C-type lectin domain 








Table 7:  Modes of RNF41 regulation. 
Regulator Type of RNF41 regulation References 
LPS mRNA and protein upregulation [280,295] 
Androgen receptor mRNA and protein upregulation [316,317] 
Celexocib mRNA and protein upregulation [318] 
miR-497 inhibition of translation [356] 
ABPN upregulation of protein levels [325] 
Doxorubicin upregulation  of protein levels [329] 
Lenalidomide inhibition of E3 ligase activity resulting in protein stabilization [357] 
RTN4A sequestration in ER resulting in inhibition of E3 ligase activity and 
protein stabilization 
[274] 
CLEC16A protein stabilization [352,354] 
USP8 protein stabilization  [276] 
RNF41 auto-ubiquitination and protein destabilization [276,321] 
HBx protein destabilization [324] 
Par-1b PTM: phosphorylation of S254 [335] 
? PTM: S-nitrosylation of C106 [359] 
RNF41 (RING finger protein 41); LPS (lipopolysaccharide); APBN (A4-amino-2-(butyrylamino)phenyl 
(2E,4E,6E,8E)- 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)- 2,4,6,8-nonatetraenoate); RTN4A (Reticulon 4A); 
CLEC16A (C-type lectin domain family 16, member A); USP8 (ubiquitin-specific protease 8); HBx (hepatitis B virus 





3. Detection of protein-protein interactions 
PPIs (protein-protein interactions) constitute the basis of essentially all biological activities including 
signal transduction, gene regulation and catalytic enzymatic activities in addition to having a 
structural role in the cell. These PPIs differ based on physical characteristics such as the composition, 
affinity and whether they represent stable or transient interactions [360]. Consequently, studying 
these PPIs provides valuable insight into the function of a protein and can facilitate the identification 
of new drug targets. Moreover, the molecular mechanism of an unidentified protein can be 
predicted ia the so alled guilt-by-asso iatio  p i iple , based on the known and established 
function of an interacting protein. Over the years, various PPI techniques have emerged, contributing 
to the growing interactome which has been estimated to embody 650,000 interactions [361]. 
Classical techniques such as Y2H (Yeast Two-Hybrid) [362] and AP-MS (affinity-purification-mass 
spectrometry) [363] have been complemented with new and improved approaches. These enable 
the study of PPIs at their subcellular location (e.g. PLA, RET-based approaches [364,365] or in a 
physiological context, between weak and transient interactions (e.g. MAPPIT, LUMIER, BioID, 
Virotrap [366–369]), full-length integral membrane proteins (e.g. MaMTH [370]) and post-
translationally modified proteins (e.g. protein microarrays [371]). This chapter briefly highlights some 
important high-throughput approaches subdivided into binary and co-complex techniques (see 
Figure 19).  
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Figure 19: Overview of the different binary and co-complex techniques described in this thesis, see text for 
details. Y2H (Yeast Two-Hybrid); MYTH (membrane-based Y2H); MAPPIT (Mammalian Protein-Protein 
Interaction Trap); AP-MS (Affinity Purification-Mass Spectrometry); BioID (Proximity-dependent Biotin 
Identification); B (bait); P (prey); AD (activating domain); DBD (DNA binding domain); U  partial ubiquitin); JAK 
(Janus kinase); STAT (signal transducer and activator of transcription); TF (transcription factor); R (cytokine 
receptor); Cy (cytokine); VSV-G (vesicular stomatitis virus protein G). Figure adapted from [372].  
 
3.1. Binary techniques 
 
3.1.1. Yeast Two-Hybrid 
The classical Y2H method relies on a split transcription factor where the DBD (DNA binding domain) 
and the AD (activation domain) are fused to a bait or prey protein. Interaction between bait and prey 
reconstitutes the transcription factor, where the DBD binds the promotor region, while the AD 
interacts with RNA polymerase II, resulting in the transcription of the reporter gene [362]. This 
method can be implemented using one prey at a time, or like in the study of Rolland et al., using 
entire prey protein libraries [373]. Y2H is an efficient, low cost method that requires a limited 
amount of technology to perform. The eukaryotic environment and well known genome of S. 
cerevisiae allow for easy manipulation. Furthermore, reporter gene expression provides signal 
amplification which enables the detection of transient and weak PPI interactions. This method 
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however exhibits a high number of false positives and false negatives. A major limitation is that the 
interactions take place in the nucleus of yeast cells. This lack of native cellular environment hampers 
the detection of certain mammalian PPI where the proteins are not able to move to the nucleus or 
that rely on PTMs, resulting in false negative interactions. Also, Y2H false positives are often the 
result of interacting proteins that are normally spatially or temporally separated. Additionally, 
incorrectly folded proteins that bind nonspecifically to many baits or proteins that bind or activate 
the reporter gene also can give rise to false positives [374].  
Multiple alternative Y2H systems have been developed, for example reverse Y2H, which is used to 
identify mutations or proteins that impair PPIs. Here, bait and prey interaction lead to lethality of 
yeast cells in selective media, while cells expressing mutant proteins or proteins disrupting the 
interaction survive [375]. Y3H (Yeast three-hybrid) represents another variant that implements a 
third factor, for example a bridging protein, modifying enzyme, small molecule or RNA. Co-expression 
of a modifying enzyme allows for the identification of PTM interactions [376]. Y3H can also be used 
as drug discovery screening method where a small molecule of interest is linked to an anchor moiety 
(e.g. methotrexate or dexamethasone), which interacts with a ligand binding domain (e.g. DHFR 
(dihydrofolate reductase) or glucocorticoid receptor hormone binding domain) coupled to the DBD. 
Interaction between the small molecule and the target protein fused to the AD results in 
transcriptional activation of the reporter gene [377,378].  
3.1.2. Protein complementation assays 
Over the years, many other binary techniques, such as PCAs (protein complementation assays), have 
been developed to improve on the sensitivity and specificity of the original Y2H procedure. 
Generally, PCAs are based on the fusion of the bait and prey to a separate fragment of a reporter 
protein, where bait and prey interaction causes the reassembly of the split fragments ultimately 
resulting in reporter activity. For example, the split-ubiquitin system, MYTH (membrane-based Y2H), 
allows for the detection of membrane-bound proteins. Bait and prey, one or both representing an 
integral membrane protein, are fused to a C-terminal and N-terminal ubiquitin moiety. In addition, 
the C-terminal moiety is coupled to a tagged DHFR or to a transcription factor. Bait and prey 
interaction reconstitute the ubiquitin molecule that is recognized by ubiquitin specific proteases 
which subsequently cleave off the DHFR or transcription factor, allowing detection of tagged DHFR 
on Western blot or resulting in the activation of a reporter gene [379,380]. MYTH formed the basis 
for the later developed mammalian variant MaMTH (mammalian membrane two-hybrid) [370]. 
Other mammalian PCAs include BiFC (Bimolecular fluorescence complementation), where bait-prey 
interaction complements a split fluorescent protein (e.g. YFP or GFP) that can be readily detected 
using fluorescence plate readers or microscopy [381]; enzyme complementation assays, where, upon 
bait-pre  i te a tio , the e o stituted epo te  e z e e.g. β la ta ase, β gala tosidase, lu ife ase 
or DHFR) results in the enzymatic conversion of a substrate into a detectable end product [382]; and 
Split-TEV assays, where bait-prey interaction reconstitutes a TEV (tobacco etch virus) protease that 
cleaves and releases a transcription factor or luciferase enzyme which activates a reporter gene or 
results in light emission upon luciferin addition, respectively [383]. While the enzyme 
complementation and Split-TEV assays have higher sensitivity due to their signal amplification ability, 
BiFC has the added value of providing additional information about the subcellular location where 
the PPIs occur when visualized with microscopy and allows for the detection of multiple PPIs at the 
same time.  
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3.1.3. MAPPIT 
MAPPIT (MAmmalian Protein-Protein Interaction Trap) is an in-house developed method to detect 
PPIs in intact mammalian cells. It is based on the functional complementation of the JAK-STAT (Janus 
kinases-signal transducers and activators of transcription) signaling pathway of type I cytokine 
receptors upon bait and prey interaction. In this assay the bait protein is coupled to a signaling-
deficient chimeric receptor comprising the extracellular domain of the EPOR and the transmembrane 
domain and cytoplasmic tail of the LR. The three conserved tyrosine residues in the cytoplasmic tail 
of the LepR are mutated to phenylalanine, which eliminates STAT3 recruitment (Y1138F) and 
negative-feedback mechanisms (Y985F and Y1077F). The prey protein is fused to a C-terminal portion 
of the gp130 (glycoprotein 130) receptor, containing functional STAT3 recruitment sites. Upon ligand 
binding, bait and prey interaction leads to trans-phosphorylation and activation of the associated 
JAKs. In turn, JAKs phosphorylate the prey chimera followed by recruitment and activation of STAT3. 
STAT s dimerize and migrate to the nucleus resulting in transcriptional activation of a luciferase 
reporter gene [366].  
As MAPPIT operates in intact mammalian cells, it provides a natural environment for proteins in the 
presence of both endogenous cofactors and regulatory proteins enabling proper post-translational 
modifications and/or PPIs. Furthermore, this context allows analysis of (functional) PPI modulations 
triggered by exogenously stimuli that, for instance, activate certain signaling pathways or induce a 
stress response. The signal amplification at multiple levels (substrate and STAT phosphorylation, 
reporter gene transcription and luciferin conversion) contributes to the sensitivity and robustness of 
the technology, facilitating the detection of weak and transient interactions. False positive signals are 
limited due to the physical separation of the interaction zone (cytoplasm) and the read-out zone 
(nucleus), and the ligand inducible nature of the system. Moreover, MAPPIT proved to be easy 
scalable and is therefore an excellent tool for high-throughput interactome studies. By using reverse 
transfection techniques in combination with robotics, ArrayMAPPIT and the highly miniaturized 
microarrayMAPPIT allow the screening of a large collection of preys, derived from the huORF (human 
open reading frame) collection, with approximately 15.000 full size ORFs [384,385].  
A drawback of MAPPIT is the inevitable membrane anchoring of the bait protein, hindering the study 
of many PPIs at their native subcellular localization. This problem led to the development of KISS 
(KInase Substrate Sensor), a MAPPIT-derived method compatible with full-length transmembrane 
proteins that allows in situ analysis of PPIs. This method uses the conventional MAPPIT prey chimera, 
whereas the bait protein is coupled to a C-terminal, kinase-containing portion of TYK2 (tyrosine 
kinase 2). Since the Tyk2 kinase domain lacks a subcellular localization signal, localization of the 
chimeric KISS bait solely relies on the used bait protein (see addendum 1; [386]). MAPPIT further 
constitutes other interaction tools, including heteromeric MAPPIT and the three-hybrid variant 
MASPIT. Heteromeric MAPPIT enables the detection of modification-dependent interactions via the 
extracellular domains of the heteromeric GM-CSF (granulocyte-macrophage colony-stimulating 
factor) receptor which permit incorporation of modifying enzymes in the trap, while MASPIT allows 
profiling of small molecule-protein interactions [387,388]. Furthermore, MAPPIT was successfully 
used in combination with random mutagenesis, resulting in a high-throughput method that allows 
for extensive mapping of PPI interfaces (see addendum 2; [389–391]).   
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3.2. Co-complex techniques 
 
3.2.1. AP-MS 
The combination of AP-MS represents another classical method for generating interactome maps. 
This method enables the isolation of multi-protein complexes directly form cell lysates via one or 
more AP steps. The bait protein of interest is fused to an epitope tag and expressed in the cell. For 
high-throughput methods this tag is usually a Flag tag or a TAP (tandem affinity purification) tag 
[392,393]. The Flag tag is purified using an anti-Flag antibody resin and eluted with a large excess of 
competing Flag peptide. The TAP tag on the other hand, consists of a CBP (calmodulin binding 
peptide), followed by a TEV protease cleavage site and protein A, and purification of this tag requires 
multiple steps. First, a matrix coated with IgG is used, which has strong affinity for the protein A 
moiety in the TAP tag. After TEV cleavage of the tag, the CBP fused protein of interest is immobilized 
on a calmodulin coated matrix and eventually released using the calcium chelator EGTA. These tags 
have their own advantages and disadvantages. For instance, Flag-tag purification could detect 
weaker and more transient PPI compared to the TAP tag, whereas the TAP tag decreases background 
levels compared to the Flag-tag. After purification the proteins are subjected to proteolytic digestion, 
usually by trypsin, resulting in a mixture of peptides. These peptides are then separated by HPLC 
(high-performance liquid chromatography) and ionized prior to identification. The generated data 
represents the relative abundance of each ionized peptide based on its mass-to-charge ratio, which is 
used to identify proteins using different search engines [394].  
Although originally used in yeast, AP-MS can be performed in all cell types thus providing a 
physiological relevant background [392,393]. It allows for the identification of PTMs and can detect 
dynamic changes in the composition of protein complexes by using quantitative methods like SILAC 
(stable-isotope labelling with amino acids in cell culture) [395]. The biggest limitation of AP-MS is the 
lysis step in which homogenization generally results in the identification of more false positives. Next 
to this, the extensive washing steps often disrupt weak and transient interactions, resulting in more 
false negatives.  
3.2.2. BioID 
An alternative approach to AP-MS is BioID (proximity-dependent biotin identification), which exploits 
proximity-dependent in vivo protein biotinylation. In this method the bait protein is fused to a 
mutated biotin ligase, BirA*, resulting in promiscuous biotinylation [368]. Wild-type BirA catalyzes 
the reaction in which reactive biotinyl-AMP is formed from biotin and ATP, followed by the 
attachment of biotinyl-AMP to a specific lysine on a subunit of the acetyl-CoA carboxylase. BirA*, on 
the other hand, prematurely releases this generated biotinyl-AMP, resulting in the covalent 
attachment to the lysine residues of nearby proteins [396]. Interaction partners of BirA* fused baits 
can be enriched by streptavidin affinity purification followed by MS analysis. Since the biotinylation 
step precedes solubilization, it can detect weak and transient interactions, offering great advantages 
over regular AP-MS. BioID also provides a native cellular environment, allowing for the detection of 
indirect and PTM-requiring interactions. In addition, the necessity to add excess biotin to the cell 
culture medium enables the system with a built-in inducibility, thereby opening up the future 
possibility of performing pulse–chase type experiments. 
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This latter advantage also represents a downside of this method, as the permanent addition of biotin 
to lysines may lead to the loss of charge on these sites and at the same time could inhibit additional 
secondary modifications, for instance ubiquitination, necessary for the interaction with other 
proteins. Another limitation of BioID is the fact that the assay may detect adjacent proteins that are 
not true interactors, the activity radius of BirA* is currently estimated to be within 20-30nm [368]. 
Also, the fact that BirA* is a large (35kD) fusion protein, may impair normal targeting stability or 
function of the bait protein of interest. Recently, BioID2 was developed, which deals with some of 
the limitations arising from classical BioID, as this method uses a substantially smaller BirA* that 
enhances the labeling of proximate proteins, and requires less biotin supplementation [397].  
3.2.3. Virotrap 
Virotrap represents another co-purification strategy that relies on the production of VLPs (virus-like 
particles) to detect PPI and analyze protein complexes. Here, the bait protein of interest is fused to 
the C-terminus of the Gag protein of HIV. Overexpression of the Gag protein has the inherent 
potential to produce VLPs and Virotrap hereby allows the entrapment of the Gag-coupled bait 
together with its interacting partners in these VLPs. Co-expression of Flag-tagged and non-tagged 
VSV-G (vesicular stomatitis virus G) form trimers on the VLPS surface and enable the purification of 
the VLPs from the supernatant by using an anti-FLAG coated matrix. After this enrichment step the 
particles are lysed and the content can be analyzed with MS. This method allows the study of 
cytosolic complexes and also detects ER and plasma membrane residing proteins. Furthermore, 
Virotrap is suitable for the detection of small molecule interactors by fusing Gag to DHFR and 
coupling the small molecule to methotrexate. It can also be used as a binary approach, where 
labeling of both bait and prey proteins followed by Western blot analysis can validate specific PPIs 
[369].  
The Gag proteins inside the VLP form a scaffold that, due to avidity effects, can increase the 
sensitivity for interaction partners that otherwise bind with low affinity. Moreover, this method 
eliminates the need for solubilization and therefore preserves the protein complexes, limits the 
detection of false positives and enables identification of weak and transient interactions. On the 
other hand, the VLPs contain a number of non-specific background interactors like structural and 
serum proteins or proteins that are related to HIV biology. These additional false-positives however, 
can be extracted using suitable filter strategies. The size of a VLP is approximately 145nm, which also 
limits the size of the trapped protein complex, although it is currently not known what the maximum 
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RNF41 is an E3 ubiquitin ligase involved in the ubiquitination and degradation of many proteins such 
as ERBB3 receptors, BRUCE and parkin. Our lab previously showed that RNF41 influences the cell 
surface expression and signaling of the LR, LIFR and IL6R, three JAK2-associated type I cytokine 
receptors. Moreover, RNF41 was found to modulate the intracellular trafficking of these cytokine 
receptors. By ubiquitinating and suppressing USP8, RNF41 indirectly destablizes the ESCRT-0 
complex, which inhibits these receptors from undergoing lysosomal degradation and subsequently 
reroutes them towards compartments for ectodomain shedding. This thesis aimed to further 
elucidate the function of RNF41 in intracellular trafficking through the identification of new 
interaction partners. 
In the first part of the thesis we investigate the interaction between RNF41 and VPS52, a novel 
interaction partner identified via an initial array MAPPIT screen. This protein is involved in retrograde 
transport and recycling pathways and could therefore be implicated in, and further elaborate the 
functional effects of RNF41 in rerouting of cytokine receptors. This study was supported by a 
combination of random mutagenesis and MAPPIT that generates and identifies mutants specifically 
disrupting the interaction between RNF41 and VPS52.  
The second part of the thesis describes the construction of the RNF41 interactome network. Data 
from newly performed high-throughput screens were merged with preexisting data from previously 
performed microarray MAPPIT and Y2H screens in order to build a high resolution and high 
confidence map of RNF41 interaction partners. A novel candidate partner, AP2S1, was selected from 
the high confidence map for further functional validation by determining its role in RNF41 mediated 
LR shedding, degradation and signaling.  
We, and other groups, frequently observed a vesicular-like pattern for overexpressed RNF41 with 
immunofluorescence microscopy. In the last part of this thesis we attempt to characterize the 
RNF41-positive structures by using a number of known organelle and aggregate markers. In this way 



























































RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes 
       Article published in Plos One (2017) 
 
RNF41 (RING finger protein 41) is involved in the ubiquitination and downregulation of many 
substrates including BRUCE (BIR repeat containing ubiquitin-conjugating enzyme), parkin, USP8 
(Ubiquitin-specific protease 8) and the ERBB3 receptor. It is also involved in the intracellular 
transport of several type I cytokine receptors such as the LR (leptin receptor), LIFR (leukaemia 
inhibitory factor receptor) and IL-6R (interleukin 6 receptor). We aimed to further elucidate the role 
of RNF41 in intracellular trafficking by identifying new interaction partners with the in-house 
developed Array MAPPIT (Mammalian Protein-Protein interaction trap) technology. This paper 
describes the identification of VPS52 (vacuolar protein sorting 52) as a novel RNF41 interaction 
partner. VPS52 is a subunit of the GARP (Golgi-associated retrograde protein) and the EARP 
(endosome-associated recycling protein) complexes which are involved in the sorting of cargo from 
the early endosomes towards the TGN or recycling endosomes, respectively. We show that via coiled 
coil domain interactions, RNF41 ubiquitinates and relocates VPS52 away from VPS53, another 
common subunit of the GARP and EARP complexes, towards RNF41 positive structures. This effect 
was lost when using an RNF41 mutant, specifically disrupting the interaction between RNF41 and 
VPS52, which was identified via a straightforward, high-throughput method combining random 
mutagenesis and MAPPIT.  
The addendum describes the functional effects of RNF41 on EARP and GARP substrates, and the 
influence of VPS52 on known RNF41 functions. This data was obtained during the follow-up of this 
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Abstract
RNF41 (Ring Finger Protein 41) is an E3 ubiquitin ligase involved in the intracellular sorting
and function of a diverse set of substrates. Next to BRUCE and Parkin, RNF41 can directly
ubiquitinate ErbB3, IL-3, EPO and RARα receptors or downstream signaling molecules
such as Myd88, TBK1 and USP8. In this way it can regulate receptor signaling and routing.
To further elucidate the molecular mechanism behind the role of RNF41 in intracellular
transport we performed an Array MAPPIT (Mammalian Protein-Protein Interaction Trap)
screen using an extensive set of proteins derived from the human ORFeome collection.
This paper describes the identification of VPS52, a subunit of the GARP (Golgi-Associated
Retrograde Protein) and the EARP (Endosome-Associated Recycling Protein) complexes,
as a novel interaction partner of RNF41. Through interaction via their coiled coil domains,
RNF41 ubiquitinates and relocates VPS52 away from VPS53, a common subunit of the
GARP and EARP complexes, towards RNF41 bodies.
Introduction
Eukaryotic cells contain various types of organelles involved in the transport of proteins and
lipids. Forward trafficking of cargo in the secretory pathway is counterbalanced by retrograde
transport in which resident proteins and transport machinery components are transported
back to their original compartment [1–3]. In the endocytic pathway, molecules are internalized
at the plasma membrane and delivered to the early endosomes. These early or ‘sorting’ endo-
somes segregate cargo coming from the plasma membrane into different membrane subdo-
mains. Certain proteins are targeted for lysosomal degradation through the late endosome,
while other cargo bypass this step and undergo retrograde transport to the Golgi network, or
recycle back to the plasma membrane directly from the endosomes or via the recycling endo-
somes [4–8]. Biosynthetic, endocytic and retrograde trafficking are highly regulated by the
coordinated actions of tethering factors, SNAREs (Soluble N-Ethylmaleimide-Sensitive Factor
Attachment Protein Receptors) and small G proteins from the Rab and Arl (Arf-like) family in
order to maintain homeostasis of each organelle [9,10].
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A key regulatory mechanism of intracellular transport is ubiquitination, which acts as a sig-
nal for internalization and sorting of receptors and adaptors [11–14]. The ESCRTs (Endoso-
mal Sorting Complex Required for Transport) further mediate the sorting of ubiquitinated
cargo into ILVs (intraluminal vesicles) of MVBs (multivesicular bodies) destined for lysosomal
degradation [15,16]. Many E3 ligases have been identified to play a role in endocytosis and
lysosomal sorting of membrane proteins. RING (really interesting new gene) finger E3 ligases
act as a scaffold to coordinate ubiquitin transfer from an ubiquitin-conjugating E2 enzyme
recruited by their RING domain to a specific substrate associated with their substrate binding
domain. We previously reported that RNF41 (RING finger protein 41 or Nrdp1 (neuregulin
receptor degradation protein-1) or FLRF (fetal liver ring finger) in mouse) controls the sort-
ing and processing of JAK2-associated cytokine receptors including the LR (leptin receptor),
LIFR (leukaemia inhibitory factor receptor) and IL6R (interleukin 6 receptor). RNF41 blocks
lysosomal sorting and simultaneously enhances ectodomain shedding of these receptors by
members of the ADAM (a disintegrin and metalloproteinase) family [17]. It does so by ubiqui-
tinating, destabilizing and relocalizing the deubiquitinase USP8 (ubiquitin-specific protease
8). This leads to a destabilized ESCRT-0 complex, resulting in the rerouting of receptors from
the lysosomal degradation pathway to compartments for ectodomain shedding [18]. RNF41
has been implicated in other signaling pathways; it directly ubiquitinates and subsequently
downregulates the RARα (retinoic acid receptor alpha), the IL-3 (interleukin-3), EPO (eryth-
ropoietin) and ErbB3 receptors, independent of their respective ligands [19–22]. Moreover,
RNF41 was reported to differentially regulate Myd88- and TRIF-dependent pathways of TLR4
(Toll-like receptor 4) by ubiquitinating adaptor proteins Myd88 (poly-lys48) and TBK1 (poly-
lys63) respectively [23].
To further elucidate the function of RNF41 in intracellular transport we screened a human
ORFeome collection containing around 8500 open reading frames in search of novel interac-
tion partners of RNF41 using Array MAPPIT, a high-throughput mammalian two-hybrid
screening method [24]. One newly identified RNF41 interaction partner was VPS52 (vacuolar
protein sorting 52) which is a key component of two spatially distinct multisubunit tethering
complexes, the GARP (Golgi-Associated Retrograde Protein) and EARP (Endosome-Associ-
ated Recycling Protein) complexes. The GARP complex is mainly located at the TGN (Trans
Golgi Network) and consists of VPS52 together with Ang2, VPS53 and VPS54 [25–27]. This
complex functions as a tethering factor for retrograde transport of cargo from endosomes to
the TGN. As such, it participates in the delivery of internalized STxB (Shiga toxin B-subunit)
and in the retrieval of the M6PR (mannose-6-phosphate receptor), the TGN-resident protein
TGN46 and certain SNAREs to the TGN [25,28,29]. The GARP complex is also required for
sphingolipid homeostasis and for post-Golgi anterograde transport of GPI-anchored and
transmembrane proteins [30,31]. In the EARP complex, VPS54 is substituted by Syndetin
while the other subunits are shared with the GARP complex, giving rise to a new tethering
complex that associates with recycling endosomes and promotes the recycling of internalized
transferrin receptor to the plasma membrane [32].
In this paper we show that RNF41 and VPS52 interact with each other via their CC (coiled
coil) domains and demonstrate that RNF41 is able to ubiquitinate and relocate VPS52 from its
subcellular location.
Results
VPS52 is a novel interaction partner of RNF41
Array MAPPIT, a high throughput two-hybrid screening method developed in our lab, was used
to identify new interaction partners of RNF41 [24]. This method is based on complementation
RNF41 interacts with VPS52
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of the JAK-STAT signaling pathway of type I cytokine receptors and allows the detection of pro-
tein-protein interactions in intact mammalian cells [33]. Screening was carried out with the
RNF41 mutant C34S/H36Q bait, which lacks the ability to recruit an E2 conjugating enzyme.
This prevents possible RNF41-dependent ubiquitination and degradation of interacting preys
expressed in the system. The RNF41 mutant bait was screened against a human ORFeome col-
lection that covered up to 8.500 preys (list available upon request). VPS52 appeared as one of
the top ranked interaction partners of RNF41 amongst other known interaction partners like
KDM3B, HOMER2 and ASB6 [34, 35] (Fig 1A). Binary MAPPIT retests confirmed that VPS52
specifically interacted with RNF41 and not with the bait receptor backbone (Fig 1B). AlphaSc-
reen analysis further validated that E-tagged VPS52 specifically interacted with co-expressed
Flag-tagged RNF41 in HEK293T cells, and not with a Flag-tagged mock construct, even though
E-tagged VPS52 levels in the AlphaScreen lysate fraction were reduced upon RNF41 co-transfec-
tion (Fig 1C). Moreover, endogenous RNF41 could be precipitated using an antibody against
endogenous VPS52 in HEK293T cells (Fig 1D) and in vitro GST-pull down analysis confirmed a
direct interaction between VPS52 and RNF41 (Fig 1E). Confocal microscopy of transfected
HeLa cells showed a perinuclear localization of VPS52 reminiscent of the trans-Golgi network,
while RNF41 localized to punctate cytoplasmic structures. Upon co-transfection, RNF41 and E-
tagged VPS52 colocalized in RNF41-positive structures, which we will further refer to as RNF41
bodies(Fig 1F). Of note, the amount of ectopically expressed RNF41 used for confocal experi-
ments was similar to, or below endogenous levels of RNF41 (data not shown). Moreover, RNF41
has a potential myristoylation site at its N-terminus, which could account for membrane anchor-
ing [21], and explain the vesicular pattern of RNF41 observed in Fig 1F. For this reason only C-
terminal tagged constructs of RNF41 were used. No difference was observed between expression
of N- or C-terminally tagged VPS52. Furthermore, co-immunoprecipitation and AlphaScreen
data revealed that RNF41 exclusively interacts with VPS52 and not with the other GARP or
EARP subunits (Fig 1G–1E).
L163 in the coiled-coil domain of RNF41 is required for interaction with
VPS52 but not for RNF41oligomerization
To map the interaction of VPS52 on RNF41 we created several truncated forms of RNF41,
which were tested in MAPPIT as bait proteins against the VPS52 prey (Fig 2A). The amino-
terminal half of RNF41 (AA1-134; N-term) holds a RING domain and the carboxy-terminal
half (AA135-317; C-term) consists of a CC domain (AA135-179; CC) and a substrate binding
(AA179-317) domain [21]. Only the CC domain and C-terminal RNF41 bait, including the
CC domain, interacted with VPS52 prey, demonstrating that the CC domain of RNF41 is nec-
essary for interaction with VPS52 (Fig 2B). To further determine critical RNF41 amino acids
involved in the interaction with VPS52, we used an approach that combined randommuta-
genesis with MAPPIT [36]. Briefly, the MAPPIT RNF41 bait protein was randomly mutated
via error prone PCR, covering 113 of a total of 317 amino acids, a mutation yield of about 36%
with approximately 26% single mutations. Putative RNF41 mutants were tested against the
VPS52 prey or a JAK2-binding prey as a control for expression of the bait receptor. RNF41
mutants were selected based on a single amino acid mutation that strongly decreased the rela-
tive MAPPIT signal S1 Table. Mutations at position 163 reoccurred multiple times in the
screen and binary MAPPIT retests clearly showed a disruption of the RNF41-VPS52 interac-
tion using the RNF41 L163Q mutant bait (Fig 2B). The L163Q mutation was specific towards
VPS52, as interaction between RNF41 and other interaction partners, such as USP8 [37] and
ASB6 (manuscript in preparation), was not affected S1 Fig. Significantly, as for the L163Q
mutant, all other RNF41 mutants found to disturb the interaction with VPS52 were located in
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Fig 1. VPS52 is a novel interaction partner of RNF41. (A) Array MAPPIT screen result of the RNF41 C34S/H36Q bait against a library covering
up to 8,500 preys shown as a volcano plot of the log ratio of normalized MAPPIT luciferase activity versus P value. (B)MAPPIT analysis of
HEK293T cells transiently cotransfected with a vector encoding an RNF41 or empty bait, a VPS52 prey plasmid and the pXP2d2-rPAP1-luciferase
reporter plasmid, followed by 24 hours Epo stimulation or left untreated. The luciferase signal is expressed as fold induction (stimulated/non stimulated),
relative to the signal of a control JAK2 binding prey ± s.d. of triplicate measurements. Western blotting verified Flag-tagged prey expression and β-actin
RNF41 interacts with VPS52
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the CC domain of RNF41 S2 Table. This marks VPS52 as the first RNF4 interaction partner
that binds to its CC domain. Co-immunoprecipitation (Fig 2C) and AlphaScreen data (Fig
2D), where the RNF41 truncated forms were co-expressed with VPS52 in HEK293T cells, con-
firmed the MAPPIT results. Of note, the L163Q mutant showed no difference in stability com-
pared to WT RNF41 (data not shown).
The program Logicoil [38], predicted the CC regions of RNF41 to form a trimer, which cor-
responds to the observations in a recently published paper based on chemical crosslinking and
size exclusion chromatography [39] (Fig 2E). The trimeric coiled-coiled core does not consist
merely of hydrophobic residues, but also has hydrophilic histidine and asparagine residues.
Intermolecular salt bridges outside the core help to stabilize the coil. As RNF41 is able to tri-
merize via its CC domain, we examined whether the RNF41 L163Q mutation also affects
RNF41 oligomerization. Immunoprecipitation and AlphaScreen analysis of transfected
HEK293T cells showed that only RNF41ΔCC was able to impair RNF41 oligomerization (Fig
2F and 2G). We conclude that the CC region of RNF41, more specifically residue L163 located
in this CC region, is necessary for its interaction with VPS52, while this L163 residue is redun-
dant for RNF41 oligomerization.
D120, E124 and E127 in the CC domain of VPS52 interact with RNF41
and this interaction decreases RNF41 oligomerization
The Logicoil algorithm also predicted a CC domain in VPS52 between residues 120 and 151.
We next created a truncated form of VPS52 without the CC domain (ΔCC), and one existing
of only the CC domain (CC) (Fig 3A). We extended the CC domain from residues 109 to 151
as we observed optimal expression of the CC domain using this construct. Modeling of the CC
region of VPS52 led to the prediction of a trimeric state with an extensive hydrophobic core
(Fig 3B). MAPPIT analysis showed that the CC domain of VPS52 is essential and sufficient for
binding with RNF41, as the VPS52 CC prey interacts with the RNF41 bait, while the VPS52
ΔCC prey does not (Fig 3C). Co-immunoprecipitation with ectopically expressed RNF41
and VPS52 mutant or truncated constructs in HEK293T cells verified the MAPPIT results
(Fig 3D).
Since RNF41 and VPS52 interact with each other via their respective CC domains (Figs
2B, 2C, 3C and 3D), and RNF41 oligomerizes via its CC domain ([39] and Fig 2F and 2G),
we examined whether VPS52 binding to RNF41 interferes with RNF41 oligomerization.
VPS52 co-expression impeded the interaction between Flag-tagged and E-tagged RNF41 in
levels (loading control). (C) AlphaScreen analysis of HEK293T cells transiently cotransfected with plasmids encoding E-tagged VPS52 and Flag-tagged
RNF41 or SV40 large T antigen (SVT) as an irrelevant protein (mock). After 48 hours, cells were lysed and protein interactions were detected with the
AlphaScreen FLAGTM (M2) detection kit (PerkinElmer Life Sciences) by generation of a luminescent signal, displayed as absolute light units. Western
blotting shows E and Flag-tagged protein expression and a β-actin loading control. (D)Co-immunoprecipitation of endogenous VPS52 and RNF41.
HEK293T lysates were immunoprecipitated with anti-VPS52 or a control normal rabbit IgG. The immune complexes (first and second lane) and the
input (third lane) were analyzed by immunoblotting with an antibody specific to RNF41 (middle panel). Anti-actin was used as a loading control (E)GST-
pulldown ofEscherichia coli BL21(DE3) cell lysates expressingGST-PGC1α (negative control, lane 2) or GST-RNF41 (lane 3) using glutathione
sepharose beads and incubated with in vitro transcribed and translated Flag-tagged VPS52.Western blotting using anti-Flag and anti-GST antibodies
reveals bead-bound protein complexes and expression of Flag-tagged VPS52 (lane 1). (F)Confocal microscopy of HeLa cells transfected with plasmids
encoding either E-tagged VPS52 (left panel) or untagged RNF41 (middle panel), together with soluble IL5Rα plasmid as a control, or plasmids encoding
E-tagged VPS52 and RNF41 (right panel). Cells were fixed and stained with DAPI (nuclei staining, blue), anti-Etag (secondary Alexa Fluor 488, green)
and anti-RNF41 (secondary Alexa Fluor 568, red) antibodies. The inset shows amagnification of the boxed area. The white overlay represents the
intersect between RNF41 and VPS52 with a threshold set on standard deviation using Volocity 6.3 software (Perkin Elmer, Waltham,MA, USA). Scale
bar, 10μm. n = 3 or more for all performed experiments. (G)Co-immunoprecipitation analysis of HEK293T cells transiently cotransfected with plasmids
encoding E-taggedRNF41 and Flag-taggedGARP/EARP subunits or soluble IL5Rα. Anti-Flag immunoprecipitates (right panel) and lysates (left panel)
were visualized with anti-Flag, anti-Etag and anti-actin. (H) AlphaScreen analysis of HEK293T cells transiently cotransfected with plasmids encoding E-
tagged RNF41 and Flag-taggedGARP/EARP subunits or SVT.
https://doi.org/10.1371/journal.pone.0178132.g001
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Fig 2. L163 in the RNF41 CC interacts with VPS52 but is not required for RNF41 oligomerization. (A) Schematic representation of the amino
acid range, L163Q point mutation (indicated with x) and subdomain structure of the full length and truncated RNF41 constructs used to map the
VPS52 interaction site. Domain designations: N term, the amino-terminal domain; RING, RING domain; C term, the carboxy-terminal domain; CC,
the CC domain; ΔCC, RNF41 construct lacking the CC domain. (B)MAPPIT analysis of HEK293T cells transiently co-transfected with a vector
encoding a VPS52 prey and an empty, wild type (WT), point mutated or truncated RNF41 bait. (C)Co-immunoprecipitation analysis of HEK293T
cells transiently co-transfected with a plasmid encoding E-tagged VPS52 and Flag-taggedWT RNF41, L163Q, N-term, C-term, substrate binding
RNF41 interacts with VPS52
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AlphaScreen, whereas co-expression of the VPS52ΔCCmutant partially restored this interac-
tion (Fig 3E). As RNF41 homotrimers are prone to auto-ubiquitination and degradation, dis-
ruption of RNF41 homotrimers lead to a more stabilized RNF41 expression [39]. We observed
this in S2B Fig, where VPS52 co-expression increases RNF41 monomer expression compared
to mock- or VPS52ΔCC- transfected cells. This was compensated for in Fig 3E. These results
fit a hypothesis where CC RNF41 and VPS52 monomers can be interchangeable to form
RNF41-VPS52 heterotrimers. The existence of such RNF41 and VPS52 heterotrimers is sup-
ported by molecular modeling that shows high electrostatic compatibility between the helices
of RNF41 and VPS52: E153, K160 and K167 of RNF41 respectively face R125, D136 and E143
in VPS52. Furthermore, E165 and E169 in RNF41 are both able to interact with R145 in
VPS52, and R148 in RNF41 can interact with D120, E124 and E127 in VPS52 (Fig 3F). Based
on this model we selected three negatively charged residues, D120, E124 and E127 in VPS52
(Fig 3A and 3B) which proved to be important for the interaction with RNF41. MAPPIT and
co-immunoprecipitation analysis demonstrated that this VPS52 DEE/RRA mutant prey dis-
rupted the interaction with the RNF41 bait (Fig 3C and 3D).
RNF41 ubiquitinates and relocates VPS52
Since RNF41 is an E3 ubiquitin ligase, we next assessed ubiquitination of VPS52. In contrast to
the L163Q mutant, expression of RNF41 clearly enhanced the endogenous ubiquitination sta-
tus of Flag-tagged VPS52 (Fig 4A). As increased ubiquitination can result in protein degrada-
tion, we analyzed the effect of RNF41 on VPS52 protein expression. Interestingly, different
conditions of cell lysis showed markedly contrasting results. Co-expression of RNF41 reduced
VPS52 protein levels in the RIPA-soluble fraction (Fig 4B, middle) and caused co-enrichment
of RNF41 and VPS52 in the sonicated RIPA-insoluble pellet fraction (Fig 4B, right), while total
VPS52 levels remained unchanged when cells were physically disrupted by sonication in
Laemmli loading buffer (Fig 4B, left). This indicates that RNF41 causes a partial redistribution
of VPS52 to the detergent-insoluble fraction. This effect was lost when using a dominant nega-
tive (DN) RNF41, a RNF41 truncated form including residues 109 to 317, thus lacking the
RING domain and myristoylation site but retaining the CC domain [20,21], or the L163Q
mutant. This indicates that the E3 ligase activity and/or membrane anchoring of RNF41 and
its specific interaction with VPS52 are necessary for this RNF41-dependent VPS52 redistribu-
tion. Moreover, enrichment of RNF41 and L163Q in the RIPA-insoluble pellet fraction (Fig
4B, right), contrary to DN abundancy in the RIPA-soluble fraction (Fig 4B, middle), indicates
that the E3 ligase activity and/or membrane anchoring of RNF41 and not merely its oligomeri-
zation are required for RNF41 enrichment in the RIPA-insoluble pellet fraction.
We next used confocal microscopy to determine whether RNF41 altered the intracellular
localization of VPS52 in HeLa cells. It is known that VPS52 mainly associates with the TGN,
together with the three other subunits of the multimeric GARP complex i.e. VPS53, VPS54
and Ang2 [26,27]. However, VPS52 can also reside at recycling endosomes together with the
domain, RNF41 CC-gp130 (prey construct used to optimize expression), RNF41 ΔCC or soluble IL5Rα (mock). Also Anti-Flag immunoprecipitates
(right panel) and lysates (input, left panel) were visualized with anti-Etag, anti-Flag and anti-actin (loading control). (D) AlphaScreen analysis of
HEK293T cells transiently co-transfected with a vector encoding E-tagged VPS52 and Flag-tagged SVT (negative control), WT RNF41 or L163Q.
(E) Side (left) and top (right) view of a model of trimeric RNF41 coiled-coils based on the RNF41 sequence using CC-builder and Logicoil. L163 is
highlighted as green spheres. (F)Co-immunoprecipitation of HEK293T cells transiently co-transfected with E-taggedWTRNF41 and Flag-tagged
RNF41, L163Q, RNF41 ΔCC or with Flag-tagged soluble IL5Rα (mock) shows that the L163Qmutation does not hamper RNF41 oligomerization.
Anti-Flag immunoprecipitates (right panels) and lysates (left panels) were visualized with anti-Flag and anti-Etag. (G) AlphaScreen analysis of
HEK293T cells transiently co-transfected with a plasmid encoding E-tagged RNF41 and Flag-tagged SVT,WT RNF41 and L163Q. n = 3 or more
for all experiments performed.
https://doi.org/10.1371/journal.pone.0178132.g002
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Fig 3. D120, E124 and E127 in the VPS52 CC interact with RNF41 resulting in decreased RNF41 oligomerization. (A) Schematic representation
of the amino acid range, point mutations (indicated with x) and subdomain structure of the full length and truncated VPS52 constructs used to map the
RNF41 interaction site. Domain designations as in Fig 2A. (B) Side (left) and top (right) view of a model of trimeric VPS52 coiled-coils based on the
VPS52 sequence using CC-builder and Logicoil. D120, E124 and E127 are highlighted as red spheres. (C)MAPPIT analysis of HEK293T cells
transiently co-transfected with a plasmid encoding an RNF41 bait and an empty; WT; mutated or truncated VPS52 prey. (D)Co-immunoprecipitation
analysis of HEK293T cells transiently co-transfected with a vector encoding E-tagged RNF41 and Flag-taggedWT VPS52, VPS52CC-gp130 (prey
construct used to optimize expression), VPS52ΔCC, VPS52 DEE/RRA or soluble IL5Rα (mock). Anti-Flag immunoprecipitates (right panel) and
lysates (left panel) were visualized with anti-Etag, anti-Flag and anti-actin (loading control). (E) Ectopic expression of VPS52 hampers RNF41
oligomerization. AlphaScreen analysis of HEK293T cells transiently co-transfected with a plasmid encoding E-tagged and Flag-tagged RNF41
RNF41 interacts with VPS52
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EARP components, VPS53, Ang2 and Syndetin [32]. To take into account both complexes, we
studied the localization of the common GARP and EARP subunits VPS52 and VPS53, solely
or together. While ectopically expressed E-tagged VPS52 mainly coincided with the TGN
marker p230, RNF41 co-expression caused a redistribution of the large majority of VPS52 to
RNF41-bodies with only little overlap between E-tagged VPS52 and p230 remaining (Fig 4C
panel I). Localization to the TGN was restored in case of the RNF41 L163Q mutant. No reloca-
lization was observed upon co-transfection of VPS53 and RNF41 or the L163Q mutant, where
VPS53 still colocalized with GM130, a Golgi network marker (Fig 4C panel II). Moreover,
RNF41 co-expression disrupted the well-established colocalization between VPS53 and E-
tagged VPS52 (Fig 4D). Also here, RNF41 reroutes VPS52 away from VPS53, while overex-
pression of the L163Q mutant does not affect VPS52 localization. AlphaScreen analysis in
HEK293T cells ascertained the disruption of the VPS52-VPS53 interaction by RNF41. Ectopic
expression of RNF41 compromised the interaction between Flag-tagged VPS53 and E-tagged
VPS52, whereas expression of the L163Q mutant did not show this effect (Fig 4E). Altogether,
these results show that RNF41 is able to ubiquitinate and relocate VPS52 towards RNF41 bod-
ies, thereby disrupting the interaction with VPS53, a common GARP and EARP subunit.
Discussion
In this paper, we identify VPS52, a subunit of two distinct tethering complexes, GARP and
EARP, as a novel interaction partner of RNF41. VPS52 was identified using the high through-
put screening method Array MAPPIT [24] and several other assays confirmed this interaction
(Fig 1). Domain mapping revealed that the CC domain of RNF41, located in between the N-
terminal RING and C-terminal substrate binding domain [21], is necessary and sufficient for
interaction with VPS52 (Fig 2B and 2C). This is remarkable, as all other known RNF41 inter-
action partners such as USP8, ASB6 and ErbB3 interact with its substrate binding domain [22,
40] and Manuscript in preparation]. A combination of randommutagenesis and MAPPIT
[36] of the entire RNF41 bait further enabled the identification of critical amino acids involved
in the RNF41-VPS52 interface. In line with the domain mapping results, all residues necessary
for the interaction with VPS52 were exclusively located in the CC domain of RNF41. We
focused on a RNF41 mutant turning a hydrophobic leucine at position 163 into a polar, non-
charged glutamine and found that this single residue is necessary for VPS52 interaction.
VPS52 also contains an N-terminal CC domain, which proved to be essential for interaction
with RNF41 (Fig 3C and 3D). In silicomodeling of the CC domains of RNF41 and VPS52 lend
further support that L163 was important for VPS52 interaction (Fig 3F) and identified a cluster
of three residues in the CC domain of VPS52 that mediated the RNF41 interaction (Fig 3B).
Next to the CC domain of RNF41, also membrane association is important for interaction
with VPS52 as a RNF41 mutant lacking the putative myristoylation site no longer interacted
with VPS52 (unpublished observation). Although not much is known about the protein struc-
ture of VPS52 and how it interacts with the GARP and EARP subunits, it has been proposed
that the N-terminus holding the CC domain is involved in association with other GARP and
possibly also EARP subunits [27,41,42]. Our findings provide the first evidence for the involve-
ment of the RNF41 and VPS52 CC domains in a protein interaction.
together withWT VPS52, VPS52ΔCC or soluble IL5Rα (mock). Values are means ± s.d from triplicate samples from one of three representative
experiments. Data and statistical analysis of biological replicates are shown in S3 Fig. (F)Model of RNF41-VPS52 heterotrimeric coiled-coils,
consisting of one RNF41 CC (upper coil) and two VPS52 CC (lower coils). R148 and L163 in RNF41 and D120, E124 and E127 in VPS52 are
highlighted as blue, green and red spheres respectively. The scheme below depicts the proposed idea of interchangeable monomers between RNF41
and VPS52. n = 3 or more for all experiments.
https://doi.org/10.1371/journal.pone.0178132.g003
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proteasomal degradation. Flag-VPS52 was immunoprecipitated and ubiquitination was determined byWestern Blotting with an anti-ubiquitin
antibody (upper panels). Expression and loading controls were visualized using anti-Flag, RNF41 and anti-β-actin antibodies (lower panels).
Statistical analysis is shown in S5A Fig. (B)RNF41 co-resides with VPS52 in the RIPA insoluble pellet fraction. HEK293T cells transiently co-
transfected with a plasmid encoding untagged VPS52 and untagged RNF41, L163Q, DN RNF41 or soluble IL5Rα (mock) were either sonicated in
2x Laemmli buffer (left) or lysed with RIPA buffer (middle). Insoluble RIPA pellets were sonicated in 2x Laemmli buffer (right). Protein levels were
detected byWestern blotting using anti-VPS52, anti-RNF41 and anti-β-actin (loading control). Statistical analysis is shown in S5B Fig. (C)RNF41
relocates VPS52 and not VPS53. (I) Confocal microscopy of HeLa cells transiently transfected with a vector encoding E-tagged VPS52 together
with soluble IL5Rα (mock, upper panel), untagged RNF41 (middle panel) or L163Q (lower panel) (right side showsmerged images) were fixed and
stained with antibodies against Etag (secondary Alexa Fluor 488, green), RNF41 (secondary Alexa Fluor 568, magenta) and Golgi marker p230
RNF41 interacts with VPS52
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Fig 4. RNF41 ubiquitinates and relocates VPS52. (A)RNF41 enhances VPS52 ubiquitination. HEK293T cells co-transfected with a plasmid
encoding Flag-tagged VPS52 and untagged RNF41, L163Q or soluble IL5Rα (mock) were incubated overnight with 5 MMG132 to inhibit
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zation while VPS52 ΔCC, unable to interact with RNF41, did not affect RNF41 oligomerization
(Fig 3E). Conversely, WT RNF41 and not the L163Q mutant reduced VPS52 oligomerization
S2A Fig. RNF41 homotrimers are intrinsically instable due to auto-ubiquitination and sub-
sequent proteasomal degradation. This can be counteracted by disrupting RNF41 homotri-
merization through the introduction of an exogenous RNF41 CC domain or by CC domain
deletion [39]. Similary, disassembly of RNF41 homotrimers by RNF41-VPS52 complex forma-
tion might reduce RNF41 auto-ubiquitination, leading to more stabilized RNF41 expression.
In accordance with this, we observed a marked increase in RNF41 monomer expression upon
co-expression of VPS52, compared to mock- or VPS52ΔCC- transfected cells S2B Fig. In addi-
tion, unlike deletion of the complete CC domain, the RNF41 L163Q mutant did not impair
RNF41 oligomerization (Fig 2F and 2G) or auto-ubiquitination (S4 Fig), while both disrupted
VPS52 interaction (Fig 2B and 2C). This indicates that this single point mutation in the CC
domain is not sufficient to disrupt RNF41 oligomerization and affect auto-ubiquitination.
Changes in the oligomerization state of CCs are a widely accepted mechanism that occurs in
intracellular transport. SNARE proteins are classical examples of unstructured monomers that
can form stable hetero-oligomeric complexes through their CC regions [43]. The MTCs (mul-
tisubunit tethering complexes) like the GARP, exocyst and COG (conserved oligomeric Golgi)
complex represent another group of multimeric protein complexes in which subunits can be
exchanged. These complexes are linked by the presence of predicted short CC regions [44].
Binding of these short CCs is specific but not exclusive as they allow the interaction with differ-
ent partners at different stages or locations. This is best exemplified by the GARP and EARP
complex with the exchange of VPS54 for Syndetin [32] and could potentially be the case for
the new RNF41-VPS52 complex.
RNF41 has multiple regulatory functions. Next to ubiquitinating BRUCE, Parkin and USP8
[18,45,46], it is known to downregulate ErbB3 and ErbB4 receptors, as well as several type I
cytokine receptors such as the IL-3, EPO, IL-6, LIF and LR [17,19–22]. RNF41 often acts as a
sorting signal in the transport of these cargo proteins. It reroutes IL6Rα, LIFRα and LR from
the lysosomal degradation pathway to compartments where ectodomain shedding occurs by
(secondary Alexa Fluor 647, red). (II) Same setup as in I, with co-transfection of VPS53 instead of E-tagged VPS52, and the use of anti-VPS53
(secondary Alexa Fluor 488, green) and co-staining with Golgi marker GM130 (secondary Alexa Fluor 647, red). n = 3 or more independent
experiments. (D)Confocal microscopy and (E) AlphaScreen analysis show that Ectopic RNF41 expression disrupts the VPS52-VPS53 interaction.
For confocal microscopy, HeLa cells were transiently transfected with a plasmid encoding E-tagged VPS52 and untagged VPS53 together with
soluble IL5Rα (mock, upper panel), untagged RNF41 (middle panel) or L163Q (lower panel) (right side shows merged images), fixed and stained
with antibodies against Etag (secondary Alexa Fluor 488, green), VPS53 (secondary Alexa Fluor 568, red) and RNF41 (secondary Alexa Fluor 647,
magenta). The inset shows a magnification of the boxed area. The white overlay represents the intersect between the golgi marker and E-tagged
VPS52 or VPS53 (C) or between E-tagged VPS52 and VPS53 (D) with a threshold set on standard deviation using Volocity 6.3 software. n = 3 or
more independent experiments. Scale bar, 10μm. For AlphaScreen analysis, HEK293T cells were transiently co-transfected with a plasmid
encoding E-tagged VPS52 and Flag-tagged VPS53 together with WT RNF41, L163Q or soluble IL5Rα (mock). Values are means ± s.d from
triplicate samples from one of three representative experiments. Data and statistical analysis of biological replicates are shown in S3 Fig.
https://doi.org/10.1371/journal.pone.0178132.g004
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Besides mediating heteromeric protein-protein interactions amongst a wide range of pro-
teins, alpha-helical CC domains also have self-associating properties. By modeling its CCs,
we predicted a trimeric state of RNF41. This is in line with cross-linking and size exclusion
chromatography data indicating that RNF41 can self-assemble into a trimeric complex via its
CC domain [39]. Similarly, the CC domains of VPS52 were predicted to form trimers (Figs
2E and 3B). Binding of RNF41 or VPS52 to RNF41 through their respective CC may not be
mutually exclusive and CC homology modeling predicted that formation of RNF41-VPS52
heterotrimeric structures might occur (Fig 3F). Intertwining of the alpha-helices of the CC
domains of RNF41 and VPS52 might lead to dynamic assembly and disassembly of homo- or
heterotrimeric protein complexes. Supporting such model, we observed competition between
RNF41-VPS52 interaction and RNF41 oligomerization. VPS52 hampered RNF41 oligomeri-
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ubiquitinating and suppressing USP8 [17,18]. Different functions of RNF41 can be ascribed to
distinct locations as ER-localized RNF41 is responsible for downregulating steady state levels
of signaling competent ErbB3 receptors by routing them to the ERAD pathway [47], while
RNF41 present in endosomes can ubiquitinate internalized ErbB3 receptors and as such
reroute them away from recycling pathways to the lysosomes for degradation [48]. All these
known functions of RNF41 are mediated by its RING domain, and substrates are known to
interact with its C-terminal substrate binding domain [18, 21]. Here, we present data imply-
ing a crucial role for the RNF41 CC domain in recruiting VPS52. RNF41, unlike the L163Q
mutant, ubiquitinated VPS52 (Fig 4A). Moreover, we observed a reduction in VPS52 protein
levels upon RNF41 expression in the soluble fraction of RIPA-lysed cells. Next to specific inter-
action between RNF41 and VPS52, this effect was also dependent on functional E3 ligase activ-
ity and/or membrane association as the L163Q mutant and a truncated RNF41 mutant with
dominant-negative properties (DN RNF41 [20,21]) did not decrease VPS52 levels. Surpris-
ingly, VPS52 levels were maintained when cells were lysed using sonication, pointing more
towards an RNF41-dependent redistribution rather than degradation of VPS52 (Fig 4B). Pre-
vious studies showed that the GARP complex largely associates with the TGN, although the
presence of vesicles coinciding with late, early and recycling endosomal markers were also
reported, while the EARP complex localizes only to recycling endosomes [26, 29, 32, 41, 49].
In our hands, the expression pattern of the shared GARP and EARP subunits VPS52 and
VPS53 primarily overlapped with Golgi markers. RNF41 relocated the majority of VPS52
away from the TGN towards RNF41 bodies, while VPS53 remained TGN associated (Fig 4C).
This is also reflected in the reduced interaction between VPS52 and VPS53 upon RNF41
expression (Fig 4D–4E). These results are consistent with our data indicating that RNF41
solely interacts with VPS52, and not with the other GARP or EARP subunits (Fig 1G and 1H).
It also further supports the observation that both RNF41 and VPS52 were enriched in the
insoluble sonicated RIPA pellet fraction (Fig 4B), indicating that RNF41 is able to relocate part
of VPS52 towards insoluble compartments. It remains to be determined which ubiquitin-
chain linkage is responsible for the observed VPS52 ubiquitination, K63- and/or M1-linked
chains that control localization of proteins would be in line with the observed relocalization of
VPS52 by RNF41 (Komander et al, 2012). However, we cannot exclude the possibility of in-
direct VPS52 ubiquitination, since the mode of interaction with VPS52 (via the CC domain)
differs from the other known RNF41 substrates (via the substrate binding domain). An alter-
native hypothesis is that RNF41 first recruits VPS52 through its CC domain, resulting in
rerouting followed by ubiquitination at its new subcellular location by RNF41 or potentially
another unidentified E3 ubiquitin ligase. It is possible that interactions with its CC region are
reserved for proteins that regulate RNF41, as exemplified in literature where certain proteins
like NS1, MAGEA1 and MAGEC2, are known to respectively interact with the CC domain of
RING finger proteins TRIM25, TRIM31 and TRIM28 thereby inhibiting or enhancing their
E3 ligase activity [50–52].
In conclusion, we identified VPS52, a component of the GARP and EARP complexes, as a
novel interaction partner of RNF41 and show that they interact via their CC domains. RNF41
ubiquitinates and relocates VPS52 away from VPS53, another shared subunit of the GARP
and EARP complexes, towards RNF41-positive structures. The nature of these RNF41 bodies
which incorporate VPS52 remains to be fully elucidated.
Materials andmethods
Plasmids and constructs
The generation of all sequence-verified constructs is shown in S3 Table.
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Array and binary MAPPIT analysis
Array MAPPIT and the preparation of the prey and reporter reverse transfection mixture was
previously described [24]. The screened prey collection entails 8.569 full length human ORF
preys selected from the human ORFeome collection version 5.1 (http://horfdb.dfci.harvard.
edu/hv5). For binary MAPPIT, 1 x 104HEK293T cells (www.atcc.org, mycoplasma negative)
were seeded in a 96-well and transfected with 50 ng of STAT3-dependent pXP2d2-rPAP1-luci-
ferase reporter, 250 ng bait and prey constructs using calcium phosphate. Cells were left
untreated or stimulated for 24 hours with human Erythropoietin (5 ng/ml). Luciferase activity
from triplicate samples was measured by chemiluminescence in an EnVision plate reader (Per-
kinElmer) and expressed as fold induction (stimulated/non-stimulated relative light units) rel-
ative to the signal generated by a JAK2 binding prey, which corrects for possible varying
expression levels of the different baits used. Randommutagenesis of RNF41 bait was per-
formed as described in Uyttendaele et al, 2012.
AlphaScreen
2 x 105 HEK293T cells were seeded in a 6-well and transfected with 1 μg of both E- and Flag-
tagged proteins using calcium phosphate. In the condition where E- and Flag tagged RNF41
are co-expressed with VPS52, only 250 ng of RNF41 was transfected. AlphaScreen experiments
were performed according to the manufacturer’s protocol (PerkinElmer). 48 h later, cells were
lysed in TAP lysis buffer (50 mM Tris–HCl pH 7.5, 125 mMNaCl, 5% glycerol, 0.2% NP40,
1.5 mMMgCl2, 25 mMNaF, 1 mMNa3VO4 and Complete
TM Protease Inhibitor without
EDTA Cocktail (Roche)). Lysates were incubated for 2 hours at 4˚C with 0.7 mg/ml biotiny-
lated anti-E-tag antibody, subsequently incubated for 1 hour at 4˚C with the AlphaScreen
FLAG™ (M2) detection kit (PerkinElmer Life Sciences) acceptor beads, and finally for 30 min-
utes at room temperature with streptavidin donor beads. Samples were measured in triplicate
using the EnVision plate reader (PerkinElmer). Expression was analyzed byWestern Blotting.
GST-pulldown
BL21(DE3) cells were transformed with GST-constructs. Protein production was induced by
0.2 mM isopropyl-D-thiogalactoside at A600 of 0.6. The bacteria were cultured overnight at
25˚C. After centrifugation at 5000 r.p.m. for 10 minutes, the bacterial pellet was resuspended
and sonicated in NETN buffer (20 mM Tris-HCl pH 8; 100 mMNaCl; 6 mMMgCl2; 1 mM
Western blot analysis
1.5 x 105HEK293T cells were seeded in a 12-well and co-transfected with 1μg of each con-
struct. Cells were washed with PBS, and lysed in RIPA buffer (50 mM Tris-HCl pH 8.0; 200
mMNaCl; 0.05% SDS; 2 mM EDTA; 1% NP-40; 0.5% deoxycholic acid; 1 mMNa3VO4;
1mMNaF; and CompleteTM Protease Inhibitor Cocktail (Roche)), or in 2x SDS gel laemmli
buffer (62.5 mM Tris- HCl pH 6.8, 3% SDS, 10% glycerol, 5% β-mercaptoethanol and 0.01%
RNF41 interacts with VPS52
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EDTA; 0.5% NP40; 1% DTT and CompleteTM Protease Inhibitor Cocktail from Roche). The
lysate was centrifuged at 12,000 r.p.m. for 10 minutes to obtain the soluble GST proteins in
the supernatant. GST proteins were immobilized on Glutathione Sepharose 4B beads (GE
Healthcare) for 1 hour at 4˚C and washed three times with NETN buffer. Flag-tagged VPS52,
expressed using the TNT T7 Quick Coupled Transcription/Translation System (Promega),
was incubated overnight with the GST beads. The beads were washed with NETN buffer and
Flag-tagged proteins bound to the GST-proteins were eluted by 10 minutes boiling in 2x SDS
gel loading buffer and analyzed by Western blotting.
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Bromophenol Blue sodium salt) and sonicated using the Bioruptor Plus (Diagenode). After
boiling, cell lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes
(Amersham Biosciences). Blots were blocked in Odyssey blocking buffer (LICOR), when using
Odyssey infrared imaging (LICOR) or in 5% milk upon ECL (enhanced chemiluminescence)
detection. Rabbit anti-VPS52 (1:1500, kind gift from F. Stenner-Liewen) and rabbit anti-
RNF41 (1:10.000; Bethyl) were revealed by SuperSignal West Pico Chemiluminescent Sub-
strate (Pierce) using peroxidase-conjugated anti-rabbit antibody (1:10.000, Jackson ImmunoR-
esearch), diluted in milk blocking buffer. Mouse anti-β-actin (1:5000, Sigma) and anti-mouse
Dylight 680-conjugated antibody (1:15.000, Pierce) diluted in Odyssey blocking buffer + 0.1%
Tween20 was used as a loading control. The following antibodies were used for expression
controls in other experiments: anti-Flag rabbit or mouse (1:5000 and 1:10.000, Sigma), anti-E-
tag mouse (1: 10.000, Phadia) and anti-GST rabbit (1:5000, Abcam) revealed with anti-rabbit
or anti-mouse DyLight 800- or DyLight 680-conjugated antibody (1:15,000, Pierce) diluted in
Odyssey blocking buffer +0.1% Tween20. For visualization of the ubiquitin signal we used
mouse anti-ubiquitin (VU-1, 1: 1000, LifeSensors), revealed with peroxidase-conjugated anti-
mouse antibody (1:10.000, Jackson ImunoResearch), diluted in milk blocking buffer.
Co-immunoprecipitation analysis
HEK293T cells (1.8 x 106 in a 60 mm petri dish) were transfected with 3μg of each construct
for 48 hours and cell extracts were prepared in lysis buffer (50 mM Tris HCl pH 7.5; 125 mM
NaCl, 0.2% NP40; 1.5 mMMgCl2; 5% glycerol and CompleteTM Protease Inhibitor Cocktail
from Roche) followed by two freezing rounds of 10 minutes at -80˚C. The lysates were
cleared by centrifugation and precleared with sepharose 4B beads (Sigma) followed by in-
cubation overnight at 4˚C with 20μl of monoclonal anti-flag M2 agarose beads (Sigma) to
precipitate the Flag-tagged proteins. Immunoprecipitates were washed three times with
lysisbuffer and eluted from the beads using Flag peptide (200μg/ml, Sigma). After adding
5x SDS gel loading buffer, samples were analyzed by Western blotting. For endogenous Co-
IPs, HEK293T cells were lysed and prepared as described above, After preclearing, 1 ml of
lysate was incubated overnight with 1.5 μg of rabbit anti-VPS52 or normal rabbit IgG (Santa
Cruz Biotechnology). Subsequently, lysates were incubated with protein A sepharose beads
(Sigma) for 2 hours at 4˚C. The beads were washed three times and resuspended in 2 x SDS
gel loading buffer.
Ubiquitination assay
HEK293T cells (1.8 x 106 in a 60 mm petri dish) were transfected with 6μg of each construct
together with 3μg of Flag-tagged VPS52. The next day, cells were washed and treated overnight
mM Tris-HCl, pH 8.0, 2 mM sodium orthovanadate, 50 mM sodium fluoride, 10 mMN-ethyl-
maleimide and CompleteTM Protease Inhibitor without EDTA Cocktail from Roche). Lysates
were sonicated using the Bioruptor Plus (Diagenode), boiled for 10 minutes and diluted in
2250 μl dilution buffer (10 mM Tris-HCl, pH 8.0, 150 mMNaCl, 2 mM EDTA, 1% Triton X-
100) for 30–60 minutes at 4˚C under rotation. The lysates were cleared by centrifugation for
30 minutes and precleared with sepharose 4B beads (Sigma) followed by incubation overnight
at 4˚C with 20μl of monoclonal anti-flag M2 agarose beads (Sigma) to precipitate the Flag-
tagged proteins. Immunoprecipitates were washed three times with wash buffer (10 mM Tris-
HCl, pH 8.0, 1 M NaCl, 1 mM EDTA, 1% NP-40) and resuspended in 2x SDS gel loading
buffer followed byWestern blot analysis.
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S2 Table. Randommutagenesis combined with MAPPIT, specific single mutants.
Table representing only the specific single mutants for interaction with VPS52 or ASB6.
(XLSX)
S3 Table. Generation and origin of the constructs used in this paper.
(XLSX)
S1 Fig. L163Q specifically disrupts interaction with VPS52.MAPPIT analysis of HEK293T
cells transiently co-transfected with a plasmid encoding an empty, VPS52, ASB6 or USP8 prey
together with a RNF41 or L163Q bait.
(TIF)
S2 Fig. (A) Ectopic expression of RNF41 hampers VPS52 oligomerization. AlphaScreen
analysis of HEK293T cells transiently co-transfected with a plasmid encoding an E-tagged and
Flag-tagged VPS52 together with untagged WT RNF41, L163Q or sol IL5Rα (mock). Values
are means ± s.d from triplicate samples from one of three representative experiments. Data
and statistical analysis of biological replicates are shown in S3 Fig. (B) Ectopic expression of
VPS52 hampers RNF41 oligomerization and auto-ubiquitination thereby stabilizing
RNF41.HEK293T cells transiently co-transfected with a plasmid encoding an E-tagged and
Flag-tagged RNF41 together with WT VPS52, VPS52ΔCC or sol IL5Rα (mock).
(TIF)
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S1 Table. Randommutagenesis combined with MAPPIT, single mutants.
Table representing all single RNF41 mutants resulting from the screen. Column 1 and 2 show
the positions and mutations in RNF41. Column 3, 4 and 5 represent the relative MAPPIT sig-
nals of the preys tested against the RNF41 mutants, with EFH1A, a JAK2 binder, as a positive
control. The relative MAPPIT signal was calculated as the median of the normalized MAPPIT
value, which is the result of the fold induction of each mutant divided by the median of the
fold induction of the six WT controls on that plate.
(XLSX)
1.5 x 105 HeLa cells (www.atcc.org, mycoplasma negative) were seeded on No.1.5 glass coverslips
(Zeiss) in a 6 well coated with poly-L-lysine (Sigma-Aldrich). The next day, cells were transfected
with 100 ng of construct using JetPrime (Polyplus). 24 hours later, cells were rinsed with PBS and
fixed for 15 minutes at room temperature in 4% paraformaldehyde. Cellswere washed with
100mM phosphate buffer (100 mM Na2HPO4; 100 mM NaH2PO4, pH 7.4), permeabilized and
blocked in blocking buffer (20 mM phosphate buffer; 100 mM NaCl; 0.23% Triton X-100 and
10% donkey serum) for 30 minutes. Samples were incubated for 1.5 hours at room temperature
with goat anti-Etag (1:2000, Bethyl), mouse anti-RNF41 (1:500, Santa Cruz), rabbit anti-p230
(1:800, Santa Cruz), goat anti-GM130 (1:150, Santa Cruz) or rabbit anti-VPS53 (1:1500,
Abcam). After washing in blocking buffer without donkey serum, cells were incubated
for 1 hour at room temperature with donkey anti-goat Alexa Fluor 488 or 647, donkey anti-
mouse Alexa Fluor 568 or 647 and donkey anti-rabbit Alexa Fluor 647, 488 or 568. Images were
acquired using a 60x 1.35 NA objective on an Olympus IX-81 laser scanning confocal
microscope.Intersect was determined using a threshold set on standard deviation intensity in the
Volocity 6.3software (Perkin Elmer, Waltham, MA, USA). Noise removal was done with medium
filters.
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S3 Fig. Data and statistical analysis of biological replicates from AlphaScreen experiments
in Figs 3E, 4E and S2.One-way ANOVA (randomized block design) showed a marginal sig-
nificant difference (Fig 3E: P = 0.0983; Fig 4E: P = 0.1106; S2 Fig: P = 0.0693).
(TIF)
S4 Fig. L163Q does not influence RNF41 auto-ubiquitination. HEK293T cells co-transfected
with pMet7-vectors encoding Flag-tagged RNF41, L163Q, ΔCC or sol IL5Rα (mock), together
with HA-ubiquitin were incubated overnight with 5μMMG132 and 25μM chlolorquine to
inhibit proteasomal or lysosomal degradation. Flag immunoprecipitation followed by anti-HA
staining revealed the ubiquitination state of the RNF41 mutants.
(TIF)
S5 Fig. Statistical analysis of biological replicates from the data in Fig 4A and 4B. The
Western Blots in Fig 4A and 4B, together with biological replicates, were quantified using
Image J. (A) The ubiquitination signal was normalized for the amount of immunoprecipitated
Flag-tagged VPS52 and compared between the mock, RNF41 and L163Q condition. A one-
way ANOVA (randomized block design) showed a significant difference in VPS52 ubiquitina-
tion between the RNF41 and mock or L163Q transfected cells (p<0.01). (B) For each condi-
tion (i.e. mock, RNF41, L163Q and DN ectopic expression) the amount of VPS52 in the
soluble RIPA and insoluble pellet fraction was compared to the total amount of VPS52 in the
sonicated fraction. These results were subjected to a two-way ANOVA with post-hoc compari-
son (Bonferroni correction) that showed statistical difference between RNF41 and mock or
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29. Pérez-Victoria FJ, Mardones GA, Bonifacino JS. Requirement of the humanGARP complex for man-
nose 6-phosphate-receptor-dependent sorting of cathepsin D to lysosomes. Mol Biol Cell. 2008; 19
(6):2350–62. https://doi.org/10.1091/mbc.E07-11-1189 PMID: 18367545
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S1 Fig. L163Q specifically disrupts interaction with VPS52. MAPPIT analysis of HEK293T cells 
transiently co-transfected with a plasmid encoding an empty, VPS52, ASB6 or USP8 prey together 





S2 Fig. (A) Ectopic expression of RNF41 hampers VPS52 oligomerization. AlphaScreen analysis of 
HEK293T cells transiently co-transfected with a plasmid encoding an E-tagged and Flag-tagged VPS52 
together with untagged WT RNF41, L163Q or sol IL5Rα (mock). Values are means ± s.d from triplicate 
samples from one of three representative experiments. Data and statistical analysis of biological 
replicates are shown in S3 Fig. (B) Ectopic expression of VPS52 hampers RNF41 oligomerization and 
auto-ubiquitination thereby stabilizing RNF41. HEK293T cells transiently co-transfected with a 




S3 Fig. Data and statistical analysis of biological replicates from AlphaScreen experiments in Figs 
3E, 4E and S2. One-way ANOVA (randomized block design) showed a marginal significant difference 




S4 Fig. L163Q does not influence RNF41 auto-ubiquitination. HEK293T cells co-transfected with 
pMet7-vectors encoding Flag-tagged RNF , L Q, ΔCC o  sol IL Rα o k , togethe  ith HA-
u i uiti  e e i u ated o e ight ith μM MG  a d μM hlolo ui e to i hi it p oteaso al 
or lysosomal degradation. Flag immunoprecipitation followed by anti-HA staining revealed the 
ubiquitination state of the RNF41 mutants. 
104
 
S5 Fig. Statistical analysis of biological replicates from the data in Fig 4A and 4B. The Western Blots 
in Fig 4A and 4B, together with biological replicates, were quantified using Image J. (A) The 
ubiquitination signal was normalized for the amount of immunoprecipitated Flag-tagged VPS52 and 
compared between the mock, RNF41 and L163Q condition. A one-way ANOVA (randomized block 
design) showed a significant difference in VPS52 ubiquitination between the RNF41 and mock or 
L163Q transfected cells (p<0.01). (B) For each condition (i.e. mock, RNF41, L163Q and DN ectopic 
expression) the amount of VPS52 in the soluble RIPA and insoluble pellet fraction was compared to 
the total amount of VPS52 in the sonicated fraction. These results were subjected to a two-way 
ANOVA with post-hoc comparison (Bonferroni correction) that showed statistical difference between 
RNF41 and mock or L163Q (p<0.05) for the RIPA fraction and between RNF41 and mock or L163Q 
(p<0.001) for the pellet fraction. 
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S1 Table 
    position AA mutation ASB6 VPS52 EFH1A 
61 T61K 0,36953379 0,9765057 1,76387244 
61 T61M 0,81138884 0,9205568 0,57520708 
69 P69S 0,26674214 1,0171002 1,24527236 
70 R70L 0,29473992 0,9133219 1,52407841 
77 S77P 0,23317792 0,8492693 1,50581454 
77 S77L 0,39010404 0,8320182 1,25147287 
83 C83Y 0,44192332 0,8713712 0,97628475 
84 D84N 0,53683349 0,5856752 0,81151709 
84 D84H 0,20569557 0,7694646 0,80168029 
87 V87M 0,61083071 0,7898355 1,30962211 
88 F88L 0,7052382 0,8216528 0,9502522 
89 G89C 0,59263895 0,7043611 0,98598522 
95 R95W 0,71101018 0,5756181 0,97809111 
98 N98Y 0,70216297 0,8069333 0,94798535 
98 N98K 0,53783121 0,814843 0,69769663 
99 L99P 0,39546577 0,8087754 1,60896744 
99 L99H 0,599362 0,8735778 1,10681031 
104 S104R 0,93735962 0,6996397 0,91254602 
106 C106Y 0,0303103 1,1247857 1,89875227 
108 H108L 0,40391465 0,6113655 1,58700698 
109 N109D 0,39682419 0,6581925 1,61009644 
112 R112W 0,60085023 0,8032191 0,5779027 
112 R112Q 0,43723491 0,7779057 1,03485664 
116 C116R 0,65947628 0,2729743 0,84368137 
118 Q118L 0,13541155 1,033833 2,08993146 
119 G119C 0,44310937 0,223739 0,98768949 
120 C120R 0,25577075 0,3047095 3,83534916 
121 G121V 0,89125768 0,4572335 1,14480579 
123 E123K 0,4249667 0,5712967 1,20344867 
124 M124I 0,51394861 0,1958864 1,24007061 
125 P125H 0,59638946 0,7874175 1,35386965 
125 P125S 0,40353784 0,7269915 1,77422282 
126 K126R 0,57686988 0,9245272 1,05453877 
128 E128G 0,89576424 1,1337548 0,84111114 
128 E128G 0,45919151 0,6058244 0,81726463 
131 N131I 0,31523403 0,9275294 0,67591963 
131 N131Y 0,74638044 1,0611953 1,19637756 
132 H132Y 0,36382778 0,4360728 1,86941938 
132 H132D 0,58719157 0,4493198 0,64406366 
132 H132Y 0,26170408 0,4604682 2,55686161 
133 N133S 0,77775007 0,7981179 0,99617495 
133 N133I 0,71741573 0,6657585 1,06049731 
135 I135N 0,58615098 0,2547316 1,26975014 
137 H137R 0,64231627 0,0737958 0,96691063 
106
137 H137L 0,13247004 0,0381617 1,250844 
138 L138M 0,53022579 0,8138754 0,92516765 
138 L138Q 1,12159729 0,0137276 1,25982683 
145 Q145H 0,63460622 1,0098923 1,12321961 
145 Q145P 0,69613933 0,007918 1,65567993 
148 R148C 0,74732301 0,0249683 0,56571647 
153 E153V 0,36930322 0,8740117 1,24213892 
154 K154N 0,39995637 1,0830125 1,27193649 
158 E158D 0,60540626 0,8338607 1,42900827 
159 H159Y 0,66878298 0,1825419 1,0885409 
159 H159L 0,29299475 1,0356296 1,36760387 
160 K160I 0,29829513 0,3138894 1,42107399 
162 Q162H 0,91147987 0,444721 1,15373185 
162 Q162H 0,10568623 0,4294918 1,5335004 
163 L163Q 0,90016639 0,0172903 0,73068434 
163 L163P 0,78227081 0,0123849 2,27892326 
166 Q166L 0,60097216 1,083836 1,00260842 
170 I170T 0,69004037 0,0422675 1,59038753 
170 I170N 1,08606692 0,0083806 1,56940262 
173 L173I 0,73222053 0,5874012 0,66896773 
177 M177I 0,58005133 0,4477608 0,87087843 
181 R181L 0,41147357 1,0420746 1,42487205 
189 N189Y 0,38893986 0,7095052 0,90633139 
190 L190P 0,75336332 0,6450948 1,19609293 
191 E191V 0,50056665 0,6676948 1,21310995 
194 I194N 0,45496932 0,795848 0,92522264 
196 Y196H 0,59914826 0,5100577 1,10397687 
196 Y196H 0,79911322 0,6675553 1,6046442 
197 N197D 0,40769161 0,7204851 1,07986732 
202 W202C 0,20399165 0,6176285 0,82454233 
202 W202R 0,03475107 0,226162 1,44722133 
202 W202G 0,30338769 0,6579043 1,22299636 
203 V203M 0,2891222 0,8123217 1,55712024 
209 A209V 0,8418015 0,9964533 0,56552768 
210 R210T 0,6312329 0,9108947 0,73449505 
212 T212S 0,67697595 0,8496229 1,20198263 
212 T212I 0,41666707 1,0510252 1,75015759 
213 R213C 1,27536555 1,0030178 1,62772469 
214 W214C 0,06938865 0,2534766 1,86723334 
214 W214R 0,02466675 0,2558658 2,04787534 
215 G215E 1,05631278 0,7737422 1,01054552 
215 G215E 0,73419574 0,8905318 1,56391109 
217 M217V 1,00201168 0,8358497 0,87630082 
217 M217V 0,7050458 1,0304211 1,17864915 
217 M217T 0,02390221 0,2068466 2,84426797 
219 S219L 0,0250253 0,3320982 2,7125154 
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220 T220A 0,07583181 0,9542239 0,69473643 
220 T220A 0,08262559 0,8179446 1,29958976 
224 V224M 0,49805743 0,8622194 1,78376505 
225 L225H 0,26953317 0,7184912 4,38121763 
226 Q226K 0,47316154 0,8199195 0,8427934 
227 A227T 0,33329783 0,6797115 2,99979382 
230 K230E 0,63474093 0,8833858 1,03930697 
230 K230E 0,32020533 0,9607123 2,19294952 
233 L233D 0,03386514 0,2386468 1,70000543 
235 E235G 0,44818036 0,8241216 1,71725224 
236 S236N 0,07795108 0,4113383 0,77694015 
237 G237D 0,4990214 0,6722196 1,55562555 
238 C238S 0,10641084 0,5620076 1,63988696 
238 C238S 0,02143371 0,3581456 1,03879535 
239 P239H 0,05584209 0,4554081 2,63663451 
241 S241Y 0,28236384 0,6284714 2,43537669 
242 I242V 0,57361819 1,05869 1,46452623 
242 I242N 0,01752322 0,3926028 1,33901094 
243 V243A 0,1735202 0,6690218 2,34624823 
244 N244I 0,55590401 0,7774884 1,83675393 
246 L246P 0,02036139 0,1353056 2,22176205 
247 I247N 0,04962493 0,6955627 3,44135717 
247 247N 0,34294189 0,72627 1,49723382 
251 H251Q 0,2423014 0,6258655 0,95378616 
255 W255C 0,0160425 0,218247 1,52967704 
256 P256A 0,04424429 0,4732772 3,10481799 
258 G258D 0,14379154 0,6231628 1,67786724 
260 A260V 0,0883241 0,8177156 2,57269432 
261 T261A 0,6031658 0,8845948 1,09522172 
262 L262Q 0,03561199 0,768548 1,90280073 
262 L262P 0,06217264 0,7424845 2,66096872 
263 E263K 0,38895868 1,0035017 1,88776407 
265 R265I 0,02153525 0,1855592 2,02042303 
265 R265I 0,02471793 0,3074393 1,77281739 
266 Q266H 0,01869853 0,0036522 1,52683597 
268 N268I 0,0479824 0,440682 3,38603192 
268 N268Y 0,57904903 0,8842708 0,97521592 
268 N268S 1,8977434 1,5231281 1,67949586 
270 R270H 0,45870775 0,7547494 0,79869686 
271 Y271D 0,12039595 0,778755 1,66866256 
276 V276E 0,66315592 0,9360612 1,38424629 
276 V276A 0,32247799 0,6845931 1,17607085 
276 V276M 0,0631523 0,4767385 1,06595941 
276 V276A 0,54079229 0,9443168 1,17664623 
277 A227D 0,79301777 0,9468914 1,09701436 
278 Y278H 0,04926894 0,2899932 1,79121952 
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281 P281T 0,51625353 0,7722161 3,49617351 
284 Q284Y 0,45139053 0,6588139 2,83838955 
285 A285V 1,38189036 0,6686424 1,64653189 
285 A285T 0,04514166 0,2800539 4,68300979 
286 V286G 0,03397093 0,4031727 1,79444051 
287 V287A 0,47048914 0,8759703 1,97940248 
289 M289I 0,39101166 0,8616651 1,90447005 
289 M289V 0,03401168 0,2555988 1,92115812 
289 M289V 0,23919631 0,8042051 1,90156195 
294 N294K 0,01448356 0,1920535 2,15082707 
295 H295Y 0,27135391 0,628407 2,74143467 
295 H295Y 0,1559407 0,6193911 2,16052302 
296 M296R 0,05835019 0,3139475 2,26912644 
298 D298G 0,44532592 0,8200294 1,37310982 
298 D298G 0,254024 1,0540513 3,55073719 
300 M300K 0,41055777 0,7614755 2,3358728 
300 M300L 1,26435444 0,9676143 0,77333363 
307 V307F 0,02649419 0,2068875 1,84447728 
308 M308V 0,61321524 0,8115375 0,74176665 
310 F310Y 0,22394057 0,7988185 2,50516772 
310 F310L 0,01485981 0,2373833 1,56290907 
310 F310I 0,01761029 0,28476 1,63835576 
312 H312Q 0,51944572 0,7122444 1,51638264 
312 H312R 0,89871509 0,9056529 1,08823494 




position AA mutation ASB6 VPS52 EFH1A
106 C106Y 0,03031 1,12479 1,89875
118 Q118L 0,13541 1,03383 2,08993
137 H137R 0,64232 0,0738 0,96691
138 L138Q 1,1216 0,01373 1,25983
145 Q145P 0,69614 0,00792 1,65568
148 R148C 0,74732 0,02497 0,56572
159 H159Y 0,66878 0,18254 1,08854
163 L163Q 0,90017 0,01729 0,73068
163 L163P 0,78227 0,01238 2,27892
170 I170T 0,69004 0,04227 1,59039
170 I170N 1,08607 0,00838 1,5694
202 W202C 0,20399 0,61763 0,82454
203 V203M 0,28912 0,81232 1,55712
220 T220A 0,07583 0,95422 0,69474
220 T220A 0,08263 0,81794 1,29959
247 I247N 0,04962 0,69556 3,44136
258 G258D 0,14379 0,62316 1,67787
260 A260V 0,08832 0,81772 2,57269
262 L262Q 0,03561 0,76855 1,9028
262 L262P 0,06217 0,74248 2,66097
276 V276M 0,06315 0,47674 1,06596
289 M289V 0,2392 0,80421 1,90156
298 D298G 0,25402 1,05405 3,55074
310 F310Y 0,22394 0,79882 2,50517
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SacI-NotI ’-GCGGAGCTCGATGGGGTATGATGTAACCCGTTTCC- ’ 
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SacI-NotI ’-GCCGAGCTCCATGATTAAGCACCTGCGCTCAGTGG- ’ 
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pMG1 EcoRI-NotI ’-GCCGAATTCGCCATGGCTGTCCTGGAGCG- ’ 
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pMET7 EcoRI-NotI ’-GCCGAATTCACCATGATTAAGCACCTGCGC- ’ 
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pMET7 EcoRI-NotI ’-GCGAATTCGCCATGGCAATCCGCAGTGTCAACCCC- ’ 
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digest 
’-CTGCTAAAGGCATACGATATCGCAATCCGCAGTGTC- ’  
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G- ’  
        ’-GGCCGCGGCCGCCCCACAGTCTCTTTTTAATGAG- ’ 
pXP2d2-rPAP1-luficerase reporter; pMET7-Flag-SVT; PMET7-RNF41 DN  (Wauman et al, 2011) 
  







Addendum  RNF  i tera ts ith the VPS  su u it of the GARP a d EARP o ple es  
 
RNF41 does not affect STxB transport  
We established that RNF41 relocalizes VPS52 and in this way disrupts the interaction between VPS52 
and VPS53, a shared subunit of the GARP and EARP complexes. Therefore, we examined the 
importance of RNF41 in retrograde transport and endocytic recycling, two pathways regulated by the 
GARP and EARP complex respectively [1,2]. We first focused on retrograde transport by examining 
the GARP-dependent delivery of the Shiga toxin B-subunit (STxB) to the TGN [1,3]. Uptake 
experiments of Cy3-labeled STxB (STxB-Cy3) in mock-transfected HeLa cells were in line with previous 
reports showing correct STxB retrograde transport and delivery to the TGN [4] (Fig A1). Remarkably, 
RNF41-overexpressing cells showed no difference in retrograde delivery of STxB to the TGN, as StxB-
Cy3 still localized to the Golgi ribbon. Also, in cells expressing dominant negative (DN) RNF  or ∆CC, 
STxB was correctly transported to the Golgi region, resembling the situation in control cells. It is 
noteworthy that, at similar expression levels, DN RNF41 and RNF41 ∆CC show a different expression 
pattern compared to WT RNF41 in confocal microscopy. These truncated forms do not show the 
vesicular dots we usually observe with RNF41 or the L163Q mutant, but seem to be dispersed almost 
homogenously throughout the cytoplasm of the HeLa cells.  
 
Figure A1: Ectopic RNF41 expression does not interfere with STxB transport. Confocal microscopy of 
HeLa ells tra sie tl  tra sfe ted ith a plas id e odi g solu le IL Rα o k , E-tagged WT RNF41, 
E-tagged DN RNF41 or E-tagged RNF ∆CC. Cells ere i u ated o  i e ith  µg/ l ST B-Cy3 (red) 
for 30 min and chased in complete medium for 60 min prior to fixation and immunostaining using 
anti-Etag antibody (secondary Alexa Fluor 488, blue) and anti-p230 (secondary Alexa Fluor 647, 
green). The inset shows a magnification of the boxed area. The white overlay represents the intersect 
between p230 and StxB with a threshold set on standard deviation using Volocity 6.3 software. n=3 
or more independent experiments. Scale bar, 10µm.  
 
p230 STxB mock merge
p230 STxB RNF41-Etag merge
p230 STxB ∆CC-Etag merge
p230 STxB Etag-DN merge
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RNF41 delays Transferrin recycling 
Live cell imaging of transferrin (Tf-568) uptake in HeLa cells was used to examine endocytic recycling 
of the transferrin receptor. Significantly enhanced retention of Tf-568 was observed in cells 
expressing RNF41-EGFP compared to the control cells, ut ot i  ∆CC-EGFP expressing cells (Fig A2). 
Overexpression of the L163Q-EGFP mutant showed only marginal differences in transferrin recycling 
compared to WT RNF41, which could be explained by possible oligomerization with endogenous 
RNF41 (data not shown). We attempted to circumvent this problem by depleting cells of RNF41 and 
performing rescue experiments with an RNF41 WT-EGFP or L16Q-EGFP rescue construct. 
Unfortunately, we were unable to obtain sufficient silencing of RNF41 and lack antibodies to detect 
endogenous RNF41 with confocal microscopy (see discussion thesis). Together this indicates that 
RNF41 delays the recycling of internalized transferrin but, at this point, we are unable to confirm 
whether this is due to its interaction with VPS52. It should be noted that we observed no effects on 
transferrin internalization with any of the overexpressed constructs (data not shown).  
 
Figure A2: Ectopic RNF41 expression delays transferrin recycling. Live cell imaging using a Spinning 
disc confocal microscope of HeLa cells transiently transfected with a plasmid encoding Flag-tagged 
EGFP (mock), WT RNF41-EGFP or RNF ∆CC-EGFP. After 24h, cells were labeled with AlexaFluor-568 
conjugated transferrin (Tf) for 20min on ice, allowed to internalize for 10 min at 37°C, washed and 
chased with holo-Tf in DHB medium for the indicated time. The normalized mean intensity of Tf-568 
in transfected cells (timepoint 1=100%) was plotted as function of time using the Volocity 6.3-
software package (Perkin Elmer, Waltham, MA, USA). Values are means ± s.e.m. (n=3), P<0.01 (one-
a  ANOVA ith a Tuke ’s ultiple o pariso  post-hoc test) for o k a d ∆CC o pared to RNF  
for the analysed timepoints (10, 25 and 40 minutes). Transfected cells are indicated with dotted 
lines.  
VPS52 does not influence the RNF41 mediated shedding or degradation of the LR 
We previously reported the influence of RNF41 on LR (leptin receptor) routing [5,6]. Here, ectopic 
RNF41 expression blocks cathepsin L-mediated C-terminal stub (CTS) formation of the LR. This CTS is 
visualized after overnight incubation with the lysosomal inhibitor, chloroquine. Concomitantly, 
RNF41 enhanced LR ectodomain shedding resulting in increased soluble LR [5]. To investigate 
whether the interaction with VPS52 was involved in this RNF41-induced LR rerouting, we tested the 












































generation in HEK293T cells expressing HA-tagged LR, whereas DN RNF41, lacking the RING domain, 
generated a CTS (Fig A3). The cell culture supernatant from the same transfected cells was collected 
to analyze soluble LR levels. Here, RNF41 enhances soluble LR levels, while DN RNF41 had no effect. 
Like WT RNF41, the RNF41 L163Q mutant inhibits CTS formation and increases soluble LR levels, 
suggesting that VPS52 is not involved in this particular function of RNF41. Likewise, silencing of 
VPS52 did not hamper the RNF41-mediated increase in LR ectodomain shedding nor the blocked CTS 
formation. Silencing of VPS52 did however decrease basal LR ectodomain shedding, implying that 
VPS52 could be involved in LR recycling. On the other hand, ectopic expression of VPS52 did not 
enhance LR shedding. Collectively, our observations indicate that VPS52 is not involved in the RNF41-
mediated effects on LR rerouting.  
 
Figure A3: Overexpression or silencing of VPS52 does not influence the RNF41 mediated shedding or 
degradation of the LR. HEK293T cells were silenced for VPS52 (siVPS52) or treated with an irrelevant 
siRNA (Renilla, siRL) and/or were transiently co-transfected with a plasmid encoding a C-terminally 
HA-tagged LR a d RNF , DN RNF , L Q, VPS  or solIL Rα as a egati e o trol o k . Cell 
lysates were subjected to western blot analysis after overnight incubation with chloroquine. Full 
length LR and stub are visualized with anti-HA antibody. At the same time cell media supernatants 
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A high confidence interactome for RNF41 built on multiple orthogonal assays 
  
                                         Article published in Journal of Proteome Research (2018) 
 
This paper describes the generation of a high-confidence RNF41 (RING finger protein 41) interactome 
map based on several co-purification screens. Virotrap, BioID (proximity-dependent biotin 
identification) and AP-MS (Affinity Purification-Mass Spectrometry) were combined with known 
datasets from previously performed microarray MAPPIT (Mammalian Protein-Protein Interaction 
Trap) and Y2H (Yeast Two-Hybrid) screens. This first RNF41 interactome provides a unique tool for 
further elucidation of the role of RNF41. We selected AP2S1 (Adaptor related Protein complex 2 
Sigma 1 subunit), a newly identified RNF41 interaction partner, for more detailed analysis. We were 
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Abstract 
Ring finger protein 41 (RNF41) is an E3 ubiquitin ligase involved in the ubiquitination and degradation of 
many proteins including ERBB3 receptors, BIRC6 and parkin. Next to this, RNF41 regulates the 
intracellular trafficking of certain JAK2-associated cytokine receptors by ubiquitinating and suppressing 
USP8 which in turn destabilizes the ESCRT-0 complex. To further elucidate the function of RNF41 we 
used different orthogonal approaches to reveal the RNF41 protein complex: Affinity Purification-Mass 
Spectrometry, BioID and Virotrap. We combined these results with known datasets for RNF41 obtained 
with microarray MAPPIT and Y2H screens. This way, we establish a comprehensive high resolution 
interactome network comprising 175 candidate protein partners. To remove potential methodological 
artifacts from this network, we distilled the data into a high confidence interactome map by retaining a 
total of 19 protein hits identified in two or more of the orthogonal methods. AP2S1, a novel RNF41 
interaction partner, was selected from this high confidence interactome for further functional 
validation. We reveal a role for AP2S1 in leptin and LIF receptor signaling and show that RNF41 stabilizes 
and relocates AP2S1.  
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The high heterogeneity that underlies protein protein interactions (PPIs) resulted in the development of 
many different approaches to study these interactions. One set of methods, the so-called binary 
methods, test the specific interaction between two candidate proteins using a reporter read-out1, while 
other approaches aim at purifying the intact complex followed by identification of protein partners using 
mass spectrometry (MS)2. There is currently no universal method to obtain a comprehensive view of a 
full interactome. A valid strategy to approach this issue is by combining different complementary or 
orthogonal methods to establish a high confidence interactome. While this can indeed reveal additional 
protein partners, virtually all methods suffer from the presence of false positive associations. These can 
be explained by the nature of the method (e.g. proteins with transactivation activity in the yeast two-
hybrid system (Y2H)), or by the simple fact that many of the methods rely on forced expression of the 
bait protein (and even of the prey protein for the binary methods), a condition that can lead to many 
artifacts3. These false positives contaminate the interaction profile leading to an overestimation of the 
number of candidate partner proteins. Another way to use these complementary datasets relates to the 
generation of a confidence score based on the recurrent detection of specific partners with orthogonal 
methods. This concept was pioneered for the binary methods4 and is now starting to be explored with 
the MS-based methods5–7.     
 
RING finger protein 41 (RNF41, or NRDP1 (neuregulin receptor degradation protein-1)) is an E3 ubiquitin 
ligase with multiple roles including regulation of intracellular cargo trafficking. Next to its N-terminal 
RING finger domain responsible for recruiting E2 conjugating enzymes, it contains a coiled-coil domain, 
necessary for trimerization8,9, followed by a C-terminal substrate binding domain, which mediates 
interaction with a broad variety of proteins10. RNF41 ubiquitinates and degrades BIRC6 (or BRUCE), an 
inhibitor of apoptosis, and parki , a protei  i ol ed i  Parki so s disease11,12. Next to degradation, 
ubiquitination by RNF41 can also lead to subcellular relocalization, as demonstrated for VPS52, a protein 
involved in tethering of cargo to the Golgi network or recycling endosomes9. Moreover, differential 
ubiquitination of adaptor proteins MYD88 and TBK1 by RNF41 regulates Toll-like receptor 4 (TLR4) 
signaling resulting in suppressed production of proinflammatory cytokines and enhanced IFN-β 
production, respectively13. Next to downregulation of cytokine type I interleukin-3 (IL-3) and 
erythropoietin (EPO) receptors, RNF41 further controls the differentiation of myeloid progenitors and 
activates macrophages by respectively downregulating the transcriptio  fa tor reti oi  a id re eptor α 
RARα  a d upregulati g CCAAT/E ha er- i di g protei  β C/EBPβ 14,15. Furthermore, RNF41 can 
ubiquitinate and degrade ERBB3 receptors, thereby regulating their steady state levels. RNF41 located at 
the ER reroutes signaling competent ERBB3 receptors to the ERAD pathway, while it tags the 
internalized ERBB3 receptors for lysosomal degradation16,17. By downregulating parkin, BIRC6 and 
ERBB3, RNF41 is implicated in disorders su h as Parki so s disease18 and cardiomyopathies19,20 and in 
many cancers, like breast cancer21,22, prostate cancer23,24, glioma25–27 and pancreatic cancer28. Our 
previous studies indicated that RNF41 modulates the intracellular trafficking of the leptin receptor (LR), 
leukaemia inhibitory factor receptor (LIFR) and the interleukin-6 receptor (IL-6R), three JAK2-associated 
type I cytokine receptors29. By ubiquitinating and suppressing USP8, RNF41 indirectly destabilizes the 




subsequently reroutes them towards compartments for ectodomain shedding, resulting in the increased 
release of soluble receptors by ADAM proteases30. Furthermore, RNF41 was shown to attenuate LR, LIFR 
and IL-6R signaling by a yet unknown mechanism29. RNF41 itself is transcriptionally regulated by LPS 
stimulation13,31 and the androgen receptor32. Its regulation at posttranslational level is mostly 
accomplished by mechanisms modulating the ubiquitination state of RNF41, such as autoubiquitination 
or deubiquitination by USP833, as well as proteins stabilizing34, destabilizing35, or sequestering RNF4136.  
 
In this paper we generate a network of RNF41 interaction partners using a set of complementary MS-
based approaches Virotrap, BioID and AP-MS, and combine them with data obtained from previously 
performed binary RNF41 interaction screens to further complete the RNF41 interactome network. By 
pooling these datasets we obtained a high resolution interactome map for RNF41 and further 
condensed this into a high-confidence RNF41 interactome dataset respectively identifying 175 and 19 
candidate proteins. Since Adaptor related Protein complex 2 Sigma 1 subunit (AP2S1) is implicated in 
clathrin-mediated endocytosis (CME), we validated this newly identified RNF41 interaction partner 
based on known RNF41 functional assays involving LR signaling and trafficking. We found that AP2S1, 
which affects LR signaling, is stabilized and relocated by RNF41. 
 
Results 
High resolution and high confidence interactome profiling of RNF41 
Based on the concept as originally outlined for binary methods to obtain a confidence score4, we applied 
different MS-based methods in combination with binary methods and database information to obtain a 
comprehensive view of the RNF41 interactome (Fig 1). With the exception of Y2H, all screens were 
carried out with the RNF41 C34S/H36Q mutant preventing E3 ubiquitin ligase activity and subsequent 
possible RNF41-dependent ubiquitination and degradation of interacting proteins, including RNF41 
itself, thereby safeguarding its stability10. A classical AP-MS approach was performed by expression of a 
FLAG-tagged RNF41 C34S/H36Q protein in HEK293T cells in triplicate, while control cells were 
transfected with a FLAG-tagged EGFP construct. After lysis and purification, protein complexes were 
analyzed by mass spectrometry. The volcano plot shows the enriched proteins for a false discovery rate 
of 1% (Fig 2A and Supplementary Fig 2). The list of candidate binding proteins (Supplementary Table S2 
and Supplementary Table S3 for spectral counts) contains both known (BIRC6, HOMER2, …  a d o el 
proteins (KIAA1598 or SHOOTIN, NAV1, AP2S1, CCP110, …). As a first orthogonal approach, we 
investigated labeling of proximal proteins using the BioID technology. A FLAG-tagged promiscuous BirA* 
protein was cloned in frame on the C-terminus of RNF41 in a doxycycline-inducible expression vector. 
After recombination-assisted integration, expression of the construct was induced by doxycycline and 
verified by Western blot analysis (Supplementary Fig S1). To limit overexpression effects, a low 
doxyxycline level was chosen for the BioID experiments. We used the same liquid chromatography (LC) 
settings for peptide separations, and the same instrument and settings for MS analysis. The volcano plot 
in Figure 2A (extended in Supplementary Fig 2; Supplementary Table S2 and S3) shows the comparison 
of 4 induced RNF41-BirA*samples vs. 4 non-induced control samples. The strong binding of BIRC6 is 




levels of RNF41 and BirA* (separate entries in the proteomics database) are highly similar. As a third 
orthogonal method, we also made use of the Virotrap technology41 where expression of RNF41 
C34S/H36Q fused to GAG leads to the secretion of virus-like particles containing the RNF41 bait protein 
and its associated protein partners. Analysis of RNF41 was repeated for this study with the protocol 
described in Titeca et al.,37 to allow a side-by-side comparison with the AP-MS and BioID conditions. LC-
MS conditions were again the same for the 4 RNF41 samples and the 4 controls analyzed in the Virotrap 
study (Fig 2A, Supplementary Fig. 2; Supplementary Table S2 and S3). BIRC6 is clearly enriched in the 
particles containing RNF41 bait protein.  
By comparing the list of significantly enriched proteins for the different methods (Supplementary Table 
S4), we clearly observe overlapping and unique proteins (Fig 2B). This is a reflection of the different 
approaches with their unique advantages and disadvantages, resulting in their specific sets of missing 
partners (false negatives). While the design of experiments mostly prevents false positives in the lists, 
we cannot formally exclude their presence. For instance, the presence of BirA* in the BioID sample can 
lead to false associations with this exogenous protein.  
To further characterize the interaction profile of RNF41, we added data obtained with the MAPPIT 
technology39 and data from high throughput Y2H analysis42 (Fig 2B; Supplementary Table S4). Out of the 
175 candidate proteins in this high resolution interactome map, 15 were detected before according to 
BioGRID3.4 (entries in database on April 2017). Visualization of these candidate interactions in STRING 
(Version 10.543) reveals known associations, including known RNF41 interactions (Supplementary Fig S6). 
Based on function and localization, some associations are likely incorrect (e.g. the network around 
XRN1, related to mRNA metabolism and transcriptional regulation). To obtain a high confidence 
interactome, we selected only proteins that were detected by two or more orthogonal approaches. In 
this case we did not include the BioGRID data44 to avoid bias because of overlap with our approaches. 
This resulted in a short list of 19 high confidence interactions with RNF41 (Fig 2C) with 12 proteins also 
detected in the BioGRID data (Supplementary Table 2). While this list comprises several well 
characterized RNF41 interaction partners such as BIRC6 and USP811,30,33, it also reveals candidate 
interaction that were not previously known according to STRING, such as KIAA1598, NAV1 and AP2S1. 
Several of these novel interaction partners, i.e. KIAA1598, TACC1 and ENOPH1, were validated via co-
immunoprecipitation (Supplementary Fig S7). KIAA1598 and NAV1 are proteins involved in axon 
outgrowth and guidance, thus regulating neuronal polarization45–47. Recently, RTN4A, an ER-structural 
protein, was characterized as a new interaction partner of RNF4136. This protein is, just like KIAA1598 
and NAV1, involved in axon growth, which further illustrates the potential of orthogonal screens to 
identify functionally related proteins. Moreover, RNF41 has been implicated in the regulation of cell 
polarity in different ways. RNF41 downregulated VANGL-dependent non-canonical Wnt signaling, a 
pathway necessary for planar cell polarity in neuronal development48, while phosphorylation of RNF41 
by Par-1b is required for its role in epithelial cell polarity49. For further functional validation, we selected 
AP2S1 from the high confidence list of candidate interactions based on its involvement in clathrin-
mediated endocytosis (CME) which could have implications in RNF41-mediated JAK2-associated type I 







Figure 1. Overview of the orthogonal MS-based approaches to analyze protein complexes. The design of the 
different experiments in HEK293T cells (AP-MS and Virotrap) and in Flp-I ™ T-REx 293 cells (BioID) is shown. 
Database searches and statistical analysis were performed in the same way for the different experiments. The 
lower part of the overview shows additional data sources (Microarray MAPPIT39 and Y2H42) that were used for the 
generation of high resolution and high confidence views on the RNF41 interactome, and BioGRID44 that was used 













Figure 2. Comprehensive interaction profiling for RNF41. (A) Volcano plots for the different MS-based approaches 
showing the difference in protein quantity (X-axis, log2) against the p-value (Y-axis, -log10). FDR was set at 1% and 
S0 value was 1 for the 3 different approaches. Volcano plots with all significant proteins annotated are visualized in 




Supplementary Fig S3-5 (B) Venn diagram showing the overlap in number of proteins between the different 
approaches (http://bioinformatics.psb.ugent.be/webtools/Venn/) The data for this Venn diagram is presented in 
Supplementary Table S4. (C) The high-confidence interactome of RNF41. A STRING search was performed to reveal 
functional protein association networks (http://string-db.org/)43 using candidate proteins that were identified in 2 
orthogonal methods (19 proteins in addition of RNF41).   
 
AP2S1 depletion increases LR signaling but does not hamper RNF41-mediated effects on the LR.  
Our lab previously reported the influence of RNF41 on type I cytokine receptor signaling and routing29,30. 
We first sought to determine whether depletion of AP2S1 could modify these known RNF41-mediated 
effects. We demonstrated before that RNF41 expression inhibits LR signaling and blocks cathepsin L-
mediated C-terminal stub (CTS) formation of the LR. This CTS is visualized upon treatment with the 
lysosomal inhibitor chloroquine and serves as a read-out for lysosomal LR sorting. Concomitantly, RNF41 
stimulates LR recycling and enhances receptor ectodomain shedding by metalloproteases of the ADAM 
family leading to increased soluble LR29,30. We therefore assessed whether silencing of AP2S1 would 
influence trafficking of the LR. CTS generation in the lysates of LR transfected HEK293T cells treated with 
chloroquine and ELISA analysis of soluble LR levels in their conditioned medium was used to evaluate 
the effect on LR routing. Depletion AP2S1 did not hamper the RNF41-induced increase in LR ectodomain 
shedding nor the blocked CTS formation (Fig 3A). We next evaluated the effect of depleted AP2S1 on the 
RNF41-dependent attenuation of LR signaling. STAT3 luciferase reporter assays in HEK293T cells 
transfected with the LR showed no significant difference in RNF41 inhibited LR signaling. We noticed a 
clear increase in basal LR signaling upon silencing of AP2S1 when compared to the non-targeting (NT) 
control (Fig 3B). In addition, similar to the effects observed with ectopically expressed LR, silencing of 
AP2S1 also potentiated signaling of the endogenous LIFR in HEK293T cells. This increase in LR and LIFR 
signaling is comparable with the enhanced LR and LIFR signaling provoked by depletion of RNF41 (Fig 
3C). In conclusion, AP2S1 did not influence the RNF41-mediated effects on LR trafficking or signaling 





Figure 3. AP2S1 depletion increases LR signaling but does not hamper RNF41-mediated effects on the LR. (A) LR 
shedding and degradation. HEK293T cells were silenced (72h) for AP2S1 or treated with a non-targeting siRNA 
(siNT) and were transiently co-transfected with a plasmid encoding a C-terminally HA-tagged LR and RNF41 or 
solu le IL Rα o k . Cell l sates ere su je ted to ester  lot a al sis after o er ight i u atio  ith 
chloroquine. Full length LR and stub are visualized with anti-HA antibody. At the same time cell media 
supernatants from the transfected cells were collected and analyzed for soluble LR levels. Quantification was done 
by ELISA. Values are means ± s.d. from triplicate samples from one of three representative experiments. (B) LR 
signaling. HEK293T cells were silenced (72h) for AP2S1 or treated with siNT and were transiently co-transfected 
with C-terminally HA-tagged LR a d RNF  or solu le IL Rα o k  together ith a STAT -dependent luciferase 
reporter gene. Cells were stimulated with leptin (black bars) or left untreated (white bars). Absolute luciferase 
counts of triplicate measurements normalized for transfection efficiency from one biological replicate are 
represented (means ± s.d.). (C) Basal LR and LIFR signaling. HEK293T cells were silenced (72h) for RNF41, AP2S1 or 
treated with NT siRNA, followed by co-tra sfe tio  of LR or solu le IL Rα for e doge ous LIFR sig ali g  a d a 




Absolute luciferase counts of triplicate measurements normalized for transfection efficiency from one biological 
replicate are represented (means ± s.d.). n=3 for all experiments, data and statistical analysis of biological 
replicates are shown in Supplementary Fig S8. 
 
RNF41 stabilizes and relocates AP2S1  
Binary MAPPIT allowed us to further investigate the RNF41-AP2S1 interaction interface using different 
subdomains of RNF41 as bait to test against the AP2S1 prey. Next to full length RNF41 we used an N-
terminal construct, which holds the RING domain (AA1-134); a C-terminal construct, which contains the 
CC domain (AA135-179) and the substrate binding domain; a construct bearing only the substrate 
binding domain (AA179-317); and a truncated construct, ∆CC, which lacks the CC domain. Clearly, AP2S1 
specifically interacts with the substrate binding domain of RNF41 (Fig 4A). As interactions with this 
domain are primarily used for RNF41 substrates that undergo ubiquitination, we tested RNF41-
dependent ubiquitination of AP2S1. Surprisingly, we were unable to show that RNF41 ubiquitinates 
AP2S1 (Supplementary Fig S9). This is corroborated by in vitro GST-pulldown experiments revealing an 
indirect interaction between RNF41 and AP2S1 (Fig 4B). We next investigated whether the interaction 
between both proteins affects their stability. Depletion of AP2S1 in HEK293T and HeLa cells did not 
influence RNF41 expression levels, nor did silencing of RNF41 affect AP2S1 levels (Supplementary Fig 
S10). We therefore studied the effect of ectopically expressed RNF41 on AP2S1 protein expression in 
HEK293T cells. Co-expression of RNF41 significantly stabilized FLAG-tagged AP2S1 protein levels 
compared to the mock control. Moreover, RNF41 prevented AP2S1 from undergoing proteasomal 
degradation since this effect was lost when cells were incubated with the proteasomal inhibitor MG132 
(Fig 4C). Consistent with the absence of AP2S1 ubiquitination by RNF41, this AP2S1 stabilization 
appeared to be independent of the RNF41 E3 ligase function as the C34S/H36Q mutant, lacking the 
ability to recruit an E2 conjugating enzyme (CS/HQ10), still stabilized AP2S1. Furthermore, we did not 
observe this stabilizing effect on AP2S1 when using dominant negative (DN; AA 109-31710,50) or Gly2Ala 
(G2A) mutated RNF41. This suggests a need for RNF41 membrane-anchoring as DN RNF41 lacks the 
RING domain and a possible myristoylation site, while the mutated glycine at position 2 of the G2A 
mutant disrupts this potential myristoylation site. Co stru ts la ki g the CC do ai  ∆CC  or o l  
expressing the CC domain, which are known to disturb endogenous RNF41 oligomerization8 appear to 
further destabilize AP2S1 (Fig 4C). These results can be explained by an RNF41-mediated relocalization 
of AP2S1. This is further supported by confocal microscopy, as ectopically expressed RNF41 and the 
C34S/H36Q mutant stabilize FLAG-tagged AP2S1 and redistribute it from a more diffuse and plasma 
membrane-located pattern towards cytosolic RNF41-positive structures (Fig 4D). DN RNF41 together 
with the G2A mutant and the CC domain closely resemble the control condition where we observe a 
ore diffuse stai i g of AP S , hile e topi  e pressio  of ∆CC enhanced this diffuse pattern of FLAG-
tagged AP2S1 (Fig 4D). Since RNF41 expression is upregulated upon LPS stimulation in RAW264.7 cells13, 
we also asked whether LPS stimulation could in this way result in stabilized AP2S1. Unfortunately, we 
were not able to reproduce the LPS-mediated increased RNF41 expression in RAW264.7 cells, nor in 




Altogether, these results indicate that AP2S1 indirectly interacts with the substrate binding domain of 
RNF41 and is not ubiquitinated by RNF41. Moreover, RNF41 protects AP2S1 from proteasomal 
degradation thereby stabilizing and relocating it away from its conventional location. Membrane 
anchoring and oligomerization of RNF41 appear to be necessary for these effects on AP2S1.  
 
 
Figure 4. RNF41 stabilizes and relocates AP2S1. (A) Left, MAPPIT analysis in HEK293T cells transiently co-
transfected with plasmids encoding an AP2S1 prey together with empty, RNF41 WT or RNF41 subdomain bait and 




24 hours. The luciferase signal is expressed as fold induction (stimulated/non stimulated), relative to the signal of a 
control JAK2 binding prey ± s.d. of triplicate measurements. Western blotting verified Flag-tagged prey expression 
and β-actin levels (loading control). MAPPIT data with empty and JAK2 binding control preys are shown in 
Supplementary Fig S12. Right, representation of full length RNF41 with indicated subdomains and point mutations 
(N-term: AA1-134; C-term: AA 135-317). (B) GST-pulldown analysis. Escherichia coli BL21(DE3) cell lysates 
expressing GST-RNF41 or GST-PGC α egati e o trol  ere i u ated ith i  itro tra s ri ed a d tra slated 
FLAG-tagged AP2S1 and ASB6 (positive control). Glutatione sepharose beads precipitated the complexes which 
were revealed via Western blotting using anti-FLAG and anti-GST antibodies. (C) Effect on expression levels of 
AP2S1. HEK293T cells transiently co-transfected with a plasmid encoding FLAG-tagged AP2S1 and untagged WT, 
mutated or truncated RNF41, FLAG-tagged RNF41 CC-gp130 (prey construct used to optimize expression), or 
solu le IL Rα o k  ere treated o er ight ith µM DMSO left  or µM MG  right  prior to so i atio  i   
Laemmli buffer. Protein levels were determined by Western Blotting using anti-FLAG, anti-RNF41 or anti-β-actin 
(loading control) antibodies. A one-way ANOVA of three quantified biological replicates showed a significant 
difference in FLAG-AP2S1 levels between mock and RNF41 (p<0.01) and between mock and CS/HQ (p<0.05), 
Values are means ± s.e.m. (D) RNF41 redistributes AP2S1. Confocal microscopy of HeLa cells transiently transfected 
with a vector encoding FLAG-tagged AP S  a d solu le IL Rα o k , GFP-tagged WT, mutated or truncated 
RNF41 (green) were fixed and stained with Dapi (blue) and anti-FLAG antibody (secondary Alexa Fluor 568, red). 
The insets show a magnification of the boxed area. Scale bar, 10µm. n=3 for all performed experiments.  
 
Discussion 
To further characterize the RNF41 interactome and hence further explore the function of RNF41, we 
performed several co-purification screens, e.g. Virotrap, a method based on viral particle sorting; BioID, 
a proximity biotinylation approach and affinity purification-mass spectrometry (AP-MS), and pooled 
these results with known datasets from a mammalian two-hybrid microarray MAPPIT and a human 
proteome-wide Y2H screen39,42. The different PPI technologies all have intrinsic strengths and 
weaknesses, of which the presence of false positives and false negatives represents a limitation inherent 
to almost all PPI methods. This is supported by a number of observations in the available data sets. The 
AP-MS experiments failed to reveal USP8 and ASB6, proteins that were validated by different orthogonal 
methods, and that were functionally validated (30,39; De Ceuninck et al, manuscript in preparation). The 
absence of these proteins can be explained by degradation during lysis and purification. USP8 
degradation is likely prevented in the virus-like cage that is used in the Virotrap method41. Both USP8 
and ASB6 were readily detectable with BioID. Biotinylation of proximal proteins by BirA* occurs in the 
intact cells before the actual lysis step which may help in the detection of these partners. This may also 
explain the detection of VPS52 in the BioID data. Note also that lysines are typically biotinylated by the 
BirA* activity. This modification may prevent ubiquitination and can thus prevent degradation of some 
of the candidate interacting proteins. In addition, our MS-based approaches were performed in a single 
cellular context (i.e. in HEK293 cells), therefore limiting the interactome to the proteins that are 
expressed in these cells. The binary approaches microarray MAPPIT and Y2H were performed using an 
arrayed proteome-wide library of prey proteins which corrects the absence of proteins that are not 
endogenously expressed in the cells. While MAPPIT allows the detection of indirect interactions when 
the bridging partners are present in the cellular background (i.e. HEK293T cells), this is much less likely in 




us to generate a high-resolution interactome of RNF41, containing 175 candidate proteins, which 
revealed several functional clusters including proteins involved in ubiquitination and in receptor 
signaling pathways. Interpretation of this network should be performed with caution. This is exemplified 
by the presence of the XRN1 cluster, as the functional link between RNF41 and mRNA metabolism is not 
obvious at present (Supplementary Fig S6). From this list, 19 proteins were identified by two or more 
methods, supporting the high quality of the RNF41 interactome (Fig 2C). Altogether, these orthogonal 
assays proved to be complementary, providing both new and previously identified interaction partners 
of RNF41. Novel candidate proteins such as KIAA1598 and NAV1, which are, similarly to RNF41 and its 
recently discovered interaction partner RTN4A, implicated in cell polarization underscore the adequacy 
of our interactome profiling approach to reveal functional relevant links36,45–47,49. We selected the novel 
RNF41 candidate partner AP2S1 from the high confidence map for further functional validation.  
 
AP2S1 is the sigma subunit of the clathrin adaptor protein AP-2, a key player of CME, one of the major 
mechanisms for internalization of transmembrane proteins from the plasma membrane51. Therefore, 
AP2S1 might be functionally related to the well-established role of RNF41 in receptor trafficking and 
signaling10,13,14,29. The heterotetrameric AP-  o ple , o prises t o large su u its, α a d β , a 
medium subu it µ  a d a s all su u it σ 52. Plasma membrane binding triggers a conformational 
change in AP-2, which allows it to select and interact with internalization motifs in the cytoplasmic tail of 
cargo, followed by clathrin recruitment. In this way, AP-2 a ts as a e tral hu  for CME53,54. In an 
attempt to validate AP2S1 as a novel RNF41 interaction partner we implemented an RNAi strategy in the 
hope of linking this protein with the previously described RNF41 functions in LR shedding, degradation 
and signaling29. Depletion of AP2S1 revealed no changes in RNF41-mediated enhanced LR ectodomain 
shedding or decreased CTS formation, or on RNF41-induced attenuated LR signaling (Fig 3A-B). We did 
however observe that AP2S1 depletion increased basal LR and endogenous LIFR signaling. This 
potentiated signaling corresponds to the enhanced signaling in RNF41-depleted cells (Fig 3C). This 
suggests that AP2S1 has an inhibitory effect on LR signaling, which is further enhanced by ectopic RNF41 
expression (Fig 3B). This is in line with our observation that RNF41 stabilizes AP2S1, and hence, 
potentiates its inhibitory effect on LR signaling (Fig 4C). Next to this, RNF41 itself inhibits LR signaling via 
an unknown mechanism29, possibly entailing other interaction partners, such as the E3 ligase ASB6, 
which indirectly interacts with the LR via IRS4 (De Ceuninck et al., unpublished observations). This 
underscores the versatile nature of RNF41 function depending on its interaction partners that are likely 
spatially and temporally separated.   
 
Other than the involvement of clathrin and dynamin55, there is a lack of information regarding LR 
internalization and whether this can regulate its signaling. Therefore, our results can be interpreted in 
different ways depending on the notion if LR signaling occurs at the plasma membrane or whether LR 
signaling requires internalization, although we cannot exclude the occurrence of signaling both at the 
plasma membrane and after internalization. If AP-2 and thus AP2S1 are involved in LR internalization 
and LR signaling occurs at the plasma membrane, then AP2S1 silencing would block internalization, 
resulting in enhanced LR signaling, which is in accordance with our results. However, we observed that 
ectopic expression of a DN dynamin mutant (dynamin K44A), which is known to block CME, resulted in 




S13). In this case, depletion of AP2S1 should, similarly to DN dynamin, inhibit signaling. Since we detect 
the opposite, i.e. enhanced signaling upon AP2S depletion, it is possible that AP2S1 and AP-2 are not 
involved in LR endocytosis, and that other adaptor proteins may regulate its internalization. In line 
herewith, there are currently no reports on a putative dileucine or tyrosine-based motif in the LR, which 
are re og ized  the σ  or µ2 subunit of AP-2 respectively. It is known that CME acquires different 
adaptor proteins for mediating endocytosis, making AP-2 dispensable for certain cargo. This is 
exemplified by the EGF and LDL receptors, where AP-2 depletion does not hamper EGFR and LDLR CME, 
whereas Tfn endocytosis is blocked56.  
 
Mapping the RNF41-AP2S1 interface using distinct RNF41 subdomains revealed that the RNF41 
substrate binding domain mediates AP2S1 binding (Fig 4A). Interactions with this C-terminal domain are 
generally reserved for proteins like BIRC6, USP8 and ERBB3, that are ubiquitinated by RNF4111,57,58. 
Remarkably, we did not detect changes in the ubiquitination state of AP2S1 by RNF41 (Supplementary 
Fig S9). Since ubiquitination is a hallmark for protein stability or trafficking, it was surprising to find that 
RNF41 stabilizes AP2S1, independent of its E3 ubiquitin ligase function. Stabilization of AP2S1 when 
using RNF41 C34S/H36Q, a RING domain mutant unable to exert ubiquitination10, confirmed this result 
(Fig 4C). This stabilization could be visualized using confocal microscopy, where AP2S1, typically 
distributed homogenously throughout the cytoplasma with a predominance for the plasma membrane, 
overlapped with RNF41 and the C34S/H36Q mutant in RNF41-positive structures. This also points 
towards a redistribution of AP2S1 by RNF41 (Fig 4D). The identity of these RNF41-positive structures 
remains to be elucidated. Both myristoylation and oligomerization of RNF41 appeared to be necessary 
for its stabilizing effect on AP2S1. RNF41 has a possible myristoylation site, characterized by the Met-Gly 
sequence at its N-terminus10. A G2A mutant, disrupting this site and DN RNF41, lacking the N-terminus, 
did not mediate this effect on AP2S1, which was also seen with confocal microscopy. Furthermore, 
RNF  ∆CC and the RNF41 CC domain, both disrupting RNF41 oligomerization8, did not affect AP2S1 
stability (Fig 4C-D). Moreover, AP2S1 underwent proteasomal degradation, since incubation with the 
proteasomal inhibitor MG132 stabilized AP2S1 levels. Thus it is likely that, by its relocalization, RNF41 
prevents AP2S1 from proteasomal degradation (Fig 4C).  
Lack of RNF41-mediated ubiquitination of AP2S1 can also be explained by the observation of the indirect 
interaction between RNF41 and AP2S1 (Fig 4B). The identification of an indirect interactor in the high-
confidence interactome nicely attributes to our orthogonal approach as AP2S1 appeared as a candidate 
interactor of RNF41 in both Virotrap and microarray MAPPIT, two methods allowing the detection of 
weak, transient and indirect interactions. We and others have previously determined that USP8 and 
ASB6 require, similar to AP2S1, the substrate binding domain of RNF419,30,57). MAPPIT analysis revealed 
that RNF41 mutants specifically disrupting interaction with ASB6 and/or USP8 also resulted in a loss of 
AP2S1 binding. However, we did not detect an interaction between AP2S1 and ASB6 or USP8, indicating 
that the RNF41-AP2S1 interaction is not mediated by any of these proteins (Supplementary Fig S14). 
Since AP2S1 indirectly interacts with the substrate binding domain of RNF41 (Fig 4A-B), and RNF41 
prevented AP2S1 from proteasomal degradation (Fig 4C), it is conceivable that RNF41 directly interacts, 
via its substrate binding domain, with another currently unknown E3 ligase, which under normal 




function of this unknown E3 ligase thus preventing proteasomal degradation of AP2S1. Zhong, et al., 
described a similar situation where RNF41 degrades the E3 ligase parkin thereby stabilizing CDCrel-1, a 
parkin substrate12. Moreover, the Virotrap dataset revealed three potential E3 ubiquitin ligases, 
including CACYBP, BIRC6 and TTC1, who could possibly mediate this effect. On the other hand, RNF41 
prevented AP2S1 from proteasomal degradation, depending on its myristoylation and oligomerization 
state. RNF41 could perhaps, by membrane anchoring or hetero-oligomerization with other, unknown 
proteins, reroute AP2S1 in complex with the unknown E3 ligase, towards compartments which can be 
visualized as RNF41-positive structures.    
 Furthermore, Arg15 mutations in AP2S1 are known to cause familial hypocalciuric hypercalcemia type 3 
(FHH3), a calcium homeostasis disorder that affects parathyroid glands, kidney and bone. These 
mutations likely disrupt the interaction between AP-2 and the cytoplasmic tail of the calcium sensing 
receptor, thereby reducing its endocytosis and decreasing the sensitivity of the cells to extracellular 
calcium59. These AP2S1 Arg15 mutations did not disrupt interaction with RNF41, suggesting that RNF41 
is not implicated in FHH3 (Supplementary Fig S14) 
In conclusion, by employing complementary MS-based methods Virotrap, BioID and AP-MS screens and 
combining these results with publicly available data retrieved from microarray MAPPIT and Y2H screens 
we were able to generate high resolution and high confidence interactome maps for RNF41. As we show 
for AP2S1, these maps provide a useful resource for further functional analysis of RNF41. 
 
Experimental procedures 
Plasmids and constructs 
The generation of all sequence-verified constructs is shown in Supplementary Table S1. 
 
Co-purification methods 
For every AP-MS condition we seeded 2 PD150 dishes with 8 x 106 HEK293T cells 48 hours before 
transfection.  After PolyEthylene Imine (PEI)-based transfection for 8 hours using 14.5 µg of pMET7-
FLAG-RNF41 C34S/H36Q or pMET7-FLAG-EGFP (controls), cells were scraped the next day in ice cold 
PBS. After removal of PBS by pelleting the cell material, pellets were weighed and 400 µl lysis buffer (50 
mM HEPES-KOH pH 8.0, 100 mM KCl, 2 mM EDTA, 0.1 % NP40, 10 % glycerol, 1 mM DTT, 0.5 mM PMSF, 
Protease inhibitor cocktail tablet [Roche], 0.25 mM Na3VO4, 50 mM glycerophosphate, 10 mM NaF) was 
added for every 100 mg of pelleted cell material. 50 µl of prewashed MyOne Streptavidin T1 beads 
(Thermo Fisher Scientific) were pre-incubated with 5 µl BioM2 antibody (Sigma). The beads were added 
after washing to the pre-cleared lysates (20 min 16000 x g 4°C) and left to bind complexes for 2 hours at 
4°C by end-over-end rotation. After washing, beads were incubated overnight with 750 ng trypsin, 
followed by an additional incubation step with 250 ng trypsin for 4 hours after removal of the beads. 
After acidification, peptides were analyzed by liquid chromatography - mass spectrometry (LC-MS) using 
a Thermo S ie tifi ™ Q Exactive™ H rid Quadrupole-Orbitrap Mass Spectrometer.  
 
The pDEST-pCDNA5-RNF41 C34S/H36Q-BirA*-FLAG-C-term vector was stably integrated in the genome 




expression of the fusion construct was verified by Western blot using anti-FLAG antibody (M2, Sigma). 
80 µg of cleared lysates were loaded on 4-12 % gradient gels. For BioID experiments, 2 PD150 dishes 
were seeded the day before doxycycline induction for each sample. Cells were treated with doxycycline 
(4 repeat samples) for 48 hours or left untreated as controls (4 repeat control samples) the day after 
transfection. At around 85 % confluency cells were washed and collected in PBS. After removal of PBS, 
the cells were lysed using ice-cold RIPA lysis buffer (50 mM TRIS-HCl pH 7.5, 150 mM NaCl, 1 % NP40, 1 
mM EGTA, 0.1 % SDS, 0.5 % Sodium Deoxycholate, 250 U Benzonase and Protease inhibitor cocktail 
[Sigma 1/500]). Lysates were cleared after sonication by 15 min at 16000 x g and at 4°C. 150 µl bed 
volume of pre-washed Streptavidin Sepharose® High Performance Beads (GE) was added to each sample 
and was allowed to bind biotinylated proteins for 3 hours at 4°C by end-over-end rotation. After 
extensive washing of the beads, on bead trypsin digest and LC-MS was performed as described for the 
AP-MS approach.  
 
Virotrap experiments were performed essentially as described in Titeca et al.37. Briefly, HEK293T cells 
were seeded in T75 bottles the day before transfection with pMET7-GAG-RNF41 C34S/H36Q or with a 
pMET7-GAG-eDHFR control construct, combined with expression vectors for VSV-G and FLAG-VSV-G. 
Cell supernatants were harvested 40 hours after transfection and were cleared by low-speed 
centrifugation and by filtering (0.45 µm). Supernatants were then incubated with MyOne Streptavidin T1 
beads loaded with BioM2 antibody. Two hours after binding, beads containing Virotrap particles were 
washed, and particles were released by competition with FLAG-peptide. After removal of the beads, 
samples were processed with Amphipols and digested using trypsin. After acidification, peptides were 
analyzed by LC-MS using a Thermo S ie tifi ™ Q Exactive™ H rid Quadrupole-Orbitrap Mass 
Spectrometer. Analysis was performed on 4 independent transfections for RNF41 and control 
experiments.  
 
The peptide mixtures were first loaded on a trapping column (made in-house, 100 μm I.D. × 20 mm, 5 
μm beads C18 Reprosil-HD, Dr. Maisch, Ammerbuch-Entringen, Germany). After flushing from the 
trapping column, the sample was loaded on an analytical column (made in-house, 75 μm I.D. × 150 mm, 
5 μm beads C18 Reprosil-HD, Dr. Maisch) packed in the nanospray needle (PicoFrit SELF/P PicoTip 
emitter, PF360-75-15-N-5, NewObjective, Woburn, USA). The samples were loaded and separated with a 
linear gradient from 98 % solvent A  (0.1 % formic acid in water) to 40 % solvent B′ (0.08 % formic acid in 
water/acetonitrile, 20/80 (v/v)) in 30 min at a flow rate of 300 nl/min. This was followed by a 15 min 
wash reaching 99 % solvent B . The Q Exactive instrument was operated in data-dependent, positive 
ionization mode, automatically switching between MS and MS/MS acquisition for the 10 most abundant 
peaks in a given MS spectrum. The source voltage was 3.4 kV, and the capillary temperature was 275°C. 
One MS1 scan (m/z 400−2000, AGC target 3 × 106  ions, maximum ion injection time 80 ms) acquired at a 
resolution of 70,000 (at 200 m/z) was followed by up to 10 tandem MS scans (resolution 17,500 at 200 
m/z) of the most intense ions fulfilling the defined selection criteria (AGC target 5 × 104  ions, maximum 
ion injection time 80 ms, isolation window 2 Da, fixed first mass 140 m/z, spectrum data type: centroid, 
minimum AGC target 1000, intensity threshold 1.4 x 104,  exclusion of unassigned, 1, 5-8, and >8 charged 




collision energy was set to 25% Normalized Collision Energy and the polydimethylcyclosiloxane 
background ion at 445.120025 Da was used for internal calibration (lock mass).  
All MS data was searched using MAXQUANT (version 1.5.7.4) against the human SwissProt database (Jan 
2017; complemented with GAG, VSV-G and eDHFR sequences for Virotrap; complemented with EGFP for 
AP-MS, and BirA* for BioID), with 4,5 ppm and 20 ppm tolerance on precursor and fragment mass 
respectively, with trypsin/P settings allowing up to 2 missed cleavages, and with methionine oxidation 
and N-terminal acetylation formation as variable modifications. Minimum peptide length was set to 7, 
maximum peptide mass was 4,600 Da. PSM FDR and protein FDR were set to 0.01. Min. peptides and 
min. razor + unique peptides were set to 1. The searches were performed together with the 
corresponding control samples to allow matching of MS spectra between runs. Contaminants and 
identifications against the REVERSE database were removed in the PERSEUS (version 1.5.5.3) analysis 
after the log2 transformation of the non-normalized protein LFQ ratios.  A two-sided t-test was 
performed with multiple testing correction using 1000 randomizations. FDR was set at 1 % with the S0 
curve set at 1.  
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via 
the PRIDE 38 partner repository with the dataset identifier PXD007794. 
 
Microarray and binary MAPPIT analysis 
Microarray MAPPIT and the preparation of the prey and reporter reverse transfection mixture was 
previously described39. RNF41 C34S/H36Q was used as bait and screened against a 15K ORF prey 
collection (The human ORFeome v8.140). For binary MAPPIT, 1 x 104 HEK293T cells (www.atcc.org, 
mycoplasma negative) were seeded in a 96-well plate and transfected with 50 ng of STAT3-dependent 
pXP2d2-rPAP1-luciferase reporter, 250 ng bait and prey constructs using calcium phosphate. Cells were 
left untreated or stimulated for 24 hours with human Erythropoietin (5 ng/ml). Luciferase activity from 
triplicate samples was measured by chemiluminescence in an Envision plate reader (PerkinElmer) and 
expressed as fold induction (stimulated/non-stimulated relative light units) relative to the signal 
generated by a JAK2 binding prey, thereby correcting for varying expression levels of the different used 
baits.  
 
Western Blot analysis 
1.5 x 105 HEK293T cells were seeded in a 12-well plate and co-tra sfe ted ith  μg of ea h o stru t. 
Cells were incubated overnight with 5µM of DMSO or MG132 followed by lysis in 2x SDS gel laemmli 
buffer (62.5 mM Tris-HCl pH . , % SDS, % gl erol, % β-mercaptoethanol and 0.01% Bromophenol 
Blue sodium salt) and sonicated using the Bioruptor Plus (Diagenode). After boiling, cell lysates were 
resolved by SDS-PAGE and transferred to nitrocellulose membranes (Amersham Biosciences). Blots were 
blocked in Odyssey blocking buffer (LICOR). Rabbit anti-RNF41 (1:10.000; Bethyl), mouse anti-FLAG 
(1:10.000; Sigma) and mouse anti-β-actin (1:5000, Sigma) were revealed by Odyssey infrared imaging 
(LICOR) using anti-rabbit or anti-mouse Dylight 680-conjugated antibody (1:15.000, Pierce) diluted in 
Odyssey blocking buffer + 0.1% Tween20. Rat-anti HA (1:5000, Roche (3F10)) was used for expression 
control in other experiments, revealed with anti-rat Dylight 680-conjugated antibody (1:15.000, Pierce) 




by SuperSignal West Pico Chemiluminescent Substrate (Pierce) for detection via ECL (enhanced 
chemiluminescence), using peroxidase-conjugated anti-rabbit antibody (1:10.000, Jackson 
ImmunoResearch), diluted in milk blocking buffer. 
 
LR shedding and degradation 
1.25 x 105 HEK293T cells in a 12-well plate were reverse transfected with 50 nM siRNA using Dharmafect 
1 (Dharmacon). Transient knockdown was accomplished using AP2S1 siRNA (L-011833-01-0005, 
Dharmacon and non-targeting siRNA (D-001810-10-0020, Dharmacon). The next day, cells were 
transfected with 1 µg of pMet7-hLR-HA together with 0.5 µg of pMet7-RNF41 or pMet7-solIL Rα.  
hours later, cells were incubated overnight in serum-free OPTIMEM medium with 25 µM chloroquine. 
The next morning, cell supernatant was collected to detect soluble LR by ELISA with the Human Leptin R 
DuoSet (R&D systems), and cells were simultaneously lysed for CTS cleavage analysis using western 
blotting.  
 
Luciferase reporter assay 
2 x 105 HEK293T cells in a 6-well plate were reverse transfected as described above with the addition of 
RNF41 siRNA (D-006922-02-0020, Dharmacon). Cells were transfected the next day with 0.1 µg pMet7-
hLR-HA together with 0.2 µg of pXP2d2-rPAP1-lu iferase reporter a d .  µg of a β-gal reporter 
construct to correct for transfection efficiency with or without 1 µg of pMet7-RNF41 or pMet7-solIL Rα. 
24 hours later, cells were washed, transferred to a 96-well plate and stimulated with mouse leptin (100 
ng/ml) or human LIF (10 ng/ml) or were left untreated for 24 hours. Luciferase activity from triplicate 
samples was measured by chemiluminescence in an Envision plate reader (PerkinElmer) and expressed 
as fold induction (stimulated/non-stimulated relative light units) or as relative light units normalized for 
transfection efficiency.  
 
GST-pulldown assay 
Escherichia (E.) coli strain BL21(DE3) was transformed with vectors containing GST-RNF41 or GST-PGC α. 
Production of protein was induced by 0.2 mM isopropyl-D-thiogalactoside at A600 of 0.6. The bacteria 
were further cultured ON at 25°C. After centrifugation at 5000 rpm for 10 min, the bacterial pellet was 
resuspended and sonicated in NETN buffer (20 mM Tris-HCl pH 8; 100 mM NaCl; 6 mM MgCl2; 1 mM 
EDTA; 0.5 % NP40; 1 % DTT and protease inhibitor cocktail Complete (Roche)). The E.coli lysate was 
centrifugated at 12000 rpm for 10 min allowing separation of the soluble GST proteins in the 
supernatant. The GST proteins were immobilized on Glutathione Sepharose 4B beads (GE Healthcare) 
for 1 hour at 4°C. After incubation the beads were washed three times with NETN buffer. N-terminal 
FLAG-tagged AP2S1 or ASB6, produced using the TNT T7 Quick Coupled Transcription/Translation 
System (Promega), was added to the beads-GST protein mixture. After ON incubation the beads were 
washed three times with NETN buffer. The bound proteins were eluted by boiling in 2x SDS gel laemmli 
buffer for 10 minutes and analyzed by SDS-PAGE and immunoblotting. The following antibodies, rabbit 
anti-GST (Abcam) and mouse anti-FLAG (Sigma), were used for GST proteins and the FLAG-tagged 







1.5 x 104 HeLa cells (www.atcc.org, mycoplasma negative) were seeded on µ-Slide 8 well plates (Ibidi), 
coated with poly-L-lysine (Sigma-Aldrich). The next day, cells were transfected with 100 ng of construct 
using JetPrime (Polyplus). 24 hours later, cells were rinsed with PBS and fixed for 15 minutes at room 
temperature in 4% paraformaldehyde. Cells were washed with 100mM phosphate buffer (100 mM 
Na2HPO4; 100 mM NaH2PO4, pH 7.4), permeabilized and blocked in blocking buffer (20 mM phosphate 
buffer; 100 mM NaCl; 0.23% Triton X-100 and 10% donkey serum) for 30 minutes. Samples were 
incubated for 1.5 hours at room temperature with mouse anti-FLAG (1:5.000, Sigma). After washing in 
blocking buffer without donkey serum, cells were incubated for 1 hour at room temperature with 
donkey anti-mouse Alexa Fluor 568 (1:1000, Molecular Probes) and DAPI (1:100, Molecular Probes). 
Images were acquired using a 60x 1.35 NA objective on an Olympus IX-81 laser scanning confocal 
microscope and analyzed using Image J software. 
 
SUPPORTING INFORMATION 
Supplementary Figure S1. Inducible expression of a FLAG-tagged RNF41 C34S/H36Q-BirA*fusion 
construct in Flp-I ™ T-REx 293 cells.  
Supplementary Figure S2. Volcano plots for the different MS-based approaches showing all detected 
proteins. 
Supplementary Figure S3. Correlation plots of the LFQ intensities for the AP-MS experiments. 
Supplementary Figure S4. Correlation plots of the LFQ intensities for the BioID experiments. 
Supplementary Figure S5. Correlation plots of the LFQ intensities for the Virotrap experiments. 
Supplementary Figure S6. The high resolution interactome of RNF41.  
Supplementary Figure S7. Co-immunoprecipitation of E-tagged RNF41 and FLAG-tagged KIAA1598, 
TACC1 and ENOPH1.  
Supplementary Figure S8. Statistical analysis of 3 biological replicates from data in Figure 3.  
Supplementary Figure S9. RNF41 does not ubiquitinate AP2S1.  
Supplementary Figure S10. Effect of AP2S1 depletion on RNF41 and vice versa.  
Supplementary Figure S11. Effect of LPS on RNF41 protein expression.  
Supplementary Figure S12. Extended MAPPIT data from Figure 4A.  
Supplementary Fig S13: LR internalization is necessary for LR signaling.  
Supplementary Fig S14: AP2S1 Arg mutations do not influence RNF41 interaction, and AP2S1 does not 
interact with ASB6 or USP8.  




Supplementary Table S2: Protein lists obtained with the different methods used in this study. 
Supplementary Table S3: Spectral counts for the different proteins detected in the MS-based 
approaches.  
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Supplementary Figure S1. Inducible expression of a FLAG-tagged RNF41 C34S/H36Q-BirA*fusion 
construct in Flp-In™ T-REx 293 cells. After treatment with doxycycline, cells were lysed and cleared 
lysates were loaded for PAGE. After blotting, expression of the fusion protein was revealed by anti-FLAG 
antibodies (left panel). In the panel on the right, biotinylated proteins are revealed by fluorescently-







































Supplementary Figure S2. Volcano plots for the different MS-based approaches showing the difference 
in protein quantity (X-axis, log2) against the p-value (Y-axis, -log10). FDR was set at 1% and S0 value was 


















































Supplementary Figure S3. Correlation plots of the LFQ intensities for the AP-MS experiments. LFQ 







Supplementary Figure S4. Correlation plots of the LFQ intensities for the BioID experiments. LFQ 









Supplementary Figure S5. Correlation plots of the LFQ intensities for the Virotrap experiments. LFQ 







Supplementary Figure S6. The high resolution interactome of RNF41. All candidate partner proteins 
from the different experimental approaches and from Y2H and microarray MAPPIT were combined in a 













Supplementary Figure S7. Co-immunoprecipitation of E-tagged RNF41 and FLAG-tagged KIAA1598, 
TACC1 and ENOPH1. HEK293T cells were transiently transfected with E-tagged RNF41 and FLAG-tagged 
KIAA1598, TACC1, ENOPH1 and FLAG-tagged SVT and FKBP12 as negative controls. Anti-FLAG 








Supplementary Figure S8. Statistical analysis of 3 biological replicates from data in Figure 3. (A) Fig 3A. 
A two-tailed Mann-Whitney test showed no significant difference in LR shedding for the RNF41/mock 
ratio between siAP2S1 and the siNT control. Values are means ± s.e.m. (B) Fig 3B. Left, a two-tailed 
Mann-Whitney test showed no significant difference in LR signaling for the mock/RNF41 ratio of the FI 
(S/NS values) between siAP2S1 and the siNT control. Right, although the three biological replicates show 
the same trend, i.e. enhanced signaling with siAP2S1, no statistical significant difference in LR signaling 
for the FI (S/NS values) was observed between the different siRNA treatments using a two-tailed Mann-
Whitney test. Values are means ± s.e.m. (C) Fig 3C. Left, a one-way ANOVA showed no significant 
difference in LR signaling for the FI (S/NS values) between siAP2S1 and the siNT control, although we do 
observe enhanced LR signaling when silencing AP2S1 throughout all 3 biological replicates. Right, a one-
way ANOVA showed a significant increase in LIFR signaling for the FI (S/NS values) when cells are treated 





























































































































































































Supplementary Figure S9. RNF41 does not ubiquitinate AP2S1. (A) HEK293T cells were transiently co-
transfected with plasmids encoding FLAG-tagged AP2S1, HA-ubiquitin and either WT RNF41 or soluble 
IL5Rα (mock). FLAG immunoprecipitation followed by anti-HA staining revealed the ubiquitination state 
of AP2S1. Expression was verified using anti-FLAG, anti-RNF41 and anti-β-actin (loading control) 
antibodies. (B) The Western Blot from (A) was quantified together with two other biological replicates 
using Image J. The ubiquitination signal was normalized for the amount of immunoprecipitated FLAG-
tagged AP2S1 and compared between the mock and RNF41 condition. A two-tailed Mann-Whitney test 



















































































                                   
                
 
Supplementary Figure S10. Effect of AP2S1 depletion on RNF41 and vice versa. HEK293T and HeLa cells 
were silenced for 72h using siRNA against RNF41 or AP2S1. Protein expression levels were analyzed by 
Wester  Blotti g usi g a ti odies agai st RNF , AP S  or β-actin (loading control) and mRNA levels 
were checked via RT-qPCR. A one-way ANOVA of three biological replicates showed significant 






Supplementary Figure S11. Effect of LPS on RNF41 protein expression. HEK-BlueTM TLR4, THP-1 and 
RAW264.7 cells were incubated with LPS for 8 hours. RNF41 protein levels were analyzed by Western 
Blotting using antibodies against RNF41, p-P38 (confirmation for LPS activation) or β-actin (loading 
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Supplementary Figure S12. Extended MAPPIT data from Figure 4A, with empty (unfused gp130) and 
JAK2 binding (Rem2-gp130) prey as a negative and positive control respectively to confirm specificity 
and bait expression.  
 
Supplementary Fig S13: LR internalization is necessary for LR signaling. HEK293T cells were transiently 
co-transfected with C-terminally HA-tagged LR and DN dynamin K44A, RNF41 or soluble IL5Rα (mock) 
together with a STAT3-dependent luciferase reporter gene. Cells were stimulated with leptin (black bars) 
or left untreated (white bars). Absolute luciferase counts of triplicate measurements normalized for 






Supplementary Fig S14: AP2S1 Arg mutations do not influence RNF41 interaction, and AP2S1 does not 
interact with ASB6 or USP8. MAPPIT analysis in HEK293T cells transiently co-transfected with plasmids 
encoding WT or mutated AP2S1, ASB6 or USP8 prey together with empty, RNF41 WT or mutated RNF41 
bait and the pXP2d2-rPAP1-luciferase reporter plasmid. The next day, cells were stimulated with EPO or 
left untreated for 24 hours. The luciferase signal is expressed as fold induction (stimulated/non 
stimulated), relative to the signal of a control JAK2 binding prey ± s.d. of triplicate measurements.  
 
Supplementary Tables 
Supplementary Table S1. Generation of constructs. 
Supplementary Table S2: Protein lists obtained with the different methods used in this study. Perseus 
tables with differential proteins (FDR 0.01% S0=1) are shown for AP-MS, BioID and Virotrap experiments. 
For microarray MAPPIT the full list of retested candidates obtained for a genome-wide screen is shown. 
Interactions were also tested for a eDHFR control bait. Only positive interactions that have a 10 fold 
higher induction over control were retained for further analysis. The results obtained for different high 
throughput studies with the yeast 2 hybrid for RNF41 are displayed in the Y2H tab. The BioGRID tab 
shows the list of protein interactions present in the BioGRID3.4 database (April 2017) with references to 
the original publications. 
Supplementary Table S3: Spectral counts for the different proteins detected in the MS-based 
approaches. Spectral counts are presented for all individual samples that were analyzed by MS. 
Supplementary Table S4: Overlap of detected proteins between the different methods and between 
BioGRID. The data presented here were used as input in the Venn diagram shown in Figure 2B.  
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Supplementary Table S1.  



















































     



















’-CCCAACCATAACTGCGATATCCACCTGCGCTCAGTG- ’  
    Mutagen
esis 2 
’-CACTGAGCGCAGGTGGATATCGCAGTTATGGTTGGG- ’ 
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et al, 2011) 
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NheI-SalI ’-GGCGCTAGCGGCATGAACCCGAAGCGGCCTGTGAC- ’ 
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        GTAATCCATGCTTAAGGGCCCGCA 
pMet7-GAG-RNF41 C34S/H36Q (Eyckerman et al, 2016) 
pMet7-GAG-eDHFR  (Eyckerman et al, 2016) 
pMet7-FLAG-RNF41 C34S/H36Q  (Eyckerman et al, 2016) 
pMet7-FLAG-GFP  (Eyckerman et al, 2016) 
pSel-RNF41 = bait (De Ceuninck et al, 2013) 
pSel-RNF41 C34S/H36Q = bait  (De Ceuninck et al, 2013) 
pSel-RNF41 N-terminal = bait (Masschaele et al, 2017) 
pSel-RNF41 C-terminal = bait (Masschaele et al, 2017) 
pSel-RNF41 substrate binding = bait (Masschaele et al, 2017) 
pSel-RNF41 CC = bait (Masschaele et al, 2017) 
pSel-RNF ∆CC = bait (Masschaele et al, 2017) 
pXP2d2-rPAP1-luficerase reporter (wauman et al, 2011) 
pMet7-hLR-HA (Wauman et al, 2011) 
pMet7-sIL- Rα De Ceuninck et al,  
pMet7-RNF41 (De Ceuninck et al, 2013) 
pMet7-RNF41 DN (wauman et al, 2011) 
pMet7-RNF41 (C34S/H36Q) (De Ceuninck et al, 2013) 
pGEX-4T-GST-RNF41 (Masschaele et al, 2017) 
pGEX-4T-GST-PGC α Masschaele et al, 7  
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All interactors combinedAP-MS BioID Virotraprray MAPPIT Y2H BioGRID3.4 Combined (no BioGRID) Combined all
RNF41 1 1 1 0 1 1 4 5
TTC1 1 0 1 1 1 1 4 5
BIRC6 1 1 1 0 0 1 3 4
CACYBP 1 1 1 0 0 1 3 4
NAV1 1 1 1 0 0 1 3 4
KIAA1598 1 1 0 1 0 0 3 3
HOMER2 1 0 0 1 1 1 3 4
ASB6 0 1 0 1 1 1 3 4
VPS52 0 1 0 1 1 1 3 4
KDM3B 1 1 0 0 0 0 2 2
TACC1 1 1 0 0 0 0 2 2
SIPA1L3 0 1 1 0 0 0 2 2
USP8 0 1 1 0 0 1 2 3
LZTS2 0 0 1 0 1 1 2 3
AP2S1 0 0 1 1 0 0 2 2
ENOPH1 0 0 1 1 0 0 2 2
IFIT5 0 1 0 1 0 0 2 2
ARL6IP4 0 0 0 1 1 1 2 3
ISCA2 0 0 0 1 1 1 2 3
RFC4 0 0 0 1 1 1 2 3
CPVL 1 0 0 0 0 0 1 1
DIABLO 1 0 0 0 0 0 1 1
DNAJB12 1 0 0 0 0 0 1 1
FAR1 1 0 0 0 0 0 1 1
FMR1 1 0 0 0 0 0 1 1
FXR1 1 0 0 0 0 0 1 1
FXR2 1 0 0 0 0 0 1 1
HOMER1 1 0 0 0 0 0 1 1
MTCL1 1 0 0 0 0 1 1 2
RIF1 1 0 0 0 0 0 1 1
SOGA1 1 0 0 0 0 1 1 2
ZNF281 1 0 0 0 0 0 1 1
CTNNAL1 0 0 1 0 0 0 1 1
GIPC1 0 0 1 0 0 0 1 1
IGF1R 0 0 1 0 0 0 1 1
INSR 0 0 1 0 0 0 1 1
NEK2 0 0 1 0 0 0 1 1
PCMT1 0 0 1 0 0 0 1 1
AHNAK 0 1 0 0 0 0 1 1
BirA 0 1 0 0 0 0 1 1
CCP110 0 1 0 0 0 0 1 1
CD2AP 0 1 0 0 0 0 1 1
CEP97 0 1 0 0 0 0 1 1
CORO1B 0 1 0 0 0 0 1 1
CRK 0 1 0 0 0 0 1 1
FAM83H 0 1 0 0 0 0 1 1
FLNA 0 1 0 0 0 0 1 1
IFFO2 0 1 0 0 0 0 1 1
MKL2 0 1 0 0 0 0 1 1
TACC2 0 1 0 0 0 0 1 1
UTRN 0 1 0 0 0 0 1 1
VCPIP1 0 1 0 0 0 0 1 1
XRN1 0 1 0 0 0 0 1 1
ZBTB33 0 1 0 0 0 0 1 1
C1orf109 0 0 0 0 1 1 1 2
ABHD12B 0 0 0 1 0 0 1 1
AP4E1 0 0 0 1 0 0 1 1
APOC3 0 0 0 1 0 0 1 1
APOL5 0 0 0 1 0 0 1 1
ARHGAP22 0 0 0 1 0 0 1 1
ARL4C 0 0 0 1 0 0 1 1
ASIC4 0 0 0 1 0 0 1 1
Supplementary Table S4: Overlap of detected proteins between the different methods and between BioGRID3.4. The data presented here 
were used as input in the Venn diagram shown in Figure 2B. 
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ATXN7L1 0 0 0 1 0 0 1 1
BIRC8 0 0 0 1 0 0 1 1
C16orf48 0 0 0 1 0 0 1 1
C17orf50 0 0 0 1 0 0 1 1
C17orf82 0 0 0 1 0 0 1 1
C1orf49 0 0 0 1 0 0 1 1
C22orf13 0 0 0 1 0 0 1 1
C4orf17 0 0 0 1 0 0 1 1
C5orf27 0 0 0 1 0 0 1 1
C9orf43 0 0 0 1 0 0 1 1
CACNA1E 0 0 0 1 0 0 1 1
CDKL5 0 0 0 1 0 0 1 1
CLPP 0 0 0 1 0 0 1 1
COX5B 0 0 0 1 0 0 1 1
CPSF4L 0 0 0 1 0 0 1 1
CSNK1G2-AS1 0 0 0 1 0 0 1 1
CTAG1A 0 0 0 1 0 0 1 1
CTAG1B 0 0 0 1 0 0 1 1
CTNNA3 0 0 0 1 0 0 1 1
DCDC2B 0 0 0 1 0 0 1 1
DIS3L2 0 0 0 1 0 0 1 1
DPYD 0 0 0 1 0 0 1 1
DTX3 0 0 0 1 0 0 1 1
DUSP2 0 0 0 1 0 0 1 1
EDN3 0 0 0 1 0 0 1 1
EPB42 0 0 0 1 0 0 1 1
FAM110B 0 0 0 1 0 0 1 1
FAM117B 0 0 0 1 0 0 1 1
FAM129C 0 0 0 1 0 0 1 1
FAM72B 0 0 0 1 0 0 1 1
FGF11 0 0 0 1 0 0 1 1
GALNT3 0 0 0 1 0 0 1 1
GMNN 0 0 0 1 0 0 1 1
GNA11 0 0 0 1 0 0 1 1
GRB10 0 0 0 1 0 0 1 1
HELT 0 0 0 1 0 0 1 1
IGF2 0 0 0 1 0 0 1 1
IL16 0 0 0 1 0 0 1 1
KANK1 0 0 0 1 0 0 1 1
KCNAB2 0 0 0 1 0 0 1 1
KCNAB3 0 0 0 1 0 0 1 1
KCNB1 0 0 0 1 0 0 1 1
KLHL14 0 0 0 1 0 0 1 1
LATS1 0 0 0 1 0 0 1 1
LIMS1 0 0 0 1 0 0 1 1
LOC554206 0 0 0 1 0 0 1 1
LOC84989 0 0 0 1 0 0 1 1
MAB21L2 0 0 0 1 0 0 1 1
MCEE 0 0 0 1 0 0 1 1
MLF1 0 0 0 1 0 0 1 1
MLPH 0 0 0 1 0 0 1 1
MMAB 0 0 0 1 0 0 1 1
MRPS2 0 0 0 1 0 0 1 1
NAT6 0 0 0 1 0 0 1 1
NBLA00301 0 0 0 1 0 0 1 1
NCKAP5 0 0 0 1 0 0 1 1
NDFIP2 0 0 0 1 0 0 1 1
NGFRAP1 0 0 0 1 0 0 1 1
NKX6-3 0 0 0 1 0 0 1 1
NPHS2 0 0 0 1 0 0 1 1
OR1D5 0 0 0 1 0 0 1 1
PARP6 0 0 0 1 0 0 1 1
PARP8 0 0 0 1 0 0 1 1
PDLIM7 0 0 0 1 0 0 1 1
PDPN 0 0 0 1 0 0 1 1
PHF19 0 0 0 1 0 0 1 1
PIK3R2 0 0 0 1 0 0 1 1
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PLEKHA2 0 0 0 1 0 0 1 1
PLEKHA6 0 0 0 1 0 0 1 1
POLR3D 0 0 0 1 0 0 1 1
POP7 0 0 0 1 0 0 1 1
PRIM1 0 0 0 1 0 0 1 1
PRR25 0 0 0 1 0 0 1 1
PRRT1 0 0 0 1 0 0 1 1
PTPDC1 0 0 0 1 0 0 1 1
RAB31 0 0 0 1 0 0 1 1
RNF146 0 0 0 1 0 0 1 1
RRAGC 0 0 0 1 0 0 1 1
RSPO4 0 0 0 1 0 0 1 1
RUSC1 0 0 0 1 0 0 1 1
SENP1 0 0 0 1 0 0 1 1
SH2D2A 0 0 0 1 0 0 1 1
SKOR1 0 0 0 1 0 0 1 1
SLX1A 0 0 0 1 0 0 1 1
SMOC1 0 0 0 1 0 0 1 1
SNAPC3 0 0 0 1 0 0 1 1
SNRK 0 0 0 1 0 0 1 1
SNX29 0 0 0 1 0 0 1 1
SPATA22 0 0 0 1 0 0 1 1
SPDYC 0 0 0 1 0 0 1 1
SRR 0 0 0 1 0 0 1 1
SSX4 0 0 0 1 0 0 1 1
STAC 0 0 0 1 0 0 1 1
STC2 0 0 0 1 0 0 1 1
TCF15 0 0 0 1 0 0 1 1
TCTEX1D4 0 0 0 1 0 0 1 1
TMEM208 0 0 0 1 0 0 1 1
TMEM74 0 0 0 1 0 0 1 1
TMUB2 0 0 0 1 0 0 1 1
TRIM69 0 0 0 1 0 0 1 1
TROAP 0 0 0 1 0 0 1 1
TRPV6 0 0 0 1 0 0 1 1
USP48 0 0 0 1 0 0 1 1
VPS4A 0 0 0 1 0 0 1 1
WDFY3 0 0 0 1 0 0 1 1
WDR59 0 0 0 1 0 0 1 1
WWC3 0 0 0 1 0 0 1 1
XKR4 0 0 0 1 0 0 1 1
ZAR1L 0 0 0 1 0 0 1 1
ZBTB44 0 0 0 1 0 0 1 1
ZNF576 0 0 0 1 0 0 1 1
ZNRF2 0 0 0 1 0 0 1 1
ZSCAN1 0 0 0 1 0 0 1 1
ADRB2 0 0 0 0 0 1 0 1
APP 0 0 0 0 0 1 0 1
C1GALT1C1 0 0 0 0 0 1 0 1
CD247 0 0 0 0 0 1 0 1
CEP192 0 0 0 0 0 1 0 1
CLASP1 0 0 0 0 0 1 0 1
CLEC16A 0 0 0 0 0 1 0 1
CREB3 0 0 0 0 0 1 0 1
ELAVL1 0 0 0 0 0 1 0 1
ERBB3 0 0 0 0 0 1 0 1
ERBB4 0 0 0 0 0 1 0 1
EVI5 0 0 0 0 0 1 0 1
H3F3A 0 0 0 0 0 1 0 1
IL23A 0 0 0 0 0 1 0 1
ITSN2 0 0 0 0 0 1 0 1
KIFC3 0 0 0 0 0 1 0 1
LEPR 0 0 0 0 0 1 0 1
LPGAT1 0 0 0 0 0 1 0 1
MARK2 0 0 0 0 0 1 0 1
MARK4 0 0 0 0 0 1 0 1
MNAT1 0 0 0 0 0 1 0 1
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N4BP3 0 0 0 0 0 1 0 1
NPAT 0 0 0 0 0 1 0 1
Osgep 0 0 0 0 0 1 0 1
P4HA1 0 0 0 0 0 1 0 1
PARK2 0 0 0 0 0 1 0 1
RASIP1 0 0 0 0 0 1 0 1
RCN1 0 0 0 0 0 1 0 1
RFWD3 0 0 0 0 0 1 0 1
RNF166 0 0 0 0 0 1 0 1
SF1 0 0 0 0 0 1 0 1
SUGT1 0 0 0 0 0 1 0 1
TADA2A 0 0 0 0 0 1 0 1
TRIM32 0 0 0 0 0 1 0 1
TRIM8 0 0 0 0 0 1 0 1
TSG101 0 0 0 0 0 1 0 1
UBASH3A 0 0 0 0 0 1 0 1
UBASH3B 0 0 0 0 0 1 0 1
UBE2D3 0 0 0 0 0 1 0 1
UBE2K 0 0 0 0 0 1 0 1
UBE2U 0 0 0 0 0 1 0 1
UBE2Z 0 0 0 0 0 1 0 1
UPF3A 0 0 0 0 0 1 0 1






























The role of RNF41 in selective autophagy 
         Manuscript in preparation  
 
We and others have previously reported a vesicular pattern for overexpressed RNF41 (RING finger 
protein 41) in different cell types such as HeLa, COS, MDA-MB-468 and NIH/3T3 cells (De Ceuninck et 
al., 2013; Masschaele et al., 2017; Diamonti et al., 2002; Qiu et al., 2002; Qiu et al., 2004). In this 
paper we attempt to characterize these RNF41 bodies and find that they colocalize with p62, an 
autophagy receptor. Moreover, silencing of RNF41 decreases endogenous p62 and LC3B-II. RNF41 
depletion also results in decreased phosphorylated TBK1, which is necessary for the increased affinity 
between p62 and ubiquitinated autophagic cargo. Furthermore, RNF41 interacted with autophagy 
related proteins Beclin1, ATG14, WIPI2 and ATG5 that are involved in autophagosome formation. All 
together, this points towards a role for RNF41 in the early steps of autophagosome biogenesis which 
leads to the selective autophagy pathway aggrephagy. This new established link between RNF41 and 
autophagy further elucidates the role of RNF41 in intracellular trafficking, as autophagy shares 
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RNF41 is an E3 ubiquitin ligase involved in the ubiquitination of several substrates. As such it is 
implicated in intracellular trafficking, yet its role is not fully elucidated. To further unravel its function 
we aimed to characterize the RNF41 bodies observed with confocal microscopy by using various 
organelle and aggregate markers. This paper describes the colocalization between RNF41 and p62, an 
autophagy receptor. RNF41 depletion revealed a role for RNF41 in maintaining p62 and 
phosphorylated TBK1 levels. This, in combination with the novel detected interactions between 
RNF41 and Beclin1, ATG14, WIPI2 and ATG5, suggests that RNF41 functions in autophagosome 
biogenesis leading to the aggrephagy pathway.  
Introduction 
Autophagy is a multistep process initiating with the formation of an isolation membrane that 
expands and sequesters a portion of the cytoplasm and eventually generates a double-membraned 
vesicle called the autophagosome. This autophagosome subsequently fuses with the lysosome 
resulting in the degradation of the cytoplasmic cargo [1]. Autophagosome biogenesis is regulated by 
the hierarchical action of four protein complexes all containing ATG (autophagy-related genes) 
proteins. Initiation of the isolation membrane requires the ULK kinase complex composed of ULK1/2, 
ATG13, FIP200 and ATG101 which is inhibited by the amino acid sensor mTORC1 (mammalian target 
of rapamycin complex 1) under nutrient-rich conditions but activated upon starvation. This is 
followed by membrane nucleation, which depends on the class III PI3K complex I, consisting of 
Beclin1, VPS34, VPS15 and ATG14. Finally, two ubiquitin-like conjugation systems, ATG5-ATG12-
ATG16 and LC3 (or ATG8) coordinate the elongation and closure of the autophagosome [2]. 
Autophagy was generally thought to be a non-selective, bulk degradation process, however, 
increasing evidence illustrates that this can also be a highly selective process that mediates the 
clearance of specific cargo such as aggregated proteins (aggrephagy), mitochondria (mitophagy), 
ribosomes (ribophagy) and pathogens (xenophagy) [3]. This selectivity is achieved through autophagy 
receptors such as p62 (or SQSTM1 (sequestosome-1)), NBR1 (Neighbor of BRCA gene 1), NDP52 
(nuclear dot protein 52 kDa) and OPTN (optineurin), which all contain ubiquitin binding domains and 
LC3-interacting regions necessary for recognizing cargo and autophagosomal membrane, respectively 
[3]. 
The multifunctional protein p62 was the first discovered mammalian autophagy receptor [4]. It 
encompasses multiple domains which contribute to its versatile function by interacting with various 
binding partners involved in autophagy and in signaling pathways that regulate antioxidant response, 
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inflammation and metabolism. p62 contains an N-terminal PB1 (Phox-BEM1) domain that is 
responsible for self-oligomerisation and also interacts with aPKC and ERK1. This is followed by a ZZ-
type zinc finger domain and a TBD (TRAF6-binding domain) domain which respectively interact with 
RIP  a d TRAF  to egulate the NFκB path ay. p  also o tai s t o NLS u lea  lo alizatio  
signals), one located in between the zinc finger and TBD and the other located after the TBD, and a 
NES (nuclear export signal). The p62 C-terminus holds the LIR (LC3-interacting region) and UBA 
(ubiquitin-associated domain) domain that mediate the interaction between the autophagic 
machinery and the ubiquitinated autophagic cargo ultimately resulting in autophagic clearance. The 
affinity of this UBA domain for ubiquitinated substrates is greatly enhanced by CK2 (casein kinase 2) 
and TBK1 (TANK-binding kinase 1)-mediated Ser403 phosphorylation [5–7]. Finally, a KIR (Keap1-
interacting region) domain, located in between the LIR and UBA domain interacts with Keap1, a 
Cullin3-ubiquitin E3 ligase complex adaptor protein. This interaction results in the release of 
transcription factor Nrf2 resulting in an antioxidant response [8–10].    
In this paper we demonstrate for the first time a role for RNF41 (RING finger protein 41) in 
autophagy. RNF41 is an E3 ubiquitin ligase that mediates the ubiquitination and degradation of 
several interaction partners such as the inhibitor of apoptosis BRUCE, parkin, a protein involved in 
Pa ki so ’s disease, and the ERBB3, IL-3 (interleukin-3) and EPO (erythropoietin) receptors [11–14]. 
RNF41 hereby reduces the signaling of the IL-3R and EPOR, and attenuates the signaling of other 
JAK2-associated type I cytokine receptors including the LR (leptin receptor), LIFR (Leukaemia 
inhibitory factor receptor) and IL-6R (interleukin-6 receptor) [15,16]. RNF41 is also implicated in 
intracellular transport where it modulates the trafficking of the LR, LIFR and IL-6R [15]. This is 
accomplished by ubiquitinating and suppressing the deubiquitinase USP8, thereby indirectly 
destabilizing the ESCRT-0 complex, a complex required for proper internalization of cargo into 
multivesicular bodies leading to the degradation pathway. In this way, RNF41 inhibits receptors from 
undergoing lysosomal degradation and subsequently reroutes them towards compartments for 
ectodomain shedding [17]. Moreover, RNF41 also relocalizes VPS52, a subunit of two distinct 
tethering complexes that are involved in the sorting of cargo to the Golgi network or recycling 
endosomes [18]. This study describes the colocalization between p62 and RNF41 and reveals the 
involvement of RNF41 in maintaining p62 levels. This links RNF41 to autophagy, which further 
clarifies the role of RNF41 in intracellular trafficking since autophagy is considered to share many 
features with membrane trafficking pathways, including budding of vesicles, movement along 
microtubule tracks and tethering and fusion with late endosomes and lysosomes. Interactions 
between RNF41 and several autophagy-related proteins including Beclin1, ATG14, WIPI2 and ATG5, 
together with the effect of RNF41 on phosphorylated TBK1 imply that RNF41 functions in 
autophagosome formation.  
Results 
RNF41 bodies colocalize with autophagy receptor p62 but not with lysosome or autophagosome 
markers 
We and others previously reported a vesicular pattern for overexpressed RNF41 in several cell lines 
such as COS cells, MDA-MB-468 cells, NIH/3T3 and HeLa cells [11,13,17–19]. A potential 
myristoylation site, marked by the Met-Gly sequence at the N-terminus of RNF41 can account for 
membrane anchoring and thus explain its vesicular localization [13]. However, experimental evidence 
165
for this membrane attachment is currently missing and it is still not clear whether these RNF41 
bodies represent vesicles or aggregates. Therefore, we set out to characterize these RNF41 bodies by 
testing a number of known organelle and aggregate markers. Although we could not detect 
colocalization between ectopically expressed RNF41 and well known early and late endosomal 
makers, we did observe a clear colocalization with p62, an autophagy receptor for cargo material 
such as aggregated proteins (Fig 1A). Since p62 plays an important role in autophagy, we additionally 
tested LC3B, a well-established autophagy marker and the lysosome marker LAMP1. We did not 
detect any colocalization between these markers and the RNF41 bodies that co-stained with p62, 
implying that the RNF41 bodies are not closed autophagosomes or autolysosomes (Fig 1B).  
 
Figure 1. HeLa cells transiently transfected with a vector encoding E-tagged RNF41 or soluble IL5Rα (mock) 
were fixed and stained with anti-Etag (secondary Alexa Fluor 488, green) and anti-p62 (secondary Alexa Fluor 
568, red) (A), and co-stained with anti-LAMP1 (secondary Alexa Fluor 647, blue) or anti-LC3B (secondary Alexa 










RNF41 depletion decreases p62 and LC3B-II 
Since RNF41 colocalizes with p62, it is easily presumed that these RNF41 bodies represent aggregates 
that are eventually cleared by aggrephagy. However, the observed effects of RNF41 on this 
autophagy receptor indicate a functional role for RNF41 in the clearance of aggregates. Ectopic 
expression of RNF41 did not affect p62 levels, whereas RNF41 even partial silencing clearly decreases 
p62. Likewise, partial depletion of RNF41 also decreases the lipidated form of LC3B, LC3B-II, while 
ectopic RNF41 expression enhances LC3B-II (Fig 2A). We next investigated whether induced 
autophagy, and thus lysosomal degradation is responsible for the reduced p62 and LC3B-II levels 
upon RNF41 depletion. Incubating HeLa cells with the vacuolar ATPase inhibitor Bafilomycin A1 that 
blocks autophagosome turnover at the lysosome does not result in an accumulation of p62 and LC3B-
II. Conversely, the siNT control condition shows a clear accumulation of LC3B-II upon Bafilomycin A1 
treatment (Fig 2B). This suggests that the decrease in p62 and LC3B-II upon RNF41 depletion is not a 
consequence of enhanced autophagy and that RNF41 is important for maintaining p62 and LC3B-II 
levels. To determine whether silencing of RNF41 possibly blocks the induction of autophagy we 
attempted to promote autophagy using rapamycin. Under normal circumstances, this should result in 
enhanced LC3B-II and decreased p62 levels. Unfortunately, we were not able to reproduce these 
effects and thus could not further investigate this hypothesis (Fig 2B). It is worth mentioning that 
silencing of p62 did not affect the levels of RNF41 (Suppl Fig 1).  
 
Figure 2: (A) HeLa cells were transiently co-transfected with a plasmid encoding RNF41 or soluble IL5Rα (mock), 
or were silenced (96h) for RNF41 or treated with a non-targeting siRNA (siNT). The protein levels of RNF41, p62 
and LC3B were determined by Western Blotting using anti-RNF41, anti-p62, anti-LC3B or anti-β-actin (loading 
control) antibodies. n=3. (B) HeLa cells were silenced (96h) for RNF41 or treated with siNT and incubated for 2 
hours with 200nM of DMSO, Rapamycin or Bafilomycin A1 prior to sonication. Protein levels were analyzed by 
Western Blotting using antibodies against RNF41, p62, LC3B or β-actin (loading control). n=3.  
RNF41 interacts with several autophagy-related proteins 
The previous results implicate that RNF41 plays a role in the early steps of autophagy, therefore, we 
investigated whether RNF41 interacted with other well known ATGs and ATG-related proteins. For 
this we performed binary MAPPIT (Mammalian Protein-Protein Interaction Trap), an in-house 
developed technology to detect protein-protein interactions in intact mammalian cells [20]. We first 
wanted to establish the interaction between RNF41 and p62 since we detect a clear colocalization 
between these two proteins (Fig 1A). Next to this, we also wanted to verify the known interaction 
between TBK1 and RNF41, described by Wang et al., as TBK1 is known to cofractionate and colocalize 
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with p62 and is thereby involved in autophagy [6,21]. Surprisingly, RNF41 bait did not interact with 
TBK1 prey, nor with p62 prey (Fig 3). Co-immunoprecipitation analysis confirmed these results and 
also failed to show an interaction between RNF41 and TBK1 or p62 (Suppl Fig 2). We could also not 
detect an interaction between RNF41 and RPTOR (Regulatory-associated protein of mTOR), a 
substrate binding subunit of mTORC1 and its downstream effector, ULK1 [22,23]. However, RNF41 
clearly interacted with Beclin1 and ATG14, two members of the class III PI3K complex I, and with its 
effector protein WIPI2. Next to this, RNF41 also interacted with the ATG5 subunit of the ATG5-
ATG12-ATG16 ubiquitin-like conjugation system. No clear interaction was observed between RNF41 
and the other ubiquitin-like conjugation system, LC3B nor with ATG3, a protein necessary for LC3 
lipidation (Fig 3; [2]). These results suggest that RNF41 is implicated in autophagosome formation, 
since it interacts with various proteins involved in this process.  
 
Figure 3: MAPPIT analysis of HEK293T cells transiently co-transfected with plasmids encoding several 
autophagy-related prey proteins together with an empty or RNF41 bait and the pXP2d2-rPAP1-luciferase 
reporter plasmid. The next day, cells were stimulated with Epo or left untreated for 24 hours. The luciferase 
signal is expressed as fold induction (stimulated/non stimulated), relative to the signal of a control JAK2 binding 
prey ± s.d. of triplicate measurements. n=3.  
RNF41 contributes to TBK1 phosphorylation  
Although we could not confirm the interaction between TBK1 and RNF41 (Fig 3), we did further 
investigate the functional link between RNF41 and TBK1. TBK1 is activated by phosphorylation of 
Ser172 and in turn phosphorylates the UBA domain of p62 thereby strengthening the p62-
polyubiquitin interaction [5–7,24]. Via confocal microscopy we were able to confirm the 
colocalization between activated, and thus phosphorylated, TBK1 and p62 in HeLa cells. Moreover, 
we also detected colocalization between the RNF41 bodies and these p62 and p-S172 TBK1 positive 
structures (Fig 4A). Additionally, next to reducing p62 and LC3B levels, silencing of RNF41 also 
decreased the levels of phosphorylated TBK1, but did not influence the total amount of TBK1 (Fig 
4B). This suggests that RNF41 contributes to TBK1 phosphorylation. Furthermore, silencing of RNF41 
also strongly decreased the levels of ARF6, a small GTPase that was shown to promote 
autophagosome formation independent of mTORC activation (Fig 4B; [25]). All together, these 





Figure 4: (A) HeLa cells transiently transfected with a vector encoding E-
tagged RNF41 or soluble IL5Rα (mock) were fixed and stained with anti-
Etag (secondary Alexa Fluor 647, blue), anti-p62 (secondary Alexa Fluor 
568, red) and anti-pS172-TBK1 (secondary Alexa Fluor 488, green). The 
insets show a magnification of the boxed area. Scale bar, 10µm. n=2. (B) 
HeLa cells were silenced (96h) for RNF41 or treated with siNT. Protein 
levels were analyzed by Western Blotting using antibodies against RNF41, 




The vesicular pattern of ectopically expressed RNF41 prompted us to further characterize these 
structures using several organelle and aggregate markers. Most interestingly, p62, an autophagic 
cargo receptor colocalized with these RNF41-bodies (Fig 1A). Moreover, transient silencing of RNF41 
decreased endogenous p62 and the lipidated form of LC3B, LC3B-II (Fig 2A). This is not due to an 
increase of autophagic flux, but rather indicates a defect or delay earlier in the process, prior to 
autolysosomal degradation since treatment of the RNF41-depleted cells with the lysosome 
acidification inhibitor Bafilomycin A1 did not result in an accumulation of p62 or LC3B-II (Fig 2B). 
Additionally, RNF41 failed to colocalize with LC3B or LAMP1 (Fig 1B), which points to a role for RNF41 
in autophagy, likely in the early stages at the isolation membrane, where p62 sequesters 
ubiquitinated cargo into aggregates prior to recruitment of LC3B and formation of the 
autophagosomes. In support of this, Bjørkøy, et al., described two populations of p62 bodies in the 
cytosol, where a first population appeared as large protein aggregates, called sequestrosomes, that 
were resistant to detergent extraction and did not colocalize with Lysotracker whereas another 
lysotracker-positive p62 population represented detergent dissolvable membrane-enclosed 
p62 p-TBK1 RNF41etag merge
p62 p-TBK1 mock merge
A
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autophagsomes [26]. Our previous studies also detected ectopically expressed RNF41 in the insoluble 
pellet fraction of RIPA-lysed cells, which suggests that the RNF41 bodies are, like sequestrosomes, 
detergent resistant [17,18]. More evidence for the involvement of RNF41 in autophagosome 
formation emerged from interaction studies with MAPPIT. Here, RNF41 interacted with Beclin1 and 
ATG14, two components of the class III PI3K complex I involved in isolation membrane nucleation 
(Fig 3). This complex, consisting of Beclin1, VPS34, VPS15 and ATG14 generates PI(3)P 
(phosphatidylinositol (3)-phosphate) on the surface of the isolation membrane, which results in the 
recruitment of WIPI2 [27,28]. WIPI2 also interacted with RNF41, and this protein targets the first 
ubiquitin-like conjugating complex ATG5-ATG12-ATG16 to the PI(3)P enriched isolation membrane, 
which is necessary for isolation membrane elongation (Fig 3; [29]). Additionally, MAPPIT also showed 
an interaction between RNF41 and the ATG5 subunit of this conjugating complex, but not with the 
second ubiquitin-like conjugation system that mediates the lipidation of LC3B. Even though these 
interactions could be indirect, this further implies that the action of RNF41 is situated somewhere at 
the isolation membrane, between the nucleation and elongation process and is consistent with the 
fact that p62 also localizes to this isolation membrane, independent of LC3B ([30], Fig 5)  
TBK1 is an essential regulator of the innate immune response against pathogens and also plays a role 
in the selective autophagy pathways xenophagy, mitophagy and aggrephagy by phosphorylating 
autophagy receptors OPTN and p62 [6,7,31,32]. Moreover, Wang et al described the interaction 
between RNF41 and TBK1, where RNF41 leads to K63-linked polyubiquitination of TBK1 [21]. We 
assumed that TBK1 would be an ideal candidate to further establish the role of RNF41 in autophagy 
since TBK1, similarly to our observations for RNF41, colocalizes with p62 ([6]; Fig 1A). Despite the lack 
of interaction between RNF41 and TBK1 in MAPPIT and Co-IP (Fig 3 and Suppl Fig 2), we indeed 
noticed colocalisation between phosphorylated TBK1 and RNF41 (Fig 4A). It is described in literature 
that K63-linked polyubiquitination of TBK1 is required for Ser172 phosphorylation resulting in its 
activation [33]. As RNF41 is one of the E3 ligases involved in TBK1 K63-linked polyubiquitination, it is 
therefore plausible that RNF41 is required for this activation of TBK1. Indeed, RNF41 depletion 
resulted in a decrease of phosphorylated, and thus activated, TBK1 (Fig 4B). Since activated TBK1 
phosphorylates the UBA domain of p62 and thereby increases the binding affinity of p62 for ubiquitin 
chains on autophagic cargo [5], it is possible that RNF41 in this way regulates p62 recruitment to 
autophagic cargo. On the other hand, we cannot exclude the possibility that RNF41 directly 
ubiquitinates autophagic cargo, and as such mediates the binding of p62 to these cargo. Further 
evidence for a role of RNF41 in the early stages of autophagosome biogenesis emanates from the 
effect of RNF41 on ARF6. Figure 4B showed that RNF41 depletion also decreased the levels of ARF6, a 
small GTPase that modulates autophagosome formation by influencing membrane delivery to the 
autophagosome formation site via the production of PI(4,5)P2 (phosphatidylinositol 4,5-
bisphosphate), and by regulating phospholipase D activity independent of mTORC [25].  
170
 
Figure 5. Overview of RNF41 implicated in autophagosome formation. Autophagosome formation is initiated by 
(1) the ULK1 kinase complex (ULK1, ATG13, FIP200, ATG101) and (2) the Class III PI3K complex I (Beclin1, VPS34, 
VPS15, ATG14) which are recruited to the isolation membrane. (3) The ATG12-ATG5-ATG16 complex and (4) 
LC3-II are formed via an ubiquitin-like conjugation system and are subsequently recruited to the isolation 
membrane where they play a role in the elongation process. Our results suggest that RNF41 interacts with 
Beclin1 and ATG14 of the Class III PI3K complex I, its effector WIPI2, and with ATG5 of the first ubiquitin-like 
conjugation complex, prior to LC3 recruitment. Next to this, phosphorylated and activated TBK1 in turn 
phosphorylates p62, which is recruited to and binds ubiquitinated protein aggregates and is targeted to the 
isolation membrane. Our results indicate that RNF41 is required for phosphorylated TBK1 and in this way 
maintains p62 levels. Proteins that interact with RNF41 or are regulated by RNF41 are indicated in red.  
 
Although p62 depletion shows little effect on autophagy due to the presence of other autophagy 
receptors such as NBR1, NDP52 and OPTN [34,35], p62 is critical for aggregation of ubiquitinated 
proteins and thereby has a protective effect on cell survival [36,37]. Also, dysfunctional p62 resulting 
in impaired aggrephagy is involved in many neurodegenerative diseases such as ALS (amyotrophic 
lateral sclerosis), frontotemporal dementia and hu ti gto ’s disease and also causes Paget disease, a 
bone disorder [26,38]. Therefore it is imperative to determine proteins involved in the regulation or 
dysregulation of p62, such as RNF41. At this time, it is still unclear why silencing of RNF41, even with 
only partial knockdown efficiencies, results in decreased endogenous p62 (Fig 2A). We hypothesize 
that silencing of RNF41 inhibits TBK1 activation and thereby the phosphorylation of p62, which in 
turn could possibly enhance the turnover of p62 by proteasomal degradation. Indeed, next to 
autophagic degradation, p62 also undergoes proteasomal degradation [39]. Here, the E3 ligase 
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parkin ubiquitinates p62 and is in this way responsible for its proteasomal degradation. The authors 
also suggest that mutated parkin or impaired E3 ligase activity of parkin could possibly result in an 
increase in the level of p62. Since RNF41 is known to degrade parkin [12], silencing of RNF41 should 
stabilize parkin and thus decrease the levels of p62, which would be in concordance with our 
observations. Experiments using the proteasomal inhibitor MG132 should help clarifing this 
hypothesis (Fig 6).   
 
Figure 6. Hypothesis of RNF41 function. RNF41 is involved in K63-linked polyubiquitination of TBK1. This type of 
ubiquitination is necessary for phosphorylation of Ser172 in TBK1, which leads to TBK1 activation. 
Phosphorylated and activated TBK1 can phosphorylate Ser403 in p62, resulting in an increased binding affinity 
for K63-linked polyubiquitinated chains on autophagic cargo. Silencing of RNF41 inhibits TBK1 phosphorylation 
and activation, thus resulting in decreased levels of phosphorylated p62. Silencing of RNF41 also inhibits the 
degradation of parkin, which can lead to parkin-mediated K48-linked polyubiquitination of p62, resulting in its 
proteasomal degradation, which would explain the loss of p62.  
Parkin and USP8, another RNF41 interacting protein, were shown to be involved in the selective 
autophagic pathway mitophagy. Parkin is recruited to the depolarized mitochondria and activated by 
PINK1 (PTEN-induced putative kinase protein 1) [40]. This recruitment also depends on the 
deubiquitinating enzyme USP8, which removes non-canonical K6-linked ubiquitin chains from parkin 
[41]. Activated parkin results in the K63-linked polyubiquitination of outer mitochondrial membrane 
proteins, which are recognized and clustered by p62 and destined for mitophagy [42]. Although these 
RNF41 interaction partners are involved in mitophagy, we did not observe colocalization between 
our RNF41 bodies that co-stained with p62 and mitochondria (Suppl Fig 3). CCCP (carbonyl cyanide 
m-chlorophenylhydrazone) treatment which severely reduces the mitochondrial membrane potential 
and generally induces parkin recruitment to depolarized mitochondria also failed to show 
colocalization between RNF41 and mitochondria (Suppl Fig 3; [40]). Moreover, Durcan et al. 
described that the USP8 effect on mitophagy was not associated with its function in the ESCRT 
pathway, further suggesting that the RNF41-USP8 interaction only acts at the latter stage, and 
probably not affects mitophagy [41]. Instead, we argue for a role of RNF41 in aggrephagy. In this 
selective autophagic pathway, misfolded and aggregated proteins are polyubiquitinated (K63-linked) 
and selectively recognized by HDAC6 (histone deacetylase 6). HDAC6 links the polyubiquitinated 
cargo to dynein which results in delivery towards the microtubule organizing center to form the 
aggresome. Here, the K63-linked polyubiquitin chains are recognized by p62 or by other autophagic 
receptors which recruit further autophagic machinery and subsequently lead to autophagic clearance 
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[43]. HDAC6 was also identified as an RNF41 interaction partner in an arrayMAPPIT screen performed 
in our lab, where the RNF41 bait was tested against a large collection of about 8500 preys derived 
from the human ORFeome collection (data not shown). Furthermore, parkin was also found to be a 
key regulator of aggrephagy, by mediating K63-linked polyubiquitination of misfolded proteins when 
proteasomal degradation is impaired. This promotes the recruitment p62 and further autophagic 
machinery leading to autophagic clearance [44]. We observed sequestering of parkin by RNF41 
suggesting that RNF41 can also be recruited to the aggregated proteins by its interaction with parkin 
and as such function in the aggrephagy pathway (Suppl Fig 4). Expression of mutant huntingtin 
results in the upregulation of p62, which protects the cell from toxicity by linking these ubiquitinated 
polyglutamine protein aggregates to the autophagic machinery [26,45]. This could be used to 
evaluate whether RNF41 indeed plays a role in aggrephagy, as silencing of RNF41 should result in an 
accumulation of these mutant huntingtin aggregates. 
In conclusion, we detect colocalization between RNF41 and p62, and observe that RNF41 is necessary 
for maintaining p62 and phosphorylated TBK1 levels. Interactions between RNF41 and autophagy-
related proteins Beclin1, ATG14, WIPI2 and ATG5 further suggest that RNF41 is implicated in 
autophagosome formation leading to the selective autophagy pathway aggrephagy.  
Materials and methods 
Constructs 
The pXP2d2-rPAP1-luficerase reporter and pMet7-RNF41-Etag vector were previously described [15], 
as were the pSEL-RNF41 bait, pSEL-emtpy, pMG1-emtpy, pMG1-Rem2, pMet7-RNF41, and pMet7-
sIL- Rα e to s [17]. pMG1-p62, pMG1-TBK1, pMG1-RPTOR, pMG1-LC3B, pMG1-Beclin1, pMG1-
ULK1, pMG1-ATG16, pMG1-ATG5, pMG1-ATG12, pMG1-ATG3, pMG1-ATG14 and pMG1-WIPI2 were 
generated via an LR reaction (Invitrogen) to transfer the genes from a Gateway entry clone of the 
human ORFeome v5.1 collection to a previously described pMG1 destination vector [46]. All 
constructs were verified by DNA sequence analysis.  
 
Confocal microscopy 
1.5 x 104 HeLa cells (www.atcc.org, mycoplasma negative) were seeded on µ-Slide 8 well plates 
(Ibidi), coated with poly-L-lysine (Sigma-Aldrich). The next day, cells were transfected with 10 ng of 
construct using JetPrime (Polyplus). 24 hours later, cells were rinsed with PBS and fixed for 15 
minutes at room temperature in 4% paraformaldehyde. Cells were washed with 100mM phosphate 
buffer (100 mM Na2HPO4; 100 mM NaH2PO4, pH 7.4), permeabilized and blocked in blocking buffer 
(20 mM phosphate buffer; 100 mM NaCl; 0.23% Triton X-100 and 10% donkey serum) for 30 minutes. 
Samples were incubated for 1.5 hours at room temperature with goat anti-Etag (1:2000, Bethyl), 
mouse anti-p62 (1:200, BD Bioscience), rat anti-LAMP (1:500, Abcam), rabbit anti-LC3B (1:1000, MBL 
international) or rabbit anti-p-TBK1 (1:120, Cell Signaling). After washing in blocking buffer without 
donkey serum, cells were incubated for 1 hour at room temperature with donkey anti-goat Alexa 
Fluor 488 or 647, donkey anti-mouse Alexa Fluor 568, donkey anti-rat Alexa Fluor 647 or donkey anti-
rabbit Alexa Fluor 647 or 488 (1:1000, Molecular Probes). Images were acquired using a 60x 1.35 NA 





Western Blot analysis 
2 x 105 HeLa cells were seeded in a 12-well plate and transfected with 1µg of pMet7-sIL- Rα o  
pMet7-RNF41. After 48h, cells were lysed in 2x SDS gel laemmli buffer (62.5 mM Tris-HCl pH 6.8, 3% 
SDS, 10% glycerol, 5% β-mercaptoethanol and 0.01% Bromophenol Blue sodium salt) and sonicated 
using the Bioruptor Plus (Diagenode). For silencing, 2 x 105 HeLa cells in a 6-well plate were reverse 
transfected with 50 nM siRNA using Dharmafect 1 (Dharmacon). Transient knockdown was 
accomplished using RNF41 siRNA (D-006922-02-0020, Dharmacon) and non-targeting siRNA (D-
001810-10-0020, Dharmacon). After 48h, cells were detached and 1.5 x 105 of the silenced HeLa cells 
were re-seeded in a 12-well plate and lysed via sonication after another 48h. For the perturbation 
experiment, the re-seeded cells were incubated for 2 hours with 200nM of DMSO (Sigma), 
Rapamycin (Sigma) or Bafilomcin A1 (Sigma) prior to cell lysis with sonication. After boiling, cell 
lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes (Amersham 
Biosciences). Blots were blocked in Odyssey blocking buffer (LICOR). Mouse anti-β-actin (1:5000, 
Sigma) was revealed by Odyssey infrared imaging (LICOR) using anti-mouse Dylight 680-conjugated 
antibody (1:15.000, Pierce) diluted in Odyssey blocking buffer + 0.1% Tween20. Rabbit anti-RNF41 
(1:10.000; Bethyl), mouse-anti p62 (1:1000, BD Bioscience), rabbit anti-LC3B (1:1000, Cell Signaling), 
rabbit anti-TBK1 (1:2000, Abcam), rabbit anti-p-TBK1 (1:1000, Cell Signaling) and mouse anti-ARF6 
(1:500, Santa Cruz) were revealed with SuperSignal West Pico Chemiluminescent Substrate (Pierce) 
for detection via ECL (enhanced chemiluminescence), using peroxidase-conjugated anti-rabbit or 
mouse antibody (1:10.000, Jackson ImmunoResearch), diluted in milk blocking buffer. 
 
Binary MAPPIT analysis 
For binary MAPPIT, 1 x 104 HEK293T cells (www.atcc.org, mycoplasma negative) were seeded in a 96-
well plate and transfected with 50 ng of STAT3-dependent pXP2d2-rPAP1-luciferase reporter, 250 ng 
bait and prey constructs using calcium phosphate. Cells were left untreated or stimulated for 24 
hours with human Erythropoietin (5 ng/ml). Luciferase activity from triplicate samples was measured 
by chemiluminescence in an Envision plate reader (PerkinElmer) and expressed as fold induction 
(stimulated/non-stimulated relative light units) relative to the signal generated by a JAK2 binding 



















Suppl Fig 1: 
 
Suppl Fig 1. HeLa cells were silenced (96h) for RNF41, p62 or treated with siNT. Protein levels were analyzed by 
Western Blotting using antibodies against RNF41, p62 or β-actin (loading control). n=3.  
 
Suppl Fig 2: 
 
Suppl Fig 2. (A) Co-immunoprecipitation analysis of HEK293T cells transiently co-transfected with a plasmid 
encoding Flag-tagged p  a d RNF  o  solu le IL Rα o k . A ti-Flag immunoprecipitates (upper panels) and 
lysates (lower panels) were visualized with anti-Flag, anti-RNF41 and anti-actin (loading control). n=3. (B) Co-
immunoprecipitation analysis of HEK293T cells transiently co-transfected with a plasmid encoding E-tagged 
TBK1 and Flag-tagged RNF  o  solu le IL Rα o k . A ti-Flag immunoprecipitates (upper panels) and lysates 










Suppl Fig 3:  
 
Suppl Fig 3. HeLa cells transiently transfected with a vector encoding E-tagged RNF41 were treated with 20µM 
DMSO or CCCP for 4hours prior to fixing and staining with anti-Etag (secondary Alexa Fluor 488, green), anti-
p62 (secondary Alexa Fluor 568, red) and anti-COXIV (secondary Alexa Fluor 647, blue). COXIV was used to 
identify the inner membrane of mitochondria. The insets show a magnification of the boxed area. n=1. 
 
 
Suppl Fig 4: 
 
Suppl Fig 4. U2OS cells, stably expressing GFP-parkin, were transiently transfected with a vector encoding E-
tagged RNF41. After fixation, cells were stained with anti-Etag (secondary Alexa Fluor 568, red) and anti-MFN2 
(secondary Alexa Fluor 647, blue). MFN2 (mitofusin 2) embedded in the outer membrane of mitochondria was 












parkin-GFP RNF41-etag MFN2 merge
176
References 
1 Mizushima N (2007) Autophagy: process and function. Genes Dev. 21, 2861–73. 
2 Shibutani ST & Yoshimori T (2014) A current perspective of autophagosome biogenesis. Cell Res. 24, 58–68. 
3 Stolz A, Ernst A & Dikic I (2014) Cargo recognition and trafficking in selective autophagy. Nat. Cell Biol. 16, 
495–501. 
4 Shin J (1998) P62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res. 21, 
629–33. 
5 Matsumoto G, Wada K, Okuno M, Kurosawa M & Nukina N (2011) Serine 403 phosphorylation of 
p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 44, 279–89. 
6 Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N, Ornatowski W, Jiang S, 
Bradfute SB, Bruun J-A, Hansen TE, Johansen T & Deretic V (2012) TBK-1 promotes autophagy-mediated 
antimicrobial defense by controlling autophagosome maturation. Immunity 37, 223–34. 
7 Matsumoto G, Shimogori T, Hattori N & Nukina N (2015) TBK1 controls autophagosomal engulfment of 
polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum. Mol. Genet. 24, 4429–42. 
8 Lin X, Li S, Zhao Y, Ma X, Zhang K, He X & Wang Z (2013) Interaction domains of p62: a bridge between p62 
and selective autophagy. DNA Cell Biol. 32, 220–7. 
9 Lippai M & Low P (2014) The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. 
Biomed Res. Int. 
10 Katsuragi Y, Ichimura Y & Komatsu M (2015) p62/SQSTM1 functions as a signaling hub and an autophagy 
adaptor. FEBS J. 282. 
11 Qiu X-B, Markant SL, Yuan J & Goldberg AL (2004) Nrdp1-mediated degradation of the gigantic IAP, BRUCE, 
is a novel pathway for triggering apoptosis. EMBO J. 23, 800–10. 
12 Zhong L, Tan Y, Zhou A, Yu Q & Zhou J (2005) RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF 
regulates parkin stability and activity. J. Biol. Chem. 280, 9425–30. 
13 Qiu X-B & Goldberg AL (2002) Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of 
the epidermal growth factor receptor family member, ErbB3. Proc. Natl. Acad. Sci. U. S. A. 99, 14843–8. 
14 Jing X, Infante J, Nachtman RG & Jurecic R (2008) E3 ligase FLRF (Rnf41) regulates differentiation of 
hematopoietic progenitors by governing steady-state levels of cytokine and retinoic acid receptors. Exp. 
Hematol. 36, 1110–20. 
15 Wauman J, De Ceuninck L, Vanderroost N, Lievens S & Tavernier J (2011) RNF41 (Nrdp1) controls type 1 
cytokine receptor degradation and ectodomain shedding. J. Cell Sci. 124, 921–32. 
16 Basiorka AA, McGraw KL, De Ceuninck L, Griner LN, Zhang L, Clark JA, Caceres G, Sokol L, Komrokji RS, 
Reuther GW, Wei S, Tavernier J & List AF (2016) Lenalidomide Stabilizes the Erythropoietin Receptor by 
Inhibiting the E3 Ubiquitin Ligase RNF41. Cancer Res. 76. 
17 De Ceuninck L, Wauman J, Masschaele D, Peelman F & Tavernier J (2013) Reciprocal cross-regulation 
between RNF41 and USP8 controls cytokine receptor sorting and processing. J. Cell Sci. 126, 3770–81. 
18 Masschaele D, De Ceuninck L, Wauman J, Defever D, Stenner F, Lievens S, Peelman F & Tavernier J (2017) 
RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes. PLoS One 12, e0178132. 
19 Diamonti AJ, Guy PM, Ivanof C, Wong K, Sweeney C & Carraway KL (2002) An RBCC protein implicated in 
maintenance of steady-state neuregulin receptor levels. Proc. Natl. Acad. Sci. U. S. A. 99, 2866–71. 
20 Eyckerman S, Verhee A, Van der Heyden J, Lemmens I, Van Ostade X, Vandekerckhove J & Tavernier J (2001) 
Design and application of a cytokine-receptor-based interaction trap. Nat. Cell Biol. 3, 1114–1119. 
 Wa g C, Che  T, Zha g J, Ya g M, Li N, Xu X & Cao X 9  The E  u i uiti  ligase N dp  p efe e tially  
promotes TLR-mediated production of type I interferon. Nat. Immunol. 10, 744–52. 
22 Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J & Yonezawa K (2002) Raptor, 
a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177–89. 
23 Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, 
Guan J-L, Oshiro N & Mizushima N (2009) Nutrient-dependent mTORC1 association with the ULK1-Atg13-
FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981–91. 
24 Ma X, Helgason E, Phung QT, Quan CL, Iyer RS, Lee MW, Bowman KK, Starovasnik MA & Dueber EC (2012) 
Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc. Natl. Acad. Sci. U. 
S. A. 109, 9378–83. 
25 Moreau K, Ravikumar B, Puri C & Rubinsztein DC (2012) Arf6 promotes autophagosome formation via 
effects on phosphatidylinositol 4,5-bisphosphate and phospholipase D. J. Cell Biol. 196, 483–96. 
26 Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H & Johansen T (2005) 
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-
177
induced cell death. J. Cell Biol. 171, 603–14. 
27 Russell RC, Tian Y, Yuan H, Park HW, Chang Y-Y, Kim J, Kim H, Neufeld TP, Dillin A & Guan K-L (2013) ULK1 
induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741–
50. 
28 Roberts R & Ktistakis NT (2013) Omegasomes: PI3P platforms that manufacture autophagosomes. Essays 
Biochem. 55. 
29 Dooley HC, Razi M, Polson HEJ, Girardin SE, Wilson MI & Tooze SA (2014) WIPI2 Links LC3 Conjugation with 
PI3P, Autophagosome Formation, and Pathogen Clearance by Recruiting Atg12–5-16L1. Mol. Cell 55, 
238–252. 
30 Itakura E & Mizushima N (2011) p62 Targeting to the autophagosome formation site requires self-
oligomerization but not LC3 binding. J. Cell Biol. 192, 17–27. 
31 Weidberg H & Elazar Z (2011) TBK1 mediates crosstalk between the innate immune response and 
autophagy. Sci. Signal. 4, pe39. 
32 Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, Behl C, Terzic J & Dikic I (2013) Ubiquitin-
independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 126, 580–
592. 
33 Tu D, Zhu Z, Zhou AY, Yun C, Lee K-E, Toms A V, Li Y, Dunn GP, Chan E, Thai T, Yang S, Ficarro SB, Marto JA, 
Jeon H, Hahn WC, Barbie DA & Eck MJ (2013) Structure and ubiquitination-dependent activation of TANK-
binding kinase 1. Cell Rep. 3, 747–58. 
34 Korolchuk VI, Mansilla A, Menzies FM & Rubinsztein DC (2009) Autophagy Inhibition Compromises 
Degradation of Ubiquitin-Proteasome Pathway Substrates. Mol. Cell 33, 517–527. 
35 Zaffagnini G & Martens S (2016) Mechanisms of Selective Autophagy. J. Mol. Biol. 428, 1714–24. 
36 Komatsu M, Waguri S, Koike M, Sou Y-S, Ueno T, Hara T, Mizushima T, Iwata J-I, Ezaki J, Murata S, Hamazaki 
J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, Kobayashi A, 
Yamamoto M, Yue Z, Uchiyama Y, Kominami E & Tanaka K (2007) Homeostatic Levels of p62 Control 
Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Micee. Cell 131, 1149–1163. 
37 Wooten MW, Hu X, Babu JR, Seibenhener ML, Geetha T, Paine MG & Wooten MC (2006) Signaling, 
polyubi uiti atio , t affi ki g, a d i lusio s: se uestoso e /p ’s ole i  eu odege e ati e disease. 
J. Biomed. Biotechnol. 2006, 62079. 
38 Rea SL, Majcher V, Searle MS & Layfield R (2014) SQSTM1 mutations – Bridging Paget disease of bone and 
ALS/FTLD. Exp. Cell Res. 325, 27–37. 
39 Song P, Li S, Wu H, Gao R, Rao G, Wang D, Chen Z, Ma B, Wang H, Sui N, Deng H, Zhang Z, Tang T, Tan Z, Han 
Z, Lu T, Zhu Y & Chen Q (2016) Parkin promotes proteasomal degradation of p62: implication of selective 
vulnerability of neuro al ells i  the pathoge esis of Pa ki so ’s disease. Protein Cell 7, 114–29. 
40 Narendra D, Tanaka A, Suen D-F & Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria 
and promotes their autophagy. J. Cell Biol. 183. 
41 Durcan TM, Tang MY, Pérusse JR, Dashti EA, Aguileta MA, McLelland G-L, Gros P, Shaler TA, Faubert D, 
Coulombe B & Fon EA (2014) USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from 
parkin. EMBO J. 33, 2473–91. 
42 Narendra D, Kane LA, Hauser DN, Fearnley IM & Youle RJ (2010) p62/SQSTM1 is required for Parkin-induced 
mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6, 1090–106. 
43 Lamark T & Johansen T (2012) Aggrephagy: Selective Disposal of Protein Aggregates by Macroautophagy. 
Int. J. Cell Biol. 2012, 1–21. 
44 Chin L-S, Olzmann JA & Li L (2010) Parkin-mediated ubiquitin signalling in aggresome formation and 
autophagy. Biochem. Soc. Trans. 38, 144–9. 
45 Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, Oyama F & Nukina N (2004) Increased expression 
of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J. 
Neurochem. 91, 57–68. 
46 Lievens S, Vanderroost N, Van der Heyden J, Gesellchen V, Vidal M & Tavernier J (2009) Array MAPPIT: High-















































































The in-house developed MAPPIT (Mammalian Protein-Protein Interaction Trap) technique proved to 
be a highly valuable tool to analyze PPIs (protein-protein interactions) [1]. The high-throughput 
screening platforms array MAPPIT and microarray MAPPIT allow the extensive screening for new 
interaction partners of a protein of interest [2,3]. A common feature of PPI screening methods is the 
presence of technical false positive hits. In the case of MAPPIT these false positives usually interact 
with the LR tail of the MAPPIT bait receptor or bind with JAK2. Through the years this list of intrinsic 
false positives became well defined and was excluded from subsequent MAPPIT screening analyses. 
On the other hand, such screening artifacts could also serve as internal controls to determine 
expression of the bait chimera. RNF41 (RING finger protein 41), more specifically RNF41-encoding 
preys with truncated RING domains, were frequently detected as false positives. These truncated 
preys resembled DN (dominant negative) RNF41, as they lack the functional RING domain 
responsible for recruiting the ubiquitination machinery. Such RNF41 DN effect was first described for 
the ERBB3 and ERBB4 receptors as its expression resulted in enhanced signaling [4]. Our lab 
therefore decided to further investigate the functional significance of RNF41 in LR (leptin receptor) 
signaling and indeed found that RNF41 suppressed LR signaling, and in extension also LIFR (leukaemia 
inhibitory factor receptor), IL-6R (interleukin 6 receptor), EPOR (erythropoietin receptor) and IL-3R 
(interleukin 3 receptor) signaling [5]. Moreover, further research uncovered a role for RNF41 in the 
intracellular trafficking of these JAK2-associated type I cytokine receptors. RNF41 was found to 
reroute these receptors from the lysosomal degradation pathway to compartments for ectodomain 
shedding by ubiquitinating and suppressing the deubiquitinase USP8 (Ubiquitin-specific protease 8) 
which leads to a destabilized ESCRT-0 complex [6].  
RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes 
In the first part of this thesis we further explored the molecular mechanisms underlying the role of 
RNF41 in intracellular rerouting by focusing on newly identified RNF41 interaction partners from an 
initial array MAPPIT screen. VPS52 (vacuolar protein sorting 52), which is a component of two 
spatially distinct multisubunit tethering complexes GARP (Golgi-associated retrograde protein) and 
EARP (endosome-associated recycling protein), appeared as one of the top-ranked hits. These 
complexes mediate transport of cargo from the endosomes to the TGN (trans-Golgi network) or to 
the PM (plasma membrane), respectively. We therefore reasoned that this RNF41-VPS52 interaction 
could potentially be involved in the effects of RNF41 on intracellular transport of the LR. Detailed 
interaction analysis revealed that RNF41 and VPS52 interacted with each other via their coiled-coil 
domains. This was confirmed by a screen that combined random mutagenesis with MAPPIT to reveal 
RNF41 mutants that specifically disrupted the interaction between RNF41 and VPS52, which were al 
located in the RNF41 coiled-coil domain. This approach also led to the identification of the RNF41 
L163Q mutant which was used throughout the paper to determine the specificity of the RNF41-
VPS52 interaction in the observed RNF41-provoked effects. RNF41 ubiquitinated and relocated 
VPS52 away from VPS53, which is another shared subunit of the GARP and EARP complexes. This 
relocalisation of VPS52 towards RNF41-positive structures, which we refer to as RNF41-bodies, 
depended on the E3 ligase activity and membrane anchoring potential of RNF41 since DN RNF41, 
lacking both features, RNF41 C34S/H36Q, with impaired E3 ligase activity (unpublished observations), 
and RNF41 G2A, with a mutated myristoylation site necessary for membrane anchoring, did not 
exhibit this effect. In line with other reports [7], we established that both RNF41 and VPS52 
oligomerize, and our results indicated that VPS52 hindered this RNF41 oligomerization and vice 
versa. Molecular modeling of the coiled-coil regions of one RNF41 and two VPS52 monomers 
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accentuates a high electrostatic compatibility between the RNF41 and VPS52 coiled-coils, where 
positively charged basic amino acids, such as Arg and Lys, frequently face negatively charged acidic 
amino acids, like Asp and Glu. Therefore, we envisioned a complex where the RNF41 and VPS52 
monomers are interchangeable, thereby cycling between a new RNF41-VPS52 complex and existing 
RNF41 complexes, GARP or EARP complexes. Exchange between coiled-coil proteins is often 
observed in intracellular trafficking. SNARE (soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor) proteins, for example, can assemble into stable four-helix bundle SNARE complexes 
via their coiled-coil containing SNARE motifs. A single SNARE protein can hereby get incorporated in 
multiple SNARE complexes and in this way regulate multiple fusion events [8,9]. Moreover, the GARP 
and EARP multisubunit tethering complexes share the VPS51, VPS52 and VPS53 subunits, while the 
exchange of VPS54 in GARP for Syndetin in EARP defines the specificity of the location of these 
complexes [10]. Furthermore, the coiled-coil tethering factor p115 is able to interact with the coiled-
coil tether Giantin on COPI (coat protein complex I) vesicles. This is followed by binding with coiled-
coil tether GM130 on the Golgi in order to link COPI vesicles with the Golgi [11], which further 
illustrates the sequential interaction potential of coiled-coil domains. In the future we could make 
use of SEC-MALS (Size exclusion chromatography- Multi-angle light scattering) to determine the 
oligomeric state of the RNF41, VPS52 or RNF41-VPS52 complexes. This biochemical approach enables 
accurate molecular weight determination of proteins, oligomers and complexes where the SEC 
column separates molecules by size, while MALS calculates the molar mass of eluting proteins based 
on the intensity of light scattering [12]. 
At this point it is unclear what type of ubiquitin linkage is responsible for the RNF41-mediated 
ubiquitination of VPS52 or whether this is direct or via the recruitment of other E3 ligases. Since this 
ubiquitination does not result in the degradation of VPS52 we are inclined to exclude K48-chains, and 
believe that this ubiquitination could involve K63- and/or M1-linked chains. These chains are usually 
implicated in regulating protein localization and are thus in line with the observed relocalization of 
VPS52 by RNF41 [13]. Experiments with appropriate antibodies or K48, K63 and M1 mutants together 
with an in vitro ubiquitin assay should allow to determine the type of ubiquitination and whether this 
ubiquitination of VPS52 by RNF41 is direct or indirect.  
Considering that RNF41 relocates VPS52 and thereby hampers the interaction between VPS52 and 
the GARP or EARP complex, we further investigated the influence of RNF41 on known substrates of 
these complexes and added the results in the addendum of this paper. Since the GARP complex 
participates in the retrograde transport of Shiga toxin B-subunit (STxB) and depletion of any of the 
GARP subunits altered STxB distribution [14,15], we expected RNF41 to mimic this effect. 
Surprisingly, RNF41 did not hamper STxB transport to the TGN. We next examined the EARP complex, 
which is involved in the recycling of internalized transferrin receptor back to the plasma membrane 
[10]. Ectopic RNF41 expression clearly interfered with the transferrin recycling pathway and resulted 
in an accumulation of transferrin, resembling the situation of VPS52 depleted cells [10]. Since 
expression of the L163Q mutant also resulted in accumulated transferrin, we were not able to 
ascribe this effect to the RNF41-VPS52 interaction (unpublished data). However, we can also not 
exclude this, as the L163Q mutant is still able to oligomerize with WT RNF41, which could explain the 
lack of functional effect. Unfortunately, we cannot determine the effect of RNF41 silencing on 
transferrin recycling or STxB transport at this point due to poor silencing efficiencies and failing 
endogenous RNF41 antibodies for immunofluorescence. We reason that RNF41 interacts with and 
relocalizes VPS52 destined for the EARP complex. This may explain why the GARP complex remains 
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functional but transferrin recycling, mediated by the EARP complex, is inhibited. This is similar to a 
situation described by Otto et al, where overexpression of the t-SNARE STX6 (syntaxin 6) together 
with its interaction partner SHIP164 (Syntaxin 6 Habc-Interacting Protein Of 164 kDa) caused a 
relocalization of VPS52 which also resulted in inhibited transferrin receptor recycling [16].  
Conversely, we wanted to investigate the effect of the RNF41-VPS52 interaction on the known 
RNF41-mediated enhanced LR shedding and inhibited LR degradation. Silencing of VPS52 still 
increased LR shedding upon RNF41 expression and ectopic expression of the L163Q mutant 
resembled WT RNF41, indicating that VPS52 is not involved in the RNF41-mediated effects on LR 
rerouting. We can at this point not explain the apparent contradiction between the effect of RNF41 
on LR and transferrin recycling where RNF41 enhances LR recycling and subsequent shedding, 
whereas RNF41, similar to VPS52 depletion, delays transferrin recycling. It is possible that the effect 
of RNF41 on transferrin recycling is indeed depending on the interaction with VPS52, where RNF41 
interferes with EARP function by sequestering VPS52 away, whereas the effects of RNF41 on LR 
routing are independent of VPS52. This LR rerouting depends on the RNF41-USP8 interaction, where 
RNF41-mediated loss of USP8 actively stimulates LR recycling [6]. This is coherent with the idea that 
RNF41 functions at separate stages and possibly at different timepoints during intracellular 
trafficking, where RNF41-VPS52 functions at the recycling endosomes while RNF41-USP8 operates at 
the sorting endosome (see Figure 20).  
On the other hand, we did notice that silencing of VPS52 decreased basal LR ectodomain shedding, 
which suggests that VPS52 could be involved in LR recycling. This is in line with the function of the 
EARP complex in protein recycling, although the LR did not appear to undergo recycling in basal 
circumstances [6,17]. Also, the LR was not detected in transferrin-positive recycling endosomes after 
their internalization from the PM, indicating that these two receptors follow different pathways [17]. 
Transferrin is a CME (clathrin-mediated endocytosis) cargo protein that is known to undergo fast and 
slow, ERC (endocytic recycling compartment)-dependent recycling via RAB4 and RAB11 respectively. 
Next to these CME-dependent recycling pathways, another ARF6-, RAB11- and RAB22-dependent 
slow recycling pathway exists [18,19]. Perhaps the LR recycles via this latter pathway, although this 
pathway is known to carry clathrin-independent endocytosed cargo back to the PM via recycling 
endosomes, while LR was reported to undergo CME [20]. It is possible that VPS52 influences basal LR 
recycling via another unknown mechanism, or that the effect of VPS52 on LR recycling depends on 
the interaction with other proteins, for instance MAGEL2 (melanoma antigen L2). Indeed, in a recent 
collaboration with the group of prof. Wevrick (University of Alberta, Canada), we established that 
VPS52 interacted with MAGEL2, a protein that is known to regulate retromer-mediated recycling 
both towards the TGN and the PM [21]. MAGEL2 was found to recruit the LR via necdin to the RNF41-
USP8-ESCRT-0 ubiquitination complex on the sorting endosomes to regulate its trafficking [22]. 
MAGEL2 could form a separate complex with VPS52 and function somewhere at the retromer-
mediated recycling pathway towards the PM, which could explain the effects of silenced VPS52 on LR 
shedding.  
A high confidence interactome for RNF41 built on multiple orthogonal assays 
In the second part of this thesis we expanded the array MAPPIT-derived list of RNF41 interaction 
partners with data obtained from orthogonal screening methods in order to build an RNF41 
interactome network. Mapping and analyzing the RNF41 interactome network will provide useful 
185
information for future studies that further elucidate the role of RNF41 and can reveal how this 
protein relates to human disease. Virotrap, BioID (proximity-dependent biotin identification) and AP-
MS (affinity-purification-mass spectrometry) screens were performed and their resulting datasets 
were pooled with available data from previously performed microarray MAPPIT and Y2H screens 
[3,23]. The combined datasets were incorporated in a high-resolution RNF41 interactome map that 
encompassed all detected interactions. This map includes many known RNF41 interaction partners 
such as USP8, BRUCE (BIR repeat containing ubiquitin-conjugating enzyme) and KDM3B (lysine-
specific demethylase 3B) thereby confirming the efficiency of the screens. In addition, it revealed 
several functional clusters of proteins involved in ubiquitination and in the insulin receptor signaling 
pathway. This high-resolution interactome map also resulted in the discovery of new RNF41 
interaction partners, such as CCP110 (Centriolar Coiled-Coil Protein of 110 kDa), which was identified 
with BioID. This protein regulates centrosome duplication and separation, and modulates 
ciliogenesis. Next to suppressing ciliogenesis, it has recently been found to also promote cilia 
formation depending on the accessible interacting proteins and the cellular microenvironment [24–
27]. The involvement of this candidate protein in ciliogenesis is in line with the function of another 
well-known RNF41 interaction partner USP8 and thus illustrates the competence of an interactome 
map to uncover functional links. USP  deu i uiti ates a d sta ilizes the t a s iptio  fa to  HIF α 
(hypoxia-inducible factor α), an essential ilioge esis fa to . I  this a , HIF α supp esses the RAB5 
effector Rabaptin5 thereby hindering early endosome fusion and promoting ciliogenesis [28].  
Candidate proteins that were identified in two or more of the orthogonal methods were assembled 
in the high-confidence RNF41 interactome map. This map comprises 19 high-confident RNF41 
interaction partners including functionally well-characterized proteins such as BRUCE and USP8, and 
novel candidate proteins such as KIAA1598, NAV1 (Neuron navigator 1) and AP2S1 (Adaptor related 
Protein complex 2 sigma 1 subunit). KIAA1598 and NAV1 were both picked up in the BioID and AP-
MS screen. Next to this, KIAA1598 also appeared as an RNF41 interaction partner in the microarray 
MAPPIT screen, while NAV1 interacted with RNF41 in Virotrap. Both proteins are involved in axon 
outgrowth and guidance [29–31]. PAK1 (p21-activated kinase 1) induces phosphorylation of 
KIAA1598 thereby enabling the interaction with F-actin. In this way KIAA1598 bridges the interaction 
between F-actin and neuronal cell adhesion molecule L1-CAM, which further promotes axon 
outgrowth [29,30]. The recent characterization of RTN4A as a new RNF41 interaction partner further 
supports a role for RNF41 and candidate interaction partners in neuronal development. This key 
structural protein of ER tubules was also found to interact with receptors on the axonal growth cone 
and inhibits axonal regeneration [32,33]. Furthermore, KIAA1598 also regulates neural polarization 
by accumulating and recruiting PI3K (phosphatidylinositol-3-kinase) activity in the growing axon [34]. 
Likewise, RNF41 plays a role in planar cell polarity required for neuronal development by 
downregulating VANGL (Vang-like protein)-dependent non-canonical Wnt signaling. Through 
interactions with KITENIN (KAI1 C-terminal interacting tetraspanin) and VANGL2, RNF41 mediates the 
K63-linked polyubiquitination of DVL (Dishevelled), which inhibits its recruitment to activated Frizzled 
receptors, resulting in suppressed Wnt signaling [35]. In addition, Par-1b mediated phosphorylation 
of RNF41 targets laminin-111 receptors to the basolateral membrane which establish cell-ECM 
contacts with laminin-111 required for apical-basal cell polarity in epithelial cells [36]. Although 
Virotrap, BioID and AP-MS screens were performed in non-polarized HEK293T cells, the identification 
of RNF41 interaction partners involved in cell polarity is not so surprising as many endocytic traffic 
proteins appeared to be involved in processes such as epithelial and neuronal planar cell polarity 
186
[37]. Of note, the HEK293 cell line was found to have characteristics of immature neurons, 
presumably originating from migrating neural crest cells in the kidney [38].  
This also further suggests a potential role for RNF41 in intracellular trafficking, which is emphasized 
by the identification of AP2S1 as another novel RNF41 interaction partner in a Virotrap and 
microarray MAPPIT screen. AP2S1 represents the σ2 subunit of the clathrin adaptor protein AP-2 
which plays a crucial role in CME. This heterotetrameric AP-2 complex further comprises two large 
subunits, α and β2, and a medium subunit µ2 [39]. Binding of AP-2 to the PM triggers a 
conformational change, which enables interaction with internalization motifs in the cytoplasmic tail 
of cargo proteins, followed by clathrin recruitment [40,41]. Further investigation revealed that AP2S1 
was not involved in the well-established function of RNF41 in LR shedding, degradation and signaling 
as silencing of AP2S1 did not hamper the RNF41-mediated enhanced ectodomain shedding, blocked 
CTS formation or decreased LR signaling. Instead we observed an increase in basal LR and LIFR 
signaling when cells were depleted of AP2S1, which corresponds to the enhanced signaling observed 
in RNF41-depleted cells [5]. At this point it is unclear whether AP2S1 and thus AP-2 are involved in LR 
internalization. We observed enhanced LR signaling upon depletion of AP2S1, suggesting that if 
AP2S1 is involved in LR internalization, LR signaling would occur at the plasma membrane. However, 
our observations revealed that LR internalization was necessary for LR signaling, which implies that 
AP2S1 and AP-2 are not involved in LR endocytosis. This is also supported by the lack of a putative 
dileucine or tyrosine-based motif in cytoplasmic tail of the LR which could be recognized by the σ2 or 
µ2 subunit of AP-2 respectively. It is possible that other adaptor proteins regulate LR internalization, 
as seen for the EGF (Epidermal growth factor) and LDL (low-density lipoprotein) receptors, where AP-
2 depletion does not influence EGFR and LDLR CME [42].  
Domain mapping showed that the substrate binding domain of RNF41 is responsible for AP2S1 
interaction. Surprisingly we did not detect ubiquitination of AP2S1 by RNF41, although interactions 
with this substrate binding domain are usually conserved for proteins, like BRUCE, USP8 and ERBB3 
that undergo RNF41-mediated ubiquitination [43–45]. This can be attributed to the observed indirect 
interaction between RNF41 and AP2S1.  Nonetheless, we did observe a stabilization of AP2S1 upon 
RNF41 ectopic expression. Moreover, experiments with the proteasomal inhibitor MG132 revealed 
that RNF41 likely stabilizes AP2S1 by preventing its proteasomal degradation. This RNF41-evoked 
stabilization of AP2S1 appeared to be independent of its E3 ubiquitin ligase function but relied on its 
membrane anchoring and oligomerization ability since a RING domain mutant still stabilized AP2S1, 
hile the G A a d ∆CC uta ts did ot.  
This stabilizing effect of RNF41 on AP2S1 is in contrast to its effect on VPS52, where RNF41 directly 
interacts with and relocates VPS52 depending on its E3 ligase activity [46]. Both effects however, 
require a proper myristoylation site and a domain for oligomerization, suggesting that membrane 
anchoring and the ability to homo- or hetero-oligomerize is important for general RNF41 function. It 
is likely that RNF41 exerts its function on both proteins in a temporal or spatial distinct manner (see 
Figure 20).  
As AP2S1 indirectly interacts with the substrate binding domain of RNF41 and RNF41 prevented 
AP2S1 from proteasomal degradation it is possible that RNF41 directly interacts, via its substrate 
binding domain, with another currently unknown E3 ligase, which under normal circumstances 
ubiquitinates AP2S1 resulting in proteasomal degradation. This resembles a similar situation where 
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RNF41 degrades the E3 ligase parkin thereby stabilizing parkin substrate CDCrel-1 [47]. Since AP2S1 
was identified via Virotrap, we reasoned that this dataset likely contains the potential E3 ubiquitin 
ligase that mediates this effect. Indeed, the Virotrap list entails three ubiquitin ligases. BRUCE, a well-
known E3 ligase, could potentially be involved in this RNF41-AP2S1 interaction since it is an 
important regulator of cytokinesis, a process implicating both clathrin and AP-2 [48–50]. TTC1 
(tetratricopeptide repeat protein 1), an unknown protein that contains a TPR (tetratricopeptide 
repeat) domain, can potentially function as an E3 ubiquitin ligase since the related E3 ligase, TTC3, 
contains a TPR motif and a canonical RING finger [51]. And finally, CACYBP (Calcyclin-binding protein), 
a protein involved in the ubiquitin-mediated degradation of β-catenin [52]. Future experiments using 
siRNA will determine the involvement of these E3 ligases in the AP2S1-RNF41 interaction. 
The high-confidence interactome of RNF41 also identified the E3 ubiquitin ligase ASB6 (ankyrin 
repeat and SOCS box protein 6), as an RNF41 interaction partner. RNF41 was found to stabilize and 
relocate ASB6, analogous to our observations for AP2S1. Moreover, ASB6 was implicated in LR 
signaling and knockdown of ASB6, like knockdown of AP2S1, potentiated LR signaling (De Ceuninck, 
manuscript in preparation). Although AP2S1 and ASB6 are both stabilized by RNF41 and appear to 
have similar functions, these proteins were not found to interact with, or influence each other. USP8, 
which shares the RNF41 interaction interface with ASB6 also failed to interact with AP2S1, despite 
the fact that RNF41 mutants specifically disrupting this interface resulted in a loss of AP2S1 binding.   
The role of RNF41 in selective autophagy 
In the third part of this thesis we characterized the RNF41-bodies observed with 
immunofluorescence. These RNF41-bodies are assumed to be detergent-resistant as ectopically 
expressed RNF41 resided only in the insoluble fraction of RIPA lysed cells detected by 
immunoblotting [46]. Due to its oligomerization properties it is easily presumed that these RNF41 
bodies represent aggregates. However, DN RNF41 and the RNF41 G2A mutant, both lacking the 
putative myristoylation site but retaining the coiled-coil domain, were found to have a more 
homogenous cytosolic distribution, thus arguing against this non-functional aggregation. Moreover, 
we show that the RNF41-bodies colocalize with the autophagic cargo receptor p62, indicating a role 
for RNF41 in cargo tagging. RNF41 was found to maintain endogenous p62 and lipidated LC3B-II 
levels as RNF41 depletion decreased these proteins, independently of increased autolysosomal 
turnover. Since the RNF41-bodies failed to colocalize with LC3B or LAMP1 (lysosomal-associated 
membrane protein 1) we presumed that RNF41 exerts its function somewhere in the early stages of 
autophagy, at the autophagosome formation site. In line with this, it is known that p62 sequesters 
ubiquitinated cargo into aggregates prior to the recruitment of LC3B. These detergent resistant p62-
positive structures did not colocalize with lysosomal markers and represented a stage before the 
formation of detergent dissolvable autophagosomes [53–55]. Furthermore, binary MAPPIT studies 
showed that RNF41 interacted with class III PI3K complex I components Beclin1 and ATG14 
(autophagy-related protein 14), its effector WIPI2 and with ATG5 of the ubiquitin-like conjugating 
complex ATG5-ATG12-ATG16. These complexes are required for autophagosome formation through 
their involvement in the nucleation and elongation of the isolation membrane which further 
supports a role for RNF41 at the early stage of autophagosome biogenesis (see Figure 20).  
The isolation membrane originates from different sources such as the ER, mitochondria, Golgi, 
endosomes and plasma membrane [56,57]. The small GTPase ARF6 (ADP ribosylation factor 6), a key 
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regulator of clathrin-independent endocytic trafficking also plays a role in plasma membrane delivery 
to the isolation membrane via its ability to generate PI(4,5)P2 [58]. This places ARF6 somewhere 
upstream in autophagosome biogenesis which correlates with our hypothesized role for RNF41 in 
autophagosome formation since RNF41 depletion lowers the levels of ARF6. Furthermore, ARF6 has 
also been implicated in CME, another essential mediator in the contribution of plasma membrane to 
the autophagosomal formation site [59–61]. As AP-2 was found to associate with ARF6 in both CME 
and CIE, and ARF6 functions cooperatively with PI(4,5)P2 to recruit AP-2 to membranes [59,62], it is 
possible that AP2S1 also functions in the delivery of membrane to the isolation membrane, 
connecting yet another RNF41 interaction partner to autophagosome biogenesis.  
Next to ARF6, many other proteins involved in intracellular trafficking are known to influence 
autophagy. This is also true for VPS52, where silencing of VPS52 and other members of the GARP 
complex resulted in defective autophagy. In this case dysfunctional autophagy was caused by 
impaired lysosomal turnover, as depleted GARP subunits reduced the amount of acid hydrolases in 
the lysosomes [10,15]. This is in contrast to our observations of RNF41 in autophagy, although we did 
observe colocalisation between VPS52 and our p62-positive RNF41 bodies (unpublished 
observations). 
Despite the inability to detect an interaction between TBK1 (TANK-binding kinase 1) and RNF41, 
although this is described in literature [63], we did observe colocalization between RNF41 and 
phosphorylated TBK1. TBK1 is activated upon phosphorylation and can in turn phosphorylate the 
ubiquitin binding domain of p62, thereby increasing binding affinity for ubiquitinated cargo [64–66]. 
Since K63-linked polyubiquitination of TBK1 is required for TBK1 phosphorylation, and RNF41 is one 
of the E3 ligases responsible for this ubiquitination [63,67], we presume that RNF41 is required for its 
activation, which is further corroborated by our finding that silencing of RNF41 decreased 
phosphorylated and thus activated TBK. Moreover, RNF41 could in this way indirectly regulate p62 
recruitment to autophagic cargo. This could also explain the observation that RNF41 silencing 
decreases p62, as inhibited TBK1 results in unphosphorylated p62 which has a low affinity for 
ubiquitinated cargo, making it more available to E3 ligases, such as parkin, responsible for its 
proteasomal degradation [68]. And since RNF41 degrades parkin [47], silencing RNF41 should 
stabilize parkin, thereby further enabling the proteasomal degradation of p62.  
Although several RNF41 interaction partners such as parkin, CLEC16A (C-type lectin domain family 
16, member A) and USP8 were found to be involved in mitophagy [69–71], we found no association 
between the RNF41-bodies and mitochondria, which again highlights the possible temporal and 
spatial distinct function of many RNF41 interactions. We presume that RNF41 plays a role in 
aggrephagy, another selective autophagic pathway where misfolded and aggregated proteins are 
first recognized by HDAC6 (histon deacetylase 6) which results in their delivery to the microtubule 
organizing center to form aggresomes. This is followed by the recognition of the K63-linked 
polyubiquitined cargo by p62 resulting in recruitment of the autophagic machinery and eventual 
autophagic clearance [72]. The identification of HDAC6 as an RNF41 interaction partner in our initial 
array MAPPIT screen further supports this hypothesis. Moreover, parkin is known to regulate 
aggrephagy by mediating K63-linked polyubiquitination of misfolded proteins [73]. Our observation 
that RNF41 sequesters parkin indicates that RNF41 could be involved in the clearance of aggresomes 
via its interaction with parkin and thereby assists in the further recruitment of the autophagic 
machinery. On the other hand, it is also possible that RNF41, similarly to parkin, directly ubiquitinates 
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autophagic cargo and in this way mediates the binding of p62 to these K63-linked polyubiquitinated 
cargo. 
 
Figure 20. Overview of the spatially distinct functions of RNF41. The RNF41-USP8 interaction determines the 
fate of JAK2-associated type I cytokine receptors, such as the LR (leptin receptor, blue). At the early endosome, 
RNF41 ubiquitinates and suppresses USP8 thereby destabilizing the ESCRT-0 complex required for incorporation 
of these receptors into intraluminal vesicles in the late endosomes, ultimately resulting in inhibited degradation.  
As a consequence, receptors are rerouted towards the plasma membrane via slow and fast recycling pathways, 
where they can undergo ectodomain shedding by members of the ADAM (a disintegrin and metalloproteinase) 
family (note: it is currently unclear where shedding of these receptors occurs, as ADAMs are found at the 
plasma membrane, endosomes and Golgi). The RNF41-VPS52 interaction likely occurs at the recycling 
endosomes where RNF41 ubiquitinates and sequesters VPS52 away from the EARP complex thereby inhibiting 
TfR (transferrin receptor, green) recycling. The stabilizing effect of RNF41 on AP2S1 results in relocalization of 
AP2S1 from its normal subcellular location at the plasma membrane possibly affecting internalization routes of 
certain cargo. Finally, RNF41 interaction with ATG-related proteins Beclin1, ATG14, WIPI2 and ATG5 occurs at 
the isolation membrane. This location of RNF41 possibly enables RNF41 to phosphorylate TBK1 which in turn 
phosphorylates p62 in this way maintaining p62 levels resulting in sequestering of polyubiquitinated cargo 
destined for aggrephagy.  
Conclusion and future prospects 
The study of PPIs can provide valuable insights into the function of a protein as interacting proteins 
are often involved in the same cellular processes. The function of an unidentified protein can 
potentially be predicted based on the known function of its binding partner, and detailed analysis of 
PPIs can in this way reveal the molecular mechanism of cellular processes [74]. By applying this 
principle throughout this thesis we were able to obtain new insights into RNF41 function. Novel 
candidates such as VPS52 and AP2S1 indicated additional roles for RNF41 in intracellular transport, 
more specifically at the level of cargo recycling and internalization, although further investigation is 
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needed to clarify the functional link between RNF41 and VPS52 or AP2S1 in these processes. Next to 
this, we also revealed a clear connection between autophagy and RNF41 (see Figure 20 for 
overview). As the results in this thesis suggest, it is important to keep in mind that RNF41 most likely 
functions at spatially and temporally distinct stages and is greatly influenced by local interaction 
partners that regulate its stability. For instance, USP8 stabilizes RNF41 at the level of the sorting 
endosomes, while Rtn4A at the ER inhibits its E3 ligase activity [6,32]. Furthermore, intracellular 
trafficking comprises many pathways, some of which appear to be functional redundant or exert 
compensatory mechanisms when tempered with, which often complicates the study of these 
processes.  
Characterizing the protein interaction network further elucidates the functionality of a certain PPI 
and can be a valuable tool for drug discovery and development. Specific perturbation of a single PPI 
o  edgetic perturbation , while retaining all others has a more subtle effect on the network and 
has proven to be more useful than the removal of an entire protein o  ode  which often results in 
a drastic alteration of the network structure and function [75]. In accordance to this, we applied a 
strategy that combines random mutagenesis with MAPPIT in order to generate and identify single 
mutants that specifically disrupt an interaction between RNF41 and a certain interaction partner. A 
limitation to this method is the need for overexpression, and as WT RNF41 is known to oligomerize, it 
can easily hetero-oligomerize with these mutants thereby affecting and minimizing the observed 
phenotypes. A way to circumvent this problem is by first silencing RNF41 followed by ectopic 
expression of these mutants. However, several attempts by our lab to make a cell line with stable 
RNF41 knockdown were unsuccessful, as the initial partial knockdown was gradually lost overtime 
even though the selection pressure was maintained.  Although we have proven before that transient 
knockdown of RNF41 using siRNA has an effect on LR surface expression and signaling [5] and affects 
endogenous p62 levels (Results section 3), this transient treatment only yields partial knockdown. 
This is in line with previously published results in literature describing poor RNF41 knockdown 
efficiencies [36,76] and indicates that RNF41 is essential for cell viability. Consequently, cells with too 
low RNF41 protein levels will be negatively selected and cells in transient or stable knockdown 
experiments will always maintain a basal endogenous RNF41 protein pool, which complicates the 
interpretation of RNF41 knockdown and ectopic expression of RNF41 mutants in functional assays 
(addendum Results section 1).  
Since RNF41 represents a tightly regulated protein where an imbalance caused by excessive or 
insufficient amounts likely results in its dysfunction, we now aim to circumvent these problems by 
introducing intrabodies as a new method to selectively modulate RNF41 interactions. These 
intrabodies represent intracellularly expressed nanobodies that target distinct binding sites in RNF41 
and can in this way be used to block specific cellular functions. As intrabodies do not appear to suffer 
from the reducing environment of the cell, they have been successfully used to target intracellular 
proteins, such the F-actin capping protein CapG and the actin-binding proteins fascin and cortactin 
[77,78]. Nanobodies against fascin and cortactin, which respectively inhibit F-actin bundling and 
perturb WIP (WASP interacting protein) recruitment towards the plasma membrane, revealed their 
role in invadopodium formation and cancer cell invasion [78]. Moreover, the anti-CapG nanobody 
prevented the interaction between CapG and actin polymers, thereby reducing cell migration of 
breast cancer cells and diminishing lung metastasis in xenograft tumor mouse models [77]. RNF41 
intrabodies are currently being developed and will first be tested against known interaction partners 
using MAPPIT. Intrabodies that disrupt the interaction between RNF41 and VPS52 or AP2S1 will help 
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clarify the role of these interactions in transferrin recycling and CME. Additionally, we could couple 
intrabodies to GFP, thus creating chromobodies [78,79], which would enable us to visualize the 
location of endogenous RNF41 since we do not have an anti-RNF41 antibody suitable for 
immunofluorescent detection of endogenous RNF41. By comparing intrabodies that disrupt the 
specific interactions between RNF41 and its corresponding partner we could trace the loss-of-
interaction effect on the subcellular location of endogenous RNF41. 
RNF41 is implicated in various diseases via its interaction with distinct proteins. RNF41 acts as a 
tumor suppressor through its ability to maintain ERBB3 receptors at modest levels [80–88]. It is also 
considered to be a pro-apoptotic protein by targeting BRUCE [43,89–91], and could potentially be 
used as a the apeuti  ta get fo  Pa ki so ’s disease si e it supp esses the le els of pa ki  
[47,92,93]. Characterization of the RNF41 interactome is therefore crucial to determine the 
interaction partners of RNF41 that function as inhibitors or activators, or vice versa, determine 
whether RNF41 acts as an inhibitor or activator of a certain interaction partner in order to specifically 
target and modify the interaction involved in that particular disease. It would be interesting to find 
an intrabody that targets the interaction between RNF41 and parkin, as RNF41 acts as a culprit in this 
disease by ubiquitinating and degrading parkin, thereby stabilizing parkin substrates which result in 
the death of dopaminergic neurons [47,92]. Cell-specific targeting of such intrabodies would require 
a proper delivery system that can cross the BBB (blood-brain-barrier) such as viral delivery systems 
with expression under cell type-specific promoters or perhaps intrabody encapsulated 
immunoliposomes that are decorated with monoclonal antibodies via PEGylation, which target 
transferrin and in this way mediate their endocytosis across the BBB [94,95]. Additionally, the 
potential role of RNF41 in autophagy is also of great interest, as autophagy plays a dual role in 
cancer. On the one hand it acts as a tumor suppressor by preventing accumulation of damaged 
proteins and organelles, whereas on the other hand it induces tumor growth by its response to 
cellular stress and increased metabolic demands due to rapid cell proliferation which enables tumor 
cell survival [96,97]. Since autophagy is emerging as a new target for drug development, our study 
revealing a function of RNF41 in this process provides a possible new means to modulate autophagy 
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This manuscript describes a detailed protocol for KISS (Kinase Substrate Sensor), a MAPPIT 
(Mammalian Protein-Protein interaction trap) derived two-hybrid technology that allows in situ 
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KISS, a mammalian two-hybrid method for in situ analysis of protein-protein interactions  




KISS (KInase Substrate Sensor) is a recently developed two-hybrid technology that allows in situ 
analysis of protein-protein interactions in intact mammalian cells. In this method, which is derived 
from MAPPIT (MAmmalian Protein-Protein Interaction Trap), the bait protein is coupled to the kinase 
domain of TYK2, while the prey protein is fused to a fragment of the gp130 cytokine receptor chain. 
Bait and prey interaction leads to phosphorylation of the gp130 anchor by TYK2, followed by 
recruitment and activation of STAT3, resulting in transcription of a STAT3-dependent luciferase 
reporter system. This approach enables the identification of interactions between proteins, including 
transmembrane and cytosolic proteins, and their modulation in response to physiological or 
pharmacological challenges. Here, we describe a detailed step-by-step protocol for the detection of 
an interaction between two proteins of interest using KISS.  
 
Key words 




Our lab previously developed the two-hybrid technology MAPPIT (MAmmalian Protein-Protein 
Interaction Trap) to detect PPIs (protein-protein interactions) in intact mammalian cells (1). MAPPIT 
is based on the functional complementation of the JAK-STAT (Janus kinases-signal transducers and 
activators of transcription) signaling pathway of type I cytokine receptors upon bait and prey 
interaction. In this assay the bait protein is coupled to a signaling-deficient chimeric receptor 
comprising the extracellular domain of the EpoR (erythropoietin receptor) and the transmembrane 
domain and cytoplasmic tail of the LepR (leptin receptor). The three conserved tyrosine residues in 
the cytoplasmic tail of the LepR are mutated to phenylalanine, thereby eliminating STAT3 
recruitment (Y1138F) and negative-feedback mechanisms (Y985F and Y1077F). The prey protein is 
fused to a C-terminal portion of the gp130 (glycoprotein 130) receptor, containing functional STAT3 
recruitment sites. Upon ligand binding, bait and prey interaction leads to trans-phosphorylation and 
activation of the associated JAKs. In turn, JAKs phosphorylate the prey chimera followed by 
re ruit e t a d a ti atio  of STAT . STAT s di erize a d igrate to the u leus resulti g i  
transcriptional activation of a luciferase reporter gene (Fig. 1a). An important limitation of MAPPIT is 
the fact that genetic fusions of full size transmembrane proteins with the cytokine receptor portion 
of the chimeric bait are mostly dysfunctional. In addition, MAPPIT samples PPIs in the cytoplasm, 
close to cell membrane, which for many baits is not their native cellular environment. To overcome 
these shortcomings, KISS (KInase Substrate Sensor), a binary mapping approach enabling in situ 
analysis of PPIs in mammalian cells, was developed (2). In this method, the prey protein is fused to 
the gp130 anchor, similar to the MAPPIT prey chimera, while the bait protein is coupled to a C-
terminal, kinase-containing portion of TYK2 (tyrosine kinase 2). Importantly, the Tyk2 kinase does not 
provide a subcellular localization signal and hence localization of chimeric KISS baits is strictly 
determined by sequences present in the specific bait. As the name KISS suggests, upon bait-prey 
interaction, the TYK2 domain (kinase) phosphorylates both the STAT3 docking sites of the gp130 
anchor and STAT3 (substrates). This results in STAT3 dimerization, migration and luciferase reporter 
gene activation, identical to MAPPIT (Fig. 1b).  
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Fig 1. Principle of MAPPIT and KISS. (a) MAPPIT. The MAPPIT bait is coupled to a signaling-deficient chimeric 
receptor, lacking STAT3 recruitment sites. The prey is fused to the gp130 anchor. Upon ligand stimulation, bait-
prey interaction leads to phosphorylation and recruitment of STAT3 to the gp130 anchor, thereby 
complementing the JAK-STAT signaling pathway, resulting in luciferase reporter gene activation. (b) KISS. The 
KISS bait is fused to the kinase-containing portion of TYK2, while the prey is coupled to the gp130 anchor, 
similar to MAPPIT. Bait-prey interaction leads to STAT3 phosphorylation resulting in luciferase reporter gene 
activation. EpoR, erythropoetin receptor; LepR, leptin receptor; JAK, Janus kinase; gp130, glycoprotein 130; 
STAT, signal transducer and activator of transcription 3; TYK2, tyrosine kinase 2.  
 
KISS has been shown to detect interactions between p51 and p66, two cytosolic subunits of the HIV-1 
RT (human immunodeficiency virus 1 reverse transcriptase), as well as interactions involving 
transmembrane proteins, like GPCRs (G-protein coupled receptors) and ERN1 (endoplasmic reticulum 
to u leus sig ali g . Re ruit e t of ARRB  β-arrestin2) to SSTR2 (somatostatin receptor 2) or 
AGTR1 (angiotensin receptor 1) upon addition of their respective ligand, combined with specific 
inhibition of this signal when adding their proper antagonists indicates that KISS can be used to study 
modulations of ligand-dependent interactions. Next to indirect pharmacological interference, direct 
PPI disruptors such as Nutlin-3 and ABT-737, which respectively interfered with the KISS interaction 
between p53 (tumor protein p53) and MDM2 (human homolog of mouse double minute 2), and BCL2 
(B-cell lymphoma 2) and BAD (BCL-2-associated agonist of cell death) can also be assayed with this 
method. In addition, KISS successfully detected enhanced oligomerization of ERN1 upon ER stress 
induced with tunicamycin, further illustrating the potential of this method to evaluate PPI 
modulations in complex cellular processes. Moreover, the ERN1 bait and prey fusion proteins 
correctly localized to the ER, demonstrating the in situ behavior of this PPI sensor.  
Importantly, not only does KISS extend the repertoire and complexity of PPIs that can be detected 
with MAPPIT, it still offers the same advantages. The system operates in living mammalian cells, 
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which allows the detection of interactions relying on PTMs (post-translational modifications). 
Moreover, signal amplification via the luciferase reporter read-out results in a high signal-to-noise 
ratio and enables the detection of weak and transient interactions. Benchmarking experiments using 
the previously established PRS (positive reference set) and RRS (random reference set) (3) validated 
the ethod s spe ifi it  a d se siti it , hi h as o parable to that of MAPPIT, Y2H (yeast two-
hybrid), LUMIER (luminescence-based mammalian interactome mapping), wNAPPA (a variant of 
nucleic acid programmable protein array) and a YFP (yellow fluorescent)-based PCA (protein 
fragment complementation assay). These scores could be even higher, if the reference sets, with 
approximately 35% of membrane proteins, were more enriched for these types of proteins. As 
reported for other assays (3, 4), KISS also detected a different subset of PPIs.  
Since the preys in MAPPIT and KISS are identical, we can adopt the entire prey collection, derived 
from the huORF (human open reading frame) collection (± 15.000 full size ORFs), which was used for 
arrayMAPPIT and microarrayMAPPIT (5, 6). This, together with a downscaling of the method with the 
help of robotics from a 96-well to a 384-well, or even a cell-microarray format, covering 6912 spots 
per plate, creates the possibility of using KISS as a high-throughput screening method. Furthermore, 
similar to the three-hybrid MAPPIT setup, MASPIT (7, 8), a three-hybrid variant of KISS was 
developed that allows screening for interactions between small molecules and integral membrane 
target proteins in a physiological relevant environment. Here, the small molecule is introduced as a 
bait inside the cell by means of chemical tethering to MTX (methotrexate) which binds eDHFR (E. coli 
dihydrofolate reductase) fused to the TYK2 kinase domain. This system validated the interaction 
between the drugs FK506 and simvastatin and their respective protein targets FKBP12 (FK506 binding 
protein) and HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), which illustrates its potential as 
new drug-screening platform (2). 
Here, we outline a standard KISS protocol that allows in situ detection of both cytosolic and 
transmembrane protein interactions and their responses to physiological or pharmacological 
challenges in 96-well plate format. In brief, this protocol describes the cloning of the appropriate KISS 
bait and prey plasmids, transfection of the necessary constructs in HEK293T cells, an optional 
stimulation step depending on the interaction of interest followed by luciferase reporter activity 
measurement. This binary assay can be performed in 4 days from seeding the cells up to the signal 













1. Bait plasmid: 
The KISS bait vector pMT comprises the protein of interest C-terminally fused to a 
fragment of human TYK2 (AA589-1187) followed by an HA-tag in a pMET7 mammalian 
expression vector containing the SRα pro otor. Alternately, other backbone vectors and 
configurations, depending on the topology of your protein of interest, can be used for 
cloning (see Note 1, (2)).  
2. Prey plasmid: The pMG1 constructs used for MAPPIT experiments are suitable for KISS. 
These pMET7 backbone vectors contain the prey protein of interest N-terminally coupled 
to a FLAG-tagged part of the gp130 (glycoprotein 130; AA 760-918) (1). 
3. Luciferase reporter plasmid: the pXP2d2-rPAP1-luci construct, controlled by a STAT3-
responsive rPAP1 (rat Pancreatitis Associated Protein 1) promotor (1).  
4. Thermal cycler  
 
2.2 Cell culture 
1. 96-well black tissue-culture plates. Clear bottom plates can be used for microscopic 
inspection of cells and transfection precipitate.  
2. HEK (human embryonic kidney) 293 T cells.  
3. Culture ediu : DMEM Dul e o s odified Eagle s ediu  supple ented with 10% 
fetal calf serum. Antibiotics (gentamycin or penicillin/streptomycin) can be added to 
avoid contamination. 
4. Agonists or antagonists, for KISS experiments that involve treatment.   
 
2.3 Transfection 
The standard calcium phosphate transfection method is applied for transfecting HEK293T 
cells. 
1. CaCl2 buffer: prepare a 2.5 M CaCl2 stock solution in distilled water. Filter-sterilize (0.45 
µM nitrocellulose membrane) and store at -20°C. 
2. 2x HeBS (Hepes-buffered saline) buffer: prepare 280 mM NaCl, 1.5 mM Na2HPO4 and 50 
mM Hepes in 90 ml of distilled water. Adjust the pH to 7.05 with 1 M NaOH and adjust 
the volume to 100 ml. Filter-sterilize (0.45 µM nitrocellulose membrane) and store at -
20°C.  
 
2.4 Luciferase assay 
1. Lysis buffer: prepare 25 mM Tris-phosphate, pH 7.8, 2 mM DTT, 2 mM CDTA (trans-1,2-
diaminocyclohexane- N,N,N’,N’-tetraacetic acid), 10% glycerol and 1% Triton X-100 in 
500ml of distilled water. Aliquot into 50-ml volumes and store at -20°C. 
2. Luciferase substrate buffer: prepare 40 mM Tricine, 2.14 mM (MgCO3)4Mg(OH)2.5H2O, 
5.34 mM MgSO4, 66.6 mM DTT, 0.2 mM EDTA, 509 µM Coenzyme A, 734 µM ATP and 
940 µM D-luciferin in 500 ml of distilled water. Aliquot into 50-ml volumes, store at -20°C 
and protect from light as the reagent is light sensitive.  





3.1 Cloning bait and prey of interest 
1. Design primers flanking your gene of interest that contain restriction sites compatible to 
the sites in the pMT bait or pMG1 prey vector. Cloning of the bait protein in the pMT 
vector requires the EcoRI and SalI restriction sites, while the prey protein can be cloned 
in the pMG1 vector using EcoRI and NotI or XbaI (Fig. 2). 
2. Carry out a PCR (Polymerase Chain Reaction) using a DNA polymerase with proof-reading 
activity (Pfu or high-fidelity Q5) in a thermal cycler.  
3. Digest your DNA, isolate your vector and insert by gel purification and ligate your insert 
in the designated vector to obtain the desired bait and prey construct.  
4. Transform your ligation product into a bacterial line (e.g. DH10B) 
5. Pick single colonies and prepare plasmid DNA of a quality suitable for transfection. Check 
and verify the plasmids by restriction digest or sequencing (see Note 2).  
 
 
Fig 2. KISS prey and bait plasmid. The pMG1 plasmid is used for cloning of the prey. The prey protein of interest 
is N-terminally fused to a FLAG-tagged portion of the gp130 cytokine receptor with the help of EcoRI and NotI 
or XbaI restriction sites. A GGS hinge (glycine-glycine-serine) is placed between the gp130 anchor and the prey 
for more flexibility. The pMT plasmid is used for bait cloning. The bait protein of interest is C-terminally fused 
to the kinase containing fragment of TYK2, followed by a HA tag using EcoRI and SalI restriction sites. Also here, 
the GSS hinge alows for more flexibility. gp130, glycoprotein 130; SRα, promotor consisting of SV40 (simian 
virus 40 early promotor) and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat; pA, 




3.2 Seeding cells (day 1) 
1. Seed 5 x 103 HEK293T cells per well in a 96-well plate in 100 µl of culture medium (see 
Notes 3, 4 and 5). Each bait-prey interaction is tested in three wells. When using 
agonists/antagonists or compounds to stimulate or modulate the interaction, use an 
additional three wells per condition. The relevant controls for possible background 
include an irrelevant or empty prey for each bait tested and an irrelevant or empty bait 
for each prey tested. 
2. Incubate overnight at 37°C and 5-8% CO2.  
 
3.3 Transfection of cells (day 2) 
1. For each bait-prey interaction, make a mixture of DNA and CaCl2 containing 6,25 ng of 
the bait plasmid, 12,5 ng of the prey plasmid, and 5 ng of the rPAP1-luci reporter 
together with 5µl of sterile 2.5M CaCl2 in a total volume of 50µl of distilled water per well 
in a 96- ell plate, the i  plate see Note 6).  
2. Add 50 µl of 2x HeBS to each well of the mix plate (see Note 7). 
3. Shake the mix plate for 1 min at 800 rpm 
4. Resuspend the wells of the mix plate 
5. Add 10 µl to the cells in the 96-well plate in triplicate for every bait-prey interaction.  
6. In case you used clear bottom-plates, check the precipitates under a conventional light 
microscope. You should be able to see small speckles surrounding your cells in the plate.  
7. Incubate the cells overnight at 37°C and 5-8% CO2 
 
3.4 Stimulation of cells with agonist/antagonist or compound (optional) (day 3) 
1. For bait-prey interactions where agonist/antagonist or treatment is used, stimulate the 
three extra wells with 50 µl of your agonist/antagonist or compound diluted in culture 
medium (see Note 8). Add 50 µl of culture medium in the wells with the same bait-prey 
interaction that are left unstimulated.  
2. Incubate the cells overnight at 37°C and 5-8 % CO2.  
 
3.5 Luciferase read-out (day 4) 
1. Remove culture medium from the 96-well plates.  
2. Add 50 µl of lysis buffer to each well and incubate for 10 min at room temperature (see 
Note 9).  
3. Add 35 µl of luciferase substrate buffer to each well and immediately measure luciferase 
activity using a chemiluminescence meter.  
 
3.6 Data analysis 
1. For every bait-prey interaction, calculate the fold induction value by dividing the average 
of the triplicate luciferase counts of the specific bait-prey interaction by the average of 
the triplicate luciferase counts obtained for the interaction of that specific bait with an 
empty/irrelevant prey. In case you investigate the effect of a treatment on a PPI, you can 
calculate the fold induction for each bait-prey interaction by dividing the mean value of 
the stimulated wells by the mean value of the non-stimulated wells. In addition, compare 
the fold induction for the specific bait-prey interaction to that obtained for the 
interaction of an empty/irrelevant bait with the specific prey. 
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2. A bait-prey interaction is considered positive, if the fold induction value is at least three 
times higher than both the fold induction of the bait-empty/irrelevant prey and the 
empty/irrelevant bait-prey interactions.  
 
4. Notes 
1. Depending on the protein of interest, better fold inductions can be obtained when using an 
alternative bait backbone vector such as the pSVSport. This carries the weak early SV40 
promotor giving rise to low expression levels in cells, which can lead to higher fold 
inductions. Alternatively the pcDNA5/FRT plasmid can be used. Although this contains the 
strong CMV promotor, it can be advantageous as it is designed for the use with Flp-inTM 
systems thereby creating stable cell lines which can be useful for high-throughput screening. 
To further increase the fold induction signal, a pMG2 prey construct can be used, containing 
the gp130 anchor in duplicate (9). However, next to an increased fold induction, this can also 
elevate the background signal. To further optimize your bait and prey interaction, different 
configurations can be tested to reduce steric hindrance of the tag or to preclude incorrect 
location of your protein. For this, the bait or prey protein can be N-terminally or C-terminally 
fused to the TYK2 domain or gp130 anchor respectively. In case of type I, III and IV 
transmembrane proteins, a C-terminal TYK2 or gp130 fusion should be used, whereas an N-
terminal fusion is necessary for type II transmembrane proteins. Furthermore, all bait and 
prey backbone vectors can be made compatible for Gateway recombination cloning by 
inserting the Gateway Reading Frame Cassette B from the Gateway Vector Conversion 
System (Invitrogen) into the vectors. In this way, all ORFs from the huORF collection (10) can 
easily be cloned into the designated bait or prey vectors using an LR clonase reaction, 
thereby greatly facilitating the cloning process.  
2. It is favorable to check the subcellular location of your bait and prey fusion protein with 
confocal microscopy as tags can sometimes interfere with the native location of proteins. 
The used bait and prey vectors contain an HA and FLAG-tag respectively, which simplify 
confocal imaging of the proteins. 
3. Like for MAPPIT, the KISS strategy is not restricted to HEK293T cells, other easy transfectable 
cell lines can be used that contain a sufficient amount of endogenous STAT3 (e.g. 
erythroleukaemia TF-1 or N38 hypothalamic cell lines (11, 12)) which may provide a more 
physiological setting to study your protein-protein interaction.  
4. Make sure your cells are in a logarithmic growth phase and are kept subconfluent at all times 
(maximum density of 20 x 106 cells per 175-cm2 flask). U health  ells a  greatl  affe t 
transfection efficiencies.  
5. We tend to not use the outside rows and columns of the 96-well plate. These wells are filled 
with culture medium as they are prone to evaporation during the incubation process which 
can possibly skew the results.  
6. Depending on your protein-protein interaction, different amounts of bait and prey DNA can 
lead to a higher fold induction. We have noticed that low amounts of DNA often yield higher 
signals, usually due to a reduced background. 
7. The pH of the 2x HeBS buffer is critical for transfection efficiency (optimal range between 
7.05 and 7.12), avoid repeated freeze-thaw cycles to maintain this pH. Also, it is important 
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not to wait too long before adding the DNA precipitates to the cells after the 1 minute of 
shaking in the mix plate, as long incubation time can reduce the transfection efficiency.  
8. A reduced fold induction can be due to toxicity of the added treatment. Therefore, check the 
toxicity of your compound and perform a dose-response analysis of the interaction upon 
treatment. If your compound is dissolved in a reagent such as DMSO, which can be toxic for 
the cells, then add the same amount of reagent diluted in culture medium to the 
unstimulated wells. An extra control to check whether your treatment does not affect STAT3 
signaling is to additionally stimulate your cells with LIF (leukaemia inhibitory factor) since the 
LIFR, which is endogenously present in HEK293T cells, also operates via STAT3 signaling.  
9. After lysis, plates can be stored at -20°C for a few days before measuring. 
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Straightforward protein-protein interaction interface mapping via random mutagenesis and 
MAPPIT  
      Manuscript submitted in Biotech Methods (2017) 
 
This manuscript describes the method that combines random mutagenesis with MAPPIT (Mammalian 
Protein-Protein Interaction trap), a technique that allows extensive mapping of protein-protein 
interaction interfaces in intact human cells. We have used this method to detect RNF41 mutants that 
specifically disrupted the interaction between RNF41 and a particular interaction partner (see Results 
section 1).  
The random mutagenesis-MAPPIT method was developed by Frank Peelman and this manuscript was 
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The MAPPIT (mammalian protein protein interaction trap) method allows high-throughput detection 
of protein interactions by very simple co-transfection of three plasmids in HEK293T cells, followed by 
luciferase readout. MAPPIT detects a large percentage of all protein interactions, including those 
requiring posttranslational modifications and endogenous or exogenous ligands. Here, we present a 
straightforward method that allows detailed mapping of interaction interfaces via MAPPIT. By 
combining error-prone PCR for random mutagenesis, 96-well DNA prepping, Sanger sequencing, and 
MAPPIT via 384-well transfections, we test the effects of a large number of mutations of a selected 
protein on its protein interactions. The entire screen takes less than three months and interactions 
with multiple partners can be studied in parallel. The effect of mutations on the MAPPIT readout is 
mapped on the protein structure, allowing unbiased identification of all putative interaction sites. 
We thus far analyzed 6 proteins, and mapped their interfaces for 16 different interaction partners. 
Our method is broadly applicable as the required tools are simple and widely available. 
 
Abbreviations: Apobec3G, apolipoprotein B messenger RNA-editing catalytic polypeptide-like G; 
Epo, erythropoietin; gp130, glycoprotein 130; JAK, Janus kinase; LepR, leptin receptor; Mal, MyD88 
adapter-like; MAPPIT, mammalian protein-protein interaction trap; MyD88, myeloid differentiation 
primary response gene 88; NMR, nuclear magnetic resonance; PPAR-α, peroxisome proliferator-
activated receptor α; PPI, protein-protein interaction; PTM, post-translational modification; RNF41, 
ring finger protein 41; STAT, signal transducers and activators of transcription; TIR, Toll/interleukin-1 




The expansion of the protein interactomics field is driven by a wide variety of techniques for 
detection of protein-protein interactions (PPIs). Classical techniques such as yeast two-hybrid [1] and 
affinity-purification coupled to mass spectrometry [2] have been complemented with new and 
improved approaches. These enable the study of PPIs at their subcellular location [3,4] or in a 
physiological context between weak and transient interactions [5–7], full-length integral membrane 
proteins [8] and post-translationally modified proteins [9]. Our laboratory developed the mammalian 
protein-protein interaction trap (MAPPIT), a method combining many of these traits. MAPPIT is 
based on the Janus kinases-signal transducers and activators of transcription (JAK-STAT) signaling 
pathway of type I cytokine receptors upon bait and prey interaction (Fig. 1A). As MAPPIT acts in 
intact mammalian cells, it allows detection of proteins requiring intracellular cofactors or post-
translational modifications (PTMs) [10]. A typical MAPPIT experiment simply involves co-transfection 
of three plasmids in HEK293T cells: a bait, a prey, and a STAT3-inducible luciferase reporter plasmid 
(Fig. 1B). Interaction between bait and prey protein is detected by luciferase activity induced after 
stimulation with erythropoietin (Epo) or leptin, depending on the extracellular domain of the bait. 
MAPPIT can detect up to one third of all protein interactions in high-throughput screening modus, 
but this number can probably be increased by switching bait and prey, using different bait constructs 
or using domains instead of full-length proteins [11–13].  
 
Figure 1. MAPPIT (A) MAPPIT principle. The pSEL MAPPIT bait is fused to a signaling-deficient chimeric receptor 
comprising the extracellular EpoR and transmembrane and intracellular LepR, lacking STAT3 recruitment sites. 
The prey is coupled to the gp130 anchor. Upon Epo stimulation, bait-prey interaction leads to phosphorylation 
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and recruitment of STAT3 to the gp130 anchor, thereby complementing the JAK-STAT signaling pathway, 
resulting in luciferase reporter gene activation. For the alternative pSEG and pCLG MAPPIT baits, the 
intracellular LepR domain C-terminal of the JAK2 binding site is replaced by a GGS (glycine-glycine-serine) linker 
allowing more flexibility. The pCLL and pCLG baits consist of the extracellular LepR domain. (B) MAPPIT outline. 
HEK293T cells are seeded and transfected the next day with bait, prey and reporter constructs. 24h post-
transfection, cells are stimulated with Epo. The next day, luciferase activity (luminescence, in counts per 
second) is measured. The MAPPIT signal represents the fold induction between stimulated and non-stimulated 
wells.  
High-resolution structure determination of protein complexes via X-ray crystallography, nuclear 
magnetic resonance (NMR) spectroscopy or cryo-electron microscopy is inherently slow and often 
remains very challenging. Even with the major advances and speedup in structure determination, 
these methods cannot keep up with the rapid growth of the interactome [14]. This leads to a huge 
and growing gap between the number of known protein interactions and the number of structurally 
characterized complexes.  
Alternatively, many approaches can predict protein complex structures based on the separate 
models or structures of the interacting proteins in the complex [14,15].  Several methods provide 
experimental insight in the location of the protein interaction interface [15]. Examples include NMR 
titration/chemical shift perturbation experiments or mass spectrometry combined with limited 
proteolysis, chemical crosslinking or deuterium exchange. Similarly, mutagenesis combined with a 
detection method of protein interactions can identify critical interacting residues. Combining 
experimental insights on the location of the interacting interfaces with homology modeling or in 
silico protein-protein docking, enables building of reliable models for the protein complex [15,16].  
In this paper, we describe a straightforward method combining random mutagenesis with MAPPIT 
that allows extensive mapping of PPI interfaces in intact human cells.  
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2 Materials and methods 
Figure 2 summarizes the 6-step workflow of our method.  Below, we describe the six steps in more 
detail. 
2.1 Step 1: Optimization of the MAPPIT readout 
We first set up and optimize MAPPIT assays that specifically detect the interaction between the 
protein of interest and its interaction partners (Fig. 2A). Their cDNA is cloned in both MAPPIT bait 
and MAPPIT prey plasmid vectors. The MAPPIT assay is optimized by testing the protein of interest 
both as bait and prey and by varying the concentration of bait and prey plasmids. To ensure the 
specificity of the assay, baits and preys are also tested versus negative control baits and preys, 
expressing an irrelevant protein. The induction of luciferase activity upon cytokine stimulation should 
be at least 10-fold. Both prey and bait can be randomly mutated. Below, we describe the screening 
process, where the mutation target is cloned as prey.  
2.2 Step 2: Random mutagenesis via error-prone PCR 
The DNA insert is randomly mutated via error-prone PCR using Mutazyme II DNA polymerase 
following the guidelines of the Ge e orph™ II Ra do  Mutage esis kit Agile t Te h ologies, Santa 
Clara, CA, USA) (Fig. 2B). This permits a suitable mutation rate and a balanced mutation spectrum 
[17]. To obtain a maximum number of single missense mutants, the PCR condition is first optimized 
by varying the concentration of input DNA and number of PCR cycles. The PCR primers contain 
unique restriction sites allowing in-frame ligation of the linear PCR product into the MAPPIT prey 
plasmid vector. The ligation product is electroporated into E. coli DH10B cells. For each PCR 
condition, 24 colonies are grown overnight in 2x Yeast Tryptone medium in a 96-deepwell block. DNA 
is purified via a 96-well i iprep proto ol usi g the Nu leospi ™ Ro ot-96 plasmid kit (Machery 
Nagel, Easton, PA, USA). Next, the MAPPIT mutants are sequenced on Applied Biosystems 3730XL 
DNA Analyzers to determine the PCR condition with the highest number of single missense 
mutations. In our studies, up to one third of the random mutant clones contain single missense 
mutations [18,19] 
2.3 Step 3: Generation of a mutant plasmid library in 96-well format 
Mutant E. coli colonies of the optimal PCR condition are plated and single colonies are inoculated in 
96-deepwell blocks for DNA miniprep purification, as described above (Fig. 2C). In the automated 
DNA minipreps, DNA is eluted in water into UV-transparent flat-bottom 96-well plates and DNA 
concentration is measured via the Magellan UV spectrophotometer (Tecan, Männedorf, Switzerland). 
The OD 260/280 ratio should be above 1.8 for every sample to obtain reliable MAPPIT results. Next, 
DNA is normalized to the optimized concentration for transfection. The sequences of all randomly 
mutated plasmids are determined via Sanger sequencing and plasmids with a single missense 
mutation are transferred into 96-well plates (Fig. 2C). Two individual rows of each 96-well plate 
contain plasmids with a wildtype and a negative control prey. 
2.4 Step 4: MAPPIT in 384-well assay 
The normalized 96-well MAPPIT prey plates are co-transfected with the MAPPIT bait and STAT3 
luciferase (pXP2d2-rPAPI-luciferase) reporter plasmids, as optimized in step 1 (Fig. 2D). The first day, 
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3000 HEK293T cells/well are seeded into black 384-well plates. The next day, cells are transfected 
with the MAPPIT prey together with a mixture of MAPPIT bait and STAT3 luciferase reporter plasmids 
using a calcium phosphate precipitation method. Each unique prey/bait mixture is transfected in 8 
384-wells. One 96-well plate with prey mutant DNA thus requires transfection of two 384-well plates. 
As the optimized 96-well DNA plates contain 12 wildtype and 12 negative control prey plasmids, each 
transfected 384-well plate contains 6 different wildtype preys and up to 36 different prey mutants.  
On day three, 4 out of 8 wells for each transfection mixture are stimulated with leptin or Epo. The 4 
other wells are left unstimulated (Fig. 2D). After 24 hours, cells are lysed in 15µl of Cell Culture Lysis 
Reagent buffer (25 mM Tris/phosphate (pH 7.8), 2 mM DTT, 2 mM CDTA, 10% glycerol, 1% Triton X-
100) followed by the addition of 11 µl of luciferase substrate buffer (40 mM Tricine, 2.14 mM 
(MgCO3)4Mg(OH)2.5H2O, 5.34 mM MgSO4.7H2O, 66.6 mM DTT, 0.2 mM EDTA, 270 µM coenzyme A 
(Sigma-Aldrich, St. Louis, MO, USA), 530 µM ATP (Sigma-Aldrich, St. Louis, MO, USA), 470 µM luciferin 
(Duchefa, Haarlem, The Netherlands)). The luminescence is measured via the EnSpire plate reader 
(PerkinElmer Life Sciences, Waltham, MA, USA). 
2.5 Step 5: Data analysis 
First, the MAPPIT sig al  is determined by dividing the average of the luciferase counts of the 4 
stimulated wells by the average of the luciferase counts of the 4 unstimulated wells (Fig. 2E). Then, 
the or alized MAPPIT sig al  of each mutant is calculated by dividing its MAPPIT signal by the 
median of the MAPPIT signals of the 6 wildtype preys on the same 384-well plate. As each MAPPIT 
transfection experiment is performed three times, the relative MAPPIT signal  of each mutant is 
determined by the average of the normalized MAPPIT signals in these three experiments. 
We also calculate the relative MAPPIT signals of the wildtypes, as described above, and plot the 
variation (Fig. 3A). However, the MAPPIT signal of each wildtype is divided by the median of the 
MAPPIT signals of the 5 other wildtypes on the same 384-well plate. We consider that a mutant has 
an effect on the interaction when its relative MAPPIT signal is below the minimum relative MAPPIT 
signal of all wildtypes (Fig. 3B).  
2.6 Step 6: Mapping of relative MAPPIT signals 
First, we create an attribute list in a fixed .txt format in which the relative MAPPIT signal is assigned 
to the corresponding residue number. This attribute list is then loaded in the modelling program 
University of California San Francisco (UCSF) Chimera [20]. The relative MAPPIT signals of the 
utated residues are apped o  the te plate stru ture usi g the re der  attri ute  tool (Fig. 
3C). Based on the histogram of the relative MAPPIT signals, up to three threshold values with 
respective colors can be determined. The color intensity of each mutated residue depends on the 










Figure 2. 6-step workflow of the MAPPIT-based interface mapping method. (A) MAPPIT transfection 
conditions are optimized by varying the concentration of bait and prey plasmids and by reversing the order of 
bait and prey proteins. (B) The target protein is randomly mutated via error-prone PCR. The linear PCR product 
is cloned into the MAPPIT prey plasmid vector and electroporated into E. coli DH10B cells, resulting in the 
MAPPIT mutant prey library. (C) Individual E. coli colonies are inoculated in 96-deepwell blocks. Mutant prey 
DNA is isolated via a 96-well DNA miniprep protocol and sequenced by Sanger sequencing. (D) MAPPIT prey 
mutants harboring a single missense mutation are co-transfected with the MAPPIT bait and STAT3 luciferase 
reporter plasmids in 384-well plates seeded with HEK293T cells. (E) After cytokine stimulation via Epo or leptin, 
the luciferase activity is measured and normalized MAPPIT signals are calculated. (F) The relative MAPPIT signal 




Figure 3. Random mutagenesis and MAPPIT reveal potential binding sites in MyD88 TIR involved in MyD88 
TIR prey–MyD88 bait interaction. (A) Relative MAPPIT signal distribution of all MyD88 TIR wildtypes (WTs) for 
MyD88 TIR prey-MyD88 bait interaction. The lowest and highest wildtype relative MAPPIT signal determine 
lower and upper cutoff value, respectively. (B) Relative MAPPIT signal distribution of all unique single mutants 
for MyD88 TIR prey-MyD88 bait interaction. Mutants with a relative MAPPIT signal below the lower cutoff 
value or a ove the upper utoff value are o sidered havi g a  effe t o  the i tera tio . C  The re der  
attri ute  tool of Chi era e a les appi g of relative MAPPIT sig als o  the te plate stru ture. E teri g the 
attribute list leads to automatic generation of the relative MAPPIT signal distribution. Up to three threshold 
values with respective colors can be selected. (D) Effect of mutations on the MyD88 TIR prey-MyD88 bait 
interaction. Residues are colored on the MyD88 TIR crystal structure according to their indicated relative 
MAPPIT signal [23]. A cluster of red-colored residues forms a potential binding site (BB-loop). Green-colored 
residues do not alter the interaction compared to the wildtype. Non-mutated residues are gray and backbone 










3 Results and Discussion 
3.1 MAPPIT detects interfaces in diverse target proteins  
We successfully applied random mutagenesis combined with MAPPIT for interaction interface 
analysis of six targets in four unrelated protein families: the antiviral host restriction factor 
apolipoprotein B messenger RNA-editing catalytic polypeptide-like G (Apobec3G) [21], the ring finger 
protein 41 (RNF41), the ligand binding domain of peroxisome proliferator-activated receptor α 
(PPAR-α), and the Toll/IL-1R (TIR) domains of the Toll-like receptor adapters MyD88 adapter-like 
(Mal) [18], myeloid differentiation primary response gene 88 (MyD88) [19], and TIR-domain-
containing adapter inducing interferon-β TRIF). For five of these targets, we tested the interaction of 
the mutant libraries with three or four different interactors in parallel. We thus mapped interaction 
interfaces for 16 protein-protein interactions. Figure 3 shows an example of a MAPPIT random 
mutagenesis screen, testing the interaction of MyD88 coupled as bait with random mutants of the 
prey MyD88 TIR domain. A mutant library of 17 96-well plates led to 185 unique single missense 
mutants, resulting in a coverage of 78% of the entire MyD88 TIR domain. No MyD88 TIR wildtype has 
a relative MAPPIT signal below 60% or above 155%, which were used as lower and upper cutoff 
values, respectively (Fig. 3A). Figure 3B illustrates that 37% of all unique single missense mutants has 
a relative MAPPIT signal below the lower cutoff value. Figure 3D shows one of the 4 protein 
interaction interfaces detected in this screen. Residues in the center of this interface have a relative 
MAPPIT signal well below the 60% cutoff. Typical for all interfaces found in the screens, these 
residues are surrounded by mutations having a relative MAPPIT signal between the lower cutoff 
value and the average wildtype relative MAPPIT signal. To confirm these effects, we reisolate DNA of 
the putative interface mutations and new wildtype clones, and retest these selected samples in 
triplicate MAPPIT experiments. 
3.2 Interfaces detected via MAPPIT are confirmed via other methods and studies 
All tested mutants are available as individual clones and easily cloned into other vectors. This permits 
retesting of a large number of mutations in different assays without the need of extra mutagenesis. 
The biological importance of new potential interfaces identified via MAPPIT was confirmed via 
orthogonal assays, such as co-immunoprecipitation and signaling assays [18,19]. Protein interfaces 
identified via our method are well in line with other studies. We confirmed the well-known 
importance of the TIR BB-loop  in TIR interactions of MyD88, Mal, and TRIF (Fig. 3D) [18,19]. In 
agreement with other studies, MAPPIT analysis demonstrated that one of two crystallographic 
interfaces in the Mal TIR crystal structures is a Mal homodimerization interface [18]. By mapping our 
MAPPIT data on a homology model for Apobec3G, we identified an extensive Apobec3G 
homodimerization site, as found in parallel studies [21]. We demonstrated that this complete area is 
also critical for the interaction with the viral infectivity factor (Vif)of HIV, later confirmed by the NMR 
structure of the Apobec3G N-terminal domain. 
3.3 Interactions requiring additional ligands or phosphorylation can be studied via MAPPIT 
MAPPIT operates in intact mammalian cells, providing a natural environment with endogenous 
cofactors and regulatory proteins, and is therefore able to detect protein interactions requiring PTMs 
such as phosphorylation. Via inhibitory and phosphomimetic mutations of phosphorylated residues 
in the MAPPIT bait or prey, we were able to study the crucial role of phosphorylation on protein 
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interactions [19,21]. MAPPIT also allowed to study interactions of Apobec3G that required cellular 
RNA as additional ligand [21], while interactions of PPAR-α could only be studied after adding an 
exogenous ligand.   
3.4 Critical considerations in data interpretation 
The MAPPIT signal is also affected by mutations disrupting the structure or proper folding of the 
protein. For example, most mutations in the core of the protein affect the MAPPIT signal. As 
mutations at the protein surface can equally disrupt the protein structure, it is mandatory to 
carefully inspect possible structural effects. As a tool for estimating the mutational effect on the 
protein structure, we use the FoldX prediction program [22]. However, in silico predictions remain 
quite unreliable. In this context, any mutation of an isolated surface residue should be considered 
with caution. Potential interface areas rather present themselves as patches of multiple adjacent 
residues with missense mutations that all affect the interaction (Fig. 3D).  
We analyze expression levels of prey or bait mutants to exclude an effect on the MAPPIT interaction 
due to differential expression. Expression levels of MAPPIT preys can be determined via Western 
blot, as these contain a Flag-tag. Expression of the MAPPIT baits can be determined in a (parallel) 
MAPPIT experiment with a MAPPIT prey specifically recognizing the receptor portion or JAK2 portion 
of the bait. However, expression levels of bait or prey mutants are not a good measure for their 
proper folding or structural integrity. Very often, mutations that clearly disrupt the structure or 
folding of the protein hardly affect the expression level. 
Our method identifies all regions required for protein interaction, and some of these do not 
necessarily represent the actual interface between bait and prey. This is relevant for proteins binding 
their target as a homodimer or requiring a third interaction partner. In MAPPIT, both bait and prey 
proteins are free to homodimerize or even homo-oligomerize. We do find that mutations in the 
homodimerization interface of the mutated target affect its heterotypical interaction. Similarly, for 
interactions that require an extra third protein or other ligand, mutations in the binding site of these 
ligands also affect the MAPPIT readout [19].  
4   Concluding remarks 
Our combination of MAPPIT and random mutagenesis allows extensive and unbiased validation of 
interfaces in high- or low-resolution structures. Interface residues identified via MAPPIT can also 
guide the docking process in in silico data-driven protein-protein docking [19]. A major advantage of 
our screening method lies in its simplicity and rapid setup. The entire optimization and screening 
process is performed in three months. We therefore believe that our MAPPIT-based interface 
mapping method is an excellent tool for detailed study of a large number of PPIs. 
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